From	Entry	Reviewed	Entry Name	Protein names	Gene Names	Pathway	Function [CC]	Organism (ID)	Gene Ontology (cellular component)	Gene Ontology (biological process)	Gene Ontology (GO)	Gene Ontology (molecular function)	Gene Ontology IDs	Organism
NP_001323295.1	A0A384KYT1	unreviewed	A0A384KYT1_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AXX17_At1g03200			3702	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_171888.1	A0A384KYT1	unreviewed	A0A384KYT1_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AXX17_At1g03200			3702	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_175130.2	F4HPN2	reviewed	IRE4_ARATH	Probable serine/threonine protein kinase IRE4 (AtIRE4) (EC 2.7.11.1)	IRE4 At1g45160 F27F5.23			3702		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270; GO:0016301; GO:0035556; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_001031155.4	F4HYG2	reviewed	IRE3_ARATH	Probable serine/threonine protein kinase IRE3 (AtIRE3) (EC 2.7.11.1)	IRE3 At1g48490 T1N15.10			3702	root hair [GO:0035618]	defense response to bacterium [GO:0042742]; intracellular signal transduction [GO:0035556]	root hair [GO:0035618]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270; GO:0016301; GO:0035556; GO:0035618; GO:0042742; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_001031155.4	A0A178WE40	unreviewed	A0A178WE40_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AXX17_At1g42590			3702			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270	Arabidopsis thaliana (Mouse-ear cress)
NP_001154409.1	F4HYG2	reviewed	IRE3_ARATH	Probable serine/threonine protein kinase IRE3 (AtIRE3) (EC 2.7.11.1)	IRE3 At1g48490 T1N15.10			3702	root hair [GO:0035618]	defense response to bacterium [GO:0042742]; intracellular signal transduction [GO:0035556]	root hair [GO:0035618]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270; GO:0016301; GO:0035556; GO:0035618; GO:0042742; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_001154409.1	A0A178WE40	unreviewed	A0A178WE40_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AXX17_At1g42590			3702			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270	Arabidopsis thaliana (Mouse-ear cress)
NP_564529.4	F4HYG2	reviewed	IRE3_ARATH	Probable serine/threonine protein kinase IRE3 (AtIRE3) (EC 2.7.11.1)	IRE3 At1g48490 T1N15.10			3702	root hair [GO:0035618]	defense response to bacterium [GO:0042742]; intracellular signal transduction [GO:0035556]	root hair [GO:0035618]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270; GO:0016301; GO:0035556; GO:0035618; GO:0042742; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_564529.4	A0A178WE40	unreviewed	A0A178WE40_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AXX17_At1g42590			3702			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270	Arabidopsis thaliana (Mouse-ear cress)
NP_001323023.1	A0A1P8AVQ0	unreviewed	A0A1P8AVQ0_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	IRE3 At1g48490 T1N15.10 T1N15_10			3702			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270	Arabidopsis thaliana (Mouse-ear cress)
NP_001327294.1	Q39030	reviewed	KPK2_ARATH	Serine/threonine-protein kinase AtPK2/AtPK19 (EC 2.7.11.1) (Ribosomal-protein S6 kinase homolog 2)	ATPK2 ATPK19 S6K2 At3g08720 F17O14.19		FUNCTION: Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions. Mediates the phosphorylation of MRFs (e.g. MRF1) (PubMed:29084871). {ECO:0000269|PubMed:29084871}.	3702	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cellular response to hypoxia [GO:0071456]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to salt stress [GO:0009651]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to hypoxia [GO:0071456]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to salt stress [GO:0009651]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0009408; GO:0009409; GO:0009651; GO:0016301; GO:0045727; GO:0071456; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_001327295.1	Q39030	reviewed	KPK2_ARATH	Serine/threonine-protein kinase AtPK2/AtPK19 (EC 2.7.11.1) (Ribosomal-protein S6 kinase homolog 2)	ATPK2 ATPK19 S6K2 At3g08720 F17O14.19		FUNCTION: Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions. Mediates the phosphorylation of MRFs (e.g. MRF1) (PubMed:29084871). {ECO:0000269|PubMed:29084871}.	3702	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cellular response to hypoxia [GO:0071456]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to salt stress [GO:0009651]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to hypoxia [GO:0071456]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to salt stress [GO:0009651]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0009408; GO:0009409; GO:0009651; GO:0016301; GO:0045727; GO:0071456; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_187484.1	Q39030	reviewed	KPK2_ARATH	Serine/threonine-protein kinase AtPK2/AtPK19 (EC 2.7.11.1) (Ribosomal-protein S6 kinase homolog 2)	ATPK2 ATPK19 S6K2 At3g08720 F17O14.19		FUNCTION: Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions. Mediates the phosphorylation of MRFs (e.g. MRF1) (PubMed:29084871). {ECO:0000269|PubMed:29084871}.	3702	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cellular response to hypoxia [GO:0071456]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to salt stress [GO:0009651]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to hypoxia [GO:0071456]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to salt stress [GO:0009651]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0009408; GO:0009409; GO:0009651; GO:0016301; GO:0045727; GO:0071456; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_850543.1	Q39030	reviewed	KPK2_ARATH	Serine/threonine-protein kinase AtPK2/AtPK19 (EC 2.7.11.1) (Ribosomal-protein S6 kinase homolog 2)	ATPK2 ATPK19 S6K2 At3g08720 F17O14.19		FUNCTION: Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions. Mediates the phosphorylation of MRFs (e.g. MRF1) (PubMed:29084871). {ECO:0000269|PubMed:29084871}.	3702	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cellular response to hypoxia [GO:0071456]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to salt stress [GO:0009651]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to hypoxia [GO:0071456]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to salt stress [GO:0009651]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0009408; GO:0009409; GO:0009651; GO:0016301; GO:0045727; GO:0071456; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
XP_809943.1	Q4D6D3	unreviewed	Q4D6D3_TRYCC	Rac serine-threonine kinase, putative	Tc00.1047053509047.110			353153			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Trypanosoma cruzi (strain CL Brener)
XP_042926603.1	A0A2K3DZH4	unreviewed	A0A2K3DZH4_CHLRE	cGMP-dependent protein kinase (EC 2.7.11.12)	CHLRE_03g199050v5			3055	cAMP-dependent protein kinase complex [GO:0005952]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	GO:0004691; GO:0004692; GO:0005524; GO:0005952; GO:0007189; GO:0030553; GO:0046872	Chlamydomonas reinhardtii (Chlamydomonas smithii)
XP_002500126.1	C1DY87	unreviewed	C1DY87_MICCC	non-specific serine/threonine protein kinase (EC 2.7.11.1)	MICPUN_56023			296587			ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0106310	Micromonas commoda (strain RCC299 / NOUM17 / CCMP2709) (Picoplanktonic green alga)
XP_002506253.1	C1EHI1	unreviewed	C1EHI1_MICCC	non-specific serine/threonine protein kinase (EC 2.7.11.1)	MICPUN_64236			296587	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737	Micromonas commoda (strain RCC299 / NOUM17 / CCMP2709) (Picoplanktonic green alga)
XP_002506490.1	C1EHV2	unreviewed	C1EHV2_MICCC	cGMP-dependent protein kinase (EC 2.7.11.12)	CPKG1 MICPUN_64355			296587			ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]	GO:0004692; GO:0005524; GO:0030553	Micromonas commoda (strain RCC299 / NOUM17 / CCMP2709) (Picoplanktonic green alga)
NP_001318824.1	P93025	reviewed	PHOT2_ARATH	Phototropin-2 (EC 2.7.11.1) (Defective in chloroplast avoidance protein 1) (Non-phototropic hypocotyl 1-like protein 1) (AtKin7) (NPH1-like protein 1)	PHOT2 CAV1 KIN7 NPL1 At5g58140 K21L19.6		FUNCTION: Protein kinase that acts as a blue light photoreceptor in a signal-transduction pathway for photo-induced movements (PubMed:14739272, PubMed:15821287, PubMed:31904040, PubMed:32855213). Triggers the phosphorylation of AHA1 and AHA2 C-terminal penultimate Thr in guard cells to activate them and induce stomatal opening in response to blue light (BL) (PubMed:15821287, PubMed:31904040). Also phosphorylates BLUS1, a kinase involved in stomatal opening (PubMed:23811955). Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. {ECO:0000269|PubMed:11251116, ECO:0000269|PubMed:11371609, ECO:0000269|PubMed:12821778, ECO:0000269|PubMed:14739272, ECO:0000269|PubMed:14982991, ECO:0000269|PubMed:15031408, ECO:0000269|PubMed:15821287, ECO:0000269|PubMed:23811955, ECO:0000269|PubMed:31904040, ECO:0000269|PubMed:32855213, ECO:0000303|PubMed:15821287, ECO:0000303|PubMed:31904040}.	3702	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plastid [GO:0009536]	blue light signaling pathway [GO:0009785]; chloroplast relocation [GO:0009902]; circadian rhythm [GO:0007623]; phototropism [GO:0009638]; response to blue light [GO:0009637]; stomatal movement [GO:0010118]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plastid [GO:0009536]; ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; blue light signaling pathway [GO:0009785]; chloroplast relocation [GO:0009902]; circadian rhythm [GO:0007623]; phototropism [GO:0009638]; response to blue light [GO:0009637]; stomatal movement [GO:0010118]	ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0007623; GO:0009536; GO:0009637; GO:0009638; GO:0009785; GO:0009882; GO:0009902; GO:0010118; GO:0010181; GO:0016020; GO:0016301; GO:0042802; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_001330355.1	P93025	reviewed	PHOT2_ARATH	Phototropin-2 (EC 2.7.11.1) (Defective in chloroplast avoidance protein 1) (Non-phototropic hypocotyl 1-like protein 1) (AtKin7) (NPH1-like protein 1)	PHOT2 CAV1 KIN7 NPL1 At5g58140 K21L19.6		FUNCTION: Protein kinase that acts as a blue light photoreceptor in a signal-transduction pathway for photo-induced movements (PubMed:14739272, PubMed:15821287, PubMed:31904040, PubMed:32855213). Triggers the phosphorylation of AHA1 and AHA2 C-terminal penultimate Thr in guard cells to activate them and induce stomatal opening in response to blue light (BL) (PubMed:15821287, PubMed:31904040). Also phosphorylates BLUS1, a kinase involved in stomatal opening (PubMed:23811955). Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. {ECO:0000269|PubMed:11251116, ECO:0000269|PubMed:11371609, ECO:0000269|PubMed:12821778, ECO:0000269|PubMed:14739272, ECO:0000269|PubMed:14982991, ECO:0000269|PubMed:15031408, ECO:0000269|PubMed:15821287, ECO:0000269|PubMed:23811955, ECO:0000269|PubMed:31904040, ECO:0000269|PubMed:32855213, ECO:0000303|PubMed:15821287, ECO:0000303|PubMed:31904040}.	3702	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plastid [GO:0009536]	blue light signaling pathway [GO:0009785]; chloroplast relocation [GO:0009902]; circadian rhythm [GO:0007623]; phototropism [GO:0009638]; response to blue light [GO:0009637]; stomatal movement [GO:0010118]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plastid [GO:0009536]; ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; blue light signaling pathway [GO:0009785]; chloroplast relocation [GO:0009902]; circadian rhythm [GO:0007623]; phototropism [GO:0009638]; response to blue light [GO:0009637]; stomatal movement [GO:0010118]	ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0007623; GO:0009536; GO:0009637; GO:0009638; GO:0009785; GO:0009882; GO:0009902; GO:0010118; GO:0010181; GO:0016020; GO:0016301; GO:0042802; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_001330356.1	P93025	reviewed	PHOT2_ARATH	Phototropin-2 (EC 2.7.11.1) (Defective in chloroplast avoidance protein 1) (Non-phototropic hypocotyl 1-like protein 1) (AtKin7) (NPH1-like protein 1)	PHOT2 CAV1 KIN7 NPL1 At5g58140 K21L19.6		FUNCTION: Protein kinase that acts as a blue light photoreceptor in a signal-transduction pathway for photo-induced movements (PubMed:14739272, PubMed:15821287, PubMed:31904040, PubMed:32855213). Triggers the phosphorylation of AHA1 and AHA2 C-terminal penultimate Thr in guard cells to activate them and induce stomatal opening in response to blue light (BL) (PubMed:15821287, PubMed:31904040). Also phosphorylates BLUS1, a kinase involved in stomatal opening (PubMed:23811955). Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. {ECO:0000269|PubMed:11251116, ECO:0000269|PubMed:11371609, ECO:0000269|PubMed:12821778, ECO:0000269|PubMed:14739272, ECO:0000269|PubMed:14982991, ECO:0000269|PubMed:15031408, ECO:0000269|PubMed:15821287, ECO:0000269|PubMed:23811955, ECO:0000269|PubMed:31904040, ECO:0000269|PubMed:32855213, ECO:0000303|PubMed:15821287, ECO:0000303|PubMed:31904040}.	3702	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plastid [GO:0009536]	blue light signaling pathway [GO:0009785]; chloroplast relocation [GO:0009902]; circadian rhythm [GO:0007623]; phototropism [GO:0009638]; response to blue light [GO:0009637]; stomatal movement [GO:0010118]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plastid [GO:0009536]; ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; blue light signaling pathway [GO:0009785]; chloroplast relocation [GO:0009902]; circadian rhythm [GO:0007623]; phototropism [GO:0009638]; response to blue light [GO:0009637]; stomatal movement [GO:0010118]	ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0007623; GO:0009536; GO:0009637; GO:0009638; GO:0009785; GO:0009882; GO:0009902; GO:0010118; GO:0010181; GO:0016020; GO:0016301; GO:0042802; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_851210.1	P93025	reviewed	PHOT2_ARATH	Phototropin-2 (EC 2.7.11.1) (Defective in chloroplast avoidance protein 1) (Non-phototropic hypocotyl 1-like protein 1) (AtKin7) (NPH1-like protein 1)	PHOT2 CAV1 KIN7 NPL1 At5g58140 K21L19.6		FUNCTION: Protein kinase that acts as a blue light photoreceptor in a signal-transduction pathway for photo-induced movements (PubMed:14739272, PubMed:15821287, PubMed:31904040, PubMed:32855213). Triggers the phosphorylation of AHA1 and AHA2 C-terminal penultimate Thr in guard cells to activate them and induce stomatal opening in response to blue light (BL) (PubMed:15821287, PubMed:31904040). Also phosphorylates BLUS1, a kinase involved in stomatal opening (PubMed:23811955). Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. {ECO:0000269|PubMed:11251116, ECO:0000269|PubMed:11371609, ECO:0000269|PubMed:12821778, ECO:0000269|PubMed:14739272, ECO:0000269|PubMed:14982991, ECO:0000269|PubMed:15031408, ECO:0000269|PubMed:15821287, ECO:0000269|PubMed:23811955, ECO:0000269|PubMed:31904040, ECO:0000269|PubMed:32855213, ECO:0000303|PubMed:15821287, ECO:0000303|PubMed:31904040}.	3702	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plastid [GO:0009536]	blue light signaling pathway [GO:0009785]; chloroplast relocation [GO:0009902]; circadian rhythm [GO:0007623]; phototropism [GO:0009638]; response to blue light [GO:0009637]; stomatal movement [GO:0010118]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plastid [GO:0009536]; ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; blue light signaling pathway [GO:0009785]; chloroplast relocation [GO:0009902]; circadian rhythm [GO:0007623]; phototropism [GO:0009638]; response to blue light [GO:0009637]; stomatal movement [GO:0010118]	ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0007623; GO:0009536; GO:0009637; GO:0009638; GO:0009785; GO:0009882; GO:0009902; GO:0010118; GO:0010181; GO:0016020; GO:0016301; GO:0042802; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_851211.1	P93025	reviewed	PHOT2_ARATH	Phototropin-2 (EC 2.7.11.1) (Defective in chloroplast avoidance protein 1) (Non-phototropic hypocotyl 1-like protein 1) (AtKin7) (NPH1-like protein 1)	PHOT2 CAV1 KIN7 NPL1 At5g58140 K21L19.6		FUNCTION: Protein kinase that acts as a blue light photoreceptor in a signal-transduction pathway for photo-induced movements (PubMed:14739272, PubMed:15821287, PubMed:31904040, PubMed:32855213). Triggers the phosphorylation of AHA1 and AHA2 C-terminal penultimate Thr in guard cells to activate them and induce stomatal opening in response to blue light (BL) (PubMed:15821287, PubMed:31904040). Also phosphorylates BLUS1, a kinase involved in stomatal opening (PubMed:23811955). Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. {ECO:0000269|PubMed:11251116, ECO:0000269|PubMed:11371609, ECO:0000269|PubMed:12821778, ECO:0000269|PubMed:14739272, ECO:0000269|PubMed:14982991, ECO:0000269|PubMed:15031408, ECO:0000269|PubMed:15821287, ECO:0000269|PubMed:23811955, ECO:0000269|PubMed:31904040, ECO:0000269|PubMed:32855213, ECO:0000303|PubMed:15821287, ECO:0000303|PubMed:31904040}.	3702	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plastid [GO:0009536]	blue light signaling pathway [GO:0009785]; chloroplast relocation [GO:0009902]; circadian rhythm [GO:0007623]; phototropism [GO:0009638]; response to blue light [GO:0009637]; stomatal movement [GO:0010118]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plastid [GO:0009536]; ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; blue light signaling pathway [GO:0009785]; chloroplast relocation [GO:0009902]; circadian rhythm [GO:0007623]; phototropism [GO:0009638]; response to blue light [GO:0009637]; stomatal movement [GO:0010118]	ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0007623; GO:0009536; GO:0009637; GO:0009638; GO:0009785; GO:0009882; GO:0009902; GO:0010118; GO:0010181; GO:0016020; GO:0016301; GO:0042802; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_851212.2	A8MS49	unreviewed	A8MS49_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	PHOT2 AtPHOT2 NPL1 phototropin 2 At5g58140 K21L19.6 K21L19_6			3702	plasma membrane [GO:0005886]	chloroplast relocation [GO:0009902]; circadian rhythm [GO:0007623]; phototropism [GO:0009638]	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; chloroplast relocation [GO:0009902]; circadian rhythm [GO:0007623]; phototropism [GO:0009638]	ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005886; GO:0007623; GO:0009638; GO:0009882; GO:0009902; GO:0010181; GO:0042802	Arabidopsis thaliana (Mouse-ear cress)
NP_201037.1	Q9LE81	reviewed	IRE_ARATH	Probable serine/threonine protein kinase IRE (EC 2.7.11.1) (Protein INCOMPLETE ROOT HAIR ELONGATION) (AtIRE)	IRE At5g62310		FUNCTION: Modulates root tip growth. May play a common role in the tip growth of plant cells. {ECO:0000269|PubMed:12000677}.	3702		intracellular signal transduction [GO:0035556]; unidimensional cell growth [GO:0009826]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; unidimensional cell growth [GO:0009826]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270; GO:0009826; GO:0016301; GO:0035556; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_188412.2	F4J6F6	reviewed	IREH1_ARATH	Probable serine/threonine protein kinase IREH1 (EC 2.7.11.1) (Protein IRE homolog 1) (AtIREH1)	IREH1 At3g17850 MEB5.7		FUNCTION: May be involved in root hair elongation. {ECO:0000303|PubMed:12000677}.	3702	root hair [GO:0035618]	intracellular signal transduction [GO:0035556]	root hair [GO:0035618]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270; GO:0016301; GO:0035556; GO:0035618; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_188973.2	A0A384LNK0	unreviewed	A0A384LNK0_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AXX17_At3g25350 AN1_LOCUS13794 AT9943_LOCUS11839 C24_LOCUS13632			3702	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737	Arabidopsis thaliana (Mouse-ear cress)
NP_188973.2	Q9LW66	unreviewed	Q9LW66_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	At3g23310			3702	cytoplasm [GO:0005737]	intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0016301; GO:0035556	Arabidopsis thaliana (Mouse-ear cress)
NP_001030814.1	O48963	reviewed	PHOT1_ARATH	Phototropin-1 (EC 2.7.11.1) (Non-phototropic hypocotyl protein 1) (Root phototropism protein 1)	PHOT1 JK224 NPH1 RPT1 At3g45780 T6D9_110		FUNCTION: Protein kinase that acts as a blue light (BL) photoreceptor in a signal-transduction pathway for photo-induced movements (PubMed:14739272, PubMed:15821287, PubMed:29101334, PubMed:31904040, PubMed:32855213). Triggers the phosphorylation of AHA1 and AHA2 C-terminal penultimate Thr in guard cells to activate them and induce stomatal opening in response to blue light (BL) (PubMed:15821287, PubMed:31904040). Also phosphorylates BLUS1, a kinase involved in stomatal opening (PubMed:23811955). Mediates the phosphorylation of CBC1 in stomata, but not of CBC2, in response to blue light (PubMed:29101334). Required for blue light mediated mRNA destabilization. Mediates calcium spiking of extracellular origin in response to a low rate of blue light. Also mediates rapid membrane depolarization and growth inhibition in response to blue light. Necessary for root phototropism. Involved in hypocotyl phototropism under a low rate but not under a high rate of blue light. Contributes to the chloroplast accumulation but does not seem to be required for chloroplast translocation. Regulates stomata opening and photomorphogenesis response of leaf tissue. Confers sensitivity to drought. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Involved in the regulation of leaf position and morphology via the phosphorylation of ABCB19 during blue light responses to modulate auxin distribution (PubMed:32855213). {ECO:0000269|PubMed:10662859, ECO:0000269|PubMed:11439133, ECO:0000269|PubMed:12650626, ECO:0000269|PubMed:12821778, ECO:0000269|PubMed:14739272, ECO:0000269|PubMed:14982991, ECO:0000269|PubMed:15031408, ECO:0000269|PubMed:15821287, ECO:0000269|PubMed:16777956, ECO:0000269|PubMed:20031924, ECO:0000269|PubMed:23811955, ECO:0000269|PubMed:29101334, ECO:0000269|PubMed:31904040, ECO:0000269|PubMed:32855213, ECO:0000303|PubMed:15821287, ECO:0000303|PubMed:31904040}.	3702	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; nucleus [GO:0005634]; plant-type vacuole [GO:0000325]; plasma membrane [GO:0005886]	blue light signaling pathway [GO:0009785]; cellular response to blue light [GO:0071483]; chloroplast accumulation movement [GO:0009904]; chloroplast avoidance movement [GO:0009903]; circadian rhythm [GO:0007623]; leaf phyllotactic patterning [GO:0060772]; phototropism [GO:0009638]; regulation of leaf morphogenesis [GO:1901371]; regulation of proton transport [GO:0010155]; regulation of stomatal movement [GO:0010119]; response to blue light [GO:0009637]; response to red or far red light [GO:0009639]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; nucleus [GO:0005634]; plant-type vacuole [GO:0000325]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; mRNA binding [GO:0003729]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; blue light signaling pathway [GO:0009785]; cellular response to blue light [GO:0071483]; chloroplast accumulation movement [GO:0009904]; chloroplast avoidance movement [GO:0009903]; circadian rhythm [GO:0007623]; leaf phyllotactic patterning [GO:0060772]; phototropism [GO:0009638]; regulation of leaf morphogenesis [GO:1901371]; regulation of proton transport [GO:0010155]; regulation of stomatal movement [GO:0010119]; response to blue light [GO:0009637]; response to red or far red light [GO:0009639]	ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; mRNA binding [GO:0003729]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000325; GO:0003729; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0007623; GO:0009637; GO:0009638; GO:0009639; GO:0009785; GO:0009882; GO:0009898; GO:0009903; GO:0009904; GO:0009986; GO:0010119; GO:0010155; GO:0010181; GO:0016301; GO:0042802; GO:0060772; GO:0071483; GO:0106310; GO:1901371	Arabidopsis thaliana (Mouse-ear cress)
NP_190164.1	O48963	reviewed	PHOT1_ARATH	Phototropin-1 (EC 2.7.11.1) (Non-phototropic hypocotyl protein 1) (Root phototropism protein 1)	PHOT1 JK224 NPH1 RPT1 At3g45780 T6D9_110		FUNCTION: Protein kinase that acts as a blue light (BL) photoreceptor in a signal-transduction pathway for photo-induced movements (PubMed:14739272, PubMed:15821287, PubMed:29101334, PubMed:31904040, PubMed:32855213). Triggers the phosphorylation of AHA1 and AHA2 C-terminal penultimate Thr in guard cells to activate them and induce stomatal opening in response to blue light (BL) (PubMed:15821287, PubMed:31904040). Also phosphorylates BLUS1, a kinase involved in stomatal opening (PubMed:23811955). Mediates the phosphorylation of CBC1 in stomata, but not of CBC2, in response to blue light (PubMed:29101334). Required for blue light mediated mRNA destabilization. Mediates calcium spiking of extracellular origin in response to a low rate of blue light. Also mediates rapid membrane depolarization and growth inhibition in response to blue light. Necessary for root phototropism. Involved in hypocotyl phototropism under a low rate but not under a high rate of blue light. Contributes to the chloroplast accumulation but does not seem to be required for chloroplast translocation. Regulates stomata opening and photomorphogenesis response of leaf tissue. Confers sensitivity to drought. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Involved in the regulation of leaf position and morphology via the phosphorylation of ABCB19 during blue light responses to modulate auxin distribution (PubMed:32855213). {ECO:0000269|PubMed:10662859, ECO:0000269|PubMed:11439133, ECO:0000269|PubMed:12650626, ECO:0000269|PubMed:12821778, ECO:0000269|PubMed:14739272, ECO:0000269|PubMed:14982991, ECO:0000269|PubMed:15031408, ECO:0000269|PubMed:15821287, ECO:0000269|PubMed:16777956, ECO:0000269|PubMed:20031924, ECO:0000269|PubMed:23811955, ECO:0000269|PubMed:29101334, ECO:0000269|PubMed:31904040, ECO:0000269|PubMed:32855213, ECO:0000303|PubMed:15821287, ECO:0000303|PubMed:31904040}.	3702	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; nucleus [GO:0005634]; plant-type vacuole [GO:0000325]; plasma membrane [GO:0005886]	blue light signaling pathway [GO:0009785]; cellular response to blue light [GO:0071483]; chloroplast accumulation movement [GO:0009904]; chloroplast avoidance movement [GO:0009903]; circadian rhythm [GO:0007623]; leaf phyllotactic patterning [GO:0060772]; phototropism [GO:0009638]; regulation of leaf morphogenesis [GO:1901371]; regulation of proton transport [GO:0010155]; regulation of stomatal movement [GO:0010119]; response to blue light [GO:0009637]; response to red or far red light [GO:0009639]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; nucleus [GO:0005634]; plant-type vacuole [GO:0000325]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; mRNA binding [GO:0003729]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; blue light signaling pathway [GO:0009785]; cellular response to blue light [GO:0071483]; chloroplast accumulation movement [GO:0009904]; chloroplast avoidance movement [GO:0009903]; circadian rhythm [GO:0007623]; leaf phyllotactic patterning [GO:0060772]; phototropism [GO:0009638]; regulation of leaf morphogenesis [GO:1901371]; regulation of proton transport [GO:0010155]; regulation of stomatal movement [GO:0010119]; response to blue light [GO:0009637]; response to red or far red light [GO:0009639]	ATP binding [GO:0005524]; blue light photoreceptor activity [GO:0009882]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; mRNA binding [GO:0003729]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000325; GO:0003729; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0007623; GO:0009637; GO:0009638; GO:0009639; GO:0009785; GO:0009882; GO:0009898; GO:0009903; GO:0009904; GO:0009986; GO:0010119; GO:0010155; GO:0010181; GO:0016301; GO:0042802; GO:0060772; GO:0071483; GO:0106310; GO:1901371	Arabidopsis thaliana (Mouse-ear cress)
NP_001329677.1	A0A384L6K2	unreviewed	A0A384L6K2_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AXX17_At4g16530			3702	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_001329677.1	Q8L7S7	unreviewed	Q8L7S7_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	DL3215C At4g14350 FCAALL.182			3702	cytoplasm [GO:0005737]; nucleus [GO:0005634]; phragmoplast [GO:0009524]	intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0009524; GO:0016301; GO:0035556	Arabidopsis thaliana (Mouse-ear cress)
NP_193171.2	A0A384L6K2	unreviewed	A0A384L6K2_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AXX17_At4g16530			3702	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_193171.2	Q8L7S7	unreviewed	Q8L7S7_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	DL3215C At4g14350 FCAALL.182			3702	cytoplasm [GO:0005737]; nucleus [GO:0005634]; phragmoplast [GO:0009524]	intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0009524; GO:0016301; GO:0035556	Arabidopsis thaliana (Mouse-ear cress)
NP_849380.1	A0A384L6K2	unreviewed	A0A384L6K2_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AXX17_At4g16530			3702	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
NP_849380.1	Q8L7S7	unreviewed	Q8L7S7_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	DL3215C At4g14350 FCAALL.182			3702	cytoplasm [GO:0005737]; nucleus [GO:0005634]; phragmoplast [GO:0009524]	intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0009524; GO:0016301; GO:0035556	Arabidopsis thaliana (Mouse-ear cress)
NP_001078388.1	A8MR48	unreviewed	A8MR48_ARATH	non-specific serine/threonine protein kinase (EC 2.7.11.1)	DL3215C At4g14350 FCAALL.182			3702	cytoplasm [GO:0005737]; nucleus [GO:0005634]; phragmoplast [GO:0009524]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; phragmoplast [GO:0009524]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0009524; GO:0016301; GO:0106310	Arabidopsis thaliana (Mouse-ear cress)
XP_003862279.1	E9BJQ1	unreviewed	E9BJQ1_LEIDO	Protein kinase domain family protein (Zinc finger protein kinase-like)	CGC21_22350 LDBPK_281800			5661			ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035091	Leishmania donovani
XP_003862798.1	A0A3Q8IRT6	unreviewed	A0A3Q8IRT6_LEIDO	Protein kinase domain family protein (Rac serine-threonine kinase, putative) (Rac_serine-threonine_kinase_putative/GeneDB:LmjF. 30.0800)	CGC21_35205 LDBPK_300850 LdCL_300013600 LDHU3_30.1060			5661			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Leishmania donovani
XP_003860122.1	A0A3Q8IB30	unreviewed	A0A3Q8IB30_LEIDO	Protein kinase A catalytic subunit (Protein kinase domain family protein) (Protein_kinase_A_catalytic_subunit/GeneDB:LmjF.18.1080)	CGC20_39235 CGC21_3020 LDBPK_181090 LdCL_180016100 LDHU3_18.1390			5661	cAMP-dependent protein kinase complex [GO:0005952]	anatomical structure morphogenesis [GO:0009653]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; anatomical structure morphogenesis [GO:0009653]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0009653	Leishmania donovani
XP_005537943.1	M1VFW2	unreviewed	M1VFW2_CYAM1	non-specific serine/threonine protein kinase (EC 2.7.11.1)	CYME_CMP312C			280699			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Cyanidioschyzon merolae (strain NIES-3377 / 10D) (Unicellular red alga)
XP_005708474.1	M2Y7Z8	unreviewed	M2Y7Z8_GALSU	non-specific serine/threonine protein kinase (EC 2.7.11.1)	Gasu_10180			130081	cell periphery [GO:0071944]; cytoplasm [GO:0005737]		cell periphery [GO:0071944]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0071944; GO:0106310	Galdieria sulphuraria (Red alga)
XP_005711380.1	R7QUD6	unreviewed	R7QUD6_CHOCR	non-specific serine/threonine protein kinase (EC 2.7.11.1)	CHC_T00008666001			2769	cell periphery [GO:0071944]; cytoplasm [GO:0005737]		cell periphery [GO:0071944]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0071944	Chondrus crispus (Carrageen Irish moss) (Polymorpha crispa)
XP_042928534.1	A0A2K3E6P9	unreviewed	A0A2K3E6P9_CHLRE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	CHLRE_01g029850v5			3055		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Chlamydomonas reinhardtii (Chlamydomonas smithii)
XP_005538470.1	M1VB39	unreviewed	M1VB39_CYAM1	non-specific serine/threonine protein kinase (EC 2.7.11.1)	CYME_CMR193C			280699			ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0106310	Cyanidioschyzon merolae (strain NIES-3377 / 10D) (Unicellular red alga)
XP_005707913.1	M2Y5Z1	unreviewed	M2Y5Z1_GALSU	non-specific serine/threonine protein kinase (EC 2.7.11.1)	Gasu_13570			130081			ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0106310	Galdieria sulphuraria (Red alga)
XP_001697887.2	A0A2K3CTP9	unreviewed	A0A2K3CTP9_CHLRE	cGMP-dependent protein kinase (EC 2.7.11.12)	CHLRE_16g663200v5			3055	cAMP-dependent protein kinase complex [GO:0005952]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]	GO:0004691; GO:0004692; GO:0005524; GO:0005952; GO:0007189; GO:0030553	Chlamydomonas reinhardtii (Chlamydomonas smithii)
NP_001258972.1	P23443	reviewed	KS6B1_HUMAN	Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA)	RPS6KB1 STK14A		FUNCTION: Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression (PubMed:11500364, PubMed:12801526, PubMed:14673156, PubMed:15071500, PubMed:15341740, PubMed:16286006, PubMed:17052453, PubMed:17053147, PubMed:17936702, PubMed:18952604, PubMed:19085255, PubMed:19720745, PubMed:19935711, PubMed:19995915, PubMed:22017876, PubMed:23429703, PubMed:28178239). Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD (PubMed:11500364, PubMed:12801526, PubMed:14673156, PubMed:15071500, PubMed:15341740, PubMed:16286006, PubMed:17052453, PubMed:17053147, PubMed:17936702, PubMed:18952604, PubMed:19085255, PubMed:19720745, PubMed:19935711, PubMed:19995915, PubMed:22017876, PubMed:23429703, PubMed:28178239). Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex (PubMed:16286006). Upon mitogenic stimulation, phosphorylation by the mechanistic target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation (PubMed:16286006). The active form then phosphorylates and activates several substrates in the pre-initiation complex, including the EIF2B complex and the cap-binding complex component EIF4B (PubMed:16286006). Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis (PubMed:17053147). Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR (PubMed:15341740). In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2 (PubMed:11500364). Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating MAPKAP1/SIN1, MTOR and RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling (PubMed:15899889, PubMed:19720745, PubMed:19935711, PubMed:19995915). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function (By similarity). Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex (PubMed:17936702). The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at Thr-412, which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function (PubMed:17936702). Mediates TNF-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1 (PubMed:18952604). In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B (PubMed:17052453). May be involved in cytoskeletal rearrangement through binding to neurabin (By similarity). Phosphorylates and activates the pyrimidine biosynthesis enzyme CAD, downstream of MTOR (PubMed:23429703). Following activation by mTORC1, phosphorylates EPRS and thereby plays a key role in fatty acid uptake by adipocytes and also most probably in interferon-gamma-induced translation inhibition (PubMed:28178239). {ECO:0000250|UniProtKB:P67999, ECO:0000250|UniProtKB:Q8BSK8, ECO:0000269|PubMed:11500364, ECO:0000269|PubMed:12801526, ECO:0000269|PubMed:14673156, ECO:0000269|PubMed:15071500, ECO:0000269|PubMed:15341740, ECO:0000269|PubMed:15899889, ECO:0000269|PubMed:16286006, ECO:0000269|PubMed:17052453, ECO:0000269|PubMed:17053147, ECO:0000269|PubMed:17936702, ECO:0000269|PubMed:18952604, ECO:0000269|PubMed:19085255, ECO:0000269|PubMed:19720745, ECO:0000269|PubMed:19935711, ECO:0000269|PubMed:19995915, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:23429703, ECO:0000269|PubMed:28178239}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000082; GO:0001662; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0007165; GO:0007281; GO:0018105; GO:0031667; GO:0031670; GO:0031929; GO:0032869; GO:0038202; GO:0043005; GO:0043066; GO:0044539; GO:0045727; GO:0045931; GO:0045948; GO:0046627; GO:0048015; GO:0050804; GO:0071346; GO:0071363; GO:0071549; GO:0098978; GO:0106310; GO:1903940; GO:1904263; GO:2001237	Homo sapiens (Human)
NP_001258973.1	P23443	reviewed	KS6B1_HUMAN	Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA)	RPS6KB1 STK14A		FUNCTION: Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression (PubMed:11500364, PubMed:12801526, PubMed:14673156, PubMed:15071500, PubMed:15341740, PubMed:16286006, PubMed:17052453, PubMed:17053147, PubMed:17936702, PubMed:18952604, PubMed:19085255, PubMed:19720745, PubMed:19935711, PubMed:19995915, PubMed:22017876, PubMed:23429703, PubMed:28178239). Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD (PubMed:11500364, PubMed:12801526, PubMed:14673156, PubMed:15071500, PubMed:15341740, PubMed:16286006, PubMed:17052453, PubMed:17053147, PubMed:17936702, PubMed:18952604, PubMed:19085255, PubMed:19720745, PubMed:19935711, PubMed:19995915, PubMed:22017876, PubMed:23429703, PubMed:28178239). Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex (PubMed:16286006). Upon mitogenic stimulation, phosphorylation by the mechanistic target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation (PubMed:16286006). The active form then phosphorylates and activates several substrates in the pre-initiation complex, including the EIF2B complex and the cap-binding complex component EIF4B (PubMed:16286006). Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis (PubMed:17053147). Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR (PubMed:15341740). In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2 (PubMed:11500364). Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating MAPKAP1/SIN1, MTOR and RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling (PubMed:15899889, PubMed:19720745, PubMed:19935711, PubMed:19995915). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function (By similarity). Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex (PubMed:17936702). The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at Thr-412, which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function (PubMed:17936702). Mediates TNF-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1 (PubMed:18952604). In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B (PubMed:17052453). May be involved in cytoskeletal rearrangement through binding to neurabin (By similarity). Phosphorylates and activates the pyrimidine biosynthesis enzyme CAD, downstream of MTOR (PubMed:23429703). Following activation by mTORC1, phosphorylates EPRS and thereby plays a key role in fatty acid uptake by adipocytes and also most probably in interferon-gamma-induced translation inhibition (PubMed:28178239). {ECO:0000250|UniProtKB:P67999, ECO:0000250|UniProtKB:Q8BSK8, ECO:0000269|PubMed:11500364, ECO:0000269|PubMed:12801526, ECO:0000269|PubMed:14673156, ECO:0000269|PubMed:15071500, ECO:0000269|PubMed:15341740, ECO:0000269|PubMed:15899889, ECO:0000269|PubMed:16286006, ECO:0000269|PubMed:17052453, ECO:0000269|PubMed:17053147, ECO:0000269|PubMed:17936702, ECO:0000269|PubMed:18952604, ECO:0000269|PubMed:19085255, ECO:0000269|PubMed:19720745, ECO:0000269|PubMed:19935711, ECO:0000269|PubMed:19995915, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:23429703, ECO:0000269|PubMed:28178239}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000082; GO:0001662; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0007165; GO:0007281; GO:0018105; GO:0031667; GO:0031670; GO:0031929; GO:0032869; GO:0038202; GO:0043005; GO:0043066; GO:0044539; GO:0045727; GO:0045931; GO:0045948; GO:0046627; GO:0048015; GO:0050804; GO:0071346; GO:0071363; GO:0071549; GO:0098978; GO:0106310; GO:1903940; GO:1904263; GO:2001237	Homo sapiens (Human)
NP_001261450.1	Q94533	unreviewed	Q94533_DROME	Ribosomal protein S6 kinase (EC 2.7.11.1)	S6k 10539 7-10 7084 d-S6K Dmel\CG10539 Dp70[s6k] dp70[S6k] Dp70S6k Dp70s6k dP70S6K dp70s6k dps6k DS6K dS6K dS6k ds6k dS6K1 fs(3)07084 l(3)07084 p-S6K p70 S6K p70/S6K p70[S6 kinase] p70[S6K] p70[S6k] p70[S6kinase] p70S6K p70S6k p70s6K Pk64F Pk?6 pS6K S6 S6 K S6K s6k S6k-RA S6K1 s6k11 CG10539 Dmel_CG10539			7227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; presynaptic active zone [GO:0048786]	cellular response to amino acid stimulus [GO:0071230]; cellular response to insulin stimulus [GO:0032869]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; female germ-line stem cell population maintenance [GO:0036099]; insulin receptor signaling pathway [GO:0008286]; larval feeding behavior [GO:0030536]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of macroautophagy [GO:0016239]; regulation of response to drug [GO:2001023]; response to oxidative stress [GO:0006979]; synaptic assembly at neuromuscular junction [GO:0051124]; TORC1 signaling [GO:0038202]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; presynaptic active zone [GO:0048786]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; cellular response to amino acid stimulus [GO:0071230]; cellular response to insulin stimulus [GO:0032869]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; female germ-line stem cell population maintenance [GO:0036099]; insulin receptor signaling pathway [GO:0008286]; larval feeding behavior [GO:0030536]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of macroautophagy [GO:0016239]; regulation of response to drug [GO:2001023]; response to oxidative stress [GO:0006979]; synaptic assembly at neuromuscular junction [GO:0051124]; TORC1 signaling [GO:0038202]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0004674; GO:0004711; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006979; GO:0008286; GO:0008340; GO:0016239; GO:0030307; GO:0030536; GO:0032869; GO:0035264; GO:0036099; GO:0038202; GO:0045793; GO:0048010; GO:0048786; GO:0048813; GO:0051124; GO:0055088; GO:0071230; GO:1902669; GO:2001023	Drosophila melanogaster (Fruit fly)
NP_523941.2	Q94533	unreviewed	Q94533_DROME	Ribosomal protein S6 kinase (EC 2.7.11.1)	S6k 10539 7-10 7084 d-S6K Dmel\CG10539 Dp70[s6k] dp70[S6k] Dp70S6k Dp70s6k dP70S6K dp70s6k dps6k DS6K dS6K dS6k ds6k dS6K1 fs(3)07084 l(3)07084 p-S6K p70 S6K p70/S6K p70[S6 kinase] p70[S6K] p70[S6k] p70[S6kinase] p70S6K p70S6k p70s6K Pk64F Pk?6 pS6K S6 S6 K S6K s6k S6k-RA S6K1 s6k11 CG10539 Dmel_CG10539			7227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; presynaptic active zone [GO:0048786]	cellular response to amino acid stimulus [GO:0071230]; cellular response to insulin stimulus [GO:0032869]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; female germ-line stem cell population maintenance [GO:0036099]; insulin receptor signaling pathway [GO:0008286]; larval feeding behavior [GO:0030536]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of macroautophagy [GO:0016239]; regulation of response to drug [GO:2001023]; response to oxidative stress [GO:0006979]; synaptic assembly at neuromuscular junction [GO:0051124]; TORC1 signaling [GO:0038202]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; presynaptic active zone [GO:0048786]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; cellular response to amino acid stimulus [GO:0071230]; cellular response to insulin stimulus [GO:0032869]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; female germ-line stem cell population maintenance [GO:0036099]; insulin receptor signaling pathway [GO:0008286]; larval feeding behavior [GO:0030536]; lipid homeostasis [GO:0055088]; multicellular organism growth [GO:0035264]; positive regulation of axon guidance [GO:1902669]; positive regulation of cell growth [GO:0030307]; positive regulation of cell size [GO:0045793]; positive regulation of macroautophagy [GO:0016239]; regulation of response to drug [GO:2001023]; response to oxidative stress [GO:0006979]; synaptic assembly at neuromuscular junction [GO:0051124]; TORC1 signaling [GO:0038202]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0004674; GO:0004711; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006979; GO:0008286; GO:0008340; GO:0016239; GO:0030307; GO:0030536; GO:0032869; GO:0035264; GO:0036099; GO:0038202; GO:0045793; GO:0048010; GO:0048786; GO:0048813; GO:0051124; GO:0055088; GO:0071230; GO:1902669; GO:2001023	Drosophila melanogaster (Fruit fly)
NP_001258989.1	P23443	reviewed	KS6B1_HUMAN	Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA)	RPS6KB1 STK14A		FUNCTION: Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression (PubMed:11500364, PubMed:12801526, PubMed:14673156, PubMed:15071500, PubMed:15341740, PubMed:16286006, PubMed:17052453, PubMed:17053147, PubMed:17936702, PubMed:18952604, PubMed:19085255, PubMed:19720745, PubMed:19935711, PubMed:19995915, PubMed:22017876, PubMed:23429703, PubMed:28178239). Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD (PubMed:11500364, PubMed:12801526, PubMed:14673156, PubMed:15071500, PubMed:15341740, PubMed:16286006, PubMed:17052453, PubMed:17053147, PubMed:17936702, PubMed:18952604, PubMed:19085255, PubMed:19720745, PubMed:19935711, PubMed:19995915, PubMed:22017876, PubMed:23429703, PubMed:28178239). Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex (PubMed:16286006). Upon mitogenic stimulation, phosphorylation by the mechanistic target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation (PubMed:16286006). The active form then phosphorylates and activates several substrates in the pre-initiation complex, including the EIF2B complex and the cap-binding complex component EIF4B (PubMed:16286006). Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis (PubMed:17053147). Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR (PubMed:15341740). In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2 (PubMed:11500364). Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating MAPKAP1/SIN1, MTOR and RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling (PubMed:15899889, PubMed:19720745, PubMed:19935711, PubMed:19995915). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function (By similarity). Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex (PubMed:17936702). The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at Thr-412, which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function (PubMed:17936702). Mediates TNF-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1 (PubMed:18952604). In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B (PubMed:17052453). May be involved in cytoskeletal rearrangement through binding to neurabin (By similarity). Phosphorylates and activates the pyrimidine biosynthesis enzyme CAD, downstream of MTOR (PubMed:23429703). Following activation by mTORC1, phosphorylates EPRS and thereby plays a key role in fatty acid uptake by adipocytes and also most probably in interferon-gamma-induced translation inhibition (PubMed:28178239). {ECO:0000250|UniProtKB:P67999, ECO:0000250|UniProtKB:Q8BSK8, ECO:0000269|PubMed:11500364, ECO:0000269|PubMed:12801526, ECO:0000269|PubMed:14673156, ECO:0000269|PubMed:15071500, ECO:0000269|PubMed:15341740, ECO:0000269|PubMed:15899889, ECO:0000269|PubMed:16286006, ECO:0000269|PubMed:17052453, ECO:0000269|PubMed:17053147, ECO:0000269|PubMed:17936702, ECO:0000269|PubMed:18952604, ECO:0000269|PubMed:19085255, ECO:0000269|PubMed:19720745, ECO:0000269|PubMed:19935711, ECO:0000269|PubMed:19995915, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:23429703, ECO:0000269|PubMed:28178239}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000082; GO:0001662; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0007165; GO:0007281; GO:0018105; GO:0031667; GO:0031670; GO:0031929; GO:0032869; GO:0038202; GO:0043005; GO:0043066; GO:0044539; GO:0045727; GO:0045931; GO:0045948; GO:0046627; GO:0048015; GO:0050804; GO:0071346; GO:0071363; GO:0071549; GO:0098978; GO:0106310; GO:1903940; GO:1904263; GO:2001237	Homo sapiens (Human)
NP_003152.1	P23443	reviewed	KS6B1_HUMAN	Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA)	RPS6KB1 STK14A		FUNCTION: Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression (PubMed:11500364, PubMed:12801526, PubMed:14673156, PubMed:15071500, PubMed:15341740, PubMed:16286006, PubMed:17052453, PubMed:17053147, PubMed:17936702, PubMed:18952604, PubMed:19085255, PubMed:19720745, PubMed:19935711, PubMed:19995915, PubMed:22017876, PubMed:23429703, PubMed:28178239). Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD (PubMed:11500364, PubMed:12801526, PubMed:14673156, PubMed:15071500, PubMed:15341740, PubMed:16286006, PubMed:17052453, PubMed:17053147, PubMed:17936702, PubMed:18952604, PubMed:19085255, PubMed:19720745, PubMed:19935711, PubMed:19995915, PubMed:22017876, PubMed:23429703, PubMed:28178239). Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex (PubMed:16286006). Upon mitogenic stimulation, phosphorylation by the mechanistic target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation (PubMed:16286006). The active form then phosphorylates and activates several substrates in the pre-initiation complex, including the EIF2B complex and the cap-binding complex component EIF4B (PubMed:16286006). Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis (PubMed:17053147). Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR (PubMed:15341740). In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2 (PubMed:11500364). Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating MAPKAP1/SIN1, MTOR and RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling (PubMed:15899889, PubMed:19720745, PubMed:19935711, PubMed:19995915). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function (By similarity). Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex (PubMed:17936702). The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at Thr-412, which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function (PubMed:17936702). Mediates TNF-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1 (PubMed:18952604). In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B (PubMed:17052453). May be involved in cytoskeletal rearrangement through binding to neurabin (By similarity). Phosphorylates and activates the pyrimidine biosynthesis enzyme CAD, downstream of MTOR (PubMed:23429703). Following activation by mTORC1, phosphorylates EPRS and thereby plays a key role in fatty acid uptake by adipocytes and also most probably in interferon-gamma-induced translation inhibition (PubMed:28178239). {ECO:0000250|UniProtKB:P67999, ECO:0000250|UniProtKB:Q8BSK8, ECO:0000269|PubMed:11500364, ECO:0000269|PubMed:12801526, ECO:0000269|PubMed:14673156, ECO:0000269|PubMed:15071500, ECO:0000269|PubMed:15341740, ECO:0000269|PubMed:15899889, ECO:0000269|PubMed:16286006, ECO:0000269|PubMed:17052453, ECO:0000269|PubMed:17053147, ECO:0000269|PubMed:17936702, ECO:0000269|PubMed:18952604, ECO:0000269|PubMed:19085255, ECO:0000269|PubMed:19720745, ECO:0000269|PubMed:19935711, ECO:0000269|PubMed:19995915, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:23429703, ECO:0000269|PubMed:28178239}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000082; GO:0001662; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0007165; GO:0007281; GO:0018105; GO:0031667; GO:0031670; GO:0031929; GO:0032869; GO:0038202; GO:0043005; GO:0043066; GO:0044539; GO:0045727; GO:0045931; GO:0045948; GO:0046627; GO:0048015; GO:0050804; GO:0071346; GO:0071363; GO:0071549; GO:0098978; GO:0106310; GO:1903940; GO:1904263; GO:2001237	Homo sapiens (Human)
NP_003943.2	Q9UBS0	reviewed	KS6B2_HUMAN	Ribosomal protein S6 kinase beta-2 (S6K-beta-2) (S6K2) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 2) (P70S6K2) (p70-S6K 2) (S6 kinase-related kinase) (SRK) (Serine/threonine-protein kinase 14B) (p70 ribosomal S6 kinase beta) (S6K-beta) (p70 S6 kinase beta) (p70 S6K-beta) (p70 S6KB) (p70-beta)	RPS6KB2 STK14B		FUNCTION: Phosphorylates specifically ribosomal protein S6 (PubMed:29750193). Seems to act downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression in an alternative pathway regulated by MEAK7 (PubMed:29750193). {ECO:0000269|PubMed:29750193}.	9606	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of translational initiation [GO:0045948]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translation [GO:0006412]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of translational initiation [GO:0045948]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translation [GO:0006412]	ATP binding [GO:0005524]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0004672; GO:0004674; GO:0004711; GO:0005524; GO:0005654; GO:0005737; GO:0006412; GO:0007165; GO:0031929; GO:0038202; GO:0042277; GO:0045948; GO:0046627; GO:0106310	Homo sapiens (Human)
NP_001258971.1	P23443	reviewed	KS6B1_HUMAN	Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA)	RPS6KB1 STK14A		FUNCTION: Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression (PubMed:11500364, PubMed:12801526, PubMed:14673156, PubMed:15071500, PubMed:15341740, PubMed:16286006, PubMed:17052453, PubMed:17053147, PubMed:17936702, PubMed:18952604, PubMed:19085255, PubMed:19720745, PubMed:19935711, PubMed:19995915, PubMed:22017876, PubMed:23429703, PubMed:28178239). Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD (PubMed:11500364, PubMed:12801526, PubMed:14673156, PubMed:15071500, PubMed:15341740, PubMed:16286006, PubMed:17052453, PubMed:17053147, PubMed:17936702, PubMed:18952604, PubMed:19085255, PubMed:19720745, PubMed:19935711, PubMed:19995915, PubMed:22017876, PubMed:23429703, PubMed:28178239). Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex (PubMed:16286006). Upon mitogenic stimulation, phosphorylation by the mechanistic target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation (PubMed:16286006). The active form then phosphorylates and activates several substrates in the pre-initiation complex, including the EIF2B complex and the cap-binding complex component EIF4B (PubMed:16286006). Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis (PubMed:17053147). Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR (PubMed:15341740). In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2 (PubMed:11500364). Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating MAPKAP1/SIN1, MTOR and RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling (PubMed:15899889, PubMed:19720745, PubMed:19935711, PubMed:19995915). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function (By similarity). Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex (PubMed:17936702). The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at Thr-412, which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function (PubMed:17936702). Mediates TNF-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1 (PubMed:18952604). In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B (PubMed:17052453). May be involved in cytoskeletal rearrangement through binding to neurabin (By similarity). Phosphorylates and activates the pyrimidine biosynthesis enzyme CAD, downstream of MTOR (PubMed:23429703). Following activation by mTORC1, phosphorylates EPRS and thereby plays a key role in fatty acid uptake by adipocytes and also most probably in interferon-gamma-induced translation inhibition (PubMed:28178239). {ECO:0000250|UniProtKB:P67999, ECO:0000250|UniProtKB:Q8BSK8, ECO:0000269|PubMed:11500364, ECO:0000269|PubMed:12801526, ECO:0000269|PubMed:14673156, ECO:0000269|PubMed:15071500, ECO:0000269|PubMed:15341740, ECO:0000269|PubMed:15899889, ECO:0000269|PubMed:16286006, ECO:0000269|PubMed:17052453, ECO:0000269|PubMed:17053147, ECO:0000269|PubMed:17936702, ECO:0000269|PubMed:18952604, ECO:0000269|PubMed:19085255, ECO:0000269|PubMed:19720745, ECO:0000269|PubMed:19935711, ECO:0000269|PubMed:19995915, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:23429703, ECO:0000269|PubMed:28178239}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000082; GO:0001662; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0007165; GO:0007281; GO:0018105; GO:0031667; GO:0031670; GO:0031929; GO:0032869; GO:0038202; GO:0043005; GO:0043066; GO:0044539; GO:0045727; GO:0045931; GO:0045948; GO:0046627; GO:0048015; GO:0050804; GO:0071346; GO:0071363; GO:0071549; GO:0098978; GO:0106310; GO:1903940; GO:1904263; GO:2001237	Homo sapiens (Human)
NP_001006666.1	Q15418	reviewed	KS6A1_HUMAN	Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1)	RPS6KA1 MAPKAPK1A RSK1		FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:10679322, PubMed:12213813, PubMed:15117958, PubMed:16223362, PubMed:17360704, PubMed:18722121, PubMed:26158630, PubMed:35772404, PubMed:9430688). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1, which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:18508509, PubMed:18813292). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:12213813, PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity (PubMed:18508509, PubMed:18813292). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the pre-initiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:16763566). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:15342917). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:10679322, PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:11684016). Mediates induction of hepatocyte prolifration by TGFA through phosphorylation of CEBPB (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (PubMed:18508509, PubMed:18813292). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). In response to mTORC1 activation, phosphorylates EIF4B at 'Ser-406' and 'Ser-422' which stimulates bicarbonate cotransporter SLC4A7 mRNA translation, increasing SLC4A7 protein abundance and function (PubMed:35772404). {ECO:0000269|PubMed:10679322, ECO:0000269|PubMed:11684016, ECO:0000269|PubMed:12213813, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:15342917, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:16763566, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:35772404, ECO:0000269|PubMed:9430688, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.; FUNCTION: (Microbial infection) Promotes the late transcription and translation of viral lytic genes during Kaposi's sarcoma-associated herpesvirus/HHV-8 infection, when constitutively activated. {ECO:0000269|PubMed:30842327}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]	chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0007165; GO:0007268; GO:0030307; GO:0032007; GO:0038202; GO:0043066; GO:0043555; GO:0045202; GO:0045597; GO:0045893; GO:0045944; GO:0072574; GO:0106310; GO:2000491	Homo sapiens (Human)
NP_001317370.1	Q15418	reviewed	KS6A1_HUMAN	Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1)	RPS6KA1 MAPKAPK1A RSK1		FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:10679322, PubMed:12213813, PubMed:15117958, PubMed:16223362, PubMed:17360704, PubMed:18722121, PubMed:26158630, PubMed:35772404, PubMed:9430688). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1, which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:18508509, PubMed:18813292). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:12213813, PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity (PubMed:18508509, PubMed:18813292). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the pre-initiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:16763566). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:15342917). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:10679322, PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:11684016). Mediates induction of hepatocyte prolifration by TGFA through phosphorylation of CEBPB (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (PubMed:18508509, PubMed:18813292). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). In response to mTORC1 activation, phosphorylates EIF4B at 'Ser-406' and 'Ser-422' which stimulates bicarbonate cotransporter SLC4A7 mRNA translation, increasing SLC4A7 protein abundance and function (PubMed:35772404). {ECO:0000269|PubMed:10679322, ECO:0000269|PubMed:11684016, ECO:0000269|PubMed:12213813, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:15342917, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:16763566, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:35772404, ECO:0000269|PubMed:9430688, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.; FUNCTION: (Microbial infection) Promotes the late transcription and translation of viral lytic genes during Kaposi's sarcoma-associated herpesvirus/HHV-8 infection, when constitutively activated. {ECO:0000269|PubMed:30842327}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]	chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0007165; GO:0007268; GO:0030307; GO:0032007; GO:0038202; GO:0043066; GO:0043555; GO:0045202; GO:0045597; GO:0045893; GO:0045944; GO:0072574; GO:0106310; GO:2000491	Homo sapiens (Human)
NP_002944.2	Q15418	reviewed	KS6A1_HUMAN	Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1)	RPS6KA1 MAPKAPK1A RSK1		FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:10679322, PubMed:12213813, PubMed:15117958, PubMed:16223362, PubMed:17360704, PubMed:18722121, PubMed:26158630, PubMed:35772404, PubMed:9430688). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1, which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:18508509, PubMed:18813292). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:12213813, PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity (PubMed:18508509, PubMed:18813292). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the pre-initiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:16763566). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:15342917). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:10679322, PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:11684016). Mediates induction of hepatocyte prolifration by TGFA through phosphorylation of CEBPB (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (PubMed:18508509, PubMed:18813292). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). In response to mTORC1 activation, phosphorylates EIF4B at 'Ser-406' and 'Ser-422' which stimulates bicarbonate cotransporter SLC4A7 mRNA translation, increasing SLC4A7 protein abundance and function (PubMed:35772404). {ECO:0000269|PubMed:10679322, ECO:0000269|PubMed:11684016, ECO:0000269|PubMed:12213813, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:15342917, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:16763566, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:35772404, ECO:0000269|PubMed:9430688, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.; FUNCTION: (Microbial infection) Promotes the late transcription and translation of viral lytic genes during Kaposi's sarcoma-associated herpesvirus/HHV-8 infection, when constitutively activated. {ECO:0000269|PubMed:30842327}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]	chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TOR signaling [GO:0032007]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0007165; GO:0007268; GO:0030307; GO:0032007; GO:0038202; GO:0043066; GO:0043555; GO:0045202; GO:0045597; GO:0045893; GO:0045944; GO:0072574; GO:0106310; GO:2000491	Homo sapiens (Human)
XP_002176743.1	B7FPN1	unreviewed	B7FPN1_PHATC	non-specific serine/threonine protein kinase (EC 2.7.11.1)	PHATRDRAFT_8996			556484			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phaeodactylum tricornutum (strain CCAP 1055/1)
XP_820852.1	Q4E2L0	unreviewed	Q4E2L0_TRYCC	Serine/threonine protein kinase, putative	Tc00.1047053508479.150			353153			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Trypanosoma cruzi (strain CL Brener)
XP_809454.1	Q4D4Z9	unreviewed	Q4D4Z9_TRYCC	Protein kinase A catalytic subunit, putative (EC 2.7.11.1)	Tc00.1047053511269.50			353153	cAMP-dependent protein kinase complex [GO:0005952]	anatomical structure morphogenesis [GO:0009653]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; anatomical structure morphogenesis [GO:0009653]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0009653	Trypanosoma cruzi (strain CL Brener)
XP_001426212.1	A0BJU7	unreviewed	A0BJU7_PARTE	Protein kinase domain-containing protein	GSPATT00029443001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001433856.1	A0C6P2	unreviewed	A0C6P2_PARTE	Protein kinase domain-containing protein	GSPATT00035588001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001435568.1	A0CBK4	unreviewed	A0CBK4_PARTE	Protein kinase domain-containing protein	GSPATT00036954001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001449219.1	A0DFK5	unreviewed	A0DFK5_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00016635001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001436214.1	A0CDF0	unreviewed	A0CDF0_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00007028001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001426136.1	A0BJM1	unreviewed	A0BJM1_PARTE	Protein kinase domain-containing protein	GSPATT00029366001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001435767.1	A0CC53	unreviewed	A0CC53_PARTE	Protein kinase domain-containing protein	GSPATT00037154001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001459454.1	A0E9U0	unreviewed	A0E9U0_PARTE	Protein kinase domain-containing protein	GSPATT00024788001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001452478.1	A0DPW4	unreviewed	A0DPW4_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00002480001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001437951.1	A0CID7	unreviewed	A0CID7_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00007689001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001453666.1	A0DTA2	unreviewed	A0DTA2_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00019962001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001452550.1	A0DQ36	unreviewed	A0DQ36_PARTE	Protein kinase domain-containing protein	GSPATT00002553001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001442698.1	A0CWY4	unreviewed	A0CWY4_PARTE	Protein kinase domain-containing protein	GSPATT00001504001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001452796.1	A0DQT2	unreviewed	A0DQT2_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00002799001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0106310	Paramecium tetraurelia
XP_001442425.1	A0CW61	unreviewed	A0CW61_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00001230001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0106310	Paramecium tetraurelia
XP_001439328.1	A0CMB4	unreviewed	A0CMB4_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00008410001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0106310	Paramecium tetraurelia
XP_001028087.1	I7M4Q4	unreviewed	I7M4Q4_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_00526760			312017			ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0106310	Tetrahymena thermophila (strain SB210)
XP_001346828.1	Q6BGL9	unreviewed	Q6BGL9_PARTE	Chromosome undetermined scaffold_1, whole genome shotgun sequence (Protein kinase, putative)	GSPATT00000560001 PTMB.04c			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001423522.1	Q6BGL9	unreviewed	Q6BGL9_PARTE	Chromosome undetermined scaffold_1, whole genome shotgun sequence (Protein kinase, putative)	GSPATT00000560001 PTMB.04c			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001448631.1	A0DDW7	unreviewed	A0DDW7_PARTE	Protein kinase domain-containing protein	GSPATT00016075001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001459091.1	A0E8S7	unreviewed	A0E8S7_PARTE	Protein kinase domain-containing protein	GSPATT00024424001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001424041.1	A0BDM6	unreviewed	A0BDM6_PARTE	Protein kinase domain-containing protein	GSPATT00027672001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001423123.1	A0BB08	unreviewed	A0BB08_PARTE	Protein kinase domain-containing protein	GSPATT00000160001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001347161.1	Q6BFN6	unreviewed	Q6BFN6_PARTE	Kinase, similar to Sgk1 serine/threonine-protein kinase	PTMB.336c			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001458036.1	A0E5S2	unreviewed	A0E5S2_PARTE	Protein kinase domain-containing protein	GSPATT00003501001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001438610.1	A0CK96	unreviewed	A0CK96_PARTE	Protein kinase domain-containing protein	GSPATT00000926001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001439693.1	A0CNC9	unreviewed	A0CNC9_PARTE	Protein kinase domain-containing protein	GSPATT00008738001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001446226.1	A0D712	unreviewed	A0D712_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00001870001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001450719.1	A0DJV5	unreviewed	A0DJV5_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00017666001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001031387.2	I7LZE3	unreviewed	I7LZE3_TETTS	Serine/Threonine kinase domain protein	TTHERM_00825190			312017	myosin complex [GO:0016459]		myosin complex [GO:0016459]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0016459	Tetrahymena thermophila (strain SB210)
XP_001426528.1	A0BKR3	unreviewed	A0BKR3_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00029761001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001442463.1	A0CW99	unreviewed	A0CW99_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00001268001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001454607.1	A0DVZ3	unreviewed	A0DVZ3_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00020863001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001456072.1	A0E058	unreviewed	A0E058_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00021843001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001027507.2	Q24HP6	unreviewed	Q24HP6_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_01055410			312017	myosin complex [GO:0016459]		myosin complex [GO:0016459]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0016459	Tetrahymena thermophila (strain SB210)
XP_001442536.1	A0CWH2	unreviewed	A0CWH2_PARTE	Protein kinase domain-containing protein	GSPATT00001342001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001455596.1	A0DYT2	unreviewed	A0DYT2_PARTE	Protein kinase domain-containing protein	GSPATT00003167001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001020007.2	Q23TE4	unreviewed	Q23TE4_TETTS	Serine/Threonine kinase domain protein	TTHERM_00666380			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001458902.1	A0E888	unreviewed	A0E888_PARTE	Protein kinase domain-containing protein	GSPATT00024233001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001026768.2	Q24FD5	unreviewed	Q24FD5_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_00865280			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001024711.2	I7LXE3	unreviewed	I7LXE3_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_00616410			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001458943.1	A0E8C9	unreviewed	A0E8C9_PARTE	Protein kinase domain-containing protein	GSPATT00024274001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001429763.1	A0BUZ8	unreviewed	A0BUZ8_PARTE	Protein kinase domain-containing protein	GSPATT00005611001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001438983.1	A0CLB9	unreviewed	A0CLB9_PARTE	Protein kinase domain-containing protein	GSPATT00008134001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001443640.1	A0CZM6	unreviewed	A0CZM6_PARTE	Protein kinase domain-containing protein	GSPATT00011816001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001450629.1	A0DJL5	unreviewed	A0DJL5_PARTE	Protein kinase domain-containing protein	GSPATT00017576001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001462149.1	A0EHI5	unreviewed	A0EHI5_PARTE	Protein kinase domain-containing protein	GSPATT00027100001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001427766.1	A0BPA1	unreviewed	A0BPA1_PARTE	Protein kinase domain-containing protein	GSPATT00005117001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001455942.1	A0DZS8	unreviewed	A0DZS8_PARTE	Protein kinase domain-containing protein	GSPATT00021713001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001457615.1	A0E4K1	unreviewed	A0E4K1_PARTE	Protein kinase domain-containing protein	GSPATT00023393001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001462143.1	A0EHH9	unreviewed	A0EHH9_PARTE	Protein kinase domain-containing protein	GSPATT00027094001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001427769.1	A0BPA4	unreviewed	A0BPA4_PARTE	Protein kinase domain-containing protein	GSPATT00005120001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001455874.1	A0DZL0	unreviewed	A0DZL0_PARTE	Protein kinase domain-containing protein	GSPATT00021645001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001438765.1	A0CKQ1	unreviewed	A0CKQ1_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00001082001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001439848.1	A0CNT4	unreviewed	A0CNT4_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00008893001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0106310	Paramecium tetraurelia
XP_001023012.1	I7M9T3	unreviewed	I7M9T3_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_00348570			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001459917.1	A0EB53	unreviewed	A0EB53_PARTE	Protein kinase domain-containing protein	GSPATT00025254001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001440007.1	A0CP93	unreviewed	A0CP93_PARTE	Protein kinase domain-containing protein	GSPATT00009001001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001429186.1	A0BTC1	unreviewed	A0BTC1_PARTE	Protein kinase domain-containing protein	GSPATT00032020001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001433089.1	A0C4H5	unreviewed	A0C4H5_PARTE	Protein kinase domain-containing protein	GSPATT00035172001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001426034.1	A0BJB9	unreviewed	A0BJB9_PARTE	Protein kinase domain-containing protein	GSPATT00005009001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001455776.1	A0DZB2	unreviewed	A0DZB2_PARTE	Protein kinase domain-containing protein	GSPATT00003348001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001456641.1	A0E1S7	unreviewed	A0E1S7_PARTE	Protein kinase domain-containing protein	GSPATT00022415001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001458576.1	A0E7B2	unreviewed	A0E7B2_PARTE	Protein kinase domain-containing protein	GSPATT00023907001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001032147.2	I7LZP7	unreviewed	I7LZP7_TETTS	Serine/Threonine kinase domain protein	TTHERM_00691820			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001458267.1	A0E6F3	unreviewed	A0E6F3_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00003735001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001434901.1	A0C9N7	unreviewed	A0C9N7_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00006810001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001449616.1	A0DGQ2	unreviewed	A0DGQ2_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00002348001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001433283.1	A0C519	unreviewed	A0C519_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00006385001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001440782.1	A0CRG8	unreviewed	A0CRG8_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00009700001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001436254.1	A0CDJ0	unreviewed	A0CDJ0_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00007068001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001434781.1	A0C9B7	unreviewed	A0C9B7_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00006690001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001423746.1	A0BCT1	unreviewed	A0BCT1_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00004442001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001437415.1	A0CGV1	unreviewed	A0CGV1_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00007458001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001433420.1	A0C5F6	unreviewed	A0C5F6_PARTE	Protein kinase domain-containing protein	GSPATT00006522001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001443168.1	A0CYA4	unreviewed	A0CYA4_PARTE	Protein kinase domain-containing protein	GSPATT00011371001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001015245.2	I7M160	unreviewed	I7M160_TETTS	Serine/Threonine kinase domain protein	TTHERM_00516340			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001438305.1	A0CJE1	unreviewed	A0CJE1_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00000619001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001446929.1	A0D915	unreviewed	A0D915_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00014478001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001442233.1	A0CVL9	unreviewed	A0CVL9_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00011004001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001426480.1	A0BKL5	unreviewed	A0BKL5_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00029713001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001442803.1	A0CX89	unreviewed	A0CX89_PARTE	Protein kinase domain-containing protein	GSPATT00001610001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001453674.1	A0DTB0	unreviewed	A0DTB0_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00019970001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001440561.1	A0CQU7	unreviewed	A0CQU7_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00009512001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001429090.1	A0BT25	unreviewed	A0BT25_PARTE	Protein kinase domain-containing protein	GSPATT00031924001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001460320.1	A0ECA6	unreviewed	A0ECA6_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00025660001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001427654.1	A0BNY9	unreviewed	A0BNY9_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00030895001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001456134.1	A0E0C0	unreviewed	A0E0C0_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00021905001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001437914.1	A0CIA0	unreviewed	A0CIA0_PARTE	Protein kinase domain-containing protein	GSPATT00007652001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001455304.1	A0DXZ0	unreviewed	A0DXZ0_PARTE	Protein kinase domain-containing protein	GSPATT00021531001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001457029.1	A0E2W5	unreviewed	A0E2W5_PARTE	Non-specific serine/threonine protein kinase	GSPATT00022804001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001021794.2	Q23YB5	unreviewed	Q23YB5_TETTS	Serine/Threonine kinase domain protein	TTHERM_00899480			312017	myosin complex [GO:0016459]		myosin complex [GO:0016459]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0016459	Tetrahymena thermophila (strain SB210)
XP_001437941.1	A0CIC7	unreviewed	A0CIC7_PARTE	Uncharacterized protein	GSPATT00007679001			5888	cAMP-dependent protein kinase complex [GO:0005952]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anatomical structure morphogenesis [GO:0009653]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anatomical structure morphogenesis [GO:0009653]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0007189; GO:0009653	Paramecium tetraurelia
XP_001455284.1	A0DXX0	unreviewed	A0DXX0_PARTE	Uncharacterized protein	GSPATT00021511001			5888	cAMP-dependent protein kinase complex [GO:0005952]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anatomical structure morphogenesis [GO:0009653]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anatomical structure morphogenesis [GO:0009653]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0007189; GO:0009653	Paramecium tetraurelia
XP_001456997.1	A0E2T3	unreviewed	A0E2T3_PARTE	Uncharacterized protein	GSPATT00022772001			5888	cAMP-dependent protein kinase complex [GO:0005952]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anatomical structure morphogenesis [GO:0009653]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anatomical structure morphogenesis [GO:0009653]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0007189; GO:0009653	Paramecium tetraurelia
XP_001426498.1	A0BKN3	unreviewed	A0BKN3_PARTE	Uncharacterized protein	GSPATT00029731001			5888	cAMP-dependent protein kinase complex [GO:0005952]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anatomical structure morphogenesis [GO:0009653]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anatomical structure morphogenesis [GO:0009653]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0007189; GO:0009653	Paramecium tetraurelia
XP_001455269.1	A0DXV5	unreviewed	A0DXV5_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00021496001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001456972.1	A0E2Q8	unreviewed	A0E2Q8_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00022747001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001437961.1	A0CIE7	unreviewed	A0CIE7_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00007699001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001438054.1	A0CIP0	unreviewed	A0CIP0_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00007792001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001455189.1	A0DXM5	unreviewed	A0DXM5_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00021416001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001456891.1	A0E2H7	unreviewed	A0E2H7_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00022666001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001452357.1	A0DPJ3	unreviewed	A0DPJ3_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00019142001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001443892.1	A0D0C8	unreviewed	A0D0C8_PARTE	Uncharacterized protein	GSPATT00012047001			5888	cAMP-dependent protein kinase complex [GO:0005952]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0007189	Paramecium tetraurelia
XP_001025559.2	Q24BY8	unreviewed	Q24BY8_TETTS	cAMP-dependent kinase catalytic subunit	TTHERM_01020820			312017	cAMP-dependent protein kinase complex [GO:0005952]	anatomical structure morphogenesis [GO:0009653]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; anatomical structure morphogenesis [GO:0009653]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0009653	Tetrahymena thermophila (strain SB210)
XP_001449182.1	A0DFG8	unreviewed	A0DFG8_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00016598001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001460680.1	A0EDB6	unreviewed	A0EDB6_PARTE	Protein kinase domain-containing protein	GSPATT00004152001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001441245.1	A0CST1	unreviewed	A0CST1_PARTE	Protein kinase domain-containing protein	GSPATT00010120001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001459310.1	A0E9E6	unreviewed	A0E9E6_PARTE	Protein kinase domain-containing protein	GSPATT00024644001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001427286.1	A0BMX1	unreviewed	A0BMX1_PARTE	Protein kinase domain-containing protein	GSPATT00030525001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001441197.1	A0CSN3	unreviewed	A0CSN3_PARTE	Protein kinase domain-containing protein	GSPATT00010072001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001454389.1	A0DVC5	unreviewed	A0DVC5_PARTE	Protein kinase domain-containing protein	GSPATT00020656001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001460623.1	A0ED59	unreviewed	A0ED59_PARTE	Protein kinase domain-containing protein	GSPATT00004095001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001460539.1	A0ECX5	unreviewed	A0ECX5_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00004011001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001441122.1	A0CSF8	unreviewed	A0CSF8_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00009997001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001460411.1	A0ECJ7	unreviewed	A0ECJ7_PARTE	Protein kinase domain-containing protein	GSPATT00003883001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001441008.1	A0CS44	unreviewed	A0CS44_PARTE	Protein kinase domain-containing protein	GSPATT00009883001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001454236.1	A0DUX2	unreviewed	A0DUX2_PARTE	Protein kinase domain-containing protein	GSPATT00020501001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001462399.1	A0EI85	unreviewed	A0EI85_PARTE	Protein kinase domain-containing protein	GSPATT00027355001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001032442.2	Q22HC2	unreviewed	Q22HC2_TETTS	Serine/Threonine kinase domain protein	TTHERM_00637810			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001460807.1	A0EDP3	unreviewed	A0EDP3_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00025754001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001457433.1	A0E419	unreviewed	A0E419_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00023209001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001453777.1	A0DTL3	unreviewed	A0DTL3_PARTE	Protein kinase	GSPATT00020061001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001456524.1	A0E1G0	unreviewed	A0E1G0_PARTE	Protein kinase domain-containing protein	GSPATT00022296001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001026019.1	Q24DD1	unreviewed	Q24DD1_TETTS	Serine/Threonine kinase domain protein	TTHERM_01126380			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001447448.1	A0DAI4	unreviewed	A0DAI4_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00014958001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001447759.1	A0DBE5	unreviewed	A0DBE5_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00015257001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001428864.1	A0BSE9	unreviewed	A0BSE9_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00031698001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001439415.1	A0CMK1	unreviewed	A0CMK1_PARTE	Protein kinase domain-containing protein	GSPATT00008497001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001444843.1	A0D329	unreviewed	A0D329_PARTE	Protein kinase domain-containing protein	GSPATT00012931001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001435779.1	A0CC65	unreviewed	A0CC65_PARTE	Protein kinase domain-containing protein	GSPATT00037166001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001446627.1	A0D863	unreviewed	A0D863_PARTE	Protein kinase domain-containing protein	GSPATT00014197001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001459666.1	A0EAF2	unreviewed	A0EAF2_PARTE	Protein kinase domain-containing protein	GSPATT00025001001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001440613.1	A0CQZ9	unreviewed	A0CQZ9_PARTE	Protein kinase domain-containing protein	GSPATT00038872001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001456532.1	A0E1G8	unreviewed	A0E1G8_PARTE	Protein kinase	GSPATT00022304001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001462268.1	A0EHV4	unreviewed	A0EHV4_PARTE	Protein kinase domain-containing protein	GSPATT00027222001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001435282.1	A0CAR8	unreviewed	A0CAR8_PARTE	Non-specific serine/threonine protein kinase	GSPATT00036666001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001430851.1	A0BY36	unreviewed	A0BY36_PARTE	Non-specific serine/threonine protein kinase	GSPATT00033306001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001446772.1	A0D8K8	unreviewed	A0D8K8_PARTE	Protein kinase domain-containing protein	GSPATT00014321001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001442059.1	A0CV45	unreviewed	A0CV45_PARTE	Protein kinase domain-containing protein	GSPATT00010830001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001431467.1	A0BZV2	unreviewed	A0BZV2_PARTE	Protein kinase domain-containing protein	GSPATT00005921001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001430337.1	A0BWM2	unreviewed	A0BWM2_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00032791001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001441828.1	A0CUG4	unreviewed	A0CUG4_PARTE	Protein kinase domain-containing protein	GSPATT00010631001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001453282.1	A0DS68	unreviewed	A0DS68_PARTE	Protein kinase domain-containing protein	GSPATT00019589001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001425164.1	A0BGU9	unreviewed	A0BGU9_PARTE	Protein kinase domain-containing protein	GSPATT00028801001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001434202.1	A0C7N8	unreviewed	A0C7N8_PARTE	Protein kinase domain-containing protein	GSPATT00035935001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001432136.1	A0C1S2	unreviewed	A0C1S2_PARTE	Protein kinase domain-containing protein	GSPATT00034216001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001426240.1	A0BJX5	unreviewed	A0BJX5_PARTE	Protein kinase domain-containing protein	GSPATT00029472001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001457896.1	A0E5D2	unreviewed	A0E5D2_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00023676001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001454175.1	A0DUR1	unreviewed	A0DUR1_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00020450001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001424006.1	A0BDJ1	unreviewed	A0BDJ1_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00027637001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001433533.1	A0C5R9	unreviewed	A0C5R9_PARTE	Protein kinase domain-containing protein	GSPATT00035265001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001459025.1	A0E8L1	unreviewed	A0E8L1_PARTE	Protein kinase domain-containing protein	GSPATT00024357001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001448563.1	A0DDP9	unreviewed	A0DDP9_PARTE	Protein kinase domain-containing protein	GSPATT00016007001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001450089.1	A0DI25	unreviewed	A0DI25_PARTE	Protein kinase domain-containing protein	GSPATT00017063001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001430309.1	A0BWJ4	unreviewed	A0BWJ4_PARTE	Protein kinase domain-containing protein	GSPATT00032763001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001437858.1	A0CI44	unreviewed	A0CI44_PARTE	Protein kinase domain-containing protein	GSPATT00038565001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001450839.1	A0DK75	unreviewed	A0DK75_PARTE	Protein kinase domain-containing protein	GSPATT00017771001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001436903.1	A0CFD9	unreviewed	A0CFD9_PARTE	Protein kinase domain-containing protein	GSPATT00037945001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001007481.2	Q22P73	unreviewed	Q22P73_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_00369640			312017	cAMP-dependent protein kinase complex [GO:0005952]		cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952	Tetrahymena thermophila (strain SB210)
XP_001031797.2	I7MFQ7	unreviewed	I7MFQ7_TETTS	Serine/Threonine kinase domain protein	TTHERM_00723190			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001456271.1	A0E0Q7	unreviewed	A0E0Q7_PARTE	Protein kinase domain-containing protein	GSPATT00022042001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001454992.1	A0DX28	unreviewed	A0DX28_PARTE	Protein kinase domain-containing protein	GSPATT00021227001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001437129.1	A0CG15	unreviewed	A0CG15_PARTE	Protein kinase domain-containing protein	GSPATT00038175001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001424500.1	A0BEY5	unreviewed	A0BEY5_PARTE	Protein kinase domain-containing protein	GSPATT00028137001			5888	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0016459	Paramecium tetraurelia
XP_001455101.1	A0DXD7	unreviewed	A0DXD7_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00021337001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001435420.1	A0CB56	unreviewed	A0CB56_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00036806001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0030553; GO:0035556	Paramecium tetraurelia
XP_047297952.1	A0AAU7BMN7	unreviewed	A0AAU7BMN7_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA6			9606		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0035556	Homo sapiens (Human)
XP_047297953.1	A0AAU7BMN7	unreviewed	A0AAU7BMN7_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA6			9606		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0035556	Homo sapiens (Human)
XP_054182825.1	A0AAU7BMN7	unreviewed	A0AAU7BMN7_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA6			9606		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0035556	Homo sapiens (Human)
NP_001317441.1	Q9UK32	reviewed	KS6A6_HUMAN	Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4)	RPS6KA6 RSK4		FUNCTION: Constitutively active serine/threonine-protein kinase that exhibits growth-factor-independent kinase activity and that may participate in p53/TP53-dependent cell growth arrest signaling and play an inhibitory role during embryogenesis. {ECO:0000269|PubMed:15042092, ECO:0000269|PubMed:15632195}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; ribosomal protein S6 kinase activity [GO:0004711]; central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001650; GO:0004672; GO:0004711; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0007165; GO:0007417; GO:0030330; GO:0038202; GO:0045992; GO:0070373; GO:0106310; GO:2000381	Homo sapiens (Human)
NP_001317441.1	A0AAU7BN28	unreviewed	A0AAU7BN28_HUMAN	Ribosomal protein S6 kinase (EC 2.7.11.1)	RPS6KA6			9606		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0035556	Homo sapiens (Human)
NP_055311.1	Q9UK32	reviewed	KS6A6_HUMAN	Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4)	RPS6KA6 RSK4		FUNCTION: Constitutively active serine/threonine-protein kinase that exhibits growth-factor-independent kinase activity and that may participate in p53/TP53-dependent cell growth arrest signaling and play an inhibitory role during embryogenesis. {ECO:0000269|PubMed:15042092, ECO:0000269|PubMed:15632195}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; ribosomal protein S6 kinase activity [GO:0004711]; central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001650; GO:0004672; GO:0004711; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0007165; GO:0007417; GO:0030330; GO:0038202; GO:0045992; GO:0070373; GO:0106310; GO:2000381	Homo sapiens (Human)
XP_011529219.1	Q9UK32	reviewed	KS6A6_HUMAN	Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4)	RPS6KA6 RSK4		FUNCTION: Constitutively active serine/threonine-protein kinase that exhibits growth-factor-independent kinase activity and that may participate in p53/TP53-dependent cell growth arrest signaling and play an inhibitory role during embryogenesis. {ECO:0000269|PubMed:15042092, ECO:0000269|PubMed:15632195}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; ribosomal protein S6 kinase activity [GO:0004711]; central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001650; GO:0004672; GO:0004711; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0007165; GO:0007417; GO:0030330; GO:0038202; GO:0045992; GO:0070373; GO:0106310; GO:2000381	Homo sapiens (Human)
XP_011529219.1	A0AAU7BN28	unreviewed	A0AAU7BN28_HUMAN	Ribosomal protein S6 kinase (EC 2.7.11.1)	RPS6KA6			9606		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0035556	Homo sapiens (Human)
XP_054182824.1	Q9UK32	reviewed	KS6A6_HUMAN	Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4)	RPS6KA6 RSK4		FUNCTION: Constitutively active serine/threonine-protein kinase that exhibits growth-factor-independent kinase activity and that may participate in p53/TP53-dependent cell growth arrest signaling and play an inhibitory role during embryogenesis. {ECO:0000269|PubMed:15042092, ECO:0000269|PubMed:15632195}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; ribosomal protein S6 kinase activity [GO:0004711]; central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001650; GO:0004672; GO:0004711; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0007165; GO:0007417; GO:0030330; GO:0038202; GO:0045992; GO:0070373; GO:0106310; GO:2000381	Homo sapiens (Human)
XP_054182824.1	A0AAU7BN28	unreviewed	A0AAU7BN28_HUMAN	Ribosomal protein S6 kinase (EC 2.7.11.1)	RPS6KA6			9606		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0035556	Homo sapiens (Human)
XP_001428411.1	A0BR46	unreviewed	A0BR46_PARTE	Protein kinase domain-containing protein	GSPATT00031242001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001431227.1	A0BZ62	unreviewed	A0BZ62_PARTE	Protein kinase domain-containing protein	GSPATT00033682001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001022619.2	Q240P0	unreviewed	Q240P0_TETTS	Serine/Threonine kinase domain protein	TTHERM_00624920			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001428315.1	A0BQV0	unreviewed	A0BQV0_PARTE	Protein kinase domain-containing protein	GSPATT00031146001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_977242.2	Q22LX8	unreviewed	Q22LX8_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_00040400			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001445944.1	A0D680	unreviewed	A0D680_PARTE	Protein kinase domain-containing protein	GSPATT00013977001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001424223.1	A0BE58	unreviewed	A0BE58_PARTE	cGMP-dependent protein kinase (EC 2.7.11.12)	GSPATT00027857001			5888	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	GO:0004691; GO:0004692; GO:0005524; GO:0005737; GO:0005952; GO:0007189; GO:0012505; GO:0030553; GO:0046872	Paramecium tetraurelia
XP_001023073.3	I7M3B5	unreviewed	I7M3B5_TETTS	cGMP-dependent protein kinase (EC 2.7.11.12)	TTHERM_00351160			312017	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]		cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	GO:0004691; GO:0004692; GO:0005524; GO:0005737; GO:0005952; GO:0012505; GO:0030553; GO:0046872	Tetrahymena thermophila (strain SB210)
XP_001452166.1	A0DP02	unreviewed	A0DP02_PARTE	cGMP-dependent protein kinase (EC 2.7.11.12)	GSPATT00018965001			5888	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	GO:0004691; GO:0004692; GO:0005524; GO:0005737; GO:0005952; GO:0007189; GO:0012505; GO:0030553; GO:0046872	Paramecium tetraurelia
XP_001012302.2	Q234E6	unreviewed	Q234E6_TETTS	cGMP-dependent protein kinase (EC 2.7.11.12)	TTHERM_00105520			312017	cAMP-dependent protein kinase complex [GO:0005952]; endomembrane system [GO:0012505]		cAMP-dependent protein kinase complex [GO:0005952]; endomembrane system [GO:0012505]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	GO:0004691; GO:0004692; GO:0005524; GO:0005952; GO:0012505; GO:0030553; GO:0046872	Tetrahymena thermophila (strain SB210)
XP_001017123.2	Q23KG5	unreviewed	Q23KG5_TETTS	cGMP-dependent protein kinase (EC 2.7.11.12)	TTHERM_00193700			312017	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]		cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	GO:0004691; GO:0004692; GO:0005524; GO:0005737; GO:0005952; GO:0012505; GO:0030553; GO:0046872	Tetrahymena thermophila (strain SB210)
XP_001456785.1	A0E271	unreviewed	A0E271_PARTE	Non-specific serine/threonine protein kinase	GSPATT00022560001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001454476.1	A0DVL2	unreviewed	A0DVL2_PARTE	Protein kinase domain-containing protein	GSPATT00020732001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001455977.1	A0DZW3	unreviewed	A0DZW3_PARTE	Protein kinase domain-containing protein	GSPATT00021748001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001427505.1	A0BNJ0	unreviewed	A0BNJ0_PARTE	Protein kinase domain-containing protein	GSPATT00030745001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001461324.1	A0EF60	unreviewed	A0EF60_PARTE	Protein kinase domain-containing protein	GSPATT00026274001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001457555.1	A0E4E1	unreviewed	A0E4E1_PARTE	Protein kinase domain-containing protein	GSPATT00023332001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001461412.1	A0EFE8	unreviewed	A0EFE8_PARTE	Protein kinase domain-containing protein	GSPATT00026362001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001427431.1	A0BNB6	unreviewed	A0BNB6_PARTE	Protein kinase domain-containing protein	GSPATT00030671001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001455855.1	A0DZJ1	unreviewed	A0DZJ1_PARTE	Protein kinase domain-containing protein	GSPATT00021625001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001457534.1	A0E4C0	unreviewed	A0E4C0_PARTE	Protein kinase domain-containing protein	GSPATT00023311001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001427414.1	A0BN99	unreviewed	A0BN99_PARTE	Protein kinase domain-containing protein	GSPATT00030654001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001461434.1	A0EFH0	unreviewed	A0EFH0_PARTE	Protein kinase domain-containing protein	GSPATT00026384001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001451887.1	A0DN73	unreviewed	A0DN73_PARTE	Protein kinase domain-containing protein	GSPATT00018695001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001462550.1	A0EIN6	unreviewed	A0EIN6_PARTE	Protein kinase domain-containing protein	GSPATT00027506001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001426615.1	A0BL00	unreviewed	A0BL00_PARTE	Protein kinase domain-containing protein	GSPATT00029848001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001428156.1	A0BQE1	unreviewed	A0BQE1_PARTE	Protein kinase domain-containing protein	GSPATT00030987001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001425565.1	A0BI00	unreviewed	A0BI00_PARTE	Protein kinase domain-containing protein	GSPATT00029203001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001431826.1	A0C0W1	unreviewed	A0C0W1_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00033904001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001430079.1	A0BVW4	unreviewed	A0BVW4_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00032533001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001434510.1	A0C8J6	unreviewed	A0C8J6_PARTE	Protein kinase domain-containing protein	GSPATT00036247001			5888	cytoplasm [GO:0005737]	protein refolding [GO:0042026]; response to heat [GO:0009408]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; Hsp70 protein binding [GO:0030544]; protein serine/threonine kinase activity [GO:0004674]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; protein refolding [GO:0042026]; response to heat [GO:0009408]	ATP binding [GO:0005524]; Hsp70 protein binding [GO:0030544]; protein serine/threonine kinase activity [GO:0004674]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0005737; GO:0008270; GO:0009408; GO:0030544; GO:0042026; GO:0051082; GO:0051087	Paramecium tetraurelia
XP_001443796.1	A0D032	unreviewed	A0D032_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00039147001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001429990.1	A0BVM5	unreviewed	A0BVM5_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00032444001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001433934.1	A0C6X0	unreviewed	A0C6X0_PARTE	Protein kinase domain-containing protein	GSPATT00035666001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001431309.1	A0BZE4	unreviewed	A0BZE4_PARTE	Protein kinase domain-containing protein	GSPATT00033764001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001434502.1	A0C8I8	unreviewed	A0C8I8_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00036238001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001459707.1	A0EAJ3	unreviewed	A0EAJ3_PARTE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSPATT00025044001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001431377.1	A0BZL2	unreviewed	A0BZL2_PARTE	Protein kinase domain-containing protein	GSPATT00033832001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001430252.1	A0BWD7	unreviewed	A0BWD7_PARTE	Protein kinase domain-containing protein	GSPATT00032706001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001424776.1	A0BFR1	unreviewed	A0BFR1_PARTE	Protein kinase domain-containing protein	GSPATT00028413001			5888	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Paramecium tetraurelia
XP_001013155.2	I7MID1	unreviewed	I7MID1_TETTS	Serine/Threonine kinase domain protein	TTHERM_00295230			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001031601.2	I7M5Z9	unreviewed	I7M5Z9_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_00773480			312017		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Tetrahymena thermophila (strain SB210)
XP_044556756.1	A0A6A5BB26	unreviewed	A0A6A5BB26_NAEFO	non-specific serine/threonine protein kinase (EC 2.7.11.1)	FDP41_009737			5763			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Naegleria fowleri (Brain eating amoeba)
XP_001021692.2	I7M2W8	unreviewed	I7M2W8_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_00151590			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_012897450.1	D8M5R3	unreviewed	D8M5R3_BLAHO	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSBLH_T00003285001			12968			ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0106310	Blastocystis hominis
XP_009515908.1	G4YPN6	unreviewed	G4YPN6_PHYSP	AGC protein kinase	PHYSODRAFT_284310			1094619			ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035091	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009527483.1	G4ZEG0	unreviewed	G4ZEG0_PHYSP	Cyclic AMP-dependent protein kinase-like protein catalytic subunit	PHYSODRAFT_559273			1094619	cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]	anatomical structure morphogenesis [GO:0009653]	cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; anatomical structure morphogenesis [GO:0009653]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0009653	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_018636458.1	S8EX88	unreviewed	S8EX88_TOXGM	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TGME49_291050			508771	cytoplasm [GO:0005737]	intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0035556; GO:0106310	Toxoplasma gondii (strain ATCC 50611 / Me49)
NP_997401.1	P17612	reviewed	KAPCA_HUMAN	cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11)	PRKACA PKACA		FUNCTION: Phosphorylates a large number of substrates in the cytoplasm and the nucleus (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984, PubMed:21852232, PubMed:31112131). Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, histone H1.4 (H1-4), PSMC5/RPT6, PJA2, RYR2, RORA, SOX9, UHRF1 and VASP (PubMed:15178447, PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:21423175). RORA is activated by phosphorylation (PubMed:21514275). Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts (PubMed:19949837). Involved in chondrogenesis by mediating phosphorylation of SOX9 (By similarity). Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP (PubMed:15642694, PubMed:20356841). Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated (PubMed:17333334). RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+) (PubMed:17693412). PSMC5/RPT6 activation by phosphorylation stimulates proteasome (PubMed:17565987). Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation (PubMed:15905176). NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding (PubMed:15642694). Required for phosphorylation of GLI transcription factors which inhibits them and prevents transcriptional activation of Hedgehog signaling pathway target genes (By similarity). GLI transcription factor phosphorylation is inhibited by interaction of PRKACA with SMO which sequesters PRKACA at the cell membrane (By similarity). Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis most probably through the regulation of OFD1 in ciliogenesis (PubMed:33934390). Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation (By similarity). May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT) (By similarity). Phosphorylates APOBEC3G and AICDA (PubMed:16387847, PubMed:18836454). Phosphorylates HSF1; this phosphorylation promotes HSF1 nuclear localization and transcriptional activity upon heat shock (PubMed:21085490). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). Phosphorylates AKAP19 (PubMed:27028580). {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P27791, ECO:0000269|PubMed:15178447, ECO:0000269|PubMed:15642694, ECO:0000269|PubMed:15905176, ECO:0000269|PubMed:16387847, ECO:0000269|PubMed:17333334, ECO:0000269|PubMed:17565987, ECO:0000269|PubMed:17693412, ECO:0000269|PubMed:18836454, ECO:0000269|PubMed:19949837, ECO:0000269|PubMed:20356841, ECO:0000269|PubMed:21085490, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21514275, ECO:0000269|PubMed:21812984, ECO:0000269|PubMed:21852232, ECO:0000269|PubMed:27028580, ECO:0000269|PubMed:31112131, ECO:0000269|PubMed:33934390}.; FUNCTION: [Isoform 2]: Phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation. {ECO:0000250|UniProtKB:P05132}.	9606	acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP/PKA signal transduction [GO:0141156]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; intracellular potassium ion homeostasis [GO:0030007]; mesoderm formation [GO:0001707]; mitochondrial protein catabolic process [GO:0035694]; mRNA processing [GO:0006397]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein export from nucleus [GO:0006611]; protein localization to lipid droplet [GO:1990044]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; channel activator activity [GO:0099103]; histone H1-4S35 kinase activity [GO:0140198]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; potassium channel inhibitor activity [GO:0019870]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP/PKA signal transduction [GO:0141156]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; intracellular potassium ion homeostasis [GO:0030007]; mesoderm formation [GO:0001707]; mitochondrial protein catabolic process [GO:0035694]; mRNA processing [GO:0006397]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein export from nucleus [GO:0006611]; protein localization to lipid droplet [GO:1990044]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; channel activator activity [GO:0099103]; histone H1-4S35 kinase activity [GO:0140198]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; potassium channel inhibitor activity [GO:0019870]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0003091; GO:0004674; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006397; GO:0006611; GO:0007189; GO:0007193; GO:0010881; GO:0016241; GO:0016607; GO:0019221; GO:0019870; GO:0019901; GO:0019904; GO:0021904; GO:0030007; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0032024; GO:0032703; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035694; GO:0036126; GO:0044853; GO:0045542; GO:0045667; GO:0045722; GO:0045879; GO:0046827; GO:0048240; GO:0048471; GO:0050766; GO:0050850; GO:0051726; GO:0055117; GO:0061136; GO:0070062; GO:0070417; GO:0070507; GO:0070613; GO:0071333; GO:0071374; GO:0071377; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0097700; GO:0098794; GO:0098978; GO:0099103; GO:0099170; GO:0106310; GO:0120186; GO:0140198; GO:0141156; GO:1903779; GO:1904262; GO:1904539; GO:1990044; GO:2000810	Homo sapiens (Human)
NP_997401.1	A8K8B9	unreviewed	A8K8B9_HUMAN	cAMP-dependent protein kinase catalytic subunit alpha (EC 2.7.11.11)				9606	mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]		mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005634; GO:0005739; GO:0005886	Homo sapiens (Human)
NP_002721.1	P17612	reviewed	KAPCA_HUMAN	cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11)	PRKACA PKACA		FUNCTION: Phosphorylates a large number of substrates in the cytoplasm and the nucleus (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984, PubMed:21852232, PubMed:31112131). Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, histone H1.4 (H1-4), PSMC5/RPT6, PJA2, RYR2, RORA, SOX9, UHRF1 and VASP (PubMed:15178447, PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:21423175). RORA is activated by phosphorylation (PubMed:21514275). Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts (PubMed:19949837). Involved in chondrogenesis by mediating phosphorylation of SOX9 (By similarity). Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP (PubMed:15642694, PubMed:20356841). Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated (PubMed:17333334). RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+) (PubMed:17693412). PSMC5/RPT6 activation by phosphorylation stimulates proteasome (PubMed:17565987). Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation (PubMed:15905176). NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding (PubMed:15642694). Required for phosphorylation of GLI transcription factors which inhibits them and prevents transcriptional activation of Hedgehog signaling pathway target genes (By similarity). GLI transcription factor phosphorylation is inhibited by interaction of PRKACA with SMO which sequesters PRKACA at the cell membrane (By similarity). Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis most probably through the regulation of OFD1 in ciliogenesis (PubMed:33934390). Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation (By similarity). May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT) (By similarity). Phosphorylates APOBEC3G and AICDA (PubMed:16387847, PubMed:18836454). Phosphorylates HSF1; this phosphorylation promotes HSF1 nuclear localization and transcriptional activity upon heat shock (PubMed:21085490). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). Phosphorylates AKAP19 (PubMed:27028580). {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P27791, ECO:0000269|PubMed:15178447, ECO:0000269|PubMed:15642694, ECO:0000269|PubMed:15905176, ECO:0000269|PubMed:16387847, ECO:0000269|PubMed:17333334, ECO:0000269|PubMed:17565987, ECO:0000269|PubMed:17693412, ECO:0000269|PubMed:18836454, ECO:0000269|PubMed:19949837, ECO:0000269|PubMed:20356841, ECO:0000269|PubMed:21085490, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21514275, ECO:0000269|PubMed:21812984, ECO:0000269|PubMed:21852232, ECO:0000269|PubMed:27028580, ECO:0000269|PubMed:31112131, ECO:0000269|PubMed:33934390}.; FUNCTION: [Isoform 2]: Phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation. {ECO:0000250|UniProtKB:P05132}.	9606	acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP/PKA signal transduction [GO:0141156]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; intracellular potassium ion homeostasis [GO:0030007]; mesoderm formation [GO:0001707]; mitochondrial protein catabolic process [GO:0035694]; mRNA processing [GO:0006397]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein export from nucleus [GO:0006611]; protein localization to lipid droplet [GO:1990044]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; channel activator activity [GO:0099103]; histone H1-4S35 kinase activity [GO:0140198]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; potassium channel inhibitor activity [GO:0019870]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP/PKA signal transduction [GO:0141156]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; intracellular potassium ion homeostasis [GO:0030007]; mesoderm formation [GO:0001707]; mitochondrial protein catabolic process [GO:0035694]; mRNA processing [GO:0006397]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein export from nucleus [GO:0006611]; protein localization to lipid droplet [GO:1990044]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; channel activator activity [GO:0099103]; histone H1-4S35 kinase activity [GO:0140198]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; potassium channel inhibitor activity [GO:0019870]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0003091; GO:0004674; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006397; GO:0006611; GO:0007189; GO:0007193; GO:0010881; GO:0016241; GO:0016607; GO:0019221; GO:0019870; GO:0019901; GO:0019904; GO:0021904; GO:0030007; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0032024; GO:0032703; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035694; GO:0036126; GO:0044853; GO:0045542; GO:0045667; GO:0045722; GO:0045879; GO:0046827; GO:0048240; GO:0048471; GO:0050766; GO:0050850; GO:0051726; GO:0055117; GO:0061136; GO:0070062; GO:0070417; GO:0070507; GO:0070613; GO:0071333; GO:0071374; GO:0071377; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0097700; GO:0098794; GO:0098978; GO:0099103; GO:0099170; GO:0106310; GO:0120186; GO:0140198; GO:0141156; GO:1903779; GO:1904262; GO:1904539; GO:1990044; GO:2000810	Homo sapiens (Human)
XP_821623.1	Q4E4S9	unreviewed	Q4E4S9_TRYCC	Protein kinase A catalytic subunit isoform 1, putative	Tc00.1047053508461.310			353153	cAMP-dependent protein kinase complex [GO:0005952]	anatomical structure morphogenesis [GO:0009653]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; anatomical structure morphogenesis [GO:0009653]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0009653	Trypanosoma cruzi (strain CL Brener)
XP_042924431.1	A0A2K3DRF7	unreviewed	A0A2K3DRF7_CHLRE	non-specific serine/threonine protein kinase (EC 2.7.11.1)	CHLRE_06g306950v5			3055		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270; GO:0035556	Chlamydomonas reinhardtii (Chlamydomonas smithii)
XP_009521962.1	G4Z2A1	unreviewed	G4Z2A1_PHYSP	G protein-coupled receptor kinase	PHYSODRAFT_297885			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009522551.1	G4ZAP8	unreviewed	G4ZAP8_PHYSP	AGC protein kinase	PHYSODRAFT_354246			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009522551.1	F4ZVD9	unreviewed	F4ZVD9_PHYSO	Protein kinase 141814 isoform 1	141814			67593			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009521882.1	G4Z9Q1	unreviewed	G4Z9Q1_PHYSP	Protein kinase domain-containing protein	PHYSODRAFT_494608			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009521926.1	G4ZAL2	unreviewed	G4ZAL2_PHYSP	Protein kinase domain-containing protein	PHYSODRAFT_345221			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009522184.1	G4Z521	unreviewed	G4Z521_PHYSP	AGC protein kinase	PHYSODRAFT_558276			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009534227.1	G5A3E1	unreviewed	G5A3E1_PHYSP	AGC protein kinase	PHYSODRAFT_288412			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009533395.1	G5A148	unreviewed	G5A148_PHYSP	Protein kinase domain-containing protein	PHYSODRAFT_519825			1094619		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009514785.1	G4YIC7	unreviewed	G4YIC7_PHYSP	non-specific serine/threonine protein kinase (EC 2.7.11.1)	PHYSODRAFT_554026			1094619			ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0106310	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_001023881.2	Q245J7	unreviewed	Q245J7_TETTS	Serine/Threonine kinase domain protein	TTHERM_00248510			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001031819.1	I7LZL5	unreviewed	I7LZL5_TETTS	Serine/Threonine kinase domain protein	TTHERM_00723410			312017	myosin complex [GO:0016459]		myosin complex [GO:0016459]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0016459	Tetrahymena thermophila (strain SB210)
XP_001011355.2	Q231C9	unreviewed	Q231C9_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_00431300			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001008382.2	Q22RI5	unreviewed	Q22RI5_TETTS	Serine/Threonine kinase domain protein	TTHERM_00016020			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
NP_013822.1	P18961	reviewed	YPK2_YEAST	Serine/threonine-protein kinase YPK2/YKR2 (EC 2.7.11.1)	YPK2 YKR2 YMR104C YM9718.03C		FUNCTION: Plays an essential role in the proliferation of yeast cells (PubMed:8437590). Involved in a signaling pathway, required for optimal cell wall integrity, that acts in parallel with the PKC1-SLT2-dependent pathway (PubMed:12221112). A substrate of TOR complex 2 (TORC2) and required for TORC2 to regulate spatial aspects of cell growth (PubMed:16055732). Phosphorylation of residue Thr-501 is indispensable for function. May act as a downstream kinase in the sphingolipid-mediated signaling pathway (PubMed:39490931). {ECO:0000269|PubMed:12221112, ECO:0000269|PubMed:16055732, ECO:0000269|PubMed:39490931, ECO:0000269|PubMed:8437590}.	559292	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]	cell wall organization [GO:0071555]; eisosome assembly [GO:0070941]; regulation of cell shape [GO:0008360]; regulation of fungal-type cell wall organization [GO:0060237]; sphingolipid metabolic process [GO:0006665]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell wall organization [GO:0071555]; eisosome assembly [GO:0070941]; regulation of cell shape [GO:0008360]; regulation of fungal-type cell wall organization [GO:0060237]; sphingolipid metabolic process [GO:0006665]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006665; GO:0008360; GO:0016020; GO:0060237; GO:0070941; GO:0071555; GO:0106310	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
NP_005618.2	O00141	reviewed	SGK1_HUMAN	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	SGK1 SGK		FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cellular enzymes, transcription factors, neuronal excitability, cell growth, proliferation, survival, migration and apoptosis. Plays an important role in cellular stress response. Contributes to regulation of renal Na(+) retention, renal K(+) elimination, salt appetite, gastric acid secretion, intestinal Na(+)/H(+) exchange and nutrient transport, insulin-dependent salt sensitivity of blood pressure, salt sensitivity of peripheral glucose uptake, cardiac repolarization and memory consolidation. Up-regulates Na(+) channels: SCNN1A/ENAC, SCN5A and ASIC1/ACCN2, K(+) channels: KCNJ1/ROMK1, KCNA1-5, KCNQ1-5 and KCNE1, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channels: BSND, CLCN2 and CFTR, glutamate transporters: SLC1A3/EAAT1, SLC1A2 /EAAT2, SLC1A1/EAAT3, SLC1A6/EAAT4 and SLC1A7/EAAT5, amino acid transporters: SLC1A5/ASCT2, SLC38A1/SN1 and SLC6A19, creatine transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, glutamate receptor: GRIK2/GLUR6. Up-regulates carriers: SLC9A3/NHE3, SLC12A1/NKCC2, SLC12A3/NCC, SLC5A3/SMIT, SLC2A1/GLUT1, SLC5A1/SGLT1 and SLC15A2/PEPT2. Regulates enzymes: GSK3A/B, PMM2 and Na(+)/K(+) ATPase, and transcription factors: CTNNB1 and nuclear factor NF-kappa-B. Stimulates sodium transport into epithelial cells by enhancing the stability and expression of SCNN1A/ENAC. This is achieved by phosphorylating the NEDD4L ubiquitin E3 ligase, promoting its interaction with 14-3-3 proteins, thereby preventing it from binding to SCNN1A/ENAC and targeting it for degradation. Regulates store-operated Ca(+2) entry (SOCE) by stimulating ORAI1 and STIM1. Regulates KCNJ1/ROMK1 directly via its phosphorylation or indirectly via increased interaction with SLC9A3R2/NHERF2. Phosphorylates MDM2 and activates MDM2-dependent ubiquitination of p53/TP53. Phosphorylates MAPT/TAU and mediates microtubule depolymerization and neurite formation in hippocampal neurons. Phosphorylates SLC2A4/GLUT4 and up-regulates its activity. Phosphorylates APBB1/FE65 and promotes its localization to the nucleus. Phosphorylates MAPK1/ERK2 and activates it by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Phosphorylates FBXW7 and plays an inhibitory role in the NOTCH1 signaling. Phosphorylates FOXO1 resulting in its relocalization from the nucleus to the cytoplasm. Phosphorylates FOXO3, promoting its exit from the nucleus and interference with FOXO3-dependent transcription. Phosphorylates BRAF and MAP3K3/MEKK3 and inhibits their activity. Phosphorylates SLC9A3/NHE3 in response to dexamethasone, resulting in its activation and increased localization at the cell membrane. Phosphorylates CREB1. Necessary for vascular remodeling during angiogenesis. Sustained high levels and activity may contribute to conditions such as hypertension and diabetic nephropathy. Isoform 2 exhibited a greater effect on cell plasma membrane expression of SCNN1A/ENAC and Na(+) transport than isoform 1. {ECO:0000269|PubMed:11154281, ECO:0000269|PubMed:11410590, ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12761204, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14623317, ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15234985, ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15733869, ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:15888551, ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16443776, ECO:0000269|PubMed:16982696, ECO:0000269|PubMed:17382906, ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:18304449, ECO:0000269|PubMed:18753299, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:19756449, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:20730100, ECO:0000269|PubMed:21865597}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006814; GO:0006915; GO:0006974; GO:0007616; GO:0008217; GO:0015459; GO:0016607; GO:0017080; GO:0017081; GO:0032411; GO:0035556; GO:0042127; GO:0042981; GO:0048812; GO:0050790; GO:0051090; GO:0060453; GO:0070294; GO:0106310; GO:1901796; GO:1904045	Homo sapiens (Human)
XP_009528946.1	G4ZK80	unreviewed	G4ZK80_PHYSP	non-specific serine/threonine protein kinase (EC 2.7.11.1)	PHYSODRAFT_561119			1094619			ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035091; GO:0106310	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009514608.1	G4YEW9	unreviewed	G4YEW9_PHYSP	AGC/AKT protein kinase	PHYSODRAFT_444009			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009525581.1	G4ZDZ8	unreviewed	G4ZDZ8_PHYSP	non-specific serine/threonine protein kinase (EC 2.7.11.1)	PHYSODRAFT_350990			1094619			ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0106310	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
NP_012371.2	P06244	reviewed	KAPA_YEAST	cAMP-dependent protein kinase type 1 (PKA 1) (EC 2.7.11.11) (CDC25-suppressing protein kinase) (PK-25)	TPK1 PKA1 SRA3 YJL164C J0541			559292	cAMP-dependent protein kinase complex [GO:0005952]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of cytoplasmic mRNA processing body assembly [GO:0010607]; protein import into nucleus [GO:0006606]; protein kinase A signaling [GO:0010737]; Ras protein signal transduction [GO:0007265]; regulation of macroautophagy [GO:0016241]	cAMP-dependent protein kinase complex [GO:0005952]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of cytoplasmic mRNA processing body assembly [GO:0010607]; protein import into nucleus [GO:0006606]; protein kinase A signaling [GO:0010737]; Ras protein signal transduction [GO:0007265]; regulation of macroautophagy [GO:0016241]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]	GO:0000785; GO:0004672; GO:0004691; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005952; GO:0006303; GO:0006606; GO:0007189; GO:0007265; GO:0010607; GO:0010737; GO:0016241; GO:0051301; GO:0106310	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
NP_012755.1	P05986	reviewed	KAPC_YEAST	cAMP-dependent protein kinase type 3 (PKA 3) (EC 2.7.11.11)	TPK3 PKA3 YKL166C YKL630			559292	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G1 to G0 transition [GO:0070314]; mitochondrion organization [GO:0007005]; negative regulation of cytoplasmic mRNA processing body assembly [GO:0010607]; negative regulation of cytoplasmic translation [GO:2000766]; protein kinase A signaling [GO:0010737]; Ras protein signal transduction [GO:0007265]	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G1 to G0 transition [GO:0070314]; mitochondrion organization [GO:0007005]; negative regulation of cytoplasmic mRNA processing body assembly [GO:0010607]; negative regulation of cytoplasmic translation [GO:2000766]; protein kinase A signaling [GO:0010737]; Ras protein signal transduction [GO:0007265]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]	GO:0000932; GO:0004672; GO:0004691; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005952; GO:0007005; GO:0007189; GO:0007265; GO:0010494; GO:0010607; GO:0010737; GO:0070314; GO:0106310; GO:2000766	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
NP_015121.1	P06245	reviewed	KAPB_YEAST	cAMP-dependent protein kinase type 2 (PKA 2) (EC 2.7.11.11)	TPK2 PKA2 YKR1 YPL203W			559292	cAMP-dependent protein kinase complex [GO:0005952]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to glucose stimulus [GO:0071333]; G1 to G0 transition [GO:0070314]; invasive growth in response to glucose limitation [GO:0001403]; negative regulation of cytoplasmic mRNA processing body assembly [GO:0010607]; negative regulation of cytoplasmic translation [GO:2000766]; protein kinase A signaling [GO:0010737]; Ras protein signal transduction [GO:0007265]	cAMP-dependent protein kinase complex [GO:0005952]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to glucose stimulus [GO:0071333]; G1 to G0 transition [GO:0070314]; invasive growth in response to glucose limitation [GO:0001403]; negative regulation of cytoplasmic mRNA processing body assembly [GO:0010607]; negative regulation of cytoplasmic translation [GO:2000766]; protein kinase A signaling [GO:0010737]; Ras protein signal transduction [GO:0007265]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]	GO:0000785; GO:0000932; GO:0001403; GO:0004672; GO:0004691; GO:0005524; GO:0005634; GO:0005829; GO:0005952; GO:0007189; GO:0007265; GO:0010607; GO:0010737; GO:0070314; GO:0071333; GO:0106310; GO:2000766	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
XP_001450218.1	A0DIF4	unreviewed	A0DIF4_PARTE	Protein kinase domain-containing protein	GSPATT00017193001			5888		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Paramecium tetraurelia
XP_001707242.1	E2RTY0	unreviewed	E2RTY0_GIAIC	Kinase, AGC Akt	GL50803_0011364			184922		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Giardia intestinalis (strain ATCC 50803 / WB clone C6) (Giardia lamblia)
XP_001707242.1	Q9U020	unreviewed	Q9U020_GIAIN	Serine/threonine protein kinase PKB				5741			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Giardia intestinalis (Giardia lamblia)
NP_005391.1	Q02156	reviewed	KPCE_HUMAN	Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon)	PRKCE PKCE		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays essential roles in the regulation of multiple cellular processes linked to cytoskeletal proteins, such as cell adhesion, motility, migration and cell cycle, functions in neuron growth and ion channel regulation, and is involved in immune response, cancer cell invasion and regulation of apoptosis. Mediates cell adhesion to the extracellular matrix via integrin-dependent signaling, by mediating angiotensin-2-induced activation of integrin beta-1 (ITGB1) in cardiac fibroblasts. Phosphorylates MARCKS, which phosphorylates and activates PTK2/FAK, leading to the spread of cardiomyocytes. Involved in the control of the directional transport of ITGB1 in mesenchymal cells by phosphorylating vimentin (VIM), an intermediate filament (IF) protein. In epithelial cells, associates with and phosphorylates keratin-8 (KRT8), which induces targeting of desmoplakin at desmosomes and regulates cell-cell contact. Phosphorylates IQGAP1, which binds to CDC42, mediating epithelial cell-cell detachment prior to migration. In HeLa cells, contributes to hepatocyte growth factor (HGF)-induced cell migration, and in human corneal epithelial cells, plays a critical role in wound healing after activation by HGF. During cytokinesis, forms a complex with YWHAB, which is crucial for daughter cell separation, and facilitates abscission by a mechanism which may implicate the regulation of RHOA. In cardiac myocytes, regulates myofilament function and excitation coupling at the Z-lines, where it is indirectly associated with F-actin via interaction with COPB1. During endothelin-induced cardiomyocyte hypertrophy, mediates activation of PTK2/FAK, which is critical for cardiomyocyte survival and regulation of sarcomere length. Plays a role in the pathogenesis of dilated cardiomyopathy via persistent phosphorylation of troponin I (TNNI3). Involved in nerve growth factor (NFG)-induced neurite outgrowth and neuron morphological change independently of its kinase activity, by inhibition of RHOA pathway, activation of CDC42 and cytoskeletal rearrangement. May be involved in presynaptic facilitation by mediating phorbol ester-induced synaptic potentiation. Phosphorylates gamma-aminobutyric acid receptor subunit gamma-2 (GABRG2), which reduces the response of GABA receptors to ethanol and benzodiazepines and may mediate acute tolerance to the intoxicating effects of ethanol. Upon PMA treatment, phosphorylates the capsaicin- and heat-activated cation channel TRPV1, which is required for bradykinin-induced sensitization of the heat response in nociceptive neurons. Is able to form a complex with PDLIM5 and N-type calcium channel, and may enhance channel activities and potentiates fast synaptic transmission by phosphorylating the pore-forming alpha subunit CACNA1B (CaV2.2). In prostate cancer cells, interacts with and phosphorylates STAT3, which increases DNA-binding and transcriptional activity of STAT3 and seems to be essential for prostate cancer cell invasion. Downstream of TLR4, plays an important role in the lipopolysaccharide (LPS)-induced immune response by phosphorylating and activating TICAM2/TRAM, which in turn activates the transcription factor IRF3 and subsequent cytokines production. In differentiating erythroid progenitors, is regulated by EPO and controls the protection against the TNFSF10/TRAIL-mediated apoptosis, via BCL2. May be involved in the regulation of the insulin-induced phosphorylation and activation of AKT1. Phosphorylates NLRP5/MATER and may thereby modulate AKT pathway activation in cumulus cells (PubMed:19542546). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11884385, ECO:0000269|PubMed:1374067, ECO:0000269|PubMed:15355962, ECO:0000269|PubMed:16757566, ECO:0000269|PubMed:17603037, ECO:0000269|PubMed:17875639, ECO:0000269|PubMed:17875724, ECO:0000269|PubMed:19542546, ECO:0000269|PubMed:21806543, ECO:0000269|PubMed:36040231}.	9606	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]	apoptotic process [GO:0006915]; cell division [GO:0051301]; cell-substrate adhesion [GO:0031589]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; establishment of localization in cell [GO:0051649]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; MAPK cascade [GO:0000165]; mucus secretion [GO:0070254]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transport [GO:1902306]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]; toxin catabolic process [GO:0009407]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]; xenobiotic catabolic process [GO:0042178]	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell-substrate adhesion [GO:0031589]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; establishment of localization in cell [GO:0051649]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; MAPK cascade [GO:0000165]; mucus secretion [GO:0070254]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transport [GO:1902306]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]; toxin catabolic process [GO:0009407]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]; xenobiotic catabolic process [GO:0042178]	14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546]; zinc ion binding [GO:0008270]	GO:0000165; GO:0002281; GO:0003785; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0008047; GO:0008270; GO:0009407; GO:0010634; GO:0010763; GO:0010811; GO:0019899; GO:0030073; GO:0030546; GO:0030838; GO:0031397; GO:0031589; GO:0031663; GO:0032024; GO:0032230; GO:0032467; GO:0032930; GO:0032956; GO:0035276; GO:0035556; GO:0035641; GO:0035669; GO:0038096; GO:0042178; GO:0043123; GO:0043278; GO:0043410; GO:0045111; GO:0045202; GO:0048471; GO:0050996; GO:0051279; GO:0051301; GO:0051649; GO:0051932; GO:0061178; GO:0070254; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0071944; GO:0090303; GO:0106310; GO:1902306; GO:1903078	Homo sapiens (Human)
NP_005391.1	L7RTI5	unreviewed	L7RTI5_HUMAN	Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon)	PRKCE		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays essential roles in the regulation of multiple cellular processes linked to cytoskeletal proteins, such as cell adhesion, motility, migration and cell cycle, functions in neuron growth and ion channel regulation, and is involved in immune response, cancer cell invasion and regulation of apoptosis. Mediates cell adhesion to the extracellular matrix via integrin-dependent signaling, by mediating angiotensin-2-induced activation of integrin beta-1 (ITGB1) in cardiac fibroblasts. Phosphorylates MARCKS, which phosphorylates and activates PTK2/FAK, leading to the spread of cardiomyocytes. Involved in the control of the directional transport of ITGB1 in mesenchymal cells by phosphorylating vimentin (VIM), an intermediate filament (IF) protein. In epithelial cells, associates with and phosphorylates keratin-8 (KRT8), which induces targeting of desmoplakin at desmosomes and regulates cell-cell contact. Phosphorylates IQGAP1, which binds to CDC42, mediating epithelial cell-cell detachment prior to migration. {ECO:0000256|PIRNR:PIRNR000551}.	9606	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cell division [GO:0051301]; cell-substrate adhesion [GO:0031589]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; establishment of localization in cell [GO:0051649]; insulin secretion [GO:0030073]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; MAPK cascade [GO:0000165]; mucus secretion [GO:0070254]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; synaptic transmission, GABAergic [GO:0051932]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; ethanol binding [GO:0035276]; protein serine kinase activity [GO:0106310]; signaling receptor activator activity [GO:0030546]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cell-substrate adhesion [GO:0031589]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; establishment of localization in cell [GO:0051649]; insulin secretion [GO:0030073]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; MAPK cascade [GO:0000165]; mucus secretion [GO:0070254]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; synaptic transmission, GABAergic [GO:0051932]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]	14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; ethanol binding [GO:0035276]; protein serine kinase activity [GO:0106310]; signaling receptor activator activity [GO:0030546]; zinc ion binding [GO:0008270]	GO:0000165; GO:0002281; GO:0003785; GO:0004699; GO:0005524; GO:0005634; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0008270; GO:0010763; GO:0010811; GO:0030073; GO:0030546; GO:0030838; GO:0031397; GO:0031589; GO:0031663; GO:0032024; GO:0032230; GO:0035276; GO:0035641; GO:0035669; GO:0043123; GO:0043278; GO:0043410; GO:0045111; GO:0045202; GO:0048471; GO:0050996; GO:0051279; GO:0051301; GO:0051649; GO:0051932; GO:0061178; GO:0070254; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0106310; GO:1903078	Homo sapiens (Human)
XP_005264485.1	Q02156	reviewed	KPCE_HUMAN	Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon)	PRKCE PKCE		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays essential roles in the regulation of multiple cellular processes linked to cytoskeletal proteins, such as cell adhesion, motility, migration and cell cycle, functions in neuron growth and ion channel regulation, and is involved in immune response, cancer cell invasion and regulation of apoptosis. Mediates cell adhesion to the extracellular matrix via integrin-dependent signaling, by mediating angiotensin-2-induced activation of integrin beta-1 (ITGB1) in cardiac fibroblasts. Phosphorylates MARCKS, which phosphorylates and activates PTK2/FAK, leading to the spread of cardiomyocytes. Involved in the control of the directional transport of ITGB1 in mesenchymal cells by phosphorylating vimentin (VIM), an intermediate filament (IF) protein. In epithelial cells, associates with and phosphorylates keratin-8 (KRT8), which induces targeting of desmoplakin at desmosomes and regulates cell-cell contact. Phosphorylates IQGAP1, which binds to CDC42, mediating epithelial cell-cell detachment prior to migration. In HeLa cells, contributes to hepatocyte growth factor (HGF)-induced cell migration, and in human corneal epithelial cells, plays a critical role in wound healing after activation by HGF. During cytokinesis, forms a complex with YWHAB, which is crucial for daughter cell separation, and facilitates abscission by a mechanism which may implicate the regulation of RHOA. In cardiac myocytes, regulates myofilament function and excitation coupling at the Z-lines, where it is indirectly associated with F-actin via interaction with COPB1. During endothelin-induced cardiomyocyte hypertrophy, mediates activation of PTK2/FAK, which is critical for cardiomyocyte survival and regulation of sarcomere length. Plays a role in the pathogenesis of dilated cardiomyopathy via persistent phosphorylation of troponin I (TNNI3). Involved in nerve growth factor (NFG)-induced neurite outgrowth and neuron morphological change independently of its kinase activity, by inhibition of RHOA pathway, activation of CDC42 and cytoskeletal rearrangement. May be involved in presynaptic facilitation by mediating phorbol ester-induced synaptic potentiation. Phosphorylates gamma-aminobutyric acid receptor subunit gamma-2 (GABRG2), which reduces the response of GABA receptors to ethanol and benzodiazepines and may mediate acute tolerance to the intoxicating effects of ethanol. Upon PMA treatment, phosphorylates the capsaicin- and heat-activated cation channel TRPV1, which is required for bradykinin-induced sensitization of the heat response in nociceptive neurons. Is able to form a complex with PDLIM5 and N-type calcium channel, and may enhance channel activities and potentiates fast synaptic transmission by phosphorylating the pore-forming alpha subunit CACNA1B (CaV2.2). In prostate cancer cells, interacts with and phosphorylates STAT3, which increases DNA-binding and transcriptional activity of STAT3 and seems to be essential for prostate cancer cell invasion. Downstream of TLR4, plays an important role in the lipopolysaccharide (LPS)-induced immune response by phosphorylating and activating TICAM2/TRAM, which in turn activates the transcription factor IRF3 and subsequent cytokines production. In differentiating erythroid progenitors, is regulated by EPO and controls the protection against the TNFSF10/TRAIL-mediated apoptosis, via BCL2. May be involved in the regulation of the insulin-induced phosphorylation and activation of AKT1. Phosphorylates NLRP5/MATER and may thereby modulate AKT pathway activation in cumulus cells (PubMed:19542546). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11884385, ECO:0000269|PubMed:1374067, ECO:0000269|PubMed:15355962, ECO:0000269|PubMed:16757566, ECO:0000269|PubMed:17603037, ECO:0000269|PubMed:17875639, ECO:0000269|PubMed:17875724, ECO:0000269|PubMed:19542546, ECO:0000269|PubMed:21806543, ECO:0000269|PubMed:36040231}.	9606	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]	apoptotic process [GO:0006915]; cell division [GO:0051301]; cell-substrate adhesion [GO:0031589]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; establishment of localization in cell [GO:0051649]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; MAPK cascade [GO:0000165]; mucus secretion [GO:0070254]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transport [GO:1902306]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]; toxin catabolic process [GO:0009407]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]; xenobiotic catabolic process [GO:0042178]	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell-substrate adhesion [GO:0031589]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; establishment of localization in cell [GO:0051649]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; MAPK cascade [GO:0000165]; mucus secretion [GO:0070254]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transport [GO:1902306]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]; toxin catabolic process [GO:0009407]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]; xenobiotic catabolic process [GO:0042178]	14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546]; zinc ion binding [GO:0008270]	GO:0000165; GO:0002281; GO:0003785; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0008047; GO:0008270; GO:0009407; GO:0010634; GO:0010763; GO:0010811; GO:0019899; GO:0030073; GO:0030546; GO:0030838; GO:0031397; GO:0031589; GO:0031663; GO:0032024; GO:0032230; GO:0032467; GO:0032930; GO:0032956; GO:0035276; GO:0035556; GO:0035641; GO:0035669; GO:0038096; GO:0042178; GO:0043123; GO:0043278; GO:0043410; GO:0045111; GO:0045202; GO:0048471; GO:0050996; GO:0051279; GO:0051301; GO:0051649; GO:0051932; GO:0061178; GO:0070254; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0071944; GO:0090303; GO:0106310; GO:1902306; GO:1903078	Homo sapiens (Human)
XP_005264485.1	L7RTI5	unreviewed	L7RTI5_HUMAN	Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon)	PRKCE		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays essential roles in the regulation of multiple cellular processes linked to cytoskeletal proteins, such as cell adhesion, motility, migration and cell cycle, functions in neuron growth and ion channel regulation, and is involved in immune response, cancer cell invasion and regulation of apoptosis. Mediates cell adhesion to the extracellular matrix via integrin-dependent signaling, by mediating angiotensin-2-induced activation of integrin beta-1 (ITGB1) in cardiac fibroblasts. Phosphorylates MARCKS, which phosphorylates and activates PTK2/FAK, leading to the spread of cardiomyocytes. Involved in the control of the directional transport of ITGB1 in mesenchymal cells by phosphorylating vimentin (VIM), an intermediate filament (IF) protein. In epithelial cells, associates with and phosphorylates keratin-8 (KRT8), which induces targeting of desmoplakin at desmosomes and regulates cell-cell contact. Phosphorylates IQGAP1, which binds to CDC42, mediating epithelial cell-cell detachment prior to migration. {ECO:0000256|PIRNR:PIRNR000551}.	9606	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cell division [GO:0051301]; cell-substrate adhesion [GO:0031589]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; establishment of localization in cell [GO:0051649]; insulin secretion [GO:0030073]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; MAPK cascade [GO:0000165]; mucus secretion [GO:0070254]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; synaptic transmission, GABAergic [GO:0051932]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; ethanol binding [GO:0035276]; protein serine kinase activity [GO:0106310]; signaling receptor activator activity [GO:0030546]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cell-substrate adhesion [GO:0031589]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; establishment of localization in cell [GO:0051649]; insulin secretion [GO:0030073]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; MAPK cascade [GO:0000165]; mucus secretion [GO:0070254]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; synaptic transmission, GABAergic [GO:0051932]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]	14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; ethanol binding [GO:0035276]; protein serine kinase activity [GO:0106310]; signaling receptor activator activity [GO:0030546]; zinc ion binding [GO:0008270]	GO:0000165; GO:0002281; GO:0003785; GO:0004699; GO:0005524; GO:0005634; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0008270; GO:0010763; GO:0010811; GO:0030073; GO:0030546; GO:0030838; GO:0031397; GO:0031589; GO:0031663; GO:0032024; GO:0032230; GO:0035276; GO:0035641; GO:0035669; GO:0043123; GO:0043278; GO:0043410; GO:0045111; GO:0045202; GO:0048471; GO:0050996; GO:0051279; GO:0051301; GO:0051649; GO:0051932; GO:0061178; GO:0070254; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0106310; GO:1903078	Homo sapiens (Human)
NP_001287576.1	A0A0B4LI13	unreviewed	A0A0B4LI13_DROME	Protein kinase C (EC 2.7.11.13)	Pkc98E 98F Dmel\CG1954 Dpkc3 dPKC98F Nc98F nPKC PK-C PKC PKC 98F PKC d98F PKC-98F Pkc3 PKC98C PKC98E PKC98e CG1954 Dmel_CG1954		FUNCTION: PKC is activated by diacylglycerol which in turn phosphorylates a range of cellular proteins. PKC also serves as the receptor for phorbol esters, a class of tumor promoters. {ECO:0000256|ARBA:ARBA00056408}.	7227		learning or memory [GO:0007611]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]; learning or memory [GO:0007611]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0007611; GO:0008270; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001287577.1	P13678	reviewed	KPC3_DROME	Protein kinase C (PKC) (EC 2.7.11.13) (dPKC98F)	Pkc98E Pkc3 CG1954		FUNCTION: PKC is activated by diacylglycerol which in turn phosphorylates a range of cellular proteins. PKC also serves as the receptor for phorbol esters, a class of tumor promoters.	7227	plasma membrane [GO:0005886]	dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; response to ethanol [GO:0045471]	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; response to ethanol [GO:0045471]	ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0004699; GO:0005524; GO:0005886; GO:0007030; GO:0007616; GO:0008270; GO:0008285; GO:0009950; GO:0034389; GO:0035556; GO:0045471; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_524545.2	P13678	reviewed	KPC3_DROME	Protein kinase C (PKC) (EC 2.7.11.13) (dPKC98F)	Pkc98E Pkc3 CG1954		FUNCTION: PKC is activated by diacylglycerol which in turn phosphorylates a range of cellular proteins. PKC also serves as the receptor for phorbol esters, a class of tumor promoters.	7227	plasma membrane [GO:0005886]	dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; response to ethanol [GO:0045471]	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; dorsal/ventral axis specification [GO:0009950]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet organization [GO:0034389]; long-term memory [GO:0007616]; negative regulation of cell population proliferation [GO:0008285]; response to ethanol [GO:0045471]	ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0004699; GO:0005524; GO:0005886; GO:0007030; GO:0007616; GO:0008270; GO:0008285; GO:0009950; GO:0034389; GO:0035556; GO:0045471; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001036438.1	P32865	reviewed	GPRK1_DROME	G protein-coupled receptor kinase 1 (EC 2.7.11.16)	Gprk1 Gprk-1 CG40129		FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors. {ECO:0000250}.	7227	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of phospholipase C-activating phototransduction signaling pathway [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of signal transduction [GO:0009966]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of phospholipase C-activating phototransduction signaling pathway [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of signal transduction [GO:0009966]	ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]	GO:0001664; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0007186; GO:0007603; GO:0009966; GO:0016060; GO:0035091; GO:0045880; GO:0050254	Drosophila melanogaster (Fruit fly)
NP_001036438.1	E1JGX2	unreviewed	E1JGX2_DROME	G protein-coupled receptor kinase (EC 2.7.11.-)	Gprk1 CT4320 Dmel\CG40129 Gprk-1 GPRK1 gprk1 RK Rok CG40129 Dmel_CG40129			7227		negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0007165; GO:0045744	Drosophila melanogaster (Fruit fly)
NP_001163051.1	P32865	reviewed	GPRK1_DROME	G protein-coupled receptor kinase 1 (EC 2.7.11.16)	Gprk1 Gprk-1 CG40129		FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors. {ECO:0000250}.	7227	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of phospholipase C-activating phototransduction signaling pathway [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of signal transduction [GO:0009966]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of phospholipase C-activating phototransduction signaling pathway [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of signal transduction [GO:0009966]	ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]	GO:0001664; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0007186; GO:0007603; GO:0009966; GO:0016060; GO:0035091; GO:0045880; GO:0050254	Drosophila melanogaster (Fruit fly)
NP_001163051.1	E1JGX2	unreviewed	E1JGX2_DROME	G protein-coupled receptor kinase (EC 2.7.11.-)	Gprk1 CT4320 Dmel\CG40129 Gprk-1 GPRK1 gprk1 RK Rok CG40129 Dmel_CG40129			7227		negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0007165; GO:0045744	Drosophila melanogaster (Fruit fly)
NP_001286135.1	P32865	reviewed	GPRK1_DROME	G protein-coupled receptor kinase 1 (EC 2.7.11.16)	Gprk1 Gprk-1 CG40129		FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors. {ECO:0000250}.	7227	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of phospholipase C-activating phototransduction signaling pathway [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of signal transduction [GO:0009966]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of phospholipase C-activating phototransduction signaling pathway [GO:0016060]; phototransduction, visible light [GO:0007603]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of signal transduction [GO:0009966]	ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol binding [GO:0035091]; rhodopsin kinase activity [GO:0050254]	GO:0001664; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0007186; GO:0007603; GO:0009966; GO:0016060; GO:0035091; GO:0045880; GO:0050254	Drosophila melanogaster (Fruit fly)
NP_001286135.1	E1JGX2	unreviewed	E1JGX2_DROME	G protein-coupled receptor kinase (EC 2.7.11.-)	Gprk1 CT4320 Dmel\CG40129 Gprk-1 GPRK1 gprk1 RK Rok CG40129 Dmel_CG40129			7227		negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0007165; GO:0045744	Drosophila melanogaster (Fruit fly)
NP_005151.2	P35626	reviewed	ARBK2_HUMAN	G protein-coupled receptor kinase 3 (EC 2.7.11.15) (Beta-adrenergic receptor kinase 2) (Beta-ARK-2)	GRK3 ADRBK2 BARK2		FUNCTION: receptors (By similarity). Also phosphorylates ligand-bound C3a and C5a anaphylatoxin receptors (C3AR1 and C5AR1, respectively), leading to receptor desensitization (PubMed:21799898). {ECO:0000250|UniProtKB:P26819, ECO:0000269|PubMed:21799898}.	9606	cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]	desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]	GO:0001664; GO:0002029; GO:0004672; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0007165; GO:0007186; GO:0031623; GO:0047696; GO:0098793; GO:0098794	Homo sapiens (Human)
NP_005151.2	Q8N433	unreviewed	Q8N433_HUMAN	G protein-coupled receptor kinase (EC 2.7.11.-)				9606		signal transduction [GO:0007165]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0007165; GO:0047696	Homo sapiens (Human)
NP_001610.2	P25098	reviewed	ARBK1_HUMAN	Beta-adrenergic receptor kinase 1 (Beta-ARK-1) (EC 2.7.11.15) (G-protein coupled receptor kinase 2)	GRK2 ADRBK1 BARK BARK1		FUNCTION: Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them (PubMed:19715378). Phosphorylates catecholamine-activated ADRB2 to regulate physiological cardiomyocyte contraction rate responses (By similarity). Also phosphorylates ligand-bound C3a and C5a anaphylatoxin receptors (C3AR1 and C5AR1, respectively), leading to receptor desensitization (PubMed:21799898, PubMed:23077507). Key regulator of LPAR1 signaling (PubMed:19306925). Competes with RALA for binding to LPAR1 thus affecting the signaling properties of the receptor (PubMed:19306925). Desensitizes LPAR1 and LPAR2 in a phosphorylation-independent manner (PubMed:19306925). Positively regulates ciliary smoothened (SMO)-dependent Hedgehog (Hh) signaling pathway by facilitating the trafficking of SMO into the cilium and the stimulation of SMO activity (By similarity). Inhibits relaxation of airway smooth muscle in response to blue light (PubMed:30284927). {ECO:0000250|UniProtKB:P21146, ECO:0000250|UniProtKB:Q99MK8, ECO:0000269|PubMed:19306925, ECO:0000269|PubMed:19715378, ECO:0000269|PubMed:21799898, ECO:0000269|PubMed:23077507, ECO:0000269|PubMed:30284927}.	9606	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]	cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; positive regulation of catecholamine secretion [GO:0033605]; receptor internalization [GO:0031623]; regulation of the force of heart contraction [GO:0002026]; symbiont entry into host cell [GO:0046718]; tachykinin receptor signaling pathway [GO:0007217]; viral genome replication [GO:0019079]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; positive regulation of catecholamine secretion [GO:0033605]; receptor internalization [GO:0031623]; regulation of the force of heart contraction [GO:0002026]; symbiont entry into host cell [GO:0046718]; tachykinin receptor signaling pathway [GO:0007217]; viral genome replication [GO:0019079]	alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]	GO:0001664; GO:0002026; GO:0002029; GO:0003108; GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007186; GO:0007213; GO:0007217; GO:0007507; GO:0016020; GO:0019079; GO:0031623; GO:0031694; GO:0031755; GO:0032473; GO:0033605; GO:0045988; GO:0046718; GO:0047696; GO:0060048; GO:0098793; GO:0098794; GO:1901081	Homo sapiens (Human)
NP_001610.2	A0A0S2Z392	unreviewed	A0A0S2Z392_HUMAN	G protein-coupled receptor kinase (EC 2.7.11.-)	ADRBK1		FUNCTION: Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them. Key regulator of LPAR1 signaling. Competes with RALA for binding to LPAR1 thus affecting the signaling properties of the receptor. Desensitizes LPAR1 and LPAR2 in a phosphorylation-independent manner. Positively regulates ciliary smoothened (SMO)-dependent Hedgehog (Hh) signaling pathway by facilitating the trafficking of SMO into the cilium and the stimulation of SMO activity. Inhibits relaxation of airway smooth muscle in response to blue light. {ECO:0000256|ARBA:ARBA00045687}.	9606	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]	desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; receptor internalization [GO:0031623]; regulation of the force of heart contraction [GO:0002026]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; receptor internalization [GO:0031623]; regulation of the force of heart contraction [GO:0002026]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0002026; GO:0002029; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0007186; GO:0007507; GO:0031623; GO:0047696; GO:0098793; GO:0098794; GO:1901081	Homo sapiens (Human)
XP_819033.1	Q4DXB5	unreviewed	Q4DXB5_TRYCC	Protein kinase, putative	Tc00.1047053510901.200			353153			ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270; GO:0035091	Trypanosoma cruzi (strain CL Brener)
XP_012894137.1	D8LWA0	unreviewed	D8LWA0_BLAHO	non-specific serine/threonine protein kinase (EC 2.7.11.1)	GSBLH_T00000471001			12968			ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035091	Blastocystis hominis
XP_012895420.1	D8LZY3	unreviewed	D8LZY3_BLAHO	Protein kinase domain-containing protein	GSBLH_T00001547001			12968			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Blastocystis hominis
NP_066958.2	Q15349	reviewed	KS6A2_HUMAN	Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3)	RPS6KA2 MAPKAPK1C RSK3		FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of transcription factors, regulates translation, and mediates cellular proliferation, survival, and differentiation. May function as tumor suppressor in epithelial ovarian cancer cells. {ECO:0000269|PubMed:16878154, ECO:0000269|PubMed:7623830}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; chemical synaptic transmission [GO:0007268]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; chemical synaptic transmission [GO:0007268]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001556; GO:0002035; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0007268; GO:0007507; GO:0008285; GO:0010628; GO:0010659; GO:0035556; GO:0038202; GO:0043065; GO:0045202; GO:0045786; GO:0045835; GO:0060047; GO:0070613; GO:0071322; GO:0072687; GO:0106310	Homo sapiens (Human)
NP_001006933.3	Q15349	reviewed	KS6A2_HUMAN	Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3)	RPS6KA2 MAPKAPK1C RSK3		FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of transcription factors, regulates translation, and mediates cellular proliferation, survival, and differentiation. May function as tumor suppressor in epithelial ovarian cancer cells. {ECO:0000269|PubMed:16878154, ECO:0000269|PubMed:7623830}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; chemical synaptic transmission [GO:0007268]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; chemical synaptic transmission [GO:0007268]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001556; GO:0002035; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0007268; GO:0007507; GO:0008285; GO:0010628; GO:0010659; GO:0035556; GO:0038202; GO:0043065; GO:0045202; GO:0045786; GO:0045835; GO:0060047; GO:0070613; GO:0071322; GO:0072687; GO:0106310	Homo sapiens (Human)
NP_001305865.2	Q15349	reviewed	KS6A2_HUMAN	Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3)	RPS6KA2 MAPKAPK1C RSK3		FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of transcription factors, regulates translation, and mediates cellular proliferation, survival, and differentiation. May function as tumor suppressor in epithelial ovarian cancer cells. {ECO:0000269|PubMed:16878154, ECO:0000269|PubMed:7623830}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; chemical synaptic transmission [GO:0007268]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; chemical synaptic transmission [GO:0007268]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001556; GO:0002035; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0007268; GO:0007507; GO:0008285; GO:0010628; GO:0010659; GO:0035556; GO:0038202; GO:0043065; GO:0045202; GO:0045786; GO:0045835; GO:0060047; GO:0070613; GO:0071322; GO:0072687; GO:0106310	Homo sapiens (Human)
NP_001305865.2	F2Z2J1	unreviewed	F2Z2J1_HUMAN	Ribosomal protein S6 kinase (EC 2.7.11.1)	RPS6KA2			9606		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; ribosomal protein S6 kinase activity [GO:0004711]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0004711; GO:0005524; GO:0035556; GO:0106310	Homo sapiens (Human)
XP_012895685.1	D8M0P8	unreviewed	D8M0P8_BLAHO	Protein kinase domain-containing protein	GSBLH_T00001773001			12968			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Blastocystis hominis
XP_012898618.1	D8M931	unreviewed	D8M931_BLAHO	Protein kinase	GSBLH_T00004286001			12968			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270	Blastocystis hominis
XP_002368822.1	S8GGG5	unreviewed	S8GGG5_TOXGM	AGC kinase (EC 2.7.11.13)	TGME49_267540			508771			ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]	GO:0004697; GO:0005524	Toxoplasma gondii (strain ATCC 50611 / Me49)
XP_002369273.1	A0A125YQ00	unreviewed	A0A125YQ00_TOXGM	AGC kinase (EC 2.7.11.11)	TGME49_286470			508771	cAMP-dependent protein kinase complex [GO:0005952]		cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952	Toxoplasma gondii (strain ATCC 50611 / Me49)
XP_009521586.1	G4YZS3	unreviewed	G4YZS3_PHYSP	cGMP-dependent protein kinase (EC 2.7.11.12)	PHYSODRAFT_540813			1094619	cAMP-dependent protein kinase complex [GO:0005952]	anatomical structure morphogenesis [GO:0009653]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; anatomical structure morphogenesis [GO:0009653]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]	GO:0004691; GO:0004692; GO:0005524; GO:0005952; GO:0009653; GO:0030553	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_001329056.1	A2DS63	unreviewed	A2DS63_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_447920			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_005713970.1	R7Q9T2	unreviewed	R7Q9T2_CHOCR	Serine/threonine protein kinase	CHC_T00009113001			2769			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Chondrus crispus (Carrageen Irish moss) (Polymorpha crispa)
XP_005714203.1	R7Q8M5	unreviewed	R7Q8M5_CHOCR	Serine/threonine protein kinase	CHC_T00009230001			2769			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Chondrus crispus (Carrageen Irish moss) (Polymorpha crispa)
XP_005707714.1	M2Y5R2	unreviewed	M2Y5R2_GALSU	Serine/threonine protein kinase (EC 2.7.11.1)	Gasu_14420			130081			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Galdieria sulphuraria (Red alga)
XP_005708406.1	M2W7U2	unreviewed	M2W7U2_GALSU	Serine/threonine protein kinase (EC 2.7.11.1)	Gasu_09550			130081			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Galdieria sulphuraria (Red alga)
XP_005715366.1	R7QAL8	unreviewed	R7QAL8_CHOCR	Serine/threonine protein kinase	CHC_T00004077001			2769			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Chondrus crispus (Carrageen Irish moss) (Polymorpha crispa)
XP_005716936.1	R7QF21	unreviewed	R7QF21_CHOCR	Serine/threonine protein kinase	CHC_T00009146001			2769			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Chondrus crispus (Carrageen Irish moss) (Polymorpha crispa)
XP_005711073.1	R7QRK1	unreviewed	R7QRK1_CHOCR	non-specific serine/threonine protein kinase (EC 2.7.11.1)	CHC_T00009319001			2769		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Chondrus crispus (Carrageen Irish moss) (Polymorpha crispa)
XP_001310870.1	A2FAW3	unreviewed	A2FAW3_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_316050			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001030934.2	Q22DD1	unreviewed	Q22DD1_TETTS	Serine/Threonine kinase domain protein	TTHERM_00992710			312017	cAMP-dependent protein kinase complex [GO:0005952]	anatomical structure morphogenesis [GO:0009653]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; anatomical structure morphogenesis [GO:0009653]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0009653	Tetrahymena thermophila (strain SB210)
NP_524097.2	P16912	reviewed	KAPC3_DROME	cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2)	Pka-C3 DC2 CG6117		FUNCTION: Does not have an essential role in development. {ECO:0000269|PubMed:8601490}.	7227	cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; imaginal disc-derived wing morphogenesis [GO:0007476]	cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; imaginal disc-derived wing morphogenesis [GO:0007476]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]	GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0007155; GO:0007189; GO:0007476; GO:0106310	Drosophila melanogaster (Fruit fly)
XP_009526928.1	G4ZEA7	unreviewed	G4ZEA7_PHYSP	Protein kinase domain-containing protein	PHYSODRAFT_560377			1094619	chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; phosphorylase kinase complex [GO:0005964]	glycogen metabolic process [GO:0005977]; meiotic chromosome segregation [GO:0045132]	chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; phosphorylase kinase complex [GO:0005964]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; phosphorylase kinase activity [GO:0004689]; glycogen metabolic process [GO:0005977]; meiotic chromosome segregation [GO:0045132]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; phosphorylase kinase activity [GO:0004689]	GO:0000775; GO:0004689; GO:0005516; GO:0005524; GO:0005634; GO:0005964; GO:0005977; GO:0045132; GO:0046872	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009526928.1	B5M4U8	unreviewed	B5M4U8_PHYSO	Calcium/calmodulin dependent protein kinase 4				67593	chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; phosphorylase kinase complex [GO:0005964]	glycogen metabolic process [GO:0005977]; meiotic chromosome segregation [GO:0045132]	chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; phosphorylase kinase complex [GO:0005964]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; phosphorylase kinase activity [GO:0004689]; glycogen metabolic process [GO:0005977]; meiotic chromosome segregation [GO:0045132]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; phosphorylase kinase activity [GO:0004689]	GO:0000775; GO:0004689; GO:0005516; GO:0005524; GO:0005634; GO:0005964; GO:0005977; GO:0045132; GO:0046872	Phytophthora sojae (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_016885207.1	B1AXG1	unreviewed	B1AXG1_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA3			9606		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0035556; GO:0106310	Homo sapiens (Human)
XP_016885208.1	B4DG22	unreviewed	B4DG22_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA3			9606	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	intracellular signal transduction [GO:0035556]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0005840; GO:0035556	Homo sapiens (Human)
XP_047298292.1	B4DG22	unreviewed	B4DG22_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA3			9606	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	intracellular signal transduction [GO:0035556]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0005840; GO:0035556	Homo sapiens (Human)
XP_054183510.1	B1AXG1	unreviewed	B1AXG1_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA3			9606		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0035556; GO:0106310	Homo sapiens (Human)
XP_054183511.1	B4DG22	unreviewed	B4DG22_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA3			9606	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	intracellular signal transduction [GO:0035556]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0005840; GO:0035556	Homo sapiens (Human)
XP_054183512.1	B4DG22	unreviewed	B4DG22_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA3			9606	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	intracellular signal transduction [GO:0035556]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0005840; GO:0035556	Homo sapiens (Human)
NP_001425269.1	B7ZB17	unreviewed	B7ZB17_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA3			9606	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	intracellular signal transduction [GO:0035556]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0005840; GO:0035556	Homo sapiens (Human)
XP_047298290.1	B7ZB17	unreviewed	B7ZB17_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA3			9606	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	intracellular signal transduction [GO:0035556]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0005840; GO:0035556	Homo sapiens (Human)
XP_054183507.1	B7ZB17	unreviewed	B7ZB17_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA3			9606	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	intracellular signal transduction [GO:0035556]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0005840; GO:0035556	Homo sapiens (Human)
XP_054183509.1	B7ZB17	unreviewed	B7ZB17_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA3			9606	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	intracellular signal transduction [GO:0035556]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0005840; GO:0035556	Homo sapiens (Human)
XP_009516695.1	G4YJ86	unreviewed	G4YJ86_PHYSP	AGC protein kinase	PHYSODRAFT_309785			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009517139.1	G4YQ98	unreviewed	G4YQ98_PHYSP	AGC/AKT protein kinase	PHYSODRAFT_344112			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_815140.1	Q4DL90	unreviewed	Q4DL90_TRYCC	Rac serine-threonine kinase, putative	Tc00.1047053508965.60			353153			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270	Trypanosoma cruzi (strain CL Brener)
XP_817377.1	Q4DSM2	unreviewed	Q4DSM2_TRYCC	Rac serine-threonine kinase, putative	Tc00.1047053509007.60			353153			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270	Trypanosoma cruzi (strain CL Brener)
XP_001029787.2	Q22A18	unreviewed	Q22A18_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_01298470			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001031415.4	I7LSW6	unreviewed	I7LSW6_TETTS	Serine/Threonine kinase domain protein	TTHERM_00825470			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001012943.2	Q237P3	unreviewed	Q237P3_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_00320440			312017		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Tetrahymena thermophila (strain SB210)
XP_001032568.2	I7MG69	unreviewed	I7MG69_TETTS	Serine/Threonine kinase domain protein	TTHERM_00584610			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001033178.2	I7M6N1	unreviewed	I7M6N1_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_00442650			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001032905.2	I7M004	unreviewed	I7M004_TETTS	Serine/Threonine kinase domain protein	TTHERM_00486930			312017	cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]		cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005829; GO:0005952	Tetrahymena thermophila (strain SB210)
XP_001033299.2	I7LTP9	unreviewed	I7LTP9_TETTS	Serine/Threonine kinase domain protein	TTHERM_00420440			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001011879.2	Q233E6	unreviewed	Q233E6_TETTS	Serine/Threonine kinase domain protein	TTHERM_00393030			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001011940.1	Q232Y5	unreviewed	Q232Y5_TETTS	Serine/Threonine kinase domain protein	TTHERM_00394690			312017	myosin complex [GO:0016459]		myosin complex [GO:0016459]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]	GO:0003774; GO:0004674; GO:0005524; GO:0016459	Tetrahymena thermophila (strain SB210)
XP_001016385.2	I7MJB0	unreviewed	I7MJB0_TETTS	Serine/Threonine kinase domain protein	TTHERM_00129040			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001017463.2	I7M1N1	unreviewed	I7M1N1_TETTS	Serine/Threonine kinase domain protein	TTHERM_00483500			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001018324.1	Q23NJ5	unreviewed	Q23NJ5_TETTS	Serine/Threonine kinase domain protein	TTHERM_00752250			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001018806.2	Q23PX4	unreviewed	Q23PX4_TETTS	Serine/Threonine kinase domain protein	TTHERM_00463090			312017	cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]		cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005829; GO:0005952	Tetrahymena thermophila (strain SB210)
XP_001018695.2	I7MF43	unreviewed	I7MF43_TETTS	Serine/Threonine kinase domain protein	TTHERM_00290780			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001019658.2	I7M266	unreviewed	I7M266_TETTS	Serine/Threonine kinase domain protein	TTHERM_00134780			312017	cAMP-dependent protein kinase complex [GO:0005952]		cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952	Tetrahymena thermophila (strain SB210)
XP_001027166.1	Q24GE7	unreviewed	Q24GE7_TETTS	Serine/Threonine kinase domain protein	TTHERM_00726440			312017	cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]		cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005829; GO:0005952	Tetrahymena thermophila (strain SB210)
XP_001021623.2	I7M9D4	unreviewed	I7M9D4_TETTS	Serine/Threonine kinase domain protein	TTHERM_00149880			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001022255.1	I7MGT0	unreviewed	I7MGT0_TETTS	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TTHERM_00500960			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001023361.2	I7M9Z7	unreviewed	I7M9Z7_TETTS	Serine/Threonine kinase domain protein	TTHERM_00445970			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001024089.3	I7M3P4	unreviewed	I7M3P4_TETTS	Serine/Threonine kinase domain protein	TTHERM_00658880			312017		G protein-coupled receptor signaling pathway [GO:0007186]; regulation of signal transduction [GO:0009966]	ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of signal transduction [GO:0009966]	ATP binding [GO:0005524]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0001664; GO:0004703; GO:0005524; GO:0007186; GO:0009966	Tetrahymena thermophila (strain SB210)
XP_001024208.1	I7MA96	unreviewed	I7MA96_TETTS	Serine/Threonine kinase domain protein	TTHERM_00457010			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001024149.3	I7MM38	unreviewed	I7MM38_TETTS	Serine/Threonine kinase domain protein	TTHERM_00455430			312017			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Tetrahymena thermophila (strain SB210)
XP_001297291.1	A2GEQ5	unreviewed	A2GEQ5_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_504520			412133		cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0007010; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001311729.1	A2F8E8	unreviewed	A2F8E8_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_479710			412133		cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0007010; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001323345.1	A2E8A4	unreviewed	A2E8A4_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_359020			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001301129.1	A2G3R6	unreviewed	A2G3R6_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_404590			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001302155.1	A2G0T7	unreviewed	A2G0T7_TRIV3	AGC family protein kinase	TVAG_089630			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001301207.1	A2G3J0	unreviewed	A2G3J0_TRIV3	AGC family protein kinase	TVAG_384870			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001327610.1	A2DW86	unreviewed	A2DW86_TRIV3	AGC family protein kinase	TVAG_224630			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001584133.1	A2D9C1	unreviewed	A2D9C1_TRIV3	AGC family protein kinase	TVAG_183840			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001579099.1	A2DNC5	unreviewed	A2DNC5_TRIV3	AGC family protein kinase	TVAG_306350			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001319861.1	A2EI78	unreviewed	A2EI78_TRIV3	AGC family protein kinase	TVAG_430020			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001301666.1	A2G288	unreviewed	A2G288_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_420830			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001314983.1	A2EX40	unreviewed	A2EX40_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_369880			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001321160.1	A2EED1	unreviewed	A2EED1_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_485840			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001322995.1	A2E987	unreviewed	A2E987_TRIV3	AGC family protein kinase	TVAG_121760			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001318707.1	A2ELF7	unreviewed	A2ELF7_TRIV3	AGC family protein kinase	TVAG_257220			412133		intracellular signal transduction [GO:0035556]; methylation [GO:0032259]	ATP binding [GO:0005524]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; methylation [GO:0032259]	ATP binding [GO:0005524]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein serine/threonine kinase activity [GO:0004674]	GO:0003676; GO:0004674; GO:0005524; GO:0008168; GO:0032259; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001302695.1	A2FZ96	unreviewed	A2FZ96_TRIV3	AGC family protein kinase	TVAG_352330			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001302949.1	A2FYJ4	unreviewed	A2FYJ4_TRIV3	AGC family protein kinase	TVAG_061270			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001583654.1	A2DA20	unreviewed	A2DA20_TRIV3	AGC family protein kinase	TVAG_475960			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001302862.1	A2FYT0	unreviewed	A2FYT0_TRIV3	AGC family protein kinase	TVAG_434990			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001580304.1	A2DJV4	unreviewed	A2DJV4_TRIV3	AGC family protein kinase	TVAG_452320			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001308206.1	A2FIJ5	unreviewed	A2FIJ5_TRIV3	AGC family protein kinase	TVAG_051880			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001306155.1	A2FPF2	unreviewed	A2FPF2_TRIV3	AGC family protein kinase	TVAG_245290			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001315230.1	A2EWI0	unreviewed	A2EWI0_TRIV3	AGC family protein kinase	TVAG_325790			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001306386.1	A2FNQ5	unreviewed	A2FNQ5_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_347430			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001313044.1	A2F4Q4	unreviewed	A2F4Q4_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_470980			412133		cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0007010; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001306832.1	A2FMG9	unreviewed	A2FMG9_TRIV3	AGC family protein kinase	TVAG_131900			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001307559.1	A2FKC9	unreviewed	A2FKC9_TRIV3	AGC family protein kinase	TVAG_381330			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001583331.1	A2DB15	unreviewed	A2DB15_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_378240			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001306996.1	A2FLX7	unreviewed	A2FLX7_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_195270			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001313212.1	A2F4A4	unreviewed	A2F4A4_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_324020			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001579736.1	A2DLD2	unreviewed	A2DLD2_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_267830			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001324272.1	A2E5K8	unreviewed	A2E5K8_TRIV3	AGC family protein kinase	TVAG_038960			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001308557.1	A2FHJ2	unreviewed	A2FHJ2_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_047250			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001325115.1	A2E382	unreviewed	A2E382_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_430560			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001310013.1	A2FDD2	unreviewed	A2FDD2_TRIV3	AGC family protein kinase	TVAG_086220			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001310602.1	A2FBN5	unreviewed	A2FBN5_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_346740			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001314210.1	A2F0I9	unreviewed	A2F0I9_TRIV3	AGC family protein kinase	TVAG_025670			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001314667.1	A2EY79	unreviewed	A2EY79_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_030400			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001316333.1	A2ETC0	unreviewed	A2ETC0_TRIV3	AGC family protein kinase	TVAG_483480			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001321016.1	A2EEZ5	unreviewed	A2EEZ5_TRIV3	AGC family protein kinase	TVAG_188800			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001316350.1	A2ET74	unreviewed	A2ET74_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_125670			412133	cytoplasm [GO:0005737]	intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001321801.1	A2ECT2	unreviewed	A2ECT2_TRIV3	AGC family protein kinase	TVAG_276510			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001321214.1	A2EE93	unreviewed	A2EE93_TRIV3	AGC family protein kinase	TVAG_073540			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001325461.1	A2E224	unreviewed	A2E224_TRIV3	AGC family protein kinase	TVAG_463710			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001327706.1	A2DVS0	unreviewed	A2DVS0_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_210130			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001323146.1	A2E8U1	unreviewed	A2E8U1_TRIV3	AGC family protein kinase	TVAG_260080			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001324743.1	A2E474	unreviewed	A2E474_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_139000			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001579836.1	A2DL59	unreviewed	A2DL59_TRIV3	AGC family protein kinase	TVAG_295020			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001330025.1	A2DP41	unreviewed	A2DP41_TRIV3	non-specific serine/threonine protein kinase (EC 2.7.11.1)	TVAG_011160			412133		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Trichomonas vaginalis (strain ATCC PRA-98 / G3)
XP_001704119.1	E2RTR4	unreviewed	E2RTR4_GIAIC	Kinase, AGC PKA	GL50803_0086444			184922	cytoplasm [GO:0005737]; nucleus [GO:0005634]		cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737	Giardia intestinalis (strain ATCC 50803 / WB clone C6) (Giardia lamblia)
XP_001704119.1	Q1H8W8	unreviewed	Q1H8W8_GIAIN	Serine/threonine-protein kinase	pkcb DHA2_86444			5741			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Giardia intestinalis (Giardia lamblia)
XP_009521157.1	G4Z0M0	unreviewed	G4Z0M0_PHYSP	AGC protein kinase	PHYSODRAFT_354099			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
NP_014445.1	P53739	reviewed	FPK1_YEAST	Flippase kinase 1 (EC 2.7.11.1)	FPK1 YNR047W N3449		FUNCTION: Flippase activator that phosphorylates DNF1 and DNF2 and which is involved in the generation of phospholipid asymmetry in membranes by the inward translocation of phospholipids and in the retrieval pathway from early endosomes to the trans-Golgi network (TGN). Also phosphorylates the N-terminal half of YPK1. Involved in pheromone-response. {ECO:0000269|PubMed:11337509, ECO:0000269|PubMed:18199685, ECO:0000269|PubMed:19966303}.	559292	cytoplasm [GO:0005737]; mating projection tip [GO:0043332]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	phospholipid translocation [GO:0045332]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of phospholipid translocation [GO:0061092]; response to pheromone triggering conjugation with cellular fusion [GO:0000749]	cytoplasm [GO:0005737]; mating projection tip [GO:0043332]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; phospholipid translocation [GO:0045332]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of phospholipid translocation [GO:0061092]; response to pheromone triggering conjugation with cellular fusion [GO:0000749]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000749; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0043332; GO:0045332; GO:0061092; GO:0106310; GO:2000370	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
NP_593065.1	Q09831	reviewed	PPK14_SCHPO	Serine/threonine-protein kinase ppk14 (EC 2.7.11.1)	ppk14 SPAC4G8.05			284812	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	phospholipid translocation [GO:0045332]; signaling [GO:0023052]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; phospholipid translocation [GO:0045332]; signaling [GO:0023052]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0023052; GO:0045332; GO:0106310	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
NP_010015.3	P25341	reviewed	KIN82_YEAST	Serine/threonine-protein kinase KIN82 (EC 2.7.11.1) (Flippase kinase 2)	KIN82 FPK2 YCR091W YCR1153 YCR91W		FUNCTION: Flippase activator that phosphorylates DFN1 and DFN2 and which is involved in the generation of phospholipid asymmetry in membranes by the inward translocation of phospholipids. {ECO:0000269|PubMed:18199685}.	559292	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	phospholipid translocation [GO:0045332]; response to pheromone triggering conjugation with cellular fusion [GO:0000749]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; phospholipid translocation [GO:0045332]; response to pheromone triggering conjugation with cellular fusion [GO:0000749]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000749; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0045332; GO:0106310	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
NP_596726.1	Q9USX7	reviewed	PPK22_SCHPO	Serine/threonine-protein kinase ppk22 (EC 2.7.11.1)	ppk22 SPBC1861.09			284812	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	phospholipid translocation [GO:0045332]; response to pheromone triggering conjugation with cellular fusion [GO:0000749]; signaling [GO:0023052]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; phospholipid translocation [GO:0045332]; response to pheromone triggering conjugation with cellular fusion [GO:0000749]; signaling [GO:0023052]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000749; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0023052; GO:0045332; GO:0106310	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
XP_044563312.1	A0A6A5C008	unreviewed	A0A6A5C008_NAEFO	Protein kinase domain-containing protein	FDP41_002419			5763			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Naegleria fowleri (Brain eating amoeba)
XP_044561606.1	A0A6A5BGA9	unreviewed	A0A6A5BGA9_NAEFO	non-specific serine/threonine protein kinase (EC 2.7.11.1)	FDP41_004188			5763		intein-mediated protein splicing [GO:0016539]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intein-mediated protein splicing [GO:0016539]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0016539	Naegleria fowleri (Brain eating amoeba)
XP_044556707.1	A0A6A5BA58	unreviewed	A0A6A5BA58_NAEFO	non-specific serine/threonine protein kinase (EC 2.7.11.1)	FDP41_009688			5763			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Naegleria fowleri (Brain eating amoeba)
XP_009538716.1	G5AF65	unreviewed	G5AF65_PHYSP	AGC protein kinase	PHYSODRAFT_566362			1094619			ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035091	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009533860.1	G4ZZ93	unreviewed	G4ZZ93_PHYSP	AGC/RSK/RSKP90 protein kinase	PHYSODRAFT_361747			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009532693.1	G4ZWD2	unreviewed	G4ZWD2_PHYSP	AGC protein kinase	PHYSODRAFT_361523			1094619			ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035091	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009530181.1	G4ZMP1	unreviewed	G4ZMP1_PHYSP	Protein kinase domain-containing protein	PHYSODRAFT_507490			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009525671.1	G4ZFB0	unreviewed	G4ZFB0_PHYSP	cGMP-dependent protein kinase (EC 2.7.11.12)	PHYSODRAFT_314340			1094619	cAMP-dependent protein kinase complex [GO:0005952]	anatomical structure morphogenesis [GO:0009653]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; anatomical structure morphogenesis [GO:0009653]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	GO:0004691; GO:0004692; GO:0005524; GO:0005952; GO:0009653; GO:0030553; GO:0046872	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009523430.1	G4Z222	unreviewed	G4Z222_PHYSP	Protein kinase domain-containing protein	PHYSODRAFT_345526			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009523983.1	G4ZBR2	unreviewed	G4ZBR2_PHYSP	non-specific serine/threonine protein kinase (EC 2.7.11.1)	PHYSODRAFT_350723			1094619			ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035091	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009519021.1	G4YVX9	unreviewed	G4YVX9_PHYSP	Protein kinase domain-containing protein	PHYSODRAFT_487753			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009519521.1	G4YTK5	unreviewed	G4YTK5_PHYSP	cGMP-dependent protein kinase (EC 2.7.11.12)	PHYSODRAFT_541813			1094619	cAMP-dependent protein kinase complex [GO:0005952]; endomembrane system [GO:0012505]		cAMP-dependent protein kinase complex [GO:0005952]; endomembrane system [GO:0012505]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	GO:0004691; GO:0004692; GO:0005524; GO:0005952; GO:0012505; GO:0030553; GO:0046872	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009519981.1	G4Z174	unreviewed	G4Z174_PHYSP	cGMP-dependent protein kinase (EC 2.7.11.12)	PHYSODRAFT_485920			1094619	cAMP-dependent protein kinase complex [GO:0005952]		cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]	GO:0004691; GO:0004692; GO:0005524; GO:0005952; GO:0030553; GO:0046872	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009520723.1	G4YTW4	unreviewed	G4YTW4_PHYSP	AGC/AKT protein kinase	PHYSODRAFT_555263			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0005524; GO:0008270	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009514919.1	G4YFR7	unreviewed	G4YFR7_PHYSP	AGC/AKT protein kinase	PHYSODRAFT_343629			1094619			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_009517250.1	G4YL60	unreviewed	G4YL60_PHYSP	non-specific serine/threonine protein kinase (EC 2.7.11.1)	PHYSODRAFT_553039			1094619		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0035556	Phytophthora sojae (strain P6497) (Soybean stem and root rot agent) (Phytophthora megasperma f. sp. glycines)
XP_005707841.1	M2W6E1	unreviewed	M2W6E1_GALSU	non-specific serine/threonine protein kinase (EC 2.7.11.1)	Gasu_15550			130081		cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0007010; GO:0035556; GO:0106310	Galdieria sulphuraria (Red alga)
XP_018636768.1	S8F5H7	unreviewed	S8F5H7_TOXGM	Serine/threonine protein kinase AktR, putative (EC 2.7.11.11)	TGME49_233790			508771	cAMP-dependent protein kinase complex [GO:0005952]		cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952	Toxoplasma gondii (strain ATCC 50611 / Me49)
NP_001356955.1	A0A4D6K344	unreviewed	A0A4D6K344_DROME	cGMP-dependent protein kinase (EC 2.7.11.12)	for 142251_at anon-WO0140519.260 anon-WO02059370.47 BcDNA:GM08338 DG2 Dg2 dg2 Dmel\CG10033 For FOR/PKG l(2)06860 PKG PKG2 Pkg2 Pkg24A CG10033 Dmel_CG10033			7227	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0030553; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001356892.1	Q03043	reviewed	KGP24_DROME	cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B (cGK) (EC 2.7.11.12) (Foraging protein)	for DG2 PGK2 Pkg24A CG10033			7227	cytosol [GO:0005829]; plasma membrane [GO:0005886]	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; positive regulation of Toll signaling pathway [GO:0045752]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; positive regulation of Toll signaling pathway [GO:0045752]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0005886; GO:0007168; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0045752; GO:0046959; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001356896.1	Q03043	reviewed	KGP24_DROME	cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B (cGK) (EC 2.7.11.12) (Foraging protein)	for DG2 PGK2 Pkg24A CG10033			7227	cytosol [GO:0005829]; plasma membrane [GO:0005886]	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; positive regulation of Toll signaling pathway [GO:0045752]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; positive regulation of Toll signaling pathway [GO:0045752]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0005886; GO:0007168; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0045752; GO:0046959; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001334731.1	Q03043	reviewed	KGP24_DROME	cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B (cGK) (EC 2.7.11.12) (Foraging protein)	for DG2 PGK2 Pkg24A CG10033			7227	cytosol [GO:0005829]; plasma membrane [GO:0005886]	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; positive regulation of Toll signaling pathway [GO:0045752]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; positive regulation of Toll signaling pathway [GO:0045752]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0005886; GO:0007168; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0045752; GO:0046959; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001334731.1	A0A1W5Q0S1	unreviewed	A0A1W5Q0S1_DROME	cGMP-dependent protein kinase (EC 2.7.11.12)	for 142251_at anon-WO0140519.260 anon-WO02059370.47 BcDNA:GM08338 DG2 Dg2 dg2 Dmel\CG10033 For FOR/PKG l(2)06860 PKG PKG2 Pkg2 Pkg24A CG10033 Dmel_CG10033			7227	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0030553; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001162858.1	P32023	reviewed	KGP25_DROME	cGMP-dependent protein kinase, isozyme 2 forms cD5/T2 (cGK) (EC 2.7.11.12) (Foraging protein)	for DG2 PGK2 Pkg24A CG10033			7227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0046959; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001162858.1	E1JHR9	unreviewed	E1JHR9_DROME	cGMP-dependent protein kinase (EC 2.7.11.12)	for 142251_at anon-WO0140519.260 anon-WO02059370.47 BcDNA:GM08338 DG2 Dg2 dg2 Dmel\CG10033 For FOR/PKG l(2)06860 PKG PKG2 Pkg2 Pkg24A CG10033 Dmel_CG10033			7227	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0030553; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_477489.1	P32023	reviewed	KGP25_DROME	cGMP-dependent protein kinase, isozyme 2 forms cD5/T2 (cGK) (EC 2.7.11.12) (Foraging protein)	for DG2 PGK2 Pkg24A CG10033			7227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0046959; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_477489.1	E1JHR9	unreviewed	E1JHR9_DROME	cGMP-dependent protein kinase (EC 2.7.11.12)	for 142251_at anon-WO0140519.260 anon-WO02059370.47 BcDNA:GM08338 DG2 Dg2 dg2 Dmel\CG10033 For FOR/PKG l(2)06860 PKG PKG2 Pkg2 Pkg24A CG10033 Dmel_CG10033			7227	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0030553; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_599146.1	P32023	reviewed	KGP25_DROME	cGMP-dependent protein kinase, isozyme 2 forms cD5/T2 (cGK) (EC 2.7.11.12) (Foraging protein)	for DG2 PGK2 Pkg24A CG10033			7227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0046959; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_599146.1	E1JHR9	unreviewed	E1JHR9_DROME	cGMP-dependent protein kinase (EC 2.7.11.12)	for 142251_at anon-WO0140519.260 anon-WO02059370.47 BcDNA:GM08338 DG2 Dg2 dg2 Dmel\CG10033 For FOR/PKG l(2)06860 PKG PKG2 Pkg2 Pkg24A CG10033 Dmel_CG10033			7227	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0030553; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_995629.1	P32023	reviewed	KGP25_DROME	cGMP-dependent protein kinase, isozyme 2 forms cD5/T2 (cGK) (EC 2.7.11.12) (Foraging protein)	for DG2 PGK2 Pkg24A CG10033			7227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0046959; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_995629.1	E1JHR9	unreviewed	E1JHR9_DROME	cGMP-dependent protein kinase (EC 2.7.11.12)	for 142251_at anon-WO0140519.260 anon-WO02059370.47 BcDNA:GM08338 DG2 Dg2 dg2 Dmel\CG10033 For FOR/PKG l(2)06860 PKG PKG2 Pkg2 Pkg24A CG10033 Dmel_CG10033			7227	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0030553; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001014464.1	P32023	reviewed	KGP25_DROME	cGMP-dependent protein kinase, isozyme 2 forms cD5/T2 (cGK) (EC 2.7.11.12) (Foraging protein)	for DG2 PGK2 Pkg24A CG10033			7227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0046959; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_477490.1	P32023	reviewed	KGP25_DROME	cGMP-dependent protein kinase, isozyme 2 forms cD5/T2 (cGK) (EC 2.7.11.12) (Foraging protein)	for DG2 PGK2 Pkg24A CG10033			7227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0046959; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_477487.1	Q03043	reviewed	KGP24_DROME	cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B (cGK) (EC 2.7.11.12) (Foraging protein)	for DG2 PGK2 Pkg24A CG10033			7227	cytosol [GO:0005829]; plasma membrane [GO:0005886]	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; positive regulation of Toll signaling pathway [GO:0045752]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; positive regulation of Toll signaling pathway [GO:0045752]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0005886; GO:0007168; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0045752; GO:0046959; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_995626.1	Q03043	reviewed	KGP24_DROME	cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B (cGK) (EC 2.7.11.12) (Foraging protein)	for DG2 PGK2 Pkg24A CG10033			7227	cytosol [GO:0005829]; plasma membrane [GO:0005886]	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; positive regulation of Toll signaling pathway [GO:0045752]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; positive regulation of Toll signaling pathway [GO:0045752]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0005886; GO:0007168; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0045752; GO:0046959; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_995628.1	Q03043	reviewed	KGP24_DROME	cGMP-dependent protein kinase, isozyme 2 forms cD4/T1/T3A/T3B (cGK) (EC 2.7.11.12) (Foraging protein)	for DG2 PGK2 Pkg24A CG10033			7227	cytosol [GO:0005829]; plasma membrane [GO:0005886]	feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; positive regulation of Toll signaling pathway [GO:0045752]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; feeding behavior [GO:0007631]; habituation [GO:0046959]; larval feeding behavior [GO:0030536]; larval locomotory behavior [GO:0008345]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; positive regulation of Toll signaling pathway [GO:0045752]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of heart contraction [GO:0008016]; regulation of response to food [GO:0032095]; response to sucrose [GO:0009744]; short-term memory [GO:0007614]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0005886; GO:0007168; GO:0007614; GO:0007616; GO:0007631; GO:0008016; GO:0008045; GO:0008345; GO:0009744; GO:0030536; GO:0030553; GO:0032095; GO:0045752; GO:0046959; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_005035.1	P51817	reviewed	PRKX_HUMAN	cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1)	PRKX PKX1		FUNCTION: Serine/threonine protein kinase regulated by and mediating cAMP signaling in cells. Acts through phosphorylation of downstream targets that may include CREB, SMAD6 and PKD1 and has multiple functions in cellular differentiation and epithelial morphogenesis. Regulates myeloid cell differentiation through SMAD6 phosphorylation. Involved in nephrogenesis by stimulating renal epithelial cell migration and tubulogenesis. Also involved in angiogenesis through stimulation of endothelial cell proliferation, migration and vascular-like structure formation. {ECO:0000269|PubMed:12082174, ECO:0000269|PubMed:16236808, ECO:0000269|PubMed:16491121, ECO:0000269|PubMed:17980165, ECO:0000269|PubMed:19367327, ECO:0000269|PubMed:21684272, ECO:0000269|PubMed:9860982}.	9606	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]	GO:0001525; GO:0001935; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005952; GO:0007155; GO:0007189; GO:0018105; GO:0030099; GO:0030155; GO:0030334; GO:0031589; GO:0043542; GO:0046777; GO:0060562; GO:0060993; GO:0106310; GO:2000696	Homo sapiens (Human)
XP_044561932.1	A0A6A5BWB7	unreviewed	A0A6A5BWB7_NAEFO	non-specific serine/threonine protein kinase (EC 2.7.11.1)	FDP41_003872			5763		intein-mediated protein splicing [GO:0016539]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intein-mediated protein splicing [GO:0016539]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0016539	Naegleria fowleri (Brain eating amoeba)
XP_042917497.1	A0A2K3D082	unreviewed	A0A2K3D082_CHLRE	Protein kinase domain-containing protein	CHLRE_13g579200v5			3055	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737	Chlamydomonas reinhardtii (Chlamydomonas smithii)
XP_001699230.2	A0A2K3CUB1	unreviewed	A0A2K3CUB1_CHLRE	Uncharacterized protein	CHLRE_16g669800v5			3055	cAMP-dependent protein kinase complex [GO:0005952]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]	cAMP-dependent protein kinase complex [GO:0005952]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005952; GO:0007189	Chlamydomonas reinhardtii (Chlamydomonas smithii)
NP_587830.1	Q12706	reviewed	PSK1_SCHPO	Serine/threonine-protein kinase psk1 (EC 2.7.11.1) (Ribosomal S6 kinase homolog psk1) (S6K homolog psk1)	psk1 SPCC4G3.08		FUNCTION: AGC kinase which plays a role in TOR complex 1 (TORC1) signaling pathway which mediates temporal control of cell growth in response to nutrients. Required for phosphorylation of ribosomal protein S6 (rps601/rps602) at 'Ser-235' and 'Ser-236'. {ECO:0000269|PubMed:22976295}.	284812	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	positive regulation of cytoplasmic translation [GO:2000767]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; signaling adaptor activity [GO:0035591]; positive regulation of cytoplasmic translation [GO:2000767]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; signaling adaptor activity [GO:0035591]	GO:0004674; GO:0004711; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0035591; GO:0038202; GO:0106310; GO:2000767	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
NP_588010.1	Q9P7J8	reviewed	GAD8_SCHPO	Serine/threonine-protein kinase gad8 (EC 2.7.11.1)	gad8 SPCC24B10.07		FUNCTION: Involved in a signaling module for sexual development and cell growth under stressed conditions. Required for G1 arrest under nitrogen starvation and for growth at high temperature and osmolarity. {ECO:0000269|PubMed:12805221}.	284812	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	negative regulation of TORC2 signaling [GO:1903940]; positive regulation of conjugation with cellular fusion [GO:0031139]; positive regulation of induction of conjugation with cellular fusion [GO:1900237]; positive regulation of transcription by RNA polymerase II [GO:0045944]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of conjugation with cellular fusion [GO:0031139]; positive regulation of induction of conjugation with cellular fusion [GO:1900237]; positive regulation of transcription by RNA polymerase II [GO:0045944]	ATP binding [GO:0005524]; lipid binding [GO:0008289]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000785; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0008289; GO:0031139; GO:0045944; GO:0106310; GO:1900237; GO:1903940	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
NP_012796.1	P12688	reviewed	YPK1_YEAST	Serine/threonine-protein kinase YPK1 (EC 2.7.11.1) (Sphingosine-like immunosuppressant resistant protein 2) (Yeast protein kinase 1)	YPK1 SLI2 YKL126W		FUNCTION: Plays an essential role in the proliferation of yeast cells (PubMed:8437590). Involved in a signaling pathway, required for optimal cell wall integrity, that acts in parallel with the PKC1-SLT2-dependent pathway (PubMed:12221112). Downstream kinase in the sphingolipid-mediated signaling pathway (PubMed:10825204, PubMed:34492164, PubMed:39490931). Phosphorylation is regulated by the intracellular sphingolipid concentration (PubMed:34492164). Disruption or inhibition of sphingolipid synthesis leads to the activation and phosphorylation of YPK1 through the TORC2 and PKH1 pathways, which in turn phosphorylates ORM1 and LAG1 to activate sphingolipid synthesis (PubMed:34492164). Cooperates with SLI1 in mediating resistance to the sphingolipid biosynthesis inhibitor drug myriocin (ISP-1); kinase activity is essential for the resistance. Required for both receptor-mediated and fluid-phase endocytosis, but is not necessary for receptor phosphorylation or ubiquitination. Necessary for the internalization of plasma membrane proteins carrying different types of internalization signals. Acts downstream of the PKH kinases to control endocytosis by phosphorylating components of the endocytic machinery (PubMed:39490931). Phosphorylation of residue Thr-504 in the activation loop and residue Thr-662 are essential for activity (PubMed:39490931). Phosphorylates and down-regulates flippase activator FPK1 (PubMed:19966303). {ECO:0000269|PubMed:10825204, ECO:0000269|PubMed:12221112, ECO:0000269|PubMed:15470109, ECO:0000269|PubMed:19966303, ECO:0000269|PubMed:34492164, ECO:0000269|PubMed:39490931, ECO:0000269|PubMed:8437590}.	559292	cellular bud neck [GO:0005935]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cell wall organization [GO:0071555]; cellular response to acetate [GO:0071311]; eisosome assembly [GO:0070941]; endocytosis [GO:0006897]; glycerophospholipid metabolic process [GO:0006650]; intracellular signal transduction [GO:0035556]; negative regulation of phospholipid translocation [GO:0061093]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; regulation of fungal-type cell wall organization [GO:0060237]; sphingolipid metabolic process [GO:0006665]	cellular bud neck [GO:0005935]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell wall organization [GO:0071555]; cellular response to acetate [GO:0071311]; eisosome assembly [GO:0070941]; endocytosis [GO:0006897]; glycerophospholipid metabolic process [GO:0006650]; intracellular signal transduction [GO:0035556]; negative regulation of phospholipid translocation [GO:0061093]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; regulation of fungal-type cell wall organization [GO:0060237]; sphingolipid metabolic process [GO:0006665]	ATP binding [GO:0005524]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005829; GO:0005886; GO:0005935; GO:0006650; GO:0006665; GO:0006897; GO:0019887; GO:0035556; GO:0060237; GO:0061093; GO:0070941; GO:0071311; GO:0071555; GO:0090155; GO:0106310	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
NP_595950.1	P36583	reviewed	PCK2_SCHPO	Protein kinase C-like 2 (EC 2.7.11.13)	pck2 pkc1 sts6 SPBC12D12.04c		FUNCTION: Involved in the control of the cell shape. Target of the inhibitor staurosporine.	284812	cell division site [GO:0032153]; cell tip [GO:0051286]; division septum [GO:0000935]	fungal-type cell wall biogenesis [GO:0009272]; intracellular signal transduction [GO:0035556]; negative regulation of glucose mediated signaling pathway [GO:1902660]; positive regulation of cell integrity MAPK cascade [GO:1903139]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell wall (1->3)-beta-D-glucan biosynthetic process [GO:0090334]; regulation of establishment or maintenance of cell polarity regulating cell shape [GO:2000769]; regulation of fungal-type cell wall (1->3)-alpha-glucan biosynthetic process [GO:0070610]	cell division site [GO:0032153]; cell tip [GO:0051286]; division septum [GO:0000935]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; lipid binding [GO:0008289]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; fungal-type cell wall biogenesis [GO:0009272]; intracellular signal transduction [GO:0035556]; negative regulation of glucose mediated signaling pathway [GO:1902660]; positive regulation of cell integrity MAPK cascade [GO:1903139]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell wall (1->3)-beta-D-glucan biosynthetic process [GO:0090334]; regulation of establishment or maintenance of cell polarity regulating cell shape [GO:2000769]; regulation of fungal-type cell wall (1->3)-alpha-glucan biosynthetic process [GO:0070610]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; lipid binding [GO:0008289]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000935; GO:0004674; GO:0004697; GO:0005524; GO:0008270; GO:0008289; GO:0009272; GO:0032153; GO:0032956; GO:0035556; GO:0051286; GO:0070610; GO:0090334; GO:0106310; GO:1902660; GO:1903139; GO:2000769	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
NP_009445.2	P24583	reviewed	KPC1_YEAST	Protein kinase C-like 1 (PKC 1) (EC 2.7.11.13)	PKC1 HPO2 STT1 YBL105C YBL0807		FUNCTION: Required for cell growth and for the G2->M transition of the cell division cycle. Mediates a protein kinase cascade; it activates BCK1 which itself activates MKK1/MKK2.	559292	cellular bud neck [GO:0005935]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; prospore septin filament array [GO:0032165]; site of polarized growth [GO:0030427]	cellular bud neck septin ring organization [GO:0032186]; cellular response to starvation [GO:0009267]; fungal-type cell wall biogenesis [GO:0009272]; intracellular signal transduction [GO:0035556]; pexophagy [GO:0000425]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of fungal-type cell wall organization [GO:0060237]; regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060211]; signal transduction [GO:0007165]; stress granule assembly [GO:0034063]	cellular bud neck [GO:0005935]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; prospore septin filament array [GO:0032165]; site of polarized growth [GO:0030427]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; cellular bud neck septin ring organization [GO:0032186]; cellular response to starvation [GO:0009267]; fungal-type cell wall biogenesis [GO:0009272]; intracellular signal transduction [GO:0035556]; pexophagy [GO:0000425]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of fungal-type cell wall organization [GO:0060237]; regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060211]; signal transduction [GO:0007165]; stress granule assembly [GO:0034063]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000425; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005935; GO:0007165; GO:0008270; GO:0009267; GO:0009272; GO:0010494; GO:0010606; GO:0030427; GO:0032165; GO:0032186; GO:0034063; GO:0035556; GO:0060211; GO:0060237; GO:0106310	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
NP_593737.2	P36582	reviewed	PCK1_SCHPO	Protein kinase C-like 1 (EC 2.7.11.13)	pck1 SPAC17G8.14c SPAC22H10.01c		FUNCTION: Involved in the control of the cell shape. Target of the inhibitor staurosporine.	284812	cell cortex of cell tip [GO:0051285]; cell division site [GO:0032153]; cytosol [GO:0005829]; division septum [GO:0000935]; mitotic actomyosin contractile ring [GO:0110085]; mitotic actomyosin contractile ring, intermediate layer [GO:0120105]; nucleus [GO:0005634]	intracellular signal transduction [GO:0035556]; negative regulation of mitotic actomyosin contractile ring assembly [GO:1903500]; positive regulation of cell integrity MAPK cascade [GO:1903139]; positive regulation of mitotic cytokinesis, division site positioning [GO:1903617]; regulation of cell shape [GO:0008360]; regulation of cell wall (1->3)-beta-D-glucan biosynthetic process [GO:0090334]	cell cortex of cell tip [GO:0051285]; cell division site [GO:0032153]; cytosol [GO:0005829]; division septum [GO:0000935]; mitotic actomyosin contractile ring [GO:0110085]; mitotic actomyosin contractile ring, intermediate layer [GO:0120105]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; lipid binding [GO:0008289]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; negative regulation of mitotic actomyosin contractile ring assembly [GO:1903500]; positive regulation of cell integrity MAPK cascade [GO:1903139]; positive regulation of mitotic cytokinesis, division site positioning [GO:1903617]; regulation of cell shape [GO:0008360]; regulation of cell wall (1->3)-beta-D-glucan biosynthetic process [GO:0090334]	ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; lipid binding [GO:0008289]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000935; GO:0004674; GO:0004699; GO:0005524; GO:0005634; GO:0005829; GO:0008270; GO:0008289; GO:0008360; GO:0032153; GO:0035556; GO:0051285; GO:0090334; GO:0106310; GO:0110085; GO:0120105; GO:1903139; GO:1903500; GO:1903617	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
NP_006246.2	P24723	reviewed	KPCL_HUMAN	Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta)	PRKCH PKCL PRKCL		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in the regulation of cell differentiation in keratinocytes and pre-B cell receptor, mediates regulation of epithelial tight junction integrity and foam cell formation, and is required for glioblastoma proliferation and apoptosis prevention in MCF-7 cells. In keratinocytes, binds and activates the tyrosine kinase FYN, which in turn blocks epidermal growth factor receptor (EGFR) signaling and leads to keratinocyte growth arrest and differentiation. Associates with the cyclin CCNE1-CDK2-CDKN1B complex and inhibits CDK2 kinase activity, leading to RB1 dephosphorylation and thereby G1 arrest in keratinocytes. In association with RALA activates actin depolymerization, which is necessary for keratinocyte differentiation. In the pre-B cell receptor signaling, functions downstream of BLNK by up-regulating IRF4, which in turn activates L chain gene rearrangement. Regulates epithelial tight junctions (TJs) by phosphorylating occludin (OCLN) on threonine residues, which is necessary for the assembly and maintenance of TJs. In association with PLD2 and via TLR4 signaling, is involved in lipopolysaccharide (LPS)-induced RGS2 down-regulation and foam cell formation. Upon PMA stimulation, mediates glioblastoma cell proliferation by activating the mTOR pathway, the PI3K/AKT pathway and the ERK1-dependent phosphorylation of ELK1. Involved in the protection of glioblastoma cells from irradiation-induced apoptosis by preventing caspase-9 activation. In camptothecin-treated MCF-7 cells, regulates NF-kappa-B upstream signaling by activating IKBKB, and confers protection against DNA damage-induced apoptosis. Promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Phosphorylates ATF2 which promotes its nuclear retention and transcriptional activity and negatively regulates its mitochondrial localization. {ECO:0000269|PubMed:10806212, ECO:0000269|PubMed:11112424, ECO:0000269|PubMed:11772428, ECO:0000269|PubMed:15489897, ECO:0000269|PubMed:17146445, ECO:0000269|PubMed:18780722, ECO:0000269|PubMed:19114660, ECO:0000269|PubMed:20558593, ECO:0000269|PubMed:21820409, ECO:0000269|PubMed:22304920}.	9606	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme binding [GO:0019899]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme binding [GO:0019899]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007165; GO:0008270; GO:0010744; GO:0019899; GO:0030154; GO:0031267; GO:0034351; GO:0035556; GO:0045618; GO:0050861; GO:0051092; GO:0060252; GO:0070062; GO:0106310; GO:0141212; GO:1903078; GO:2000810	Homo sapiens (Human)
XP_044567202.1	A0A6A5CB51	unreviewed	A0A6A5CB51_NAEFO	non-specific serine/threonine protein kinase (EC 2.7.11.1)	FDP41_011419			5763			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Naegleria fowleri (Brain eating amoeba)
NP_001229791.1	P22694	reviewed	KAPCB_HUMAN	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	PRKACB		FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}.	9606	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001843; GO:0003091; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0007189; GO:0019870; GO:0021904; GO:0031625; GO:0032024; GO:0034380; GO:0045879; GO:0070062; GO:0070613; GO:0097546; GO:0097700; GO:0106310; GO:1904262	Homo sapiens (Human)
NP_001229791.1	A0A087WVC4	unreviewed	A0A087WVC4_HUMAN	cAMP-dependent protein kinase (EC 2.7.11.11)	PRKACB			9606			ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524	Homo sapiens (Human)
NP_001229791.1	B7ZA00	unreviewed	B7ZA00_HUMAN	cAMP-dependent protein kinase (EC 2.7.11.11)				9606			ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524	Homo sapiens (Human)
NP_001362494.1	P22694	reviewed	KAPCB_HUMAN	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	PRKACB		FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}.	9606	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001843; GO:0003091; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0007189; GO:0019870; GO:0021904; GO:0031625; GO:0032024; GO:0034380; GO:0045879; GO:0070062; GO:0070613; GO:0097546; GO:0097700; GO:0106310; GO:1904262	Homo sapiens (Human)
NP_001229787.1	P22694	reviewed	KAPCB_HUMAN	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	PRKACB		FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}.	9606	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001843; GO:0003091; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0007189; GO:0019870; GO:0021904; GO:0031625; GO:0032024; GO:0034380; GO:0045879; GO:0070062; GO:0070613; GO:0097546; GO:0097700; GO:0106310; GO:1904262	Homo sapiens (Human)
NP_002722.1	P22694	reviewed	KAPCB_HUMAN	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	PRKACB		FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}.	9606	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001843; GO:0003091; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0007189; GO:0019870; GO:0021904; GO:0031625; GO:0032024; GO:0034380; GO:0045879; GO:0070062; GO:0070613; GO:0097546; GO:0097700; GO:0106310; GO:1904262	Homo sapiens (Human)
NP_002722.1	B2RB89	unreviewed	B2RB89_HUMAN	cAMP-dependent protein kinase (EC 2.7.11.11)	PRKACB hCG_23660			9606			ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524	Homo sapiens (Human)
NP_001362489.1	P22694	reviewed	KAPCB_HUMAN	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	PRKACB		FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}.	9606	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001843; GO:0003091; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0007189; GO:0019870; GO:0021904; GO:0031625; GO:0032024; GO:0034380; GO:0045879; GO:0070062; GO:0070613; GO:0097546; GO:0097700; GO:0106310; GO:1904262	Homo sapiens (Human)
NP_001229788.1	P22694	reviewed	KAPCB_HUMAN	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	PRKACB		FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}.	9606	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001843; GO:0003091; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0007189; GO:0019870; GO:0021904; GO:0031625; GO:0032024; GO:0034380; GO:0045879; GO:0070062; GO:0070613; GO:0097546; GO:0097700; GO:0106310; GO:1904262	Homo sapiens (Human)
NP_001229789.1	P22694	reviewed	KAPCB_HUMAN	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	PRKACB		FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}.	9606	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001843; GO:0003091; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0007189; GO:0019870; GO:0021904; GO:0031625; GO:0032024; GO:0034380; GO:0045879; GO:0070062; GO:0070613; GO:0097546; GO:0097700; GO:0106310; GO:1904262	Homo sapiens (Human)
NP_001291278.1	P17612	reviewed	KAPCA_HUMAN	cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11)	PRKACA PKACA		FUNCTION: Phosphorylates a large number of substrates in the cytoplasm and the nucleus (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984, PubMed:21852232, PubMed:31112131). Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, histone H1.4 (H1-4), PSMC5/RPT6, PJA2, RYR2, RORA, SOX9, UHRF1 and VASP (PubMed:15178447, PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:21423175). RORA is activated by phosphorylation (PubMed:21514275). Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts (PubMed:19949837). Involved in chondrogenesis by mediating phosphorylation of SOX9 (By similarity). Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP (PubMed:15642694, PubMed:20356841). Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated (PubMed:17333334). RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+) (PubMed:17693412). PSMC5/RPT6 activation by phosphorylation stimulates proteasome (PubMed:17565987). Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation (PubMed:15905176). NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding (PubMed:15642694). Required for phosphorylation of GLI transcription factors which inhibits them and prevents transcriptional activation of Hedgehog signaling pathway target genes (By similarity). GLI transcription factor phosphorylation is inhibited by interaction of PRKACA with SMO which sequesters PRKACA at the cell membrane (By similarity). Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis most probably through the regulation of OFD1 in ciliogenesis (PubMed:33934390). Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation (By similarity). May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT) (By similarity). Phosphorylates APOBEC3G and AICDA (PubMed:16387847, PubMed:18836454). Phosphorylates HSF1; this phosphorylation promotes HSF1 nuclear localization and transcriptional activity upon heat shock (PubMed:21085490). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). Phosphorylates AKAP19 (PubMed:27028580). {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P27791, ECO:0000269|PubMed:15178447, ECO:0000269|PubMed:15642694, ECO:0000269|PubMed:15905176, ECO:0000269|PubMed:16387847, ECO:0000269|PubMed:17333334, ECO:0000269|PubMed:17565987, ECO:0000269|PubMed:17693412, ECO:0000269|PubMed:18836454, ECO:0000269|PubMed:19949837, ECO:0000269|PubMed:20356841, ECO:0000269|PubMed:21085490, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21514275, ECO:0000269|PubMed:21812984, ECO:0000269|PubMed:21852232, ECO:0000269|PubMed:27028580, ECO:0000269|PubMed:31112131, ECO:0000269|PubMed:33934390}.; FUNCTION: [Isoform 2]: Phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation. {ECO:0000250|UniProtKB:P05132}.	9606	acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP/PKA signal transduction [GO:0141156]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; intracellular potassium ion homeostasis [GO:0030007]; mesoderm formation [GO:0001707]; mitochondrial protein catabolic process [GO:0035694]; mRNA processing [GO:0006397]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein export from nucleus [GO:0006611]; protein localization to lipid droplet [GO:1990044]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; channel activator activity [GO:0099103]; histone H1-4S35 kinase activity [GO:0140198]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; potassium channel inhibitor activity [GO:0019870]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP/PKA signal transduction [GO:0141156]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; intracellular potassium ion homeostasis [GO:0030007]; mesoderm formation [GO:0001707]; mitochondrial protein catabolic process [GO:0035694]; mRNA processing [GO:0006397]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein export from nucleus [GO:0006611]; protein localization to lipid droplet [GO:1990044]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; channel activator activity [GO:0099103]; histone H1-4S35 kinase activity [GO:0140198]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; potassium channel inhibitor activity [GO:0019870]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0003091; GO:0004674; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006397; GO:0006611; GO:0007189; GO:0007193; GO:0010881; GO:0016241; GO:0016607; GO:0019221; GO:0019870; GO:0019901; GO:0019904; GO:0021904; GO:0030007; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0032024; GO:0032703; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035694; GO:0036126; GO:0044853; GO:0045542; GO:0045667; GO:0045722; GO:0045879; GO:0046827; GO:0048240; GO:0048471; GO:0050766; GO:0050850; GO:0051726; GO:0055117; GO:0061136; GO:0070062; GO:0070417; GO:0070507; GO:0070613; GO:0071333; GO:0071374; GO:0071377; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0097700; GO:0098794; GO:0098978; GO:0099103; GO:0099170; GO:0106310; GO:0120186; GO:0140198; GO:0141156; GO:1903779; GO:1904262; GO:1904539; GO:1990044; GO:2000810	Homo sapiens (Human)
NP_001291278.1	A0A8V8TL59	unreviewed	A0A8V8TL59_HUMAN	cAMP-dependent protein kinase catalytic subunit alpha (EC 2.7.11.11)	PRKACA			9606	mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]		mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0004691; GO:0005524; GO:0005634; GO:0005739; GO:0005886	Homo sapiens (Human)
NP_012075.1	P11792	reviewed	SCH9_YEAST	Serine/threonine-protein kinase SCH9 (EC 2.7.11.1)	SCH9 KOM1 YHR205W		FUNCTION: Protein kinase that is part of growth control pathway which is at least partially redundant with the cAMP pathway. Regulates both BCY1 phosphorylation and MPK1 activity (PubMed:20702584). Regulates ribosome biogenesis, translation initiation, and entry into stationary phase in a TORC1-dependent manner (PubMed:17560372). {ECO:0000269|PubMed:17560372, ECO:0000269|PubMed:20702584}.	559292	chromatin [GO:0000785]; cytoplasm [GO:0005737]; fungal-type vacuole membrane [GO:0000329]; nucleus [GO:0005634]	cellular response to oxidative stress [GO:0034599]; intracellular signal transduction [GO:0035556]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of ribosomal protein gene transcription by RNA polymerase II [GO:0060963]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell size [GO:0008361]; regulation of cysteine metabolic process [GO:1901494]; regulation of protein localization [GO:0032880]; regulation of response to osmotic stress [GO:0047484]; regulation of sphingolipid biosynthetic process [GO:0090153]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; fungal-type vacuole membrane [GO:0000329]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to oxidative stress [GO:0034599]; intracellular signal transduction [GO:0035556]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of ribosomal protein gene transcription by RNA polymerase II [GO:0060963]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of cell size [GO:0008361]; regulation of cysteine metabolic process [GO:1901494]; regulation of protein localization [GO:0032880]; regulation of response to osmotic stress [GO:0047484]; regulation of sphingolipid biosynthetic process [GO:0090153]; regulation of transcription by RNA polymerase II [GO:0006357]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000329; GO:0000785; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0008361; GO:0032880; GO:0034599; GO:0035556; GO:0045943; GO:0045945; GO:0047484; GO:0060963; GO:0090153; GO:0106310; GO:1901494; GO:1904828	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
NP_593754.1	P50530	reviewed	SCK1_SCHPO	Serine/threonine-protein kinase sck1 (EC 2.7.11.1)	sck1 SPAC1B9.02c		FUNCTION: Protein kinase that is part of growth control pathway which is at least partially redundant with the cAMP pathway. Required for trehalase activation. {ECO:0000269|PubMed:9245826}.	284812	cytosol [GO:0005829]	intracellular signal transduction [GO:0035556]; negative regulation of adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway [GO:0110034]; negative regulation of conjugation with cellular fusion [GO:0031138]; TORC1 signaling [GO:0038202]	cytosol [GO:0005829]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; negative regulation of adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway [GO:0110034]; negative regulation of conjugation with cellular fusion [GO:0031138]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; lipid binding [GO:0008289]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005829; GO:0008289; GO:0031138; GO:0035556; GO:0038202; GO:0106310; GO:0110034	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
NP_594840.1	Q10364	reviewed	SCK2_SCHPO	Serine/threonine-protein kinase sck2 (EC 2.7.11.1)	sck2 SPAC22E12.14c		FUNCTION: Protein kinase that is part of growth control pathway which is at least partially redundant with the cAMP pathway. {ECO:0000269|PubMed:9560431}.	284812	cytosol [GO:0005829]; nuclear envelope [GO:0005635]	intracellular signal transduction [GO:0035556]; negative regulation of conjugation with cellular fusion [GO:0031138]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; TORC1 signaling [GO:0038202]	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; negative regulation of conjugation with cellular fusion [GO:0031138]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005635; GO:0005829; GO:0010972; GO:0031138; GO:0035556; GO:0038202; GO:0106310	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
NP_001229956.1	B4DG79	unreviewed	B4DG79_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)				9606	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737	Homo sapiens (Human)
NP_001229957.1	B4DG79	unreviewed	B4DG79_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)				9606	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737	Homo sapiens (Human)
NP_001617.1	P31751	reviewed	AKT2_HUMAN	RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC protein kinase beta) (RAC-PK-beta)	AKT2		FUNCTION: Serine/threonine kinase closely related to AKT1 and AKT3. All 3 enzymes, AKT1, AKT2 and AKT3, are collectively known as AKT kinase. AKT regulates many processes including metabolism, proliferation, cell survival, growth and angiogenesis, through the phosphorylation of a range of downstream substrates. Over 100 substrates have been reported so far, although for most of them, the precise AKT kinase catalyzing the reaction was not specified. AKT regulates glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1). AKT mediates the antiapoptotic effects of IGF1. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development (PubMed:21432781, PubMed:21620960). In response to lysophosphatidic acid stimulation, inhibits the ciliogenesis cascade. In this context, phosphorylates WDR44, hence stabilizing its interaction with Rab11 and preventing the formation of the ciliogenic Rab11-FIP3-RAB3IP complex. Also phosphorylates RAB3IP/Rabin8, thus may affect RAB3IP guanine nucleotide exchange factor (GEF) activity toward Rab8, which is important for cilia growth (PubMed:31204173). Phosphorylates PKP1, facilitating its interaction with YWHAG and translocation to the nucleus, ultimately resulting in a reduction in keratinocyte intercellular adhesion (By similarity). Phosphorylation of PKP1 increases PKP1 protein stability, translocation to the cytoplasm away from desmosome plaques and PKP1-driven cap-dependent translation (PubMed:23444369). {ECO:0000250|UniProtKB:Q60823, ECO:0000269|PubMed:23444369, ECO:0000269|PubMed:31204173, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.; FUNCTION: Several AKT2-specific substrates have been identified, including ANKRD2, C2CD5, CLK2 and PITX2. May play a role in myoblast differentiation. In this context, may act through PITX2 phosphorylation. Unphosphorylated PITX2 associates with an ELAVL1/HuR-containing complex, which stabilizes CCND1 cyclin mRNA, ensuring cell proliferation. Phosphorylation by AKT2 impairs this association, leading to CCND1 mRNA destabilization and progression towards differentiation (By similarity). Also involved in the negative regulation of myogenesis in response to stress conditions. In this context, acts by phosphorylating ANKRD2 (By similarity). May also be a key regulator of glucose uptake. Regulates insulin-stimulated glucose transport by the increase of glucose transporter GLUT4 translocation from intracellular stores to the plasma membrane. In this context, acts by phosphorylating C2CD5/CDP138 on 'Ser-197' in insulin-stimulated adipocytes (By similarity). Through the phosphorylation of CLK2 on 'Thr-343', involved in insulin-regulated suppression of hepatic gluconeogenesis (By similarity). {ECO:0000250|UniProtKB:Q60823}.	9606	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of D-glucose import [GO:0046326]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to plasma membrane [GO:0072659]; protein modification process [GO:0036211]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of D-glucose import [GO:0046326]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to plasma membrane [GO:0072659]; protein modification process [GO:0036211]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0005978; GO:0006006; GO:0007165; GO:0008286; GO:0010748; GO:0010907; GO:0030334; GO:0030335; GO:0032000; GO:0032287; GO:0032587; GO:0032869; GO:0035556; GO:0036211; GO:0043066; GO:0043536; GO:0045444; GO:0045725; GO:0046326; GO:0046872; GO:0050821; GO:0051726; GO:0060644; GO:0071486; GO:0072659; GO:0090314; GO:0097473; GO:0106310; GO:0140677; GO:1903676; GO:1903898; GO:2000147	Homo sapiens (Human)
NP_001229786.1	P22694	reviewed	KAPCB_HUMAN	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	PRKACB		FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}.	9606	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001843; GO:0003091; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0007189; GO:0019870; GO:0021904; GO:0031625; GO:0032024; GO:0034380; GO:0045879; GO:0070062; GO:0070613; GO:0097546; GO:0097700; GO:0106310; GO:1904262	Homo sapiens (Human)
NP_001163767.1	Q4QQA3	unreviewed	Q4QQA3_DROME	Protein kinase C (EC 2.7.11.13)	Pkc98E 98F Dmel\CG1954 Dpkc3 dPKC98F Nc98F nPKC PK-C PKC PKC 98F PKC d98F PKC-98F Pkc3 PKC98C PKC98E PKC98e CG1954 Dmel_CG1954			7227			ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0008270	Drosophila melanogaster (Fruit fly)
XP_011540074.1	Q16513	reviewed	PKN2_HUMAN	Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)	PKN2 PRK2 PRKCL2		FUNCTION: PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Involved in the negative regulation of ciliogenesis (PubMed:27104747). {ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11777936, ECO:0000269|PubMed:11781095, ECO:0000269|PubMed:15123640, ECO:0000269|PubMed:15364941, ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:20188095, ECO:0000269|PubMed:20974804, ECO:0000269|PubMed:21754995, ECO:0000269|PubMed:27104747, ECO:0000269|PubMed:9121475}.; FUNCTION: (Microbial infection) Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication. {ECO:0000269|PubMed:15364941}.	9606	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]	GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007155; GO:0007165; GO:0010631; GO:0016301; GO:0016604; GO:0030027; GO:0030030; GO:0030496; GO:0031267; GO:0032154; GO:0032467; GO:0032991; GO:0035556; GO:0042826; GO:0043296; GO:0043297; GO:0045070; GO:0045111; GO:0045296; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:0097700; GO:0106310; GO:2000145	Homo sapiens (Human)
XP_054193640.1	Q16513	reviewed	PKN2_HUMAN	Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)	PKN2 PRK2 PRKCL2		FUNCTION: PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Involved in the negative regulation of ciliogenesis (PubMed:27104747). {ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11777936, ECO:0000269|PubMed:11781095, ECO:0000269|PubMed:15123640, ECO:0000269|PubMed:15364941, ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:20188095, ECO:0000269|PubMed:20974804, ECO:0000269|PubMed:21754995, ECO:0000269|PubMed:27104747, ECO:0000269|PubMed:9121475}.; FUNCTION: (Microbial infection) Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication. {ECO:0000269|PubMed:15364941}.	9606	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]	GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007155; GO:0007165; GO:0010631; GO:0016301; GO:0016604; GO:0030027; GO:0030030; GO:0030496; GO:0031267; GO:0032154; GO:0032467; GO:0032991; GO:0035556; GO:0042826; GO:0043296; GO:0043297; GO:0045070; GO:0045111; GO:0045296; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:0097700; GO:0106310; GO:2000145	Homo sapiens (Human)
NP_788294.1	A1Z7T4	unreviewed	A1Z7T4_DROME	FI18952p1 (Protein kinase N, isoform E (EC 2.7.11.-))	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn Pkn-RE PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Drosophila melanogaster (Fruit fly)
NP_997700.1	P05771	reviewed	KPCB_HUMAN	Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13)	PRKCB PKCB PRKCB1		FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase involved in various cellular processes such as regulation of the B-cell receptor (BCR) signalosome, oxidative stress-induced apoptosis, androgen receptor-dependent transcription regulation, insulin signaling and endothelial cells proliferation. Plays a key role in B-cell activation by regulating BCR-induced NF-kappa-B activation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11/CARMA1 at 'Ser-559', 'Ser-644' and 'Ser-652'. Phosphorylation induces CARD11/CARMA1 association with lipid rafts and recruitment of the BCL10-MALT1 complex as well as MAP3K7/TAK1, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. Plays a direct role in the negative feedback regulation of the BCR signaling, by down-modulating BTK function via direct phosphorylation of BTK at 'Ser-180', which results in the alteration of BTK plasma membrane localization and in turn inhibition of BTK activity (PubMed:11598012). Involved in apoptosis following oxidative damage: in case of oxidative conditions, specifically phosphorylates 'Ser-36' of isoform p66Shc of SHC1, leading to mitochondrial accumulation of p66Shc, where p66Shc acts as a reactive oxygen species producer. Acts as a coactivator of androgen receptor (AR)-dependent transcription, by being recruited to AR target genes and specifically mediating phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag for epigenetic transcriptional activation that prevents demethylation of histone H3 'Lys-4' (H3K4me) by LSD1/KDM1A (PubMed:20228790). In insulin signaling, may function downstream of IRS1 in muscle cells and mediate insulin-dependent DNA synthesis through the RAF1-MAPK/ERK signaling cascade. Participates in the regulation of glucose transport in adipocytes by negatively modulating the insulin-stimulated translocation of the glucose transporter SLC2A4/GLUT4. Phosphorylates SLC2A1/GLUT1, promoting glucose uptake by SLC2A1/GLUT1 (PubMed:25982116). Under high glucose in pancreatic beta-cells, is probably involved in the inhibition of the insulin gene transcription, via regulation of MYC expression. In endothelial cells, activation of PRKCB induces increased phosphorylation of RB1, increased VEGFA-induced cell proliferation, and inhibits PI3K/AKT-dependent nitric oxide synthase (NOS3/eNOS) regulation by insulin, which causes endothelial dysfunction. Also involved in triglyceride homeostasis (By similarity). Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription (PubMed:19176525). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (PubMed:25313067). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000250|UniProtKB:P68404, ECO:0000269|PubMed:11598012, ECO:0000269|PubMed:19176525, ECO:0000269|PubMed:20228790, ECO:0000269|PubMed:25313067, ECO:0000269|PubMed:25982116, ECO:0000269|PubMed:36040231}.; FUNCTION: [Isoform Beta-II]: Acts as an activator of ferroptosis by mediating phosphorylation and activation of ACSL4 (PubMed:35027735). Also stimulates ferroptosis propagation by catalyzing phosphorylation of FOXK1, thereby promoting LGALS13 secretion (PubMed:40246981). {ECO:0000269|PubMed:35027735, ECO:0000269|PubMed:40246981}.	9606	calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; spectrin [GO:0008091]	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular response to carbohydrate stimulus [GO:0071322]; intracellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; lipoprotein transport [GO:0042953]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of D-glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of ferroptosis [GO:0160020]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]	calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; spectrin [GO:0008091]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; chromatin binding [GO:0003682]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone binding [GO:0042393]; histone H3T6 kinase activity [GO:0035403]; nuclear androgen receptor binding [GO:0050681]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular response to carbohydrate stimulus [GO:0071322]; intracellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; lipoprotein transport [GO:0042953]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of D-glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of ferroptosis [GO:0160020]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; chromatin binding [GO:0003682]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone binding [GO:0042393]; histone H3T6 kinase activity [GO:0035403]; nuclear androgen receptor binding [GO:0050681]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	GO:0002250; GO:0003682; GO:0003713; GO:0004674; GO:0004697; GO:0004698; GO:0005080; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006468; GO:0006816; GO:0006874; GO:0006915; GO:0007077; GO:0007165; GO:0007207; GO:0008091; GO:0008270; GO:0010827; GO:0010829; GO:0030949; GO:0032024; GO:0035403; GO:0035556; GO:0042113; GO:0042393; GO:0042953; GO:0043123; GO:0044305; GO:0045766; GO:0046627; GO:0050681; GO:0050853; GO:0070062; GO:0070528; GO:0071322; GO:0099171; GO:0099523; GO:0106310; GO:0160020; GO:2000300	Homo sapiens (Human)
NP_001307637.1	Q16513	reviewed	PKN2_HUMAN	Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)	PKN2 PRK2 PRKCL2		FUNCTION: PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Involved in the negative regulation of ciliogenesis (PubMed:27104747). {ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11777936, ECO:0000269|PubMed:11781095, ECO:0000269|PubMed:15123640, ECO:0000269|PubMed:15364941, ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:20188095, ECO:0000269|PubMed:20974804, ECO:0000269|PubMed:21754995, ECO:0000269|PubMed:27104747, ECO:0000269|PubMed:9121475}.; FUNCTION: (Microbial infection) Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication. {ECO:0000269|PubMed:15364941}.	9606	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]	GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007155; GO:0007165; GO:0010631; GO:0016301; GO:0016604; GO:0030027; GO:0030030; GO:0030496; GO:0031267; GO:0032154; GO:0032467; GO:0032991; GO:0035556; GO:0042826; GO:0043296; GO:0043297; GO:0045070; GO:0045111; GO:0045296; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:0097700; GO:0106310; GO:2000145	Homo sapiens (Human)
NP_002732.3	Q16512	reviewed	PKN1_HUMAN	Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N)	PKN1 PAK1 PKN PRK1 PRKCL1		FUNCTION: PKC-related serine/threonine-protein kinase involved in various processes such as regulation of the intermediate filaments of the actin cytoskeleton, cell migration, tumor cell invasion and transcription regulation. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14. Regulates the cytoskeletal network by phosphorylating proteins such as VIM and neurofilament proteins NEFH, NEFL and NEFM, leading to inhibit their polymerization. Phosphorylates 'Ser-575', 'Ser-637' and 'Ser-669' of MAPT/Tau, lowering its ability to bind to microtubules, resulting in disruption of tubulin assembly. Acts as a key coactivator of androgen receptor (AR)-dependent transcription, by being recruited to AR target genes and specifically mediating phosphorylation of 'Thr-11' of histone H3 (H3T11ph), a specific tag for epigenetic transcriptional activation that promotes demethylation of histone H3 'Lys-9' (H3K9me) by KDM4C/JMJD2C. Phosphorylates HDAC5, HDAC7 and HDAC9, leading to impair their import in the nucleus. Phosphorylates 'Thr-38' of PPP1R14A, 'Ser-159', 'Ser-163' and 'Ser-170' of MARCKS, and GFAP. Able to phosphorylate RPS6 in vitro. {ECO:0000269|PubMed:11104762, ECO:0000269|PubMed:12514133, ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:18066052, ECO:0000269|PubMed:20188095, ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:21754995, ECO:0000269|PubMed:24248594, ECO:0000269|PubMed:8557118, ECO:0000269|PubMed:8621664, ECO:0000269|PubMed:9175763}.	9606	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; epithelial cell migration [GO:0010631]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3T11 kinase activity [GO:0035402]; nuclear androgen receptor binding [GO:0050681]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; epithelial cell migration [GO:0010631]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3T11 kinase activity [GO:0035402]; nuclear androgen receptor binding [GO:0050681]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713]	GO:0001782; GO:0001783; GO:0002634; GO:0002637; GO:0003014; GO:0003682; GO:0003713; GO:0004672; GO:0004674; GO:0004697; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0006357; GO:0006468; GO:0006972; GO:0007165; GO:0010631; GO:0030496; GO:0030889; GO:0031267; GO:0032154; GO:0032991; GO:0035402; GO:0035556; GO:0042393; GO:0042826; GO:0043687; GO:0048536; GO:0050681; GO:0060765; GO:0106310; GO:2000145	Homo sapiens (Human)
NP_998725.1	Q16512	reviewed	PKN1_HUMAN	Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N)	PKN1 PAK1 PKN PRK1 PRKCL1		FUNCTION: PKC-related serine/threonine-protein kinase involved in various processes such as regulation of the intermediate filaments of the actin cytoskeleton, cell migration, tumor cell invasion and transcription regulation. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14. Regulates the cytoskeletal network by phosphorylating proteins such as VIM and neurofilament proteins NEFH, NEFL and NEFM, leading to inhibit their polymerization. Phosphorylates 'Ser-575', 'Ser-637' and 'Ser-669' of MAPT/Tau, lowering its ability to bind to microtubules, resulting in disruption of tubulin assembly. Acts as a key coactivator of androgen receptor (AR)-dependent transcription, by being recruited to AR target genes and specifically mediating phosphorylation of 'Thr-11' of histone H3 (H3T11ph), a specific tag for epigenetic transcriptional activation that promotes demethylation of histone H3 'Lys-9' (H3K9me) by KDM4C/JMJD2C. Phosphorylates HDAC5, HDAC7 and HDAC9, leading to impair their import in the nucleus. Phosphorylates 'Thr-38' of PPP1R14A, 'Ser-159', 'Ser-163' and 'Ser-170' of MARCKS, and GFAP. Able to phosphorylate RPS6 in vitro. {ECO:0000269|PubMed:11104762, ECO:0000269|PubMed:12514133, ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:18066052, ECO:0000269|PubMed:20188095, ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:21754995, ECO:0000269|PubMed:24248594, ECO:0000269|PubMed:8557118, ECO:0000269|PubMed:8621664, ECO:0000269|PubMed:9175763}.	9606	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; epithelial cell migration [GO:0010631]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3T11 kinase activity [GO:0035402]; nuclear androgen receptor binding [GO:0050681]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; epithelial cell migration [GO:0010631]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3T11 kinase activity [GO:0035402]; nuclear androgen receptor binding [GO:0050681]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713]	GO:0001782; GO:0001783; GO:0002634; GO:0002637; GO:0003014; GO:0003682; GO:0003713; GO:0004672; GO:0004674; GO:0004697; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0006357; GO:0006468; GO:0006972; GO:0007165; GO:0010631; GO:0030496; GO:0030889; GO:0031267; GO:0032154; GO:0032991; GO:0035402; GO:0035556; GO:0042393; GO:0042826; GO:0043687; GO:0048536; GO:0050681; GO:0060765; GO:0106310; GO:2000145	Homo sapiens (Human)
NP_001307636.1	Q16513	reviewed	PKN2_HUMAN	Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)	PKN2 PRK2 PRKCL2		FUNCTION: PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Involved in the negative regulation of ciliogenesis (PubMed:27104747). {ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11777936, ECO:0000269|PubMed:11781095, ECO:0000269|PubMed:15123640, ECO:0000269|PubMed:15364941, ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:20188095, ECO:0000269|PubMed:20974804, ECO:0000269|PubMed:21754995, ECO:0000269|PubMed:27104747, ECO:0000269|PubMed:9121475}.; FUNCTION: (Microbial infection) Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication. {ECO:0000269|PubMed:15364941}.	9606	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]	GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007155; GO:0007165; GO:0010631; GO:0016301; GO:0016604; GO:0030027; GO:0030030; GO:0030496; GO:0031267; GO:0032154; GO:0032467; GO:0032991; GO:0035556; GO:0042826; GO:0043296; GO:0043297; GO:0045070; GO:0045111; GO:0045296; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:0097700; GO:0106310; GO:2000145	Homo sapiens (Human)
NP_595159.1	P40376	reviewed	KAPB_SCHPO	cAMP-dependent protein kinase catalytic subunit (EC 2.7.11.11)	pka1 tpk SPBC106.10			284812	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fungal-type vacuole [GO:0000324]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway [GO:0010619]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of induction of conjugation with cellular fusion [GO:0010515]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of protein export from nucleus [GO:0046827]	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fungal-type vacuole [GO:0000324]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway [GO:0010619]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of induction of conjugation with cellular fusion [GO:0010515]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of protein export from nucleus [GO:0046827]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000122; GO:0000324; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005952; GO:0007189; GO:0010515; GO:0010619; GO:0031117; GO:0045721; GO:0046827; GO:0106310	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)
NP_891993.1	P22694	reviewed	KAPCB_HUMAN	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	PRKACB		FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}.	9606	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of insulin secretion [GO:0032024]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001843; GO:0003091; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0007189; GO:0019870; GO:0021904; GO:0031625; GO:0032024; GO:0034380; GO:0045879; GO:0070062; GO:0070613; GO:0097546; GO:0097700; GO:0106310; GO:1904262	Homo sapiens (Human)
XP_024305429.1	P24723	reviewed	KPCL_HUMAN	Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta)	PRKCH PKCL PRKCL		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in the regulation of cell differentiation in keratinocytes and pre-B cell receptor, mediates regulation of epithelial tight junction integrity and foam cell formation, and is required for glioblastoma proliferation and apoptosis prevention in MCF-7 cells. In keratinocytes, binds and activates the tyrosine kinase FYN, which in turn blocks epidermal growth factor receptor (EGFR) signaling and leads to keratinocyte growth arrest and differentiation. Associates with the cyclin CCNE1-CDK2-CDKN1B complex and inhibits CDK2 kinase activity, leading to RB1 dephosphorylation and thereby G1 arrest in keratinocytes. In association with RALA activates actin depolymerization, which is necessary for keratinocyte differentiation. In the pre-B cell receptor signaling, functions downstream of BLNK by up-regulating IRF4, which in turn activates L chain gene rearrangement. Regulates epithelial tight junctions (TJs) by phosphorylating occludin (OCLN) on threonine residues, which is necessary for the assembly and maintenance of TJs. In association with PLD2 and via TLR4 signaling, is involved in lipopolysaccharide (LPS)-induced RGS2 down-regulation and foam cell formation. Upon PMA stimulation, mediates glioblastoma cell proliferation by activating the mTOR pathway, the PI3K/AKT pathway and the ERK1-dependent phosphorylation of ELK1. Involved in the protection of glioblastoma cells from irradiation-induced apoptosis by preventing caspase-9 activation. In camptothecin-treated MCF-7 cells, regulates NF-kappa-B upstream signaling by activating IKBKB, and confers protection against DNA damage-induced apoptosis. Promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Phosphorylates ATF2 which promotes its nuclear retention and transcriptional activity and negatively regulates its mitochondrial localization. {ECO:0000269|PubMed:10806212, ECO:0000269|PubMed:11112424, ECO:0000269|PubMed:11772428, ECO:0000269|PubMed:15489897, ECO:0000269|PubMed:17146445, ECO:0000269|PubMed:18780722, ECO:0000269|PubMed:19114660, ECO:0000269|PubMed:20558593, ECO:0000269|PubMed:21820409, ECO:0000269|PubMed:22304920}.	9606	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme binding [GO:0019899]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme binding [GO:0019899]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007165; GO:0008270; GO:0010744; GO:0019899; GO:0030154; GO:0031267; GO:0034351; GO:0035556; GO:0045618; GO:0050861; GO:0051092; GO:0060252; GO:0070062; GO:0106310; GO:0141212; GO:1903078; GO:2000810	Homo sapiens (Human)
XP_024305430.1	P24723	reviewed	KPCL_HUMAN	Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta)	PRKCH PKCL PRKCL		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in the regulation of cell differentiation in keratinocytes and pre-B cell receptor, mediates regulation of epithelial tight junction integrity and foam cell formation, and is required for glioblastoma proliferation and apoptosis prevention in MCF-7 cells. In keratinocytes, binds and activates the tyrosine kinase FYN, which in turn blocks epidermal growth factor receptor (EGFR) signaling and leads to keratinocyte growth arrest and differentiation. Associates with the cyclin CCNE1-CDK2-CDKN1B complex and inhibits CDK2 kinase activity, leading to RB1 dephosphorylation and thereby G1 arrest in keratinocytes. In association with RALA activates actin depolymerization, which is necessary for keratinocyte differentiation. In the pre-B cell receptor signaling, functions downstream of BLNK by up-regulating IRF4, which in turn activates L chain gene rearrangement. Regulates epithelial tight junctions (TJs) by phosphorylating occludin (OCLN) on threonine residues, which is necessary for the assembly and maintenance of TJs. In association with PLD2 and via TLR4 signaling, is involved in lipopolysaccharide (LPS)-induced RGS2 down-regulation and foam cell formation. Upon PMA stimulation, mediates glioblastoma cell proliferation by activating the mTOR pathway, the PI3K/AKT pathway and the ERK1-dependent phosphorylation of ELK1. Involved in the protection of glioblastoma cells from irradiation-induced apoptosis by preventing caspase-9 activation. In camptothecin-treated MCF-7 cells, regulates NF-kappa-B upstream signaling by activating IKBKB, and confers protection against DNA damage-induced apoptosis. Promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Phosphorylates ATF2 which promotes its nuclear retention and transcriptional activity and negatively regulates its mitochondrial localization. {ECO:0000269|PubMed:10806212, ECO:0000269|PubMed:11112424, ECO:0000269|PubMed:11772428, ECO:0000269|PubMed:15489897, ECO:0000269|PubMed:17146445, ECO:0000269|PubMed:18780722, ECO:0000269|PubMed:19114660, ECO:0000269|PubMed:20558593, ECO:0000269|PubMed:21820409, ECO:0000269|PubMed:22304920}.	9606	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme binding [GO:0019899]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme binding [GO:0019899]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007165; GO:0008270; GO:0010744; GO:0019899; GO:0030154; GO:0031267; GO:0034351; GO:0035556; GO:0045618; GO:0050861; GO:0051092; GO:0060252; GO:0070062; GO:0106310; GO:0141212; GO:1903078; GO:2000810	Homo sapiens (Human)
XP_054232364.1	P24723	reviewed	KPCL_HUMAN	Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta)	PRKCH PKCL PRKCL		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in the regulation of cell differentiation in keratinocytes and pre-B cell receptor, mediates regulation of epithelial tight junction integrity and foam cell formation, and is required for glioblastoma proliferation and apoptosis prevention in MCF-7 cells. In keratinocytes, binds and activates the tyrosine kinase FYN, which in turn blocks epidermal growth factor receptor (EGFR) signaling and leads to keratinocyte growth arrest and differentiation. Associates with the cyclin CCNE1-CDK2-CDKN1B complex and inhibits CDK2 kinase activity, leading to RB1 dephosphorylation and thereby G1 arrest in keratinocytes. In association with RALA activates actin depolymerization, which is necessary for keratinocyte differentiation. In the pre-B cell receptor signaling, functions downstream of BLNK by up-regulating IRF4, which in turn activates L chain gene rearrangement. Regulates epithelial tight junctions (TJs) by phosphorylating occludin (OCLN) on threonine residues, which is necessary for the assembly and maintenance of TJs. In association with PLD2 and via TLR4 signaling, is involved in lipopolysaccharide (LPS)-induced RGS2 down-regulation and foam cell formation. Upon PMA stimulation, mediates glioblastoma cell proliferation by activating the mTOR pathway, the PI3K/AKT pathway and the ERK1-dependent phosphorylation of ELK1. Involved in the protection of glioblastoma cells from irradiation-induced apoptosis by preventing caspase-9 activation. In camptothecin-treated MCF-7 cells, regulates NF-kappa-B upstream signaling by activating IKBKB, and confers protection against DNA damage-induced apoptosis. Promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Phosphorylates ATF2 which promotes its nuclear retention and transcriptional activity and negatively regulates its mitochondrial localization. {ECO:0000269|PubMed:10806212, ECO:0000269|PubMed:11112424, ECO:0000269|PubMed:11772428, ECO:0000269|PubMed:15489897, ECO:0000269|PubMed:17146445, ECO:0000269|PubMed:18780722, ECO:0000269|PubMed:19114660, ECO:0000269|PubMed:20558593, ECO:0000269|PubMed:21820409, ECO:0000269|PubMed:22304920}.	9606	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme binding [GO:0019899]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme binding [GO:0019899]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007165; GO:0008270; GO:0010744; GO:0019899; GO:0030154; GO:0031267; GO:0034351; GO:0035556; GO:0045618; GO:0050861; GO:0051092; GO:0060252; GO:0070062; GO:0106310; GO:0141212; GO:1903078; GO:2000810	Homo sapiens (Human)
XP_054232365.1	P24723	reviewed	KPCL_HUMAN	Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta)	PRKCH PKCL PRKCL		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in the regulation of cell differentiation in keratinocytes and pre-B cell receptor, mediates regulation of epithelial tight junction integrity and foam cell formation, and is required for glioblastoma proliferation and apoptosis prevention in MCF-7 cells. In keratinocytes, binds and activates the tyrosine kinase FYN, which in turn blocks epidermal growth factor receptor (EGFR) signaling and leads to keratinocyte growth arrest and differentiation. Associates with the cyclin CCNE1-CDK2-CDKN1B complex and inhibits CDK2 kinase activity, leading to RB1 dephosphorylation and thereby G1 arrest in keratinocytes. In association with RALA activates actin depolymerization, which is necessary for keratinocyte differentiation. In the pre-B cell receptor signaling, functions downstream of BLNK by up-regulating IRF4, which in turn activates L chain gene rearrangement. Regulates epithelial tight junctions (TJs) by phosphorylating occludin (OCLN) on threonine residues, which is necessary for the assembly and maintenance of TJs. In association with PLD2 and via TLR4 signaling, is involved in lipopolysaccharide (LPS)-induced RGS2 down-regulation and foam cell formation. Upon PMA stimulation, mediates glioblastoma cell proliferation by activating the mTOR pathway, the PI3K/AKT pathway and the ERK1-dependent phosphorylation of ELK1. Involved in the protection of glioblastoma cells from irradiation-induced apoptosis by preventing caspase-9 activation. In camptothecin-treated MCF-7 cells, regulates NF-kappa-B upstream signaling by activating IKBKB, and confers protection against DNA damage-induced apoptosis. Promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Phosphorylates ATF2 which promotes its nuclear retention and transcriptional activity and negatively regulates its mitochondrial localization. {ECO:0000269|PubMed:10806212, ECO:0000269|PubMed:11112424, ECO:0000269|PubMed:11772428, ECO:0000269|PubMed:15489897, ECO:0000269|PubMed:17146445, ECO:0000269|PubMed:18780722, ECO:0000269|PubMed:19114660, ECO:0000269|PubMed:20558593, ECO:0000269|PubMed:21820409, ECO:0000269|PubMed:22304920}.	9606	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme binding [GO:0019899]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme binding [GO:0019899]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007165; GO:0008270; GO:0010744; GO:0019899; GO:0030154; GO:0031267; GO:0034351; GO:0035556; GO:0045618; GO:0050861; GO:0051092; GO:0060252; GO:0070062; GO:0106310; GO:0141212; GO:1903078; GO:2000810	Homo sapiens (Human)
NP_476977.1	P12370	reviewed	KAPC1_DROME	cAMP-dependent protein kinase catalytic subunit 1 (PKA C) (EC 2.7.11.11) (Protein kinase DC0)	Pka-C1 CdkA DC0 CG4379		FUNCTION: Serine/threonine-protein kinase involved in memory formation (PubMed:29473541). Promotes long-term memory by phosphorylating meng and by regulating CrebB protein stability and activity (PubMed:29473541). As part of ethanol response in the glia, mediates ethanol-induced structural remodeling of actin cytoskeleton and perineurial membrane topology when anchored to the membrane (PubMed:29444420). {ECO:0000269|PubMed:29444420, ECO:0000269|PubMed:29473541}.	7227	cAMP-dependent protein kinase complex [GO:0005952]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of Atg1/ULK1 kinase complex assembly [GO:1905866]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]	cAMP-dependent protein kinase complex [GO:0005952]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of Atg1/ULK1 kinase complex assembly [GO:1905866]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005759; GO:0005829; GO:0005886; GO:0005952; GO:0007189; GO:0007314; GO:0007317; GO:0007448; GO:0007476; GO:0007615; GO:0007622; GO:0008103; GO:0008355; GO:0008359; GO:0010628; GO:0019933; GO:0030425; GO:0032436; GO:0032956; GO:0035332; GO:0040040; GO:0042048; GO:0042981; GO:0043005; GO:0043025; GO:0044297; GO:0045187; GO:0045879; GO:0045880; GO:0046823; GO:0048477; GO:0048682; GO:0050804; GO:0071361; GO:0090298; GO:0106310; GO:1905866	Drosophila melanogaster (Fruit fly)
NP_006247.1	Q16513	reviewed	PKN2_HUMAN	Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)	PKN2 PRK2 PRKCL2		FUNCTION: PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Involved in the negative regulation of ciliogenesis (PubMed:27104747). {ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11777936, ECO:0000269|PubMed:11781095, ECO:0000269|PubMed:15123640, ECO:0000269|PubMed:15364941, ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:20188095, ECO:0000269|PubMed:20974804, ECO:0000269|PubMed:21754995, ECO:0000269|PubMed:27104747, ECO:0000269|PubMed:9121475}.; FUNCTION: (Microbial infection) Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication. {ECO:0000269|PubMed:15364941}.	9606	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]	GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007155; GO:0007165; GO:0010631; GO:0016301; GO:0016604; GO:0030027; GO:0030030; GO:0030496; GO:0031267; GO:0032154; GO:0032467; GO:0032991; GO:0035556; GO:0042826; GO:0043296; GO:0043297; GO:0045070; GO:0045111; GO:0045296; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:0097700; GO:0106310; GO:2000145	Homo sapiens (Human)
NP_001307638.1	Q16513	reviewed	PKN2_HUMAN	Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)	PKN2 PRK2 PRKCL2		FUNCTION: PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Involved in the negative regulation of ciliogenesis (PubMed:27104747). {ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11777936, ECO:0000269|PubMed:11781095, ECO:0000269|PubMed:15123640, ECO:0000269|PubMed:15364941, ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:20188095, ECO:0000269|PubMed:20974804, ECO:0000269|PubMed:21754995, ECO:0000269|PubMed:27104747, ECO:0000269|PubMed:9121475}.; FUNCTION: (Microbial infection) Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication. {ECO:0000269|PubMed:15364941}.	9606	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]	GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007155; GO:0007165; GO:0010631; GO:0016301; GO:0016604; GO:0030027; GO:0030030; GO:0030496; GO:0031267; GO:0032154; GO:0032467; GO:0032991; GO:0035556; GO:0042826; GO:0043296; GO:0043297; GO:0045070; GO:0045111; GO:0045296; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:0097700; GO:0106310; GO:2000145	Homo sapiens (Human)
NP_001286242.1	A0A0B4LEY5	unreviewed	A0A0B4LEY5_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_788290.1	A1Z7T0	reviewed	PKN_DROME	Serine/threonine-protein kinase N (EC 2.7.11.13) (Protein kinase related to PKN)	Pkn Dpkn CG2049		FUNCTION: Pkc-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. May play a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion and transcription activation signaling processes (By similarity). Plays a role in regulating Rho-mediated dorsal closure during embryogenesis. {ECO:0000250, ECO:0000269|PubMed:10323867, ECO:0000269|PubMed:17507675}.	7227	anchoring junction [GO:0070161]; apical cortex [GO:0045179]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; dorsal closure [GO:0007391]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis, division site positioning [GO:1902408]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; wing disc morphogenesis [GO:0007472]	anchoring junction [GO:0070161]; apical cortex [GO:0045179]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; dorsal closure [GO:0007391]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis, division site positioning [GO:1902408]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; wing disc morphogenesis [GO:0007472]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]	GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007155; GO:0007391; GO:0007472; GO:0030027; GO:0030036; GO:0030496; GO:0031267; GO:0032154; GO:0035556; GO:0045179; GO:0046777; GO:0070161; GO:0090303; GO:0106310; GO:1902408	Drosophila melanogaster (Fruit fly)
NP_788292.1	A1Z7T2	unreviewed	A1Z7T2_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001163095.1	E1JH15	unreviewed	E1JH15_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001246220.1	A1Z7T0	reviewed	PKN_DROME	Serine/threonine-protein kinase N (EC 2.7.11.13) (Protein kinase related to PKN)	Pkn Dpkn CG2049		FUNCTION: Pkc-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. May play a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion and transcription activation signaling processes (By similarity). Plays a role in regulating Rho-mediated dorsal closure during embryogenesis. {ECO:0000250, ECO:0000269|PubMed:10323867, ECO:0000269|PubMed:17507675}.	7227	anchoring junction [GO:0070161]; apical cortex [GO:0045179]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; dorsal closure [GO:0007391]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis, division site positioning [GO:1902408]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; wing disc morphogenesis [GO:0007472]	anchoring junction [GO:0070161]; apical cortex [GO:0045179]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; dorsal closure [GO:0007391]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis, division site positioning [GO:1902408]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; wing disc morphogenesis [GO:0007472]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]	GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007155; GO:0007391; GO:0007472; GO:0030027; GO:0030036; GO:0030496; GO:0031267; GO:0032154; GO:0035556; GO:0045179; GO:0046777; GO:0070161; GO:0090303; GO:0106310; GO:1902408	Drosophila melanogaster (Fruit fly)
NP_001246220.1	A0A0B4K6U3	unreviewed	A0A0B4K6U3_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001188895.1	A0A0B4K727	unreviewed	A0A0B4K727_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154	Drosophila melanogaster (Fruit fly)
NP_001246221.1	A0A0B4K727	unreviewed	A0A0B4K727_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154	Drosophila melanogaster (Fruit fly)
NP_001188896.1	A0A0B4JD07	unreviewed	A0A0B4JD07_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154	Drosophila melanogaster (Fruit fly)
NP_001188897.3	A0A0B4JD07	unreviewed	A0A0B4JD07_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154	Drosophila melanogaster (Fruit fly)
NP_001286244.1	A0A0B4LF03	unreviewed	A0A0B4LF03_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001286243.1	A0A0B4LEI8	unreviewed	A0A0B4LEI8_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001246377.1	D3DMK5	unreviewed	D3DMK5_DROME	protein kinase C (EC 2.7.11.13)	Pkc53E Dmel\CG6622 DPKC dPKC Dpkc1 dPKC53E(br) pck53E PK-C PKC PKC 53B PKC 53E PKC-53B PKC-53E PKC1 Pkc1 PKC53E PKC53e pkc53e Pkc53E-RC CG6622 Dmel_CG6622			7227			ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0008270	Drosophila melanogaster (Fruit fly)
NP_001261035.1	P05130	reviewed	KPC1_DROME	Protein kinase C, brain isozyme (PKC) (EC 2.7.11.13) (dPKC53E(BR))	Pkc53E PKC1 CG6622		FUNCTION: PKC is activated by diacylglycerol which in turn phosphorylates a range of cellular proteins (By similarity). PKC also serves as the receptor for phorbol esters, a class of tumor promoters (By similarity). Acts in a hh-signaling pathway which regulates the Duox-dependent gut immune response to bacterial uracil; required for the activation of Cad99C and consequently Cad99C-dependent endosome formation, which is essential for the Duox-dependent production of reactive oxygen species (ROS) in response to intestinal bacterial infection (PubMed:25639794). {ECO:0000250|UniProtKB:P34885, ECO:0000269|PubMed:25639794}.	7227	plasma membrane [GO:0005886]	intracellular signal transduction [GO:0035556]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of hemocyte proliferation [GO:0035206]	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of hemocyte proliferation [GO:0035206]	ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0004698; GO:0005524; GO:0005886; GO:0008270; GO:0035206; GO:0035556; GO:0106310; GO:2000370	Drosophila melanogaster (Fruit fly)
NP_001261035.1	A0A0B4KFT3	unreviewed	A0A0B4KFT3_DROME	Protein kinase C (EC 2.7.11.13)	Pkc53E Dmel\CG6622 DPKC dPKC Dpkc1 dPKC53E(br) pck53E PK-C PKC PKC 53B PKC 53E PKC-53B PKC-53E PKC1 Pkc1 PKC53E PKC53e pkc53E pkc53e CG6622 Dmel_CG6622			7227			ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0008270; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_476682.1	P05130	reviewed	KPC1_DROME	Protein kinase C, brain isozyme (PKC) (EC 2.7.11.13) (dPKC53E(BR))	Pkc53E PKC1 CG6622		FUNCTION: PKC is activated by diacylglycerol which in turn phosphorylates a range of cellular proteins (By similarity). PKC also serves as the receptor for phorbol esters, a class of tumor promoters (By similarity). Acts in a hh-signaling pathway which regulates the Duox-dependent gut immune response to bacterial uracil; required for the activation of Cad99C and consequently Cad99C-dependent endosome formation, which is essential for the Duox-dependent production of reactive oxygen species (ROS) in response to intestinal bacterial infection (PubMed:25639794). {ECO:0000250|UniProtKB:P34885, ECO:0000269|PubMed:25639794}.	7227	plasma membrane [GO:0005886]	intracellular signal transduction [GO:0035556]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of hemocyte proliferation [GO:0035206]	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of hemocyte proliferation [GO:0035206]	ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0004698; GO:0005524; GO:0005886; GO:0008270; GO:0035206; GO:0035556; GO:0106310; GO:2000370	Drosophila melanogaster (Fruit fly)
NP_476682.1	A0A0B4KFT3	unreviewed	A0A0B4KFT3_DROME	Protein kinase C (EC 2.7.11.13)	Pkc53E Dmel\CG6622 DPKC dPKC Dpkc1 dPKC53E(br) pck53E PK-C PKC PKC 53B PKC 53E PKC-53B PKC-53E PKC1 Pkc1 PKC53E PKC53e pkc53E pkc53e CG6622 Dmel_CG6622			7227			ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0008270; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001097350.1	A8DYG9	unreviewed	A8DYG9_DROME	Protein kinase C (EC 2.7.11.13)	Pkc53E Dmel\CG6622 DPKC dPKC Dpkc1 dPKC53E(br) pck53E PK-C PKC PKC 53B PKC 53E PKC-53B PKC-53E PKC1 Pkc1 PKC53E PKC53e pkc53e CG6622 Dmel_CG6622			7227			ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0008270	Drosophila melanogaster (Fruit fly)
NP_001246378.1	A8DYG9	unreviewed	A8DYG9_DROME	Protein kinase C (EC 2.7.11.13)	Pkc53E Dmel\CG6622 DPKC dPKC Dpkc1 dPKC53E(br) pck53E PK-C PKC PKC 53B PKC 53E PKC-53B PKC-53E PKC1 Pkc1 PKC53E PKC53e pkc53e CG6622 Dmel_CG6622			7227			ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0008270	Drosophila melanogaster (Fruit fly)
NP_725626.1	P05130	reviewed	KPC1_DROME	Protein kinase C, brain isozyme (PKC) (EC 2.7.11.13) (dPKC53E(BR))	Pkc53E PKC1 CG6622		FUNCTION: PKC is activated by diacylglycerol which in turn phosphorylates a range of cellular proteins (By similarity). PKC also serves as the receptor for phorbol esters, a class of tumor promoters (By similarity). Acts in a hh-signaling pathway which regulates the Duox-dependent gut immune response to bacterial uracil; required for the activation of Cad99C and consequently Cad99C-dependent endosome formation, which is essential for the Duox-dependent production of reactive oxygen species (ROS) in response to intestinal bacterial infection (PubMed:25639794). {ECO:0000250|UniProtKB:P34885, ECO:0000269|PubMed:25639794}.	7227	plasma membrane [GO:0005886]	intracellular signal transduction [GO:0035556]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of hemocyte proliferation [GO:0035206]	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of hemocyte proliferation [GO:0035206]	ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0004698; GO:0005524; GO:0005886; GO:0008270; GO:0035206; GO:0035556; GO:0106310; GO:2000370	Drosophila melanogaster (Fruit fly)
NP_002728.2	P17252	reviewed	KPCA_HUMAN	Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13)	PRKCA PKCA PRKACA		FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. During chemokine-induced CD4(+) T cell migration, phosphorylates CDC42-guanine exchange factor DOCK8 resulting in its dissociation from LRCH1 and the activation of GTPase CDC42 (PubMed:28028151). Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity. Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription. Phosphorylates SOCS2 at 'Ser-52' facilitating its ubiquitination and proteasomal degradation (By similarity). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (PubMed:25313067). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000250|UniProtKB:P20444, ECO:0000269|PubMed:10848585, ECO:0000269|PubMed:11909826, ECO:0000269|PubMed:12724315, ECO:0000269|PubMed:12832403, ECO:0000269|PubMed:15016832, ECO:0000269|PubMed:15504744, ECO:0000269|PubMed:15526160, ECO:0000269|PubMed:18056764, ECO:0000269|PubMed:19176525, ECO:0000269|PubMed:21576361, ECO:0000269|PubMed:21806543, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:25313067, ECO:0000269|PubMed:28028151, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9738012, ECO:0000269|PubMed:9830023, ECO:0000269|PubMed:9873035, ECO:0000269|PubMed:9927633}.	9606	alphav-beta3 integrin-PKCalpha complex [GO:0035866]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cell adhesion [GO:0007155]; central nervous system neuron axonogenesis [GO:0021955]; desmosome assembly [GO:0002159]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of translation [GO:0017148]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of angiogenesis [GO:0045766]; positive regulation of angiotensin-activated signaling pathway [GO:0110063]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synapse assembly [GO:0051965]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; regulation of platelet aggregation [GO:0090330]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to phorbol 13-acetate 12-myristate [GO:1904627]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]	alphav-beta3 integrin-PKCalpha complex [GO:0035866]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; diacylglycerol binding [GO:0019992]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; enzyme binding [GO:0019899]; histone H3T6 kinase activity [GO:0035403]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cell adhesion [GO:0007155]; central nervous system neuron axonogenesis [GO:0021955]; desmosome assembly [GO:0002159]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of translation [GO:0017148]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of angiogenesis [GO:0045766]; positive regulation of angiotensin-activated signaling pathway [GO:0110063]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synapse assembly [GO:0051965]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; regulation of platelet aggregation [GO:0090330]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to phorbol 13-acetate 12-myristate [GO:1904627]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]	ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; diacylglycerol binding [GO:0019992]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; enzyme binding [GO:0019899]; histone H3T6 kinase activity [GO:0035403]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000302; GO:0001525; GO:0001938; GO:0002159; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0005178; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007077; GO:0007155; GO:0007611; GO:0008270; GO:0009612; GO:0009636; GO:0010595; GO:0010613; GO:0017148; GO:0019899; GO:0019992; GO:0021955; GO:0030335; GO:0031666; GO:0031966; GO:0032024; GO:0032355; GO:0034351; GO:0035403; GO:0035556; GO:0035866; GO:0036064; GO:0043434; GO:0043488; GO:0043536; GO:0045471; GO:0045651; GO:0045766; GO:0045780; GO:0045785; GO:0045921; GO:0045931; GO:0048471; GO:0048661; GO:0051412; GO:0051897; GO:0051965; GO:0070062; GO:0070374; GO:0070528; GO:0070555; GO:0090330; GO:0097190; GO:0106071; GO:0106310; GO:0110063; GO:1900016; GO:1900017; GO:1904627; GO:2000707	Homo sapiens (Human)
NP_002728.2	L7RSM7	unreviewed	L7RSM7_HUMAN	Protein kinase C (EC 2.7.11.13)	PRKCA			9606	cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; central nervous system neuron axonogenesis [GO:0021955]; learning or memory [GO:0007611]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of translation [GO:0017148]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synapse assembly [GO:0051965]; protein kinase C signaling [GO:0070528]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to phorbol 13-acetate 12-myristate [GO:1904627]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]	cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; histone H3T6 kinase activity [GO:0035403]; protein serine kinase activity [GO:0106310]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; central nervous system neuron axonogenesis [GO:0021955]; learning or memory [GO:0007611]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of translation [GO:0017148]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synapse assembly [GO:0051965]; protein kinase C signaling [GO:0070528]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to phorbol 13-acetate 12-myristate [GO:1904627]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]	ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; histone H3T6 kinase activity [GO:0035403]; protein serine kinase activity [GO:0106310]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]	GO:0000302; GO:0001525; GO:0004698; GO:0005102; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006915; GO:0007077; GO:0007155; GO:0007611; GO:0008270; GO:0009612; GO:0009636; GO:0010613; GO:0017148; GO:0021955; GO:0031966; GO:0032355; GO:0032991; GO:0035403; GO:0043434; GO:0045471; GO:0045921; GO:0048471; GO:0048661; GO:0051412; GO:0051897; GO:0051965; GO:0070374; GO:0070528; GO:0106310; GO:1900016; GO:1900017; GO:1904627	Homo sapiens (Human)
NP_002728.2	Q7Z727	unreviewed	Q7Z727_HUMAN	PRKCA protein	PRKCA			9606			calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; metal ion binding [GO:0046872]	calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; metal ion binding [GO:0046872]	GO:0004698; GO:0046872	Homo sapiens (Human)
NP_002729.2	P05771	reviewed	KPCB_HUMAN	Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13)	PRKCB PKCB PRKCB1		FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase involved in various cellular processes such as regulation of the B-cell receptor (BCR) signalosome, oxidative stress-induced apoptosis, androgen receptor-dependent transcription regulation, insulin signaling and endothelial cells proliferation. Plays a key role in B-cell activation by regulating BCR-induced NF-kappa-B activation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11/CARMA1 at 'Ser-559', 'Ser-644' and 'Ser-652'. Phosphorylation induces CARD11/CARMA1 association with lipid rafts and recruitment of the BCL10-MALT1 complex as well as MAP3K7/TAK1, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. Plays a direct role in the negative feedback regulation of the BCR signaling, by down-modulating BTK function via direct phosphorylation of BTK at 'Ser-180', which results in the alteration of BTK plasma membrane localization and in turn inhibition of BTK activity (PubMed:11598012). Involved in apoptosis following oxidative damage: in case of oxidative conditions, specifically phosphorylates 'Ser-36' of isoform p66Shc of SHC1, leading to mitochondrial accumulation of p66Shc, where p66Shc acts as a reactive oxygen species producer. Acts as a coactivator of androgen receptor (AR)-dependent transcription, by being recruited to AR target genes and specifically mediating phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag for epigenetic transcriptional activation that prevents demethylation of histone H3 'Lys-4' (H3K4me) by LSD1/KDM1A (PubMed:20228790). In insulin signaling, may function downstream of IRS1 in muscle cells and mediate insulin-dependent DNA synthesis through the RAF1-MAPK/ERK signaling cascade. Participates in the regulation of glucose transport in adipocytes by negatively modulating the insulin-stimulated translocation of the glucose transporter SLC2A4/GLUT4. Phosphorylates SLC2A1/GLUT1, promoting glucose uptake by SLC2A1/GLUT1 (PubMed:25982116). Under high glucose in pancreatic beta-cells, is probably involved in the inhibition of the insulin gene transcription, via regulation of MYC expression. In endothelial cells, activation of PRKCB induces increased phosphorylation of RB1, increased VEGFA-induced cell proliferation, and inhibits PI3K/AKT-dependent nitric oxide synthase (NOS3/eNOS) regulation by insulin, which causes endothelial dysfunction. Also involved in triglyceride homeostasis (By similarity). Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription (PubMed:19176525). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (PubMed:25313067). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000250|UniProtKB:P68404, ECO:0000269|PubMed:11598012, ECO:0000269|PubMed:19176525, ECO:0000269|PubMed:20228790, ECO:0000269|PubMed:25313067, ECO:0000269|PubMed:25982116, ECO:0000269|PubMed:36040231}.; FUNCTION: [Isoform Beta-II]: Acts as an activator of ferroptosis by mediating phosphorylation and activation of ACSL4 (PubMed:35027735). Also stimulates ferroptosis propagation by catalyzing phosphorylation of FOXK1, thereby promoting LGALS13 secretion (PubMed:40246981). {ECO:0000269|PubMed:35027735, ECO:0000269|PubMed:40246981}.	9606	calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; spectrin [GO:0008091]	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular response to carbohydrate stimulus [GO:0071322]; intracellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; lipoprotein transport [GO:0042953]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of D-glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of ferroptosis [GO:0160020]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]	calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; spectrin [GO:0008091]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; chromatin binding [GO:0003682]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone binding [GO:0042393]; histone H3T6 kinase activity [GO:0035403]; nuclear androgen receptor binding [GO:0050681]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular response to carbohydrate stimulus [GO:0071322]; intracellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; lipoprotein transport [GO:0042953]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of D-glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of ferroptosis [GO:0160020]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; chromatin binding [GO:0003682]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone binding [GO:0042393]; histone H3T6 kinase activity [GO:0035403]; nuclear androgen receptor binding [GO:0050681]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	GO:0002250; GO:0003682; GO:0003713; GO:0004674; GO:0004697; GO:0004698; GO:0005080; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006468; GO:0006816; GO:0006874; GO:0006915; GO:0007077; GO:0007165; GO:0007207; GO:0008091; GO:0008270; GO:0010827; GO:0010829; GO:0030949; GO:0032024; GO:0035403; GO:0035556; GO:0042113; GO:0042393; GO:0042953; GO:0043123; GO:0044305; GO:0045766; GO:0046627; GO:0050681; GO:0050853; GO:0070062; GO:0070528; GO:0071322; GO:0099171; GO:0099523; GO:0106310; GO:0160020; GO:2000300	Homo sapiens (Human)
NP_002730.1	P05129	reviewed	KPCG_HUMAN	Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13)	PRKCG PKCG		FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays diverse roles in neuronal cells and eye tissues, such as regulation of the neuronal receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of receptors and neuronal functions related to sensitivity to opiates, pain and alcohol, mediation of synaptic function and cell survival after ischemia, and inhibition of gap junction activity after oxidative stress. Binds and phosphorylates GRIA4/GLUR4 glutamate receptor and regulates its function by increasing plasma membrane-associated GRIA4 expression. In primary cerebellar neurons treated with the agonist 3,5-dihyidroxyphenylglycine, functions downstream of the metabotropic glutamate receptor GRM5/MGLUR5 and phosphorylates GRIN1/NMDAR1 receptor which plays a key role in synaptic plasticity, synaptogenesis, excitotoxicity, memory acquisition and learning. May be involved in the regulation of hippocampal long-term potentiation (LTP), but may be not necessary for the process of synaptic plasticity. May be involved in desensitization of mu-type opioid receptor-mediated G-protein activation in the spinal cord, and may be critical for the development and/or maintenance of morphine-induced reinforcing effects in the limbic forebrain. May modulate the functionality of mu-type-opioid receptors by participating in a signaling pathway which leads to the phosphorylation and degradation of opioid receptors. May also contributes to chronic morphine-induced changes in nociceptive processing. Plays a role in neuropathic pain mechanisms and contributes to the maintenance of the allodynia pain produced by peripheral inflammation. Plays an important role in initial sensitivity and tolerance to ethanol, by mediating the behavioral effects of ethanol as well as the effects of this drug on the GABA(A) receptors. During and after cerebral ischemia modulate neurotransmission and cell survival in synaptic membranes, and is involved in insulin-induced inhibition of necrosis, an important mechanism for minimizing ischemic injury. Required for the elimination of multiple climbing fibers during innervation of Purkinje cells in developing cerebellum. Is activated in lens epithelial cells upon hydrogen peroxide treatment, and phosphorylates connexin-43 (GJA1/CX43), resulting in disassembly of GJA1 gap junction plaques and inhibition of gap junction activity which could provide a protective effect against oxidative stress (By similarity). Phosphorylates p53/TP53 and promotes p53/TP53-dependent apoptosis in response to DNA damage. Involved in the phase resetting of the cerebral cortex circadian clock during temporally restricted feeding. Stabilizes the core clock component BMAL1 by interfering with its ubiquitination, thus suppressing its degradation, resulting in phase resetting of the cerebral cortex clock (By similarity). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000250|UniProtKB:P63318, ECO:0000250|UniProtKB:P63319, ECO:0000269|PubMed:16377624, ECO:0000269|PubMed:36040231}.	9606	calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; synaptic membrane [GO:0097060]	chemical synaptic transmission [GO:0007268]; chemosensory behavior [GO:0007635]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of mismatch repair [GO:0032425]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of circadian rhythm [GO:0042752]; regulation of phagocytosis [GO:0050764]; regulation of response to food [GO:0032095]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to angiotensin [GO:1990776]; response to morphine [GO:0043278]; response to pain [GO:0048265]; response to psychosocial stress [GO:1990911]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]; synaptic signaling via neuropeptide [GO:0099538]	calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; synaptic membrane [GO:0097060]; ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; chemical synaptic transmission [GO:0007268]; chemosensory behavior [GO:0007635]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of mismatch repair [GO:0032425]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of circadian rhythm [GO:0042752]; regulation of phagocytosis [GO:0050764]; regulation of response to food [GO:0032095]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to angiotensin [GO:1990776]; response to morphine [GO:0043278]; response to pain [GO:0048265]; response to psychosocial stress [GO:1990911]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]; synaptic signaling via neuropeptide [GO:0099538]	ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0007200; GO:0007268; GO:0007611; GO:0007635; GO:0008270; GO:0009636; GO:0014069; GO:0030425; GO:0031397; GO:0032095; GO:0032425; GO:0035556; GO:0042177; GO:0042752; GO:0043278; GO:0043524; GO:0044305; GO:0048265; GO:0048471; GO:0048511; GO:0050764; GO:0060291; GO:0060384; GO:0097060; GO:0099171; GO:0099523; GO:0099524; GO:0099538; GO:0106310; GO:1901799; GO:1990776; GO:1990911; GO:2000300	Homo sapiens (Human)
NP_014238.3	P53894	reviewed	CBK1_YEAST	Serine/threonine-protein kinase CBK1 (EC 2.7.11.1) (Cell wall biosynthesis kinase)	CBK1 YNL161W N1727		FUNCTION: Protein kinase that seems to play a role in the regulation of cell morphogenesis and proliferation.	559292	cell cortex [GO:0005938]; cellular bud [GO:0005933]; cellular bud neck [GO:0005935]; cellular bud tip [GO:0005934]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; incipient cellular bud site [GO:0000131]; mating projection tip [GO:0043332]; nucleus [GO:0005634]; prospore membrane [GO:0005628]; serine/threonine protein kinase complex [GO:1902554]	budding cell apical bud growth [GO:0007118]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; establishment or maintenance of cell polarity [GO:0007163]; intracellular signal transduction [GO:0035556]; regulation of fungal-type cell wall organization [GO:0060237]; regulation of protein secretion [GO:0050708]; septum digestion after cytokinesis [GO:0000920]	cell cortex [GO:0005938]; cellular bud [GO:0005933]; cellular bud neck [GO:0005935]; cellular bud tip [GO:0005934]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; incipient cellular bud site [GO:0000131]; mating projection tip [GO:0043332]; nucleus [GO:0005634]; prospore membrane [GO:0005628]; serine/threonine protein kinase complex [GO:1902554]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; budding cell apical bud growth [GO:0007118]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; establishment or maintenance of cell polarity [GO:0007163]; intracellular signal transduction [GO:0035556]; regulation of fungal-type cell wall organization [GO:0060237]; regulation of protein secretion [GO:0050708]; septum digestion after cytokinesis [GO:0000920]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000131; GO:0000920; GO:0004674; GO:0005524; GO:0005628; GO:0005634; GO:0005737; GO:0005933; GO:0005934; GO:0005935; GO:0005938; GO:0007118; GO:0007163; GO:0010494; GO:0030950; GO:0035556; GO:0042802; GO:0043332; GO:0050708; GO:0060237; GO:0106310; GO:1902554	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
NP_001186193.1	Q9HBY8	reviewed	SGK2_HUMAN	Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2)	SGK2		FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, survival and proliferation. Up-regulates Na(+) channels: SCNN1A/ENAC, K(+) channels: KCNA3/Kv1.3, KCNE1 and KCNQ1, amino acid transporter: SLC6A19, glutamate transporter: SLC1A6/EAAT4, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase. {ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12632189, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:21865597}.	9606	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	intracellular signal transduction [GO:0035556]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]; intracellular signal transduction [GO:0035556]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	ATP binding [GO:0005524]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0015459; GO:0017080; GO:0032411; GO:0035556; GO:0042127; GO:0106310	Homo sapiens (Human)
NP_733794.1	Q9HBY8	reviewed	SGK2_HUMAN	Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2)	SGK2		FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, survival and proliferation. Up-regulates Na(+) channels: SCNN1A/ENAC, K(+) channels: KCNA3/Kv1.3, KCNE1 and KCNQ1, amino acid transporter: SLC6A19, glutamate transporter: SLC1A6/EAAT4, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase. {ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12632189, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:21865597}.	9606	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	intracellular signal transduction [GO:0035556]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]; intracellular signal transduction [GO:0035556]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	ATP binding [GO:0005524]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0015459; GO:0017080; GO:0032411; GO:0035556; GO:0042127; GO:0106310	Homo sapiens (Human)
NP_002731.4	P41743	reviewed	KPCI_HUMAN	Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota)	PRKCI DXS1179E		FUNCTION: Calcium- and diacylglycerol-independent serine/ threonine-protein kinase that plays a general protective role against apoptotic stimuli, is involved in NF-kappa-B activation, cell survival, differentiation and polarity, and contributes to the regulation of microtubule dynamics in the early secretory pathway. Is necessary for BCR-ABL oncogene-mediated resistance to apoptotic drug in leukemia cells, protecting leukemia cells against drug-induced apoptosis. In cultured neurons, prevents amyloid beta protein-induced apoptosis by interrupting cell death process at a very early step. In glioblastoma cells, may function downstream of phosphatidylinositol 3-kinase (PI(3)K) and PDPK1 in the promotion of cell survival by phosphorylating and inhibiting the pro-apoptotic factor BAD. Can form a protein complex in non-small cell lung cancer (NSCLC) cells with PARD6A and ECT2 and regulate ECT2 oncogenic activity by phosphorylation, which in turn promotes transformed growth and invasion. In response to nerve growth factor (NGF), acts downstream of SRC to phosphorylate and activate IRAK1, allowing the subsequent activation of NF-kappa-B and neuronal cell survival. Functions in the organization of the apical domain in epithelial cells by phosphorylating EZR. This step is crucial for activation and normal distribution of EZR at the early stages of intestinal epithelial cell differentiation. Forms a protein complex with LLGL1 and PARD6B independently of PARD3 to regulate epithelial cell polarity. Plays a role in microtubule dynamics in the early secretory pathway through interaction with RAB2A and GAPDH and recruitment to vesicular tubular clusters (VTCs). In human coronary artery endothelial cells (HCAEC), is activated by saturated fatty acids and mediates lipid-induced apoptosis. Involved in early synaptic long term potentiation phase in CA1 hippocampal cells and short term memory formation (By similarity). {ECO:0000250|UniProtKB:F1M7Y5, ECO:0000269|PubMed:10356400, ECO:0000269|PubMed:10467349, ECO:0000269|PubMed:10906326, ECO:0000269|PubMed:11042363, ECO:0000269|PubMed:11724794, ECO:0000269|PubMed:12871960, ECO:0000269|PubMed:14684752, ECO:0000269|PubMed:15994303, ECO:0000269|PubMed:18270268, ECO:0000269|PubMed:19327373, ECO:0000269|PubMed:21189248, ECO:0000269|PubMed:21419810, ECO:0000269|PubMed:8226978, ECO:0000269|PubMed:9346882}.	9606	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160]	actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to chemical stress [GO:0062197]; cellular response to insulin stimulus [GO:0032869]; cytoskeleton organization [GO:0007010]; establishment of apical/basal cell polarity [GO:0035089]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; secretion [GO:0046903]; vesicle-mediated transport [GO:0016192]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to chemical stress [GO:0062197]; cellular response to insulin stimulus [GO:0032869]; cytoskeleton organization [GO:0007010]; establishment of apical/basal cell polarity [GO:0035089]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; secretion [GO:0046903]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000139; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005543; GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005903; GO:0005923; GO:0005929; GO:0006468; GO:0006612; GO:0007010; GO:0007015; GO:0008270; GO:0010976; GO:0015630; GO:0016192; GO:0016324; GO:0016477; GO:0030010; GO:0031252; GO:0032869; GO:0034351; GO:0035089; GO:0035556; GO:0042462; GO:0043066; GO:0043220; GO:0043524; GO:0045171; GO:0045197; GO:0045216; GO:0045747; GO:0046326; GO:0046903; GO:0048194; GO:0051092; GO:0060252; GO:0061024; GO:0062197; GO:0070062; GO:0070160; GO:0070555; GO:0072659; GO:0098685; GO:0098978; GO:0099072; GO:0106310; GO:0120157; GO:1903078; GO:2000353	Homo sapiens (Human)
NP_002735.3	Q05513	reviewed	KPCZ_HUMAN	Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta)	PRKCZ PKC2		FUNCTION: Calcium- and diacylglycerol-independent serine/threonine-protein kinase that functions in phosphatidylinositol 3-kinase (PI3K) pathway and mitogen-activated protein (MAP) kinase cascade, and is involved in NF-kappa-B activation, mitogenic signaling, cell proliferation, cell polarity, inflammatory response and maintenance of long-term potentiation (LTP). Upon lipopolysaccharide (LPS) treatment in macrophages, or following mitogenic stimuli, functions downstream of PI3K to activate MAP2K1/MEK1-MAPK1/ERK2 signaling cascade independently of RAF1 activation. Required for insulin-dependent activation of AKT3, but may function as an adapter rather than a direct activator. Upon insulin treatment may act as a downstream effector of PI3K and contribute to the activation of translocation of the glucose transporter SLC2A4/GLUT4 and subsequent glucose transport in adipocytes. In EGF-induced cells, binds and activates MAP2K5/MEK5-MAPK7/ERK5 independently of its kinase activity and can activate JUN promoter through MEF2C. Through binding with SQSTM1/p62, functions in interleukin-1 signaling and activation of NF-kappa-B with the specific adapters RIPK1 and TRAF6. Participates in TNF-dependent transactivation of NF-kappa-B by phosphorylating and activating IKBKB kinase, which in turn leads to the degradation of NF-kappa-B inhibitors. In migrating astrocytes, forms a cytoplasmic complex with PARD6A and is recruited by CDC42 to function in the establishment of cell polarity along with the microtubule motor and dynein. In association with FEZ1, stimulates neuronal differentiation in PC12 cells. In the inflammatory response, is required for the T-helper 2 (Th2) differentiation process, including interleukin production, efficient activation of JAK1 and the subsequent phosphorylation and nuclear translocation of STAT6. May be involved in development of allergic airway inflammation (asthma), a process dependent on Th2 immune response. In the NF-kappa-B-mediated inflammatory response, can relieve SETD6-dependent repression of NF-kappa-B target genes by phosphorylating the RELA subunit at 'Ser-311'. Phosphorylates VAMP2 in vitro (PubMed:17313651). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11035106, ECO:0000269|PubMed:12162751, ECO:0000269|PubMed:15084291, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:17313651, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9447975}.; FUNCTION: [Isoform 2]: Involved in late synaptic long term potention phase in CA1 hippocampal cells and long term memory maintenance. {ECO:0000250|UniProtKB:Q02956}.	9606	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; tight junction [GO:0070160]; vesicle [GO:0031982]	cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; tight junction [GO:0070160]; vesicle [GO:0031982]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000226; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005635; GO:0005737; GO:0005768; GO:0005814; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0006468; GO:0006954; GO:0007165; GO:0008270; GO:0016020; GO:0016324; GO:0016363; GO:0030010; GO:0030054; GO:0031333; GO:0031982; GO:0032733; GO:0032736; GO:0032753; GO:0032754; GO:0032869; GO:0035556; GO:0035748; GO:0036064; GO:0043066; GO:0043203; GO:0043560; GO:0045179; GO:0045197; GO:0045630; GO:0046627; GO:0046628; GO:0051092; GO:0060291; GO:0070062; GO:0070160; GO:0070374; GO:0072659; GO:0097225; GO:0097229; GO:0106310; GO:0120157; GO:1990138; GO:2000463; GO:2000553	Homo sapiens (Human)
NP_001036541.1	A1Z9X0	reviewed	APKC_DROME	Atypical protein kinase C (EC 2.7.11.13)	aPKC CG30475		FUNCTION: Serine/threonine protein kinase which is required for apico-basal cell polarity in the germ line as well as in epithelial and neural precursor cells, for epithelial planar cell polarity and for cell proliferation. During oocyte development, required for the posterior translocation of oocyte specification factors and for the posterior establishment of the microtubule organizing center within the presumptive oocyte. Phosphorylates l(2)gl which restricts l(2)gl activity to the oocyte posterior and regulates posterior enrichment of par-1, leading to establishment of correct oocyte polarity. Essential for apical localization of l(2)gl and par-6 in neuroblasts and for exclusion of mira from the apical cortex. Phosphorylates baz which is required for targeting of baz to the postsynaptic region where it is involved in actin organization, and for apical exclusion of baz which is necessary for establishment of the apical/lateral border in epithelial cells. Phosphorylates yrt which prevents its premature apical localization and is necessary for correct epithelial cell polarization. Required for the establishment of mitotic spindle orientation during symmetric division of epithelial cells and for apical exclusion of raps/Pins. Involved in symmetric adherens junction positioning during embryogenesis. Required for polarization of the spermatid cyst which is necessary for sperm differentiation. Required for stimulation of the Toll signaling pathway which activates Dif and dl and plays a role in innate immunity. Plays a role in memory enhancement. {ECO:0000269|PubMed:10995441, ECO:0000269|PubMed:11734648, ECO:0000269|PubMed:11914720, ECO:0000269|PubMed:12446795, ECO:0000269|PubMed:14657233, ECO:0000269|PubMed:15302858, ECO:0000269|PubMed:15907474, ECO:0000269|PubMed:17488624, ECO:0000269|PubMed:18094021, ECO:0000269|PubMed:18614576, ECO:0000269|PubMed:19472188, ECO:0000269|PubMed:20434988, ECO:0000269|PubMed:22223679, ECO:0000269|PubMed:24515345, ECO:0000269|PubMed:24830287}.	7227	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]	adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000132; GO:0001738; GO:0002052; GO:0003382; GO:0004674; GO:0004697; GO:0005524; GO:0005938; GO:0007043; GO:0007163; GO:0007283; GO:0007294; GO:0007314; GO:0007416; GO:0007423; GO:0007430; GO:0007613; GO:0008270; GO:0010592; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0017022; GO:0030010; GO:0030011; GO:0030165; GO:0030860; GO:0034332; GO:0035003; GO:0035011; GO:0035331; GO:0035556; GO:0043296; GO:0045167; GO:0045176; GO:0045179; GO:0045186; GO:0045196; GO:0045197; GO:0045198; GO:0045880; GO:0046667; GO:0051491; GO:0051601; GO:0055059; GO:0060446; GO:0072659; GO:0090163; GO:0106310; GO:0120157; GO:0140591; GO:1904580	Drosophila melanogaster (Fruit fly)
NP_524892.2	A1Z9X0	reviewed	APKC_DROME	Atypical protein kinase C (EC 2.7.11.13)	aPKC CG30475		FUNCTION: Serine/threonine protein kinase which is required for apico-basal cell polarity in the germ line as well as in epithelial and neural precursor cells, for epithelial planar cell polarity and for cell proliferation. During oocyte development, required for the posterior translocation of oocyte specification factors and for the posterior establishment of the microtubule organizing center within the presumptive oocyte. Phosphorylates l(2)gl which restricts l(2)gl activity to the oocyte posterior and regulates posterior enrichment of par-1, leading to establishment of correct oocyte polarity. Essential for apical localization of l(2)gl and par-6 in neuroblasts and for exclusion of mira from the apical cortex. Phosphorylates baz which is required for targeting of baz to the postsynaptic region where it is involved in actin organization, and for apical exclusion of baz which is necessary for establishment of the apical/lateral border in epithelial cells. Phosphorylates yrt which prevents its premature apical localization and is necessary for correct epithelial cell polarization. Required for the establishment of mitotic spindle orientation during symmetric division of epithelial cells and for apical exclusion of raps/Pins. Involved in symmetric adherens junction positioning during embryogenesis. Required for polarization of the spermatid cyst which is necessary for sperm differentiation. Required for stimulation of the Toll signaling pathway which activates Dif and dl and plays a role in innate immunity. Plays a role in memory enhancement. {ECO:0000269|PubMed:10995441, ECO:0000269|PubMed:11734648, ECO:0000269|PubMed:11914720, ECO:0000269|PubMed:12446795, ECO:0000269|PubMed:14657233, ECO:0000269|PubMed:15302858, ECO:0000269|PubMed:15907474, ECO:0000269|PubMed:17488624, ECO:0000269|PubMed:18094021, ECO:0000269|PubMed:18614576, ECO:0000269|PubMed:19472188, ECO:0000269|PubMed:20434988, ECO:0000269|PubMed:22223679, ECO:0000269|PubMed:24515345, ECO:0000269|PubMed:24830287}.	7227	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]	adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000132; GO:0001738; GO:0002052; GO:0003382; GO:0004674; GO:0004697; GO:0005524; GO:0005938; GO:0007043; GO:0007163; GO:0007283; GO:0007294; GO:0007314; GO:0007416; GO:0007423; GO:0007430; GO:0007613; GO:0008270; GO:0010592; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0017022; GO:0030010; GO:0030011; GO:0030165; GO:0030860; GO:0034332; GO:0035003; GO:0035011; GO:0035331; GO:0035556; GO:0043296; GO:0045167; GO:0045176; GO:0045179; GO:0045186; GO:0045196; GO:0045197; GO:0045198; GO:0045880; GO:0046667; GO:0051491; GO:0051601; GO:0055059; GO:0060446; GO:0072659; GO:0090163; GO:0106310; GO:0120157; GO:0140591; GO:1904580	Drosophila melanogaster (Fruit fly)
NP_001036545.1	A1Z9X0	reviewed	APKC_DROME	Atypical protein kinase C (EC 2.7.11.13)	aPKC CG30475		FUNCTION: Serine/threonine protein kinase which is required for apico-basal cell polarity in the germ line as well as in epithelial and neural precursor cells, for epithelial planar cell polarity and for cell proliferation. During oocyte development, required for the posterior translocation of oocyte specification factors and for the posterior establishment of the microtubule organizing center within the presumptive oocyte. Phosphorylates l(2)gl which restricts l(2)gl activity to the oocyte posterior and regulates posterior enrichment of par-1, leading to establishment of correct oocyte polarity. Essential for apical localization of l(2)gl and par-6 in neuroblasts and for exclusion of mira from the apical cortex. Phosphorylates baz which is required for targeting of baz to the postsynaptic region where it is involved in actin organization, and for apical exclusion of baz which is necessary for establishment of the apical/lateral border in epithelial cells. Phosphorylates yrt which prevents its premature apical localization and is necessary for correct epithelial cell polarization. Required for the establishment of mitotic spindle orientation during symmetric division of epithelial cells and for apical exclusion of raps/Pins. Involved in symmetric adherens junction positioning during embryogenesis. Required for polarization of the spermatid cyst which is necessary for sperm differentiation. Required for stimulation of the Toll signaling pathway which activates Dif and dl and plays a role in innate immunity. Plays a role in memory enhancement. {ECO:0000269|PubMed:10995441, ECO:0000269|PubMed:11734648, ECO:0000269|PubMed:11914720, ECO:0000269|PubMed:12446795, ECO:0000269|PubMed:14657233, ECO:0000269|PubMed:15302858, ECO:0000269|PubMed:15907474, ECO:0000269|PubMed:17488624, ECO:0000269|PubMed:18094021, ECO:0000269|PubMed:18614576, ECO:0000269|PubMed:19472188, ECO:0000269|PubMed:20434988, ECO:0000269|PubMed:22223679, ECO:0000269|PubMed:24515345, ECO:0000269|PubMed:24830287}.	7227	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]	adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000132; GO:0001738; GO:0002052; GO:0003382; GO:0004674; GO:0004697; GO:0005524; GO:0005938; GO:0007043; GO:0007163; GO:0007283; GO:0007294; GO:0007314; GO:0007416; GO:0007423; GO:0007430; GO:0007613; GO:0008270; GO:0010592; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0017022; GO:0030010; GO:0030011; GO:0030165; GO:0030860; GO:0034332; GO:0035003; GO:0035011; GO:0035331; GO:0035556; GO:0043296; GO:0045167; GO:0045176; GO:0045179; GO:0045186; GO:0045196; GO:0045197; GO:0045198; GO:0045880; GO:0046667; GO:0051491; GO:0051601; GO:0055059; GO:0060446; GO:0072659; GO:0090163; GO:0106310; GO:0120157; GO:0140591; GO:1904580	Drosophila melanogaster (Fruit fly)
NP_001028753.1	Q05513	reviewed	KPCZ_HUMAN	Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta)	PRKCZ PKC2		FUNCTION: Calcium- and diacylglycerol-independent serine/threonine-protein kinase that functions in phosphatidylinositol 3-kinase (PI3K) pathway and mitogen-activated protein (MAP) kinase cascade, and is involved in NF-kappa-B activation, mitogenic signaling, cell proliferation, cell polarity, inflammatory response and maintenance of long-term potentiation (LTP). Upon lipopolysaccharide (LPS) treatment in macrophages, or following mitogenic stimuli, functions downstream of PI3K to activate MAP2K1/MEK1-MAPK1/ERK2 signaling cascade independently of RAF1 activation. Required for insulin-dependent activation of AKT3, but may function as an adapter rather than a direct activator. Upon insulin treatment may act as a downstream effector of PI3K and contribute to the activation of translocation of the glucose transporter SLC2A4/GLUT4 and subsequent glucose transport in adipocytes. In EGF-induced cells, binds and activates MAP2K5/MEK5-MAPK7/ERK5 independently of its kinase activity and can activate JUN promoter through MEF2C. Through binding with SQSTM1/p62, functions in interleukin-1 signaling and activation of NF-kappa-B with the specific adapters RIPK1 and TRAF6. Participates in TNF-dependent transactivation of NF-kappa-B by phosphorylating and activating IKBKB kinase, which in turn leads to the degradation of NF-kappa-B inhibitors. In migrating astrocytes, forms a cytoplasmic complex with PARD6A and is recruited by CDC42 to function in the establishment of cell polarity along with the microtubule motor and dynein. In association with FEZ1, stimulates neuronal differentiation in PC12 cells. In the inflammatory response, is required for the T-helper 2 (Th2) differentiation process, including interleukin production, efficient activation of JAK1 and the subsequent phosphorylation and nuclear translocation of STAT6. May be involved in development of allergic airway inflammation (asthma), a process dependent on Th2 immune response. In the NF-kappa-B-mediated inflammatory response, can relieve SETD6-dependent repression of NF-kappa-B target genes by phosphorylating the RELA subunit at 'Ser-311'. Phosphorylates VAMP2 in vitro (PubMed:17313651). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11035106, ECO:0000269|PubMed:12162751, ECO:0000269|PubMed:15084291, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:17313651, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9447975}.; FUNCTION: [Isoform 2]: Involved in late synaptic long term potention phase in CA1 hippocampal cells and long term memory maintenance. {ECO:0000250|UniProtKB:Q02956}.	9606	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; tight junction [GO:0070160]; vesicle [GO:0031982]	cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; tight junction [GO:0070160]; vesicle [GO:0031982]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000226; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005635; GO:0005737; GO:0005768; GO:0005814; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0006468; GO:0006954; GO:0007165; GO:0008270; GO:0016020; GO:0016324; GO:0016363; GO:0030010; GO:0030054; GO:0031333; GO:0031982; GO:0032733; GO:0032736; GO:0032753; GO:0032754; GO:0032869; GO:0035556; GO:0035748; GO:0036064; GO:0043066; GO:0043203; GO:0043560; GO:0045179; GO:0045197; GO:0045630; GO:0046627; GO:0046628; GO:0051092; GO:0060291; GO:0070062; GO:0070160; GO:0070374; GO:0072659; GO:0097225; GO:0097229; GO:0106310; GO:0120157; GO:1990138; GO:2000463; GO:2000553	Homo sapiens (Human)
NP_001028754.1	Q05513	reviewed	KPCZ_HUMAN	Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta)	PRKCZ PKC2		FUNCTION: Calcium- and diacylglycerol-independent serine/threonine-protein kinase that functions in phosphatidylinositol 3-kinase (PI3K) pathway and mitogen-activated protein (MAP) kinase cascade, and is involved in NF-kappa-B activation, mitogenic signaling, cell proliferation, cell polarity, inflammatory response and maintenance of long-term potentiation (LTP). Upon lipopolysaccharide (LPS) treatment in macrophages, or following mitogenic stimuli, functions downstream of PI3K to activate MAP2K1/MEK1-MAPK1/ERK2 signaling cascade independently of RAF1 activation. Required for insulin-dependent activation of AKT3, but may function as an adapter rather than a direct activator. Upon insulin treatment may act as a downstream effector of PI3K and contribute to the activation of translocation of the glucose transporter SLC2A4/GLUT4 and subsequent glucose transport in adipocytes. In EGF-induced cells, binds and activates MAP2K5/MEK5-MAPK7/ERK5 independently of its kinase activity and can activate JUN promoter through MEF2C. Through binding with SQSTM1/p62, functions in interleukin-1 signaling and activation of NF-kappa-B with the specific adapters RIPK1 and TRAF6. Participates in TNF-dependent transactivation of NF-kappa-B by phosphorylating and activating IKBKB kinase, which in turn leads to the degradation of NF-kappa-B inhibitors. In migrating astrocytes, forms a cytoplasmic complex with PARD6A and is recruited by CDC42 to function in the establishment of cell polarity along with the microtubule motor and dynein. In association with FEZ1, stimulates neuronal differentiation in PC12 cells. In the inflammatory response, is required for the T-helper 2 (Th2) differentiation process, including interleukin production, efficient activation of JAK1 and the subsequent phosphorylation and nuclear translocation of STAT6. May be involved in development of allergic airway inflammation (asthma), a process dependent on Th2 immune response. In the NF-kappa-B-mediated inflammatory response, can relieve SETD6-dependent repression of NF-kappa-B target genes by phosphorylating the RELA subunit at 'Ser-311'. Phosphorylates VAMP2 in vitro (PubMed:17313651). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11035106, ECO:0000269|PubMed:12162751, ECO:0000269|PubMed:15084291, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:17313651, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9447975}.; FUNCTION: [Isoform 2]: Involved in late synaptic long term potention phase in CA1 hippocampal cells and long term memory maintenance. {ECO:0000250|UniProtKB:Q02956}.	9606	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; tight junction [GO:0070160]; vesicle [GO:0031982]	cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; tight junction [GO:0070160]; vesicle [GO:0031982]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000226; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005635; GO:0005737; GO:0005768; GO:0005814; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0006468; GO:0006954; GO:0007165; GO:0008270; GO:0016020; GO:0016324; GO:0016363; GO:0030010; GO:0030054; GO:0031333; GO:0031982; GO:0032733; GO:0032736; GO:0032753; GO:0032754; GO:0032869; GO:0035556; GO:0035748; GO:0036064; GO:0043066; GO:0043203; GO:0043560; GO:0045179; GO:0045197; GO:0045630; GO:0046627; GO:0046628; GO:0051092; GO:0060291; GO:0070062; GO:0070160; GO:0070374; GO:0072659; GO:0097225; GO:0097229; GO:0106310; GO:0120157; GO:1990138; GO:2000463; GO:2000553	Homo sapiens (Human)
XP_047281304.1	Q05513	reviewed	KPCZ_HUMAN	Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta)	PRKCZ PKC2		FUNCTION: Calcium- and diacylglycerol-independent serine/threonine-protein kinase that functions in phosphatidylinositol 3-kinase (PI3K) pathway and mitogen-activated protein (MAP) kinase cascade, and is involved in NF-kappa-B activation, mitogenic signaling, cell proliferation, cell polarity, inflammatory response and maintenance of long-term potentiation (LTP). Upon lipopolysaccharide (LPS) treatment in macrophages, or following mitogenic stimuli, functions downstream of PI3K to activate MAP2K1/MEK1-MAPK1/ERK2 signaling cascade independently of RAF1 activation. Required for insulin-dependent activation of AKT3, but may function as an adapter rather than a direct activator. Upon insulin treatment may act as a downstream effector of PI3K and contribute to the activation of translocation of the glucose transporter SLC2A4/GLUT4 and subsequent glucose transport in adipocytes. In EGF-induced cells, binds and activates MAP2K5/MEK5-MAPK7/ERK5 independently of its kinase activity and can activate JUN promoter through MEF2C. Through binding with SQSTM1/p62, functions in interleukin-1 signaling and activation of NF-kappa-B with the specific adapters RIPK1 and TRAF6. Participates in TNF-dependent transactivation of NF-kappa-B by phosphorylating and activating IKBKB kinase, which in turn leads to the degradation of NF-kappa-B inhibitors. In migrating astrocytes, forms a cytoplasmic complex with PARD6A and is recruited by CDC42 to function in the establishment of cell polarity along with the microtubule motor and dynein. In association with FEZ1, stimulates neuronal differentiation in PC12 cells. In the inflammatory response, is required for the T-helper 2 (Th2) differentiation process, including interleukin production, efficient activation of JAK1 and the subsequent phosphorylation and nuclear translocation of STAT6. May be involved in development of allergic airway inflammation (asthma), a process dependent on Th2 immune response. In the NF-kappa-B-mediated inflammatory response, can relieve SETD6-dependent repression of NF-kappa-B target genes by phosphorylating the RELA subunit at 'Ser-311'. Phosphorylates VAMP2 in vitro (PubMed:17313651). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11035106, ECO:0000269|PubMed:12162751, ECO:0000269|PubMed:15084291, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:17313651, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9447975}.; FUNCTION: [Isoform 2]: Involved in late synaptic long term potention phase in CA1 hippocampal cells and long term memory maintenance. {ECO:0000250|UniProtKB:Q02956}.	9606	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; tight junction [GO:0070160]; vesicle [GO:0031982]	cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; tight junction [GO:0070160]; vesicle [GO:0031982]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000226; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005635; GO:0005737; GO:0005768; GO:0005814; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0006468; GO:0006954; GO:0007165; GO:0008270; GO:0016020; GO:0016324; GO:0016363; GO:0030010; GO:0030054; GO:0031333; GO:0031982; GO:0032733; GO:0032736; GO:0032753; GO:0032754; GO:0032869; GO:0035556; GO:0035748; GO:0036064; GO:0043066; GO:0043203; GO:0043560; GO:0045179; GO:0045197; GO:0045630; GO:0046627; GO:0046628; GO:0051092; GO:0060291; GO:0070062; GO:0070160; GO:0070374; GO:0072659; GO:0097225; GO:0097229; GO:0106310; GO:0120157; GO:1990138; GO:2000463; GO:2000553	Homo sapiens (Human)
XP_054193674.1	Q05513	reviewed	KPCZ_HUMAN	Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta)	PRKCZ PKC2		FUNCTION: Calcium- and diacylglycerol-independent serine/threonine-protein kinase that functions in phosphatidylinositol 3-kinase (PI3K) pathway and mitogen-activated protein (MAP) kinase cascade, and is involved in NF-kappa-B activation, mitogenic signaling, cell proliferation, cell polarity, inflammatory response and maintenance of long-term potentiation (LTP). Upon lipopolysaccharide (LPS) treatment in macrophages, or following mitogenic stimuli, functions downstream of PI3K to activate MAP2K1/MEK1-MAPK1/ERK2 signaling cascade independently of RAF1 activation. Required for insulin-dependent activation of AKT3, but may function as an adapter rather than a direct activator. Upon insulin treatment may act as a downstream effector of PI3K and contribute to the activation of translocation of the glucose transporter SLC2A4/GLUT4 and subsequent glucose transport in adipocytes. In EGF-induced cells, binds and activates MAP2K5/MEK5-MAPK7/ERK5 independently of its kinase activity and can activate JUN promoter through MEF2C. Through binding with SQSTM1/p62, functions in interleukin-1 signaling and activation of NF-kappa-B with the specific adapters RIPK1 and TRAF6. Participates in TNF-dependent transactivation of NF-kappa-B by phosphorylating and activating IKBKB kinase, which in turn leads to the degradation of NF-kappa-B inhibitors. In migrating astrocytes, forms a cytoplasmic complex with PARD6A and is recruited by CDC42 to function in the establishment of cell polarity along with the microtubule motor and dynein. In association with FEZ1, stimulates neuronal differentiation in PC12 cells. In the inflammatory response, is required for the T-helper 2 (Th2) differentiation process, including interleukin production, efficient activation of JAK1 and the subsequent phosphorylation and nuclear translocation of STAT6. May be involved in development of allergic airway inflammation (asthma), a process dependent on Th2 immune response. In the NF-kappa-B-mediated inflammatory response, can relieve SETD6-dependent repression of NF-kappa-B target genes by phosphorylating the RELA subunit at 'Ser-311'. Phosphorylates VAMP2 in vitro (PubMed:17313651). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11035106, ECO:0000269|PubMed:12162751, ECO:0000269|PubMed:15084291, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:17313651, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9447975}.; FUNCTION: [Isoform 2]: Involved in late synaptic long term potention phase in CA1 hippocampal cells and long term memory maintenance. {ECO:0000250|UniProtKB:Q02956}.	9606	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; tight junction [GO:0070160]; vesicle [GO:0031982]	cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; tight junction [GO:0070160]; vesicle [GO:0031982]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000226; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005635; GO:0005737; GO:0005768; GO:0005814; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0006468; GO:0006954; GO:0007165; GO:0008270; GO:0016020; GO:0016324; GO:0016363; GO:0030010; GO:0030054; GO:0031333; GO:0031982; GO:0032733; GO:0032736; GO:0032753; GO:0032754; GO:0032869; GO:0035556; GO:0035748; GO:0036064; GO:0043066; GO:0043203; GO:0043560; GO:0045179; GO:0045197; GO:0045630; GO:0046627; GO:0046628; GO:0051092; GO:0060291; GO:0070062; GO:0070160; GO:0070374; GO:0072659; GO:0097225; GO:0097229; GO:0106310; GO:0120157; GO:1990138; GO:2000463; GO:2000553	Homo sapiens (Human)
NP_001004056.1	P32298	reviewed	GRK4_HUMAN	G protein-coupled receptor kinase 4 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK4) (ITI1)	GRK4 GPRK2L GPRK4		FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors. GRK4-alpha can phosphorylate rhodopsin and its activity is inhibited by calmodulin; the other three isoforms do not phosphorylate rhodopsin and do not interact with calmodulin. GRK4-alpha and GRK4-gamma phosphorylate DRD3. Phosphorylates ADRB2. {ECO:0000269|PubMed:19520868, ECO:0000269|PubMed:8626439}.	9606	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm glycocalyx [GO:0120238]	receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of opsin-mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm glycocalyx [GO:0120238]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of opsin-mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]	GO:0004672; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008277; GO:0009966; GO:0022400; GO:0031623; GO:0050254; GO:0097381; GO:0120238	Homo sapiens (Human)
NP_892027.2	P32298	reviewed	GRK4_HUMAN	G protein-coupled receptor kinase 4 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK4) (ITI1)	GRK4 GPRK2L GPRK4		FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors. GRK4-alpha can phosphorylate rhodopsin and its activity is inhibited by calmodulin; the other three isoforms do not phosphorylate rhodopsin and do not interact with calmodulin. GRK4-alpha and GRK4-gamma phosphorylate DRD3. Phosphorylates ADRB2. {ECO:0000269|PubMed:19520868, ECO:0000269|PubMed:8626439}.	9606	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm glycocalyx [GO:0120238]	receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of opsin-mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm glycocalyx [GO:0120238]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of opsin-mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]	GO:0004672; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008277; GO:0009966; GO:0022400; GO:0031623; GO:0050254; GO:0097381; GO:0120238	Homo sapiens (Human)
NP_005298.2	P32298	reviewed	GRK4_HUMAN	G protein-coupled receptor kinase 4 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK4) (ITI1)	GRK4 GPRK2L GPRK4		FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors. GRK4-alpha can phosphorylate rhodopsin and its activity is inhibited by calmodulin; the other three isoforms do not phosphorylate rhodopsin and do not interact with calmodulin. GRK4-alpha and GRK4-gamma phosphorylate DRD3. Phosphorylates ADRB2. {ECO:0000269|PubMed:19520868, ECO:0000269|PubMed:8626439}.	9606	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm glycocalyx [GO:0120238]	receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of opsin-mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm glycocalyx [GO:0120238]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of opsin-mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]	GO:0004672; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008277; GO:0009966; GO:0022400; GO:0031623; GO:0050254; GO:0097381; GO:0120238	Homo sapiens (Human)
NP_001004057.1	P32298	reviewed	GRK4_HUMAN	G protein-coupled receptor kinase 4 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK4) (ITI1)	GRK4 GPRK2L GPRK4		FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors. GRK4-alpha can phosphorylate rhodopsin and its activity is inhibited by calmodulin; the other three isoforms do not phosphorylate rhodopsin and do not interact with calmodulin. GRK4-alpha and GRK4-gamma phosphorylate DRD3. Phosphorylates ADRB2. {ECO:0000269|PubMed:19520868, ECO:0000269|PubMed:8626439}.	9606	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm glycocalyx [GO:0120238]	receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of opsin-mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm glycocalyx [GO:0120238]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of opsin-mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]	GO:0004672; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008277; GO:0009966; GO:0022400; GO:0031623; GO:0050254; GO:0097381; GO:0120238	Homo sapiens (Human)
NP_005299.1	P34947	reviewed	GRK5_HUMAN	G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5)	GRK5 GPRK5		FUNCTION: Serine/threonine kinase that phosphorylates preferentially the activated forms of a variety of G-protein-coupled receptors (GPCRs). Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their down-regulation. Phosphorylates a variety of GPCRs, including adrenergic receptors, muscarinic acetylcholine receptors (more specifically Gi-coupled M2/M4 subtypes), dopamine receptors and opioid receptors. In addition to GPCRs, also phosphorylates various substrates: Hsc70-interacting protein/ST13, TP53/p53, HDAC5, and arrestin-1/ARRB1. Phosphorylation of ARRB1 by GRK5 inhibits G-protein independent MAPK1/MAPK3 signaling downstream of 5HT4-receptors. Phosphorylation of HDAC5, a repressor of myocyte enhancer factor 2 (MEF2) leading to nuclear export of HDAC5 and allowing MEF2-mediated transcription. Phosphorylation of TP53/p53, a crucial tumor suppressor, inhibits TP53/p53-mediated apoptosis. Phosphorylation of ST13 regulates internalization of the chemokine receptor. Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor, LRP6 during Wnt signaling (in vitro). {ECO:0000269|PubMed:19661922, ECO:0000269|PubMed:19801552, ECO:0000269|PubMed:20038610, ECO:0000269|PubMed:20124405, ECO:0000269|PubMed:21728385}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0004703; GO:0005080; GO:0005524; GO:0005543; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007186; GO:0007188; GO:0007217; GO:0008277; GO:0008284; GO:0009966; GO:0016055; GO:0016607; GO:0031965; GO:0043066; GO:0045444; GO:0046777; GO:0047696; GO:0051726	Homo sapiens (Human)
NP_001004106.1	P43250	reviewed	GRK6_HUMAN	G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6)	GRK6 GPRK6		FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors. Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their desensitization. Seems to be involved in the desensitization of D2-like dopamine receptors in striatum and chemokine receptor CXCR4 which is critical for CXCL12-induced cell chemotaxis (By similarity). Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor: LRP6 during Wnt signaling (in vitro). {ECO:0000250, ECO:0000269|PubMed:19801552, ECO:0000269|PubMed:20048153}.	9606	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]	G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; Wnt signaling pathway [GO:0016055]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0007186; GO:0008277; GO:0009966; GO:0016020; GO:0016055; GO:0047696	Homo sapiens (Human)
NP_001004105.1	P43250	reviewed	GRK6_HUMAN	G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6)	GRK6 GPRK6		FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors. Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their desensitization. Seems to be involved in the desensitization of D2-like dopamine receptors in striatum and chemokine receptor CXCR4 which is critical for CXCL12-induced cell chemotaxis (By similarity). Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor: LRP6 during Wnt signaling (in vitro). {ECO:0000250, ECO:0000269|PubMed:19801552, ECO:0000269|PubMed:20048153}.	9606	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]	G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; Wnt signaling pathway [GO:0016055]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0007186; GO:0008277; GO:0009966; GO:0016020; GO:0016055; GO:0047696	Homo sapiens (Human)
NP_002073.2	P43250	reviewed	GRK6_HUMAN	G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6)	GRK6 GPRK6		FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors. Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their desensitization. Seems to be involved in the desensitization of D2-like dopamine receptors in striatum and chemokine receptor CXCR4 which is critical for CXCL12-induced cell chemotaxis (By similarity). Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor: LRP6 during Wnt signaling (in vitro). {ECO:0000250, ECO:0000269|PubMed:19801552, ECO:0000269|PubMed:20048153}.	9606	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]	G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; Wnt signaling pathway [GO:0016055]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0007186; GO:0008277; GO:0009966; GO:0016020; GO:0016055; GO:0047696	Homo sapiens (Human)
XP_006714921.1	B3KPS5	unreviewed	B3KPS5_HUMAN	G protein-coupled receptor kinase (EC 2.7.11.-)				9606		regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0007165; GO:0008277	Homo sapiens (Human)
XP_054208434.1	B3KPS5	unreviewed	B3KPS5_HUMAN	G protein-coupled receptor kinase (EC 2.7.11.-)				9606		regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0007165; GO:0008277	Homo sapiens (Human)
NP_001263143.1	P32866	reviewed	GPRK2_DROME	G protein-coupled receptor kinase 2 (EC 2.7.11.16)	Gprk2 Gprk-2 CG17998		FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors (By similarity). Required during oogenesis and embryogenesis; component of a signaling pathway that functions during egg chamber maturation. {ECO:0000250, ECO:0000269|PubMed:9217001}.	7227	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane [GO:0005886]	apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0003384; GO:0004672; GO:0004674; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006963; GO:0007165; GO:0007476; GO:0009898; GO:0009966; GO:0045752; GO:0045879; GO:0045880; GO:0048260; GO:0048601; GO:0050830; GO:0070273	Drosophila melanogaster (Fruit fly)
NP_001263143.1	A0A0B4KI69	unreviewed	A0A0B4KI69_DROME	G protein-coupled receptor kinase (EC 2.7.11.-)	Gprk2 154978_at Dmel\CG17998 Gprk 2 Gprk-2 GPRK2 gprk2 nosh CG17998 Dmel_CG17998			7227		signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0007165	Drosophila melanogaster (Fruit fly)
NP_004577.1	P51812	reviewed	KS6A3_HUMAN	Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)	RPS6KA3 ISPK1 MAPKAPK1B RSK2		FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:16213824, PubMed:16223362, PubMed:17360704, PubMed:9770464). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:10436156, PubMed:9770464). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity (PubMed:8250835). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:18508509, PubMed:18813292). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:18722121). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (By similarity). In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3 (By similarity). Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1 (By similarity). Phosphorylates SOS1 at 'Ser-1134' and 'Ser-1161' that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). Acts as a regulator of osteoblast differentiation by mediating phosphorylation of ATF4, thereby promoting ATF4 transactivation activity (By similarity). {ECO:0000250|UniProtKB:P18654, ECO:0000269|PubMed:10436156, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:8250835, ECO:0000269|PubMed:9770464, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202]	central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0004711; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0007165; GO:0007268; GO:0007417; GO:0019901; GO:0030307; GO:0032496; GO:0038202; GO:0043066; GO:0043555; GO:0045202; GO:0045597; GO:0045944; GO:0106310	Homo sapiens (Human)
NP_004577.1	A0A384MDW3	unreviewed	A0A384MDW3_HUMAN	Ribosomal protein S6 kinase (EC 2.7.11.1)				9606	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	intracellular signal transduction [GO:0035556]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0002224; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0019901; GO:0032496; GO:0035556; GO:0106310	Homo sapiens (Human)
NP_001006945.1	O75676	reviewed	KS6A4_HUMAN	Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB)	RPS6KA4 MSK2		FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factor RELA, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors. {ECO:0000269|PubMed:11035004, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:9792677}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001818; GO:0004674; GO:0004711; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0006954; GO:0032793; GO:0035175; GO:0035556; GO:0038202; GO:0043687; GO:0044022; GO:0045202; GO:0045944; GO:0051092; GO:0070498; GO:0106310	Homo sapiens (Human)
NP_001287731.1	O75676	reviewed	KS6A4_HUMAN	Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB)	RPS6KA4 MSK2		FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factor RELA, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors. {ECO:0000269|PubMed:11035004, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:9792677}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001818; GO:0004674; GO:0004711; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0006954; GO:0032793; GO:0035175; GO:0035556; GO:0038202; GO:0043687; GO:0044022; GO:0045202; GO:0045944; GO:0051092; GO:0070498; GO:0106310	Homo sapiens (Human)
NP_001287731.1	E9PJN1	unreviewed	E9PJN1_HUMAN	Ribosomal protein S6 kinase (EC 2.7.11.1)	RPS6KA4			9606	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]	ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]	GO:0000287; GO:0001818; GO:0005524; GO:0005654; GO:0005829; GO:0006954; GO:0035175; GO:0035556; GO:0044022; GO:0070498; GO:0106310	Homo sapiens (Human)
NP_003933.1	O75676	reviewed	KS6A4_HUMAN	Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB)	RPS6KA4 MSK2		FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factor RELA, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors. {ECO:0000269|PubMed:11035004, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:9792677}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001818; GO:0004674; GO:0004711; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0006954; GO:0032793; GO:0035175; GO:0035556; GO:0038202; GO:0043687; GO:0044022; GO:0045202; GO:0045944; GO:0051092; GO:0070498; GO:0106310	Homo sapiens (Human)
NP_003933.1	A0PJF8	unreviewed	A0PJF8_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	RPS6KA4			9606		intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0035556	Homo sapiens (Human)
NP_004746.2	O75582	reviewed	KS6A5_HUMAN	Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL)	RPS6KA5 MSK1		FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factors RELA, STAT3 and ETV1/ER81, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes (PubMed:11909979, PubMed:12569367, PubMed:12763138, PubMed:18511904, PubMed:9687510, PubMed:9873047). Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin (PubMed:11909979, PubMed:9873047). Plays an essential role in the control of RELA transcriptional activity in response to TNF and upon glucocorticoid, associates in the cytoplasm with the glucocorticoid receptor NR3C1 and contributes to RELA inhibition and repression of inflammatory gene expression (PubMed:12628924, PubMed:18511904). In skeletal myoblasts is required for phosphorylation of RELA at 'Ser-276' during oxidative stress (PubMed:12628924). In erythropoietin-stimulated cells, is necessary for the 'Ser-727' phosphorylation of STAT3 and regulation of its transcriptional potential (PubMed:12763138). Phosphorylates ETV1/ER81 at 'Ser-191' and 'Ser-216', and thereby regulates its ability to stimulate transcription, which may be important during development and breast tumor formation (PubMed:12569367). Directly represses transcription via phosphorylation of 'Ser-1' of histone H2A (PubMed:15010469). Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN (PubMed:12773393). May also phosphorylate 'Ser-28' of histone H3 (PubMed:12773393). Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14) (PubMed:12773393). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines (By similarity). Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors (By similarity). Plays a role in neuronal cell death by mediating the downstream effects of excitotoxic injury (By similarity). Phosphorylates TRIM7 at 'Ser-107' in response to growth factor signaling via the MEK/ERK pathway, thereby stimulating its ubiquitin ligase activity (PubMed:25851810). {ECO:0000250|UniProtKB:Q8C050, ECO:0000269|PubMed:11909979, ECO:0000269|PubMed:12569367, ECO:0000269|PubMed:12628924, ECO:0000269|PubMed:12763138, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:15010469, ECO:0000269|PubMed:18511904, ECO:0000269|PubMed:25851810, ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9873047}.	9606	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	axon guidance [GO:0007411]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of postsynapse organization [GO:0099175]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; axon guidance [GO:0007411]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of postsynapse organization [GO:0099175]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000287; GO:0001818; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0007411; GO:0032793; GO:0035175; GO:0035556; GO:0038202; GO:0043687; GO:0044022; GO:0044024; GO:0045892; GO:0045944; GO:0051092; GO:0070498; GO:0099175; GO:0106310	Homo sapiens (Human)
NP_872198.1	O75582	reviewed	KS6A5_HUMAN	Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL)	RPS6KA5 MSK1		FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factors RELA, STAT3 and ETV1/ER81, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes (PubMed:11909979, PubMed:12569367, PubMed:12763138, PubMed:18511904, PubMed:9687510, PubMed:9873047). Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin (PubMed:11909979, PubMed:9873047). Plays an essential role in the control of RELA transcriptional activity in response to TNF and upon glucocorticoid, associates in the cytoplasm with the glucocorticoid receptor NR3C1 and contributes to RELA inhibition and repression of inflammatory gene expression (PubMed:12628924, PubMed:18511904). In skeletal myoblasts is required for phosphorylation of RELA at 'Ser-276' during oxidative stress (PubMed:12628924). In erythropoietin-stimulated cells, is necessary for the 'Ser-727' phosphorylation of STAT3 and regulation of its transcriptional potential (PubMed:12763138). Phosphorylates ETV1/ER81 at 'Ser-191' and 'Ser-216', and thereby regulates its ability to stimulate transcription, which may be important during development and breast tumor formation (PubMed:12569367). Directly represses transcription via phosphorylation of 'Ser-1' of histone H2A (PubMed:15010469). Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN (PubMed:12773393). May also phosphorylate 'Ser-28' of histone H3 (PubMed:12773393). Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14) (PubMed:12773393). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines (By similarity). Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors (By similarity). Plays a role in neuronal cell death by mediating the downstream effects of excitotoxic injury (By similarity). Phosphorylates TRIM7 at 'Ser-107' in response to growth factor signaling via the MEK/ERK pathway, thereby stimulating its ubiquitin ligase activity (PubMed:25851810). {ECO:0000250|UniProtKB:Q8C050, ECO:0000269|PubMed:11909979, ECO:0000269|PubMed:12569367, ECO:0000269|PubMed:12628924, ECO:0000269|PubMed:12763138, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:15010469, ECO:0000269|PubMed:18511904, ECO:0000269|PubMed:25851810, ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9873047}.	9606	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	axon guidance [GO:0007411]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of postsynapse organization [GO:0099175]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; axon guidance [GO:0007411]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of postsynapse organization [GO:0099175]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000287; GO:0001818; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0007411; GO:0032793; GO:0035175; GO:0035556; GO:0038202; GO:0043687; GO:0044022; GO:0044024; GO:0045892; GO:0045944; GO:0051092; GO:0070498; GO:0099175; GO:0106310	Homo sapiens (Human)
NP_001261697.1	Q9V3I5	reviewed	JIL1_DROME	Chromosomal serine/threonine-protein kinase JIL-1 (EC 2.7.11.1)	JIL-1 CG6297		FUNCTION: Phosphorylates 'Ser-10' of histone H3. May regulate gene expression by establishing or maintaining the structure of more open chromatin regions. Also required for normal polytene chromosome structure, for oogenesis and for viability throughout development. Regulates the structure of polytene chromosomes in salivary glands. May phosphorylate 'Ser-1' of histone H2A. {ECO:0000269|PubMed:10445035, ECO:0000269|PubMed:11371341, ECO:0000269|PubMed:14668387, ECO:0000269|PubMed:15574598, ECO:0000269|PubMed:15986206}.	7227	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]	chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; heterochromatin boundary formation [GO:0033696]; oogenesis [GO:0048477]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; regulation of DNA-templated transcription [GO:0006355]; telomere maintenance [GO:0000723]; TORC1 signaling [GO:0038202]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]; ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; heterochromatin boundary formation [GO:0033696]; oogenesis [GO:0048477]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; regulation of DNA-templated transcription [GO:0006355]; telomere maintenance [GO:0000723]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000228; GO:0000723; GO:0000785; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005700; GO:0005703; GO:0005705; GO:0005737; GO:0006325; GO:0006355; GO:0016456; GO:0033696; GO:0035175; GO:0038202; GO:0043687; GO:0046777; GO:0048477; GO:0051276; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001261697.1	M9PI05	unreviewed	M9PI05_DROME	non-specific serine/threonine protein kinase (EC 2.7.11.1)	JIL-1 2Ab17 anon-WO0118547.379 Dmel\CG6297 IL-1 JIL JiL-1 Jil-1 jil-1 JIL1 Jil1 mAb2A MSK MSK1 Su(var)3-1 Su(var)3-103 Su-var(3)1 Su-var(3)103 CG6297 Dmel_CG6297			7227			ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_648432.1	Q9V3I5	reviewed	JIL1_DROME	Chromosomal serine/threonine-protein kinase JIL-1 (EC 2.7.11.1)	JIL-1 CG6297		FUNCTION: Phosphorylates 'Ser-10' of histone H3. May regulate gene expression by establishing or maintaining the structure of more open chromatin regions. Also required for normal polytene chromosome structure, for oogenesis and for viability throughout development. Regulates the structure of polytene chromosomes in salivary glands. May phosphorylate 'Ser-1' of histone H2A. {ECO:0000269|PubMed:10445035, ECO:0000269|PubMed:11371341, ECO:0000269|PubMed:14668387, ECO:0000269|PubMed:15574598, ECO:0000269|PubMed:15986206}.	7227	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]	chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; heterochromatin boundary formation [GO:0033696]; oogenesis [GO:0048477]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; regulation of DNA-templated transcription [GO:0006355]; telomere maintenance [GO:0000723]; TORC1 signaling [GO:0038202]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]; ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; heterochromatin boundary formation [GO:0033696]; oogenesis [GO:0048477]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; regulation of DNA-templated transcription [GO:0006355]; telomere maintenance [GO:0000723]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000228; GO:0000723; GO:0000785; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005700; GO:0005703; GO:0005705; GO:0005737; GO:0006325; GO:0006355; GO:0016456; GO:0033696; GO:0035175; GO:0038202; GO:0043687; GO:0046777; GO:0048477; GO:0051276; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_648432.1	M9PI05	unreviewed	M9PI05_DROME	non-specific serine/threonine protein kinase (EC 2.7.11.1)	JIL-1 2Ab17 anon-WO0118547.379 Dmel\CG6297 IL-1 JIL JiL-1 Jil-1 jil-1 JIL1 Jil1 mAb2A MSK MSK1 Su(var)3-1 Su(var)3-103 Su-var(3)1 Su-var(3)103 CG6297 Dmel_CG6297			7227			ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_729661.1	Q9V3I5	reviewed	JIL1_DROME	Chromosomal serine/threonine-protein kinase JIL-1 (EC 2.7.11.1)	JIL-1 CG6297		FUNCTION: Phosphorylates 'Ser-10' of histone H3. May regulate gene expression by establishing or maintaining the structure of more open chromatin regions. Also required for normal polytene chromosome structure, for oogenesis and for viability throughout development. Regulates the structure of polytene chromosomes in salivary glands. May phosphorylate 'Ser-1' of histone H2A. {ECO:0000269|PubMed:10445035, ECO:0000269|PubMed:11371341, ECO:0000269|PubMed:14668387, ECO:0000269|PubMed:15574598, ECO:0000269|PubMed:15986206}.	7227	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]	chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; heterochromatin boundary formation [GO:0033696]; oogenesis [GO:0048477]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; regulation of DNA-templated transcription [GO:0006355]; telomere maintenance [GO:0000723]; TORC1 signaling [GO:0038202]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome interband [GO:0005705]; polytene chromosome puff [GO:0005703]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]; ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; heterochromatin boundary formation [GO:0033696]; oogenesis [GO:0048477]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; regulation of DNA-templated transcription [GO:0006355]; telomere maintenance [GO:0000723]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; histone H3S10 kinase activity [GO:0035175]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000228; GO:0000723; GO:0000785; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005700; GO:0005703; GO:0005705; GO:0005737; GO:0006325; GO:0006355; GO:0016456; GO:0033696; GO:0035175; GO:0038202; GO:0043687; GO:0046777; GO:0048477; GO:0051276; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_729661.1	M9PI05	unreviewed	M9PI05_DROME	non-specific serine/threonine protein kinase (EC 2.7.11.1)	JIL-1 2Ab17 anon-WO0118547.379 Dmel\CG6297 IL-1 JIL JiL-1 Jil-1 jil-1 JIL1 Jil1 mAb2A MSK MSK1 Su(var)3-1 Su(var)3-103 Su-var(3)1 Su-var(3)103 CG6297 Dmel_CG6297			7227			ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001014431.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
NP_001014431.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
NP_001014432.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
NP_001014432.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
NP_001369359.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
NP_001369359.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
NP_001369360.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
NP_001369360.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
NP_001369361.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
NP_001369361.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
NP_001369362.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
NP_001369362.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
NP_005154.2	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
NP_005154.2	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
NP_005154.2	B3KVH4	unreviewed	B3KVH4_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)				9606	cytoplasm [GO:0005737]	glycogen biosynthetic process [GO:0005978]; positive regulation of cell migration [GO:0030335]; response to growth hormone [GO:0060416]; response to insulin-like growth factor stimulus [GO:1990418]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; glycogen biosynthetic process [GO:0005978]; positive regulation of cell migration [GO:0030335]; response to growth hormone [GO:0060416]; response to insulin-like growth factor stimulus [GO:1990418]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737; GO:0005978; GO:0030335; GO:0060416; GO:0106310; GO:1990418	Homo sapiens (Human)
XP_047287025.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_047287025.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
XP_047287026.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_047287026.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
XP_047287027.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_047287027.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
XP_047287028.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_047287028.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
XP_047287029.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_047287029.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
XP_047287030.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_047287030.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
XP_047287031.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_047287031.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
XP_054231528.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_054231528.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
XP_054231529.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_054231529.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
XP_054231530.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_054231530.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
XP_054231531.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_054231531.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
XP_054231532.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_054231532.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
XP_054231533.1	P31749	reviewed	AKT1_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC		FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.	9606	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]	activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to rapamycin [GO:0072752]; cellular response to stress [GO:0033554]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; complement receptor mediated signaling pathway [GO:0002430]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein maturation [GO:1903318]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide metabolic process [GO:0046209]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; TORC2 complex binding [GO:1904841]	GO:0001649; GO:0001893; GO:0001938; GO:0002042; GO:0002430; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005938; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0008283; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010975; GO:0015630; GO:0016020; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019900; GO:0019901; GO:0022605; GO:0030027; GO:0030154; GO:0030235; GO:0030291; GO:0030307; GO:0030334; GO:0030335; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033011; GO:0033138; GO:0033554; GO:0034405; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045746; GO:0045861; GO:0045944; GO:0046209; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060716; GO:0070141; GO:0070848; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0072655; GO:0072656; GO:0072752; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0097700; GO:0098794; GO:0098978; GO:0099104; GO:0099175; GO:0106310; GO:0110002; GO:0120238; GO:0140052; GO:0150033; GO:0160049; GO:0160213; GO:1900087; GO:1900182; GO:1901653; GO:1901796; GO:1902018; GO:1902176; GO:1903038; GO:1903078; GO:1903318; GO:1903384; GO:1903898; GO:1904263; GO:1904515; GO:1904841; GO:1905552; GO:1905786; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240	Homo sapiens (Human)
XP_054231533.1	B0LPE5	unreviewed	B0LPE5_HUMAN	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (RAC-PK-alpha)	AKT1 hCG_96740			9606	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]	apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm glycocalyx [GO:0120238]; sperm principal piece [GO:0097228]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; execution phase of apoptosis [GO:0097194]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mammalian oogenesis stage [GO:0022605]; maternal placenta development [GO:0001893]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; osteoblast differentiation [GO:0001649]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; striated muscle cell differentiation [GO:0051146]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001649; GO:0001893; GO:0004674; GO:0005524; GO:0005654; GO:0005739; GO:0005758; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005929; GO:0005978; GO:0006006; GO:0006954; GO:0008286; GO:0008637; GO:0009408; GO:0010467; GO:0010628; GO:0010629; GO:0010763; GO:0010765; GO:0010975; GO:0015630; GO:0016567; GO:0019901; GO:0022605; GO:0031641; GO:0031663; GO:0032094; GO:0032287; GO:0032436; GO:0033011; GO:0035924; GO:0036064; GO:0036294; GO:0042593; GO:0043161; GO:0043491; GO:0045944; GO:0046622; GO:0048009; GO:0048266; GO:0051146; GO:0060416; GO:0060716; GO:0071356; GO:0071364; GO:0071380; GO:0090201; GO:0097011; GO:0097194; GO:0097228; GO:0097229; GO:0098978; GO:0099175; GO:0106310; GO:0120238; GO:1901653; GO:1903898; GO:1904515; GO:1990418; GO:2000010; GO:2001243	Homo sapiens (Human)
NP_001357003.1	Q9Y243	reviewed	AKT3_HUMAN	RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2)	AKT3 PKBG		FUNCTION: AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an important role in brain development and is crucial for the viability of malignant glioma cells. AKT3 isoform may also be the key molecule in up-regulation and down-regulation of MMP13 via IL13. Required for the coordination of mitochondrial biogenesis with growth factor-induced increases in cellular energy demands. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. {ECO:0000269|PubMed:18524868, ECO:0000269|PubMed:21191416}.	9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001938; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0007165; GO:0008286; GO:0010821; GO:0032008; GO:0035556; GO:0036064; GO:0043066; GO:0043536; GO:0045766; GO:0045793; GO:0048854; GO:0048873; GO:0090050; GO:0106310; GO:1903898; GO:1905564; GO:1905653; GO:2000773	Homo sapiens (Human)
NP_005456.1	Q9Y243	reviewed	AKT3_HUMAN	RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2)	AKT3 PKBG		FUNCTION: AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an important role in brain development and is crucial for the viability of malignant glioma cells. AKT3 isoform may also be the key molecule in up-regulation and down-regulation of MMP13 via IL13. Required for the coordination of mitochondrial biogenesis with growth factor-induced increases in cellular energy demands. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. {ECO:0000269|PubMed:18524868, ECO:0000269|PubMed:21191416}.	9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001938; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0007165; GO:0008286; GO:0010821; GO:0032008; GO:0035556; GO:0036064; GO:0043066; GO:0043536; GO:0045766; GO:0045793; GO:0048854; GO:0048873; GO:0090050; GO:0106310; GO:1903898; GO:1905564; GO:1905653; GO:2000773	Homo sapiens (Human)
XP_054184598.1	Q9Y243	reviewed	AKT3_HUMAN	RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2)	AKT3 PKBG		FUNCTION: AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an important role in brain development and is crucial for the viability of malignant glioma cells. AKT3 isoform may also be the key molecule in up-regulation and down-regulation of MMP13 via IL13. Required for the coordination of mitochondrial biogenesis with growth factor-induced increases in cellular energy demands. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. {ECO:0000269|PubMed:18524868, ECO:0000269|PubMed:21191416}.	9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001938; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0007165; GO:0008286; GO:0010821; GO:0032008; GO:0035556; GO:0036064; GO:0043066; GO:0043536; GO:0045766; GO:0045793; GO:0048854; GO:0048873; GO:0090050; GO:0106310; GO:1903898; GO:1905564; GO:1905653; GO:2000773	Homo sapiens (Human)
XP_054189659.1	Q9Y243	reviewed	AKT3_HUMAN	RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2)	AKT3 PKBG		FUNCTION: AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an important role in brain development and is crucial for the viability of malignant glioma cells. AKT3 isoform may also be the key molecule in up-regulation and down-regulation of MMP13 via IL13. Required for the coordination of mitochondrial biogenesis with growth factor-induced increases in cellular energy demands. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. {ECO:0000269|PubMed:18524868, ECO:0000269|PubMed:21191416}.	9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001938; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0007165; GO:0008286; GO:0010821; GO:0032008; GO:0035556; GO:0036064; GO:0043066; GO:0043536; GO:0045766; GO:0045793; GO:0048854; GO:0048873; GO:0090050; GO:0106310; GO:1903898; GO:1905564; GO:1905653; GO:2000773	Homo sapiens (Human)
NP_001091982.1	Q13976	reviewed	KGP1_HUMAN	cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI)	PRKG1 PRKG1B PRKGR1A PRKGR1B		FUNCTION: Serine/threonine protein kinase that acts as a key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smooth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates IRAG1 and inhibits IP3-induced Ca(2+) release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca(2+) levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation; decreasing contraction; controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling also alters gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle. {ECO:0000269|PubMed:10567269, ECO:0000269|PubMed:11162591, ECO:0000269|PubMed:11723116, ECO:0000269|PubMed:12082086, ECO:0000269|PubMed:14608379, ECO:0000269|PubMed:15194681, ECO:0000269|PubMed:16990611, ECO:0000269|PubMed:8182057}.	9606	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	bone growth [GO:0098868]; cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of testosterone biosynthetic process [GO:2000224]; regulation of vascular permeability [GO:0043114]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; bone growth [GO:0098868]; cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of testosterone biosynthetic process [GO:2000224]; regulation of vascular permeability [GO:0043114]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]	GO:0001669; GO:0001764; GO:0004672; GO:0004692; GO:0005246; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007204; GO:0007286; GO:0010920; GO:0014050; GO:0016358; GO:0019934; GO:0021549; GO:0030553; GO:0030900; GO:0042383; GO:0042753; GO:0042802; GO:0043114; GO:0048273; GO:0048668; GO:0060087; GO:0061049; GO:0090331; GO:0098868; GO:0106310; GO:1904706; GO:1904753; GO:2000224	Homo sapiens (Human)
NP_006249.1	Q13976	reviewed	KGP1_HUMAN	cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI)	PRKG1 PRKG1B PRKGR1A PRKGR1B		FUNCTION: Serine/threonine protein kinase that acts as a key mediator of the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates PRKG1, which phosphorylates serines and threonines on many cellular proteins. Numerous protein targets for PRKG1 phosphorylation are implicated in modulating cellular calcium, but the contribution of each of these targets may vary substantially among cell types. Proteins that are phosphorylated by PRKG1 regulate platelet activation and adhesion, smooth muscle contraction, cardiac function, gene expression, feedback of the NO-signaling pathway, and other processes involved in several aspects of the CNS like axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smooth muscle relaxation is mediated through lowering of intracellular free calcium, by desensitization of contractile proteins to calcium, and by decrease in the contractile state of smooth muscle or in platelet activation. Regulates intracellular calcium levels via several pathways: phosphorylates IRAG1 and inhibits IP3-induced Ca(2+) release from intracellular stores, phosphorylation of KCNMA1 (BKCa) channels decreases intracellular Ca(2+) levels, which leads to increased opening of this channel. PRKG1 phosphorylates the canonical transient receptor potential channel (TRPC) family which inactivates the associated inward calcium current. Another mode of action of NO/cGMP/PKGI signaling involves PKGI-mediated inactivation of the Ras homolog gene family member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of this protein in myriad processes: regulation of RHOA translocation; decreasing contraction; controlling vesicle trafficking, reduction of myosin light chain phosphorylation resulting in vasorelaxation. Activation of PRKG1 by NO signaling also alters gene expression in a number of tissues. In smooth muscle cells, increased cGMP and PRKG1 activity influence expression of smooth muscle-specific contractile proteins, levels of proteins in the NO/cGMP signaling pathway, down-regulation of the matrix proteins osteopontin and thrombospondin-1 to limit smooth muscle cell migration and phenotype. Regulates vasodilator-stimulated phosphoprotein (VASP) functions in platelets and smooth muscle. {ECO:0000269|PubMed:10567269, ECO:0000269|PubMed:11162591, ECO:0000269|PubMed:11723116, ECO:0000269|PubMed:12082086, ECO:0000269|PubMed:14608379, ECO:0000269|PubMed:15194681, ECO:0000269|PubMed:16990611, ECO:0000269|PubMed:8182057}.	9606	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	bone growth [GO:0098868]; cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of testosterone biosynthetic process [GO:2000224]; regulation of vascular permeability [GO:0043114]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; bone growth [GO:0098868]; cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of testosterone biosynthetic process [GO:2000224]; regulation of vascular permeability [GO:0043114]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]	GO:0001669; GO:0001764; GO:0004672; GO:0004692; GO:0005246; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007204; GO:0007286; GO:0010920; GO:0014050; GO:0016358; GO:0019934; GO:0021549; GO:0030553; GO:0030900; GO:0042383; GO:0042753; GO:0042802; GO:0043114; GO:0048273; GO:0048668; GO:0060087; GO:0061049; GO:0090331; GO:0098868; GO:0106310; GO:1904706; GO:1904753; GO:2000224	Homo sapiens (Human)
NP_001350330.1	Q13237	reviewed	KGP2_HUMAN	cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII)	PRKG2 PRKGR2		FUNCTION: Crucial regulator of intestinal secretion and bone growth. Phosphorylates and activates CFTR on the plasma membrane. Plays a key role in intestinal secretion by regulating cGMP-dependent translocation of CFTR in jejunum (PubMed:33106379). Acts downstream of NMDAR to activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By similarity). Acts as a regulator of gene expression and activator of the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2 in mechanically stimulated osteoblasts. Under fluid shear stress, mediates ERK activation and subsequent induction of FOS, FOSL1/FRA1, FOSL2/FRA2 and FOSB that play a key role in the osteoblast anabolic response to mechanical stimulation (By similarity). {ECO:0000250|UniProtKB:Q61410, ECO:0000250|UniProtKB:Q64595, ECO:0000269|PubMed:33106379}.	9606	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0007165; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0035556; GO:0042802; GO:0046146; GO:0051019; GO:0072659; GO:0106310; GO:1903829; GO:2001226	Homo sapiens (Human)
NP_001350330.1	A0A140VJM3	unreviewed	A0A140VJM3_HUMAN	cGMP-dependent protein kinase (EC 2.7.11.12)	PRKG2 hCG_25079			9606	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]	negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]	GO:0004692; GO:0005524; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0042802; GO:0072659; GO:1903829; GO:2001226	Homo sapiens (Human)
NP_006250.1	Q13237	reviewed	KGP2_HUMAN	cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII)	PRKG2 PRKGR2		FUNCTION: Crucial regulator of intestinal secretion and bone growth. Phosphorylates and activates CFTR on the plasma membrane. Plays a key role in intestinal secretion by regulating cGMP-dependent translocation of CFTR in jejunum (PubMed:33106379). Acts downstream of NMDAR to activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By similarity). Acts as a regulator of gene expression and activator of the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2 in mechanically stimulated osteoblasts. Under fluid shear stress, mediates ERK activation and subsequent induction of FOS, FOSL1/FRA1, FOSL2/FRA2 and FOSB that play a key role in the osteoblast anabolic response to mechanical stimulation (By similarity). {ECO:0000250|UniProtKB:Q61410, ECO:0000250|UniProtKB:Q64595, ECO:0000269|PubMed:33106379}.	9606	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0007165; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0035556; GO:0042802; GO:0046146; GO:0051019; GO:0072659; GO:0106310; GO:1903829; GO:2001226	Homo sapiens (Human)
NP_006250.1	A0A140VJM3	unreviewed	A0A140VJM3_HUMAN	cGMP-dependent protein kinase (EC 2.7.11.12)	PRKG2 hCG_25079			9606	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]	negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]	GO:0004692; GO:0005524; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0042802; GO:0072659; GO:1903829; GO:2001226	Homo sapiens (Human)
XP_016863904.2	Q13237	reviewed	KGP2_HUMAN	cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII)	PRKG2 PRKGR2		FUNCTION: Crucial regulator of intestinal secretion and bone growth. Phosphorylates and activates CFTR on the plasma membrane. Plays a key role in intestinal secretion by regulating cGMP-dependent translocation of CFTR in jejunum (PubMed:33106379). Acts downstream of NMDAR to activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By similarity). Acts as a regulator of gene expression and activator of the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2 in mechanically stimulated osteoblasts. Under fluid shear stress, mediates ERK activation and subsequent induction of FOS, FOSL1/FRA1, FOSL2/FRA2 and FOSB that play a key role in the osteoblast anabolic response to mechanical stimulation (By similarity). {ECO:0000250|UniProtKB:Q61410, ECO:0000250|UniProtKB:Q64595, ECO:0000269|PubMed:33106379}.	9606	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0007165; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0035556; GO:0042802; GO:0046146; GO:0051019; GO:0072659; GO:0106310; GO:1903829; GO:2001226	Homo sapiens (Human)
XP_016863904.2	A0A140VJM3	unreviewed	A0A140VJM3_HUMAN	cGMP-dependent protein kinase (EC 2.7.11.12)	PRKG2 hCG_25079			9606	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]	negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]	GO:0004692; GO:0005524; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0042802; GO:0072659; GO:1903829; GO:2001226	Homo sapiens (Human)
XP_016863905.2	Q13237	reviewed	KGP2_HUMAN	cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII)	PRKG2 PRKGR2		FUNCTION: Crucial regulator of intestinal secretion and bone growth. Phosphorylates and activates CFTR on the plasma membrane. Plays a key role in intestinal secretion by regulating cGMP-dependent translocation of CFTR in jejunum (PubMed:33106379). Acts downstream of NMDAR to activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By similarity). Acts as a regulator of gene expression and activator of the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2 in mechanically stimulated osteoblasts. Under fluid shear stress, mediates ERK activation and subsequent induction of FOS, FOSL1/FRA1, FOSL2/FRA2 and FOSB that play a key role in the osteoblast anabolic response to mechanical stimulation (By similarity). {ECO:0000250|UniProtKB:Q61410, ECO:0000250|UniProtKB:Q64595, ECO:0000269|PubMed:33106379}.	9606	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0007165; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0035556; GO:0042802; GO:0046146; GO:0051019; GO:0072659; GO:0106310; GO:1903829; GO:2001226	Homo sapiens (Human)
XP_016863905.2	A0A140VJM3	unreviewed	A0A140VJM3_HUMAN	cGMP-dependent protein kinase (EC 2.7.11.12)	PRKG2 hCG_25079			9606	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]	negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]	GO:0004692; GO:0005524; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0042802; GO:0072659; GO:1903829; GO:2001226	Homo sapiens (Human)
XP_047271919.1	Q13237	reviewed	KGP2_HUMAN	cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII)	PRKG2 PRKGR2		FUNCTION: Crucial regulator of intestinal secretion and bone growth. Phosphorylates and activates CFTR on the plasma membrane. Plays a key role in intestinal secretion by regulating cGMP-dependent translocation of CFTR in jejunum (PubMed:33106379). Acts downstream of NMDAR to activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By similarity). Acts as a regulator of gene expression and activator of the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2 in mechanically stimulated osteoblasts. Under fluid shear stress, mediates ERK activation and subsequent induction of FOS, FOSL1/FRA1, FOSL2/FRA2 and FOSB that play a key role in the osteoblast anabolic response to mechanical stimulation (By similarity). {ECO:0000250|UniProtKB:Q61410, ECO:0000250|UniProtKB:Q64595, ECO:0000269|PubMed:33106379}.	9606	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0007165; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0035556; GO:0042802; GO:0046146; GO:0051019; GO:0072659; GO:0106310; GO:1903829; GO:2001226	Homo sapiens (Human)
XP_047271919.1	A0A140VJM3	unreviewed	A0A140VJM3_HUMAN	cGMP-dependent protein kinase (EC 2.7.11.12)	PRKG2 hCG_25079			9606	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]	negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]	GO:0004692; GO:0005524; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0042802; GO:0072659; GO:1903829; GO:2001226	Homo sapiens (Human)
XP_054206479.1	Q13237	reviewed	KGP2_HUMAN	cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII)	PRKG2 PRKGR2		FUNCTION: Crucial regulator of intestinal secretion and bone growth. Phosphorylates and activates CFTR on the plasma membrane. Plays a key role in intestinal secretion by regulating cGMP-dependent translocation of CFTR in jejunum (PubMed:33106379). Acts downstream of NMDAR to activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By similarity). Acts as a regulator of gene expression and activator of the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2 in mechanically stimulated osteoblasts. Under fluid shear stress, mediates ERK activation and subsequent induction of FOS, FOSL1/FRA1, FOSL2/FRA2 and FOSB that play a key role in the osteoblast anabolic response to mechanical stimulation (By similarity). {ECO:0000250|UniProtKB:Q61410, ECO:0000250|UniProtKB:Q64595, ECO:0000269|PubMed:33106379}.	9606	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0007165; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0035556; GO:0042802; GO:0046146; GO:0051019; GO:0072659; GO:0106310; GO:1903829; GO:2001226	Homo sapiens (Human)
XP_054206479.1	A0A140VJM3	unreviewed	A0A140VJM3_HUMAN	cGMP-dependent protein kinase (EC 2.7.11.12)	PRKG2 hCG_25079			9606	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]	negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]	GO:0004692; GO:0005524; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0042802; GO:0072659; GO:1903829; GO:2001226	Homo sapiens (Human)
XP_054206480.1	Q13237	reviewed	KGP2_HUMAN	cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII)	PRKG2 PRKGR2		FUNCTION: Crucial regulator of intestinal secretion and bone growth. Phosphorylates and activates CFTR on the plasma membrane. Plays a key role in intestinal secretion by regulating cGMP-dependent translocation of CFTR in jejunum (PubMed:33106379). Acts downstream of NMDAR to activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By similarity). Acts as a regulator of gene expression and activator of the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2 in mechanically stimulated osteoblasts. Under fluid shear stress, mediates ERK activation and subsequent induction of FOS, FOSL1/FRA1, FOSL2/FRA2 and FOSB that play a key role in the osteoblast anabolic response to mechanical stimulation (By similarity). {ECO:0000250|UniProtKB:Q61410, ECO:0000250|UniProtKB:Q64595, ECO:0000269|PubMed:33106379}.	9606	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0007165; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0035556; GO:0042802; GO:0046146; GO:0051019; GO:0072659; GO:0106310; GO:1903829; GO:2001226	Homo sapiens (Human)
XP_054206480.1	A0A140VJM3	unreviewed	A0A140VJM3_HUMAN	cGMP-dependent protein kinase (EC 2.7.11.12)	PRKG2 hCG_25079			9606	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]	negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	apical plasma membrane [GO:0016324]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]	GO:0004692; GO:0005524; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0042802; GO:0072659; GO:1903829; GO:2001226	Homo sapiens (Human)
NP_001028750.1	Q96BR1	reviewed	SGK3_HUMAN	Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like)	SGK3 CISK SGKL		FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, proliferation, survival and migration. Up-regulates Na(+) channels: SCNN1A/ENAC and SCN5A, K(+) channels: KCNA3/KV1.3, KCNE1, KCNQ1 and KCNH2/HERG, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channel: BSND, creatine transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, amino acid transporters: SLC1A5/ASCT2 and SLC6A19, glutamate transporters: SLC1A3/EAAT1, SLC1A6/EAAT4 and SLC1A7/EAAT5, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase. Plays a role in the regulation of renal tubular phosphate transport and bone density. Phosphorylates NEDD4L and GSK3B. Positively regulates ER transcription activity through phosphorylation of FLII. Negatively regulates the function of ITCH/AIP4 via its phosphorylation and thereby prevents CXCR4 from being efficiently sorted to lysosomes. {ECO:0000269|PubMed:12054501, ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12632189, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16888620, ECO:0000269|PubMed:17167223, ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:19293151, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:21865597}.	9606	cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]	intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]; intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004672; GO:0004674; GO:0005246; GO:0005524; GO:0005769; GO:0005829; GO:0015459; GO:0017080; GO:0017081; GO:0035091; GO:0035556; GO:0042127; GO:0055037; GO:0106310; GO:2001240	Homo sapiens (Human)
NP_001191102.1	Q96BR1	reviewed	SGK3_HUMAN	Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like)	SGK3 CISK SGKL		FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, proliferation, survival and migration. Up-regulates Na(+) channels: SCNN1A/ENAC and SCN5A, K(+) channels: KCNA3/KV1.3, KCNE1, KCNQ1 and KCNH2/HERG, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channel: BSND, creatine transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, amino acid transporters: SLC1A5/ASCT2 and SLC6A19, glutamate transporters: SLC1A3/EAAT1, SLC1A6/EAAT4 and SLC1A7/EAAT5, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase. Plays a role in the regulation of renal tubular phosphate transport and bone density. Phosphorylates NEDD4L and GSK3B. Positively regulates ER transcription activity through phosphorylation of FLII. Negatively regulates the function of ITCH/AIP4 via its phosphorylation and thereby prevents CXCR4 from being efficiently sorted to lysosomes. {ECO:0000269|PubMed:12054501, ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12632189, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16888620, ECO:0000269|PubMed:17167223, ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:19293151, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:21865597}.	9606	cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]	intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]; intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004672; GO:0004674; GO:0005246; GO:0005524; GO:0005769; GO:0005829; GO:0015459; GO:0017080; GO:0017081; GO:0035091; GO:0035556; GO:0042127; GO:0055037; GO:0106310; GO:2001240	Homo sapiens (Human)
NP_037389.4	Q96BR1	reviewed	SGK3_HUMAN	Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like)	SGK3 CISK SGKL		FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, proliferation, survival and migration. Up-regulates Na(+) channels: SCNN1A/ENAC and SCN5A, K(+) channels: KCNA3/KV1.3, KCNE1, KCNQ1 and KCNH2/HERG, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channel: BSND, creatine transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, amino acid transporters: SLC1A5/ASCT2 and SLC6A19, glutamate transporters: SLC1A3/EAAT1, SLC1A6/EAAT4 and SLC1A7/EAAT5, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase. Plays a role in the regulation of renal tubular phosphate transport and bone density. Phosphorylates NEDD4L and GSK3B. Positively regulates ER transcription activity through phosphorylation of FLII. Negatively regulates the function of ITCH/AIP4 via its phosphorylation and thereby prevents CXCR4 from being efficiently sorted to lysosomes. {ECO:0000269|PubMed:12054501, ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12632189, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16888620, ECO:0000269|PubMed:17167223, ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:19293151, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:21865597}.	9606	cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]	intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]; intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004672; GO:0004674; GO:0005246; GO:0005524; GO:0005769; GO:0005829; GO:0015459; GO:0017080; GO:0017081; GO:0035091; GO:0035556; GO:0042127; GO:0055037; GO:0106310; GO:2001240	Homo sapiens (Human)
NP_037389.4	Q53EW6	unreviewed	Q53EW6_HUMAN	Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 3)				9606	early endosome [GO:0005769]; recycling endosome [GO:0055037]	regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004674; GO:0005524; GO:0005769; GO:0017080; GO:0035091; GO:0042127; GO:0055037	Homo sapiens (Human)
NP_733827.2	Q96BR1	reviewed	SGK3_HUMAN	Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like)	SGK3 CISK SGKL		FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, proliferation, survival and migration. Up-regulates Na(+) channels: SCNN1A/ENAC and SCN5A, K(+) channels: KCNA3/KV1.3, KCNE1, KCNQ1 and KCNH2/HERG, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channel: BSND, creatine transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, amino acid transporters: SLC1A5/ASCT2 and SLC6A19, glutamate transporters: SLC1A3/EAAT1, SLC1A6/EAAT4 and SLC1A7/EAAT5, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase. Plays a role in the regulation of renal tubular phosphate transport and bone density. Phosphorylates NEDD4L and GSK3B. Positively regulates ER transcription activity through phosphorylation of FLII. Negatively regulates the function of ITCH/AIP4 via its phosphorylation and thereby prevents CXCR4 from being efficiently sorted to lysosomes. {ECO:0000269|PubMed:12054501, ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12632189, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16888620, ECO:0000269|PubMed:17167223, ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:19293151, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:21865597}.	9606	cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]	intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]; intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004672; GO:0004674; GO:0005246; GO:0005524; GO:0005769; GO:0005829; GO:0015459; GO:0017080; GO:0017081; GO:0035091; GO:0035556; GO:0042127; GO:0055037; GO:0106310; GO:2001240	Homo sapiens (Human)
NP_733827.2	Q53EW6	unreviewed	Q53EW6_HUMAN	Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 3)				9606	early endosome [GO:0005769]; recycling endosome [GO:0055037]	regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004674; GO:0005524; GO:0005769; GO:0017080; GO:0035091; GO:0042127; GO:0055037	Homo sapiens (Human)
NP_001137148.1	O00141	reviewed	SGK1_HUMAN	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	SGK1 SGK		FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cellular enzymes, transcription factors, neuronal excitability, cell growth, proliferation, survival, migration and apoptosis. Plays an important role in cellular stress response. Contributes to regulation of renal Na(+) retention, renal K(+) elimination, salt appetite, gastric acid secretion, intestinal Na(+)/H(+) exchange and nutrient transport, insulin-dependent salt sensitivity of blood pressure, salt sensitivity of peripheral glucose uptake, cardiac repolarization and memory consolidation. Up-regulates Na(+) channels: SCNN1A/ENAC, SCN5A and ASIC1/ACCN2, K(+) channels: KCNJ1/ROMK1, KCNA1-5, KCNQ1-5 and KCNE1, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channels: BSND, CLCN2 and CFTR, glutamate transporters: SLC1A3/EAAT1, SLC1A2 /EAAT2, SLC1A1/EAAT3, SLC1A6/EAAT4 and SLC1A7/EAAT5, amino acid transporters: SLC1A5/ASCT2, SLC38A1/SN1 and SLC6A19, creatine transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, glutamate receptor: GRIK2/GLUR6. Up-regulates carriers: SLC9A3/NHE3, SLC12A1/NKCC2, SLC12A3/NCC, SLC5A3/SMIT, SLC2A1/GLUT1, SLC5A1/SGLT1 and SLC15A2/PEPT2. Regulates enzymes: GSK3A/B, PMM2 and Na(+)/K(+) ATPase, and transcription factors: CTNNB1 and nuclear factor NF-kappa-B. Stimulates sodium transport into epithelial cells by enhancing the stability and expression of SCNN1A/ENAC. This is achieved by phosphorylating the NEDD4L ubiquitin E3 ligase, promoting its interaction with 14-3-3 proteins, thereby preventing it from binding to SCNN1A/ENAC and targeting it for degradation. Regulates store-operated Ca(+2) entry (SOCE) by stimulating ORAI1 and STIM1. Regulates KCNJ1/ROMK1 directly via its phosphorylation or indirectly via increased interaction with SLC9A3R2/NHERF2. Phosphorylates MDM2 and activates MDM2-dependent ubiquitination of p53/TP53. Phosphorylates MAPT/TAU and mediates microtubule depolymerization and neurite formation in hippocampal neurons. Phosphorylates SLC2A4/GLUT4 and up-regulates its activity. Phosphorylates APBB1/FE65 and promotes its localization to the nucleus. Phosphorylates MAPK1/ERK2 and activates it by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Phosphorylates FBXW7 and plays an inhibitory role in the NOTCH1 signaling. Phosphorylates FOXO1 resulting in its relocalization from the nucleus to the cytoplasm. Phosphorylates FOXO3, promoting its exit from the nucleus and interference with FOXO3-dependent transcription. Phosphorylates BRAF and MAP3K3/MEKK3 and inhibits their activity. Phosphorylates SLC9A3/NHE3 in response to dexamethasone, resulting in its activation and increased localization at the cell membrane. Phosphorylates CREB1. Necessary for vascular remodeling during angiogenesis. Sustained high levels and activity may contribute to conditions such as hypertension and diabetic nephropathy. Isoform 2 exhibited a greater effect on cell plasma membrane expression of SCNN1A/ENAC and Na(+) transport than isoform 1. {ECO:0000269|PubMed:11154281, ECO:0000269|PubMed:11410590, ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12761204, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14623317, ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15234985, ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15733869, ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:15888551, ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16443776, ECO:0000269|PubMed:16982696, ECO:0000269|PubMed:17382906, ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:18304449, ECO:0000269|PubMed:18753299, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:19756449, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:20730100, ECO:0000269|PubMed:21865597}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006814; GO:0006915; GO:0006974; GO:0007616; GO:0008217; GO:0015459; GO:0016607; GO:0017080; GO:0017081; GO:0032411; GO:0035556; GO:0042127; GO:0042981; GO:0048812; GO:0050790; GO:0051090; GO:0060453; GO:0070294; GO:0106310; GO:1901796; GO:1904045	Homo sapiens (Human)
NP_001137150.1	O00141	reviewed	SGK1_HUMAN	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	SGK1 SGK		FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cellular enzymes, transcription factors, neuronal excitability, cell growth, proliferation, survival, migration and apoptosis. Plays an important role in cellular stress response. Contributes to regulation of renal Na(+) retention, renal K(+) elimination, salt appetite, gastric acid secretion, intestinal Na(+)/H(+) exchange and nutrient transport, insulin-dependent salt sensitivity of blood pressure, salt sensitivity of peripheral glucose uptake, cardiac repolarization and memory consolidation. Up-regulates Na(+) channels: SCNN1A/ENAC, SCN5A and ASIC1/ACCN2, K(+) channels: KCNJ1/ROMK1, KCNA1-5, KCNQ1-5 and KCNE1, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channels: BSND, CLCN2 and CFTR, glutamate transporters: SLC1A3/EAAT1, SLC1A2 /EAAT2, SLC1A1/EAAT3, SLC1A6/EAAT4 and SLC1A7/EAAT5, amino acid transporters: SLC1A5/ASCT2, SLC38A1/SN1 and SLC6A19, creatine transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, glutamate receptor: GRIK2/GLUR6. Up-regulates carriers: SLC9A3/NHE3, SLC12A1/NKCC2, SLC12A3/NCC, SLC5A3/SMIT, SLC2A1/GLUT1, SLC5A1/SGLT1 and SLC15A2/PEPT2. Regulates enzymes: GSK3A/B, PMM2 and Na(+)/K(+) ATPase, and transcription factors: CTNNB1 and nuclear factor NF-kappa-B. Stimulates sodium transport into epithelial cells by enhancing the stability and expression of SCNN1A/ENAC. This is achieved by phosphorylating the NEDD4L ubiquitin E3 ligase, promoting its interaction with 14-3-3 proteins, thereby preventing it from binding to SCNN1A/ENAC and targeting it for degradation. Regulates store-operated Ca(+2) entry (SOCE) by stimulating ORAI1 and STIM1. Regulates KCNJ1/ROMK1 directly via its phosphorylation or indirectly via increased interaction with SLC9A3R2/NHERF2. Phosphorylates MDM2 and activates MDM2-dependent ubiquitination of p53/TP53. Phosphorylates MAPT/TAU and mediates microtubule depolymerization and neurite formation in hippocampal neurons. Phosphorylates SLC2A4/GLUT4 and up-regulates its activity. Phosphorylates APBB1/FE65 and promotes its localization to the nucleus. Phosphorylates MAPK1/ERK2 and activates it by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Phosphorylates FBXW7 and plays an inhibitory role in the NOTCH1 signaling. Phosphorylates FOXO1 resulting in its relocalization from the nucleus to the cytoplasm. Phosphorylates FOXO3, promoting its exit from the nucleus and interference with FOXO3-dependent transcription. Phosphorylates BRAF and MAP3K3/MEKK3 and inhibits their activity. Phosphorylates SLC9A3/NHE3 in response to dexamethasone, resulting in its activation and increased localization at the cell membrane. Phosphorylates CREB1. Necessary for vascular remodeling during angiogenesis. Sustained high levels and activity may contribute to conditions such as hypertension and diabetic nephropathy. Isoform 2 exhibited a greater effect on cell plasma membrane expression of SCNN1A/ENAC and Na(+) transport than isoform 1. {ECO:0000269|PubMed:11154281, ECO:0000269|PubMed:11410590, ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12761204, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14623317, ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15234985, ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15733869, ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:15888551, ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16443776, ECO:0000269|PubMed:16982696, ECO:0000269|PubMed:17382906, ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:18304449, ECO:0000269|PubMed:18753299, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:19756449, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:20730100, ECO:0000269|PubMed:21865597}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006814; GO:0006915; GO:0006974; GO:0007616; GO:0008217; GO:0015459; GO:0016607; GO:0017080; GO:0017081; GO:0032411; GO:0035556; GO:0042127; GO:0042981; GO:0048812; GO:0050790; GO:0051090; GO:0060453; GO:0070294; GO:0106310; GO:1901796; GO:1904045	Homo sapiens (Human)
NP_001137149.1	O00141	reviewed	SGK1_HUMAN	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	SGK1 SGK		FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cellular enzymes, transcription factors, neuronal excitability, cell growth, proliferation, survival, migration and apoptosis. Plays an important role in cellular stress response. Contributes to regulation of renal Na(+) retention, renal K(+) elimination, salt appetite, gastric acid secretion, intestinal Na(+)/H(+) exchange and nutrient transport, insulin-dependent salt sensitivity of blood pressure, salt sensitivity of peripheral glucose uptake, cardiac repolarization and memory consolidation. Up-regulates Na(+) channels: SCNN1A/ENAC, SCN5A and ASIC1/ACCN2, K(+) channels: KCNJ1/ROMK1, KCNA1-5, KCNQ1-5 and KCNE1, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channels: BSND, CLCN2 and CFTR, glutamate transporters: SLC1A3/EAAT1, SLC1A2 /EAAT2, SLC1A1/EAAT3, SLC1A6/EAAT4 and SLC1A7/EAAT5, amino acid transporters: SLC1A5/ASCT2, SLC38A1/SN1 and SLC6A19, creatine transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, glutamate receptor: GRIK2/GLUR6. Up-regulates carriers: SLC9A3/NHE3, SLC12A1/NKCC2, SLC12A3/NCC, SLC5A3/SMIT, SLC2A1/GLUT1, SLC5A1/SGLT1 and SLC15A2/PEPT2. Regulates enzymes: GSK3A/B, PMM2 and Na(+)/K(+) ATPase, and transcription factors: CTNNB1 and nuclear factor NF-kappa-B. Stimulates sodium transport into epithelial cells by enhancing the stability and expression of SCNN1A/ENAC. This is achieved by phosphorylating the NEDD4L ubiquitin E3 ligase, promoting its interaction with 14-3-3 proteins, thereby preventing it from binding to SCNN1A/ENAC and targeting it for degradation. Regulates store-operated Ca(+2) entry (SOCE) by stimulating ORAI1 and STIM1. Regulates KCNJ1/ROMK1 directly via its phosphorylation or indirectly via increased interaction with SLC9A3R2/NHERF2. Phosphorylates MDM2 and activates MDM2-dependent ubiquitination of p53/TP53. Phosphorylates MAPT/TAU and mediates microtubule depolymerization and neurite formation in hippocampal neurons. Phosphorylates SLC2A4/GLUT4 and up-regulates its activity. Phosphorylates APBB1/FE65 and promotes its localization to the nucleus. Phosphorylates MAPK1/ERK2 and activates it by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Phosphorylates FBXW7 and plays an inhibitory role in the NOTCH1 signaling. Phosphorylates FOXO1 resulting in its relocalization from the nucleus to the cytoplasm. Phosphorylates FOXO3, promoting its exit from the nucleus and interference with FOXO3-dependent transcription. Phosphorylates BRAF and MAP3K3/MEKK3 and inhibits their activity. Phosphorylates SLC9A3/NHE3 in response to dexamethasone, resulting in its activation and increased localization at the cell membrane. Phosphorylates CREB1. Necessary for vascular remodeling during angiogenesis. Sustained high levels and activity may contribute to conditions such as hypertension and diabetic nephropathy. Isoform 2 exhibited a greater effect on cell plasma membrane expression of SCNN1A/ENAC and Na(+) transport than isoform 1. {ECO:0000269|PubMed:11154281, ECO:0000269|PubMed:11410590, ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12761204, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14623317, ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15234985, ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15733869, ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:15888551, ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16443776, ECO:0000269|PubMed:16982696, ECO:0000269|PubMed:17382906, ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:18304449, ECO:0000269|PubMed:18753299, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:19756449, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:20730100, ECO:0000269|PubMed:21865597}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006814; GO:0006915; GO:0006974; GO:0007616; GO:0008217; GO:0015459; GO:0016607; GO:0017080; GO:0017081; GO:0032411; GO:0035556; GO:0042127; GO:0042981; GO:0048812; GO:0050790; GO:0051090; GO:0060453; GO:0070294; GO:0106310; GO:1901796; GO:1904045	Homo sapiens (Human)
NP_001278924.1	O00141	reviewed	SGK1_HUMAN	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	SGK1 SGK		FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cellular enzymes, transcription factors, neuronal excitability, cell growth, proliferation, survival, migration and apoptosis. Plays an important role in cellular stress response. Contributes to regulation of renal Na(+) retention, renal K(+) elimination, salt appetite, gastric acid secretion, intestinal Na(+)/H(+) exchange and nutrient transport, insulin-dependent salt sensitivity of blood pressure, salt sensitivity of peripheral glucose uptake, cardiac repolarization and memory consolidation. Up-regulates Na(+) channels: SCNN1A/ENAC, SCN5A and ASIC1/ACCN2, K(+) channels: KCNJ1/ROMK1, KCNA1-5, KCNQ1-5 and KCNE1, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channels: BSND, CLCN2 and CFTR, glutamate transporters: SLC1A3/EAAT1, SLC1A2 /EAAT2, SLC1A1/EAAT3, SLC1A6/EAAT4 and SLC1A7/EAAT5, amino acid transporters: SLC1A5/ASCT2, SLC38A1/SN1 and SLC6A19, creatine transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, glutamate receptor: GRIK2/GLUR6. Up-regulates carriers: SLC9A3/NHE3, SLC12A1/NKCC2, SLC12A3/NCC, SLC5A3/SMIT, SLC2A1/GLUT1, SLC5A1/SGLT1 and SLC15A2/PEPT2. Regulates enzymes: GSK3A/B, PMM2 and Na(+)/K(+) ATPase, and transcription factors: CTNNB1 and nuclear factor NF-kappa-B. Stimulates sodium transport into epithelial cells by enhancing the stability and expression of SCNN1A/ENAC. This is achieved by phosphorylating the NEDD4L ubiquitin E3 ligase, promoting its interaction with 14-3-3 proteins, thereby preventing it from binding to SCNN1A/ENAC and targeting it for degradation. Regulates store-operated Ca(+2) entry (SOCE) by stimulating ORAI1 and STIM1. Regulates KCNJ1/ROMK1 directly via its phosphorylation or indirectly via increased interaction with SLC9A3R2/NHERF2. Phosphorylates MDM2 and activates MDM2-dependent ubiquitination of p53/TP53. Phosphorylates MAPT/TAU and mediates microtubule depolymerization and neurite formation in hippocampal neurons. Phosphorylates SLC2A4/GLUT4 and up-regulates its activity. Phosphorylates APBB1/FE65 and promotes its localization to the nucleus. Phosphorylates MAPK1/ERK2 and activates it by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Phosphorylates FBXW7 and plays an inhibitory role in the NOTCH1 signaling. Phosphorylates FOXO1 resulting in its relocalization from the nucleus to the cytoplasm. Phosphorylates FOXO3, promoting its exit from the nucleus and interference with FOXO3-dependent transcription. Phosphorylates BRAF and MAP3K3/MEKK3 and inhibits their activity. Phosphorylates SLC9A3/NHE3 in response to dexamethasone, resulting in its activation and increased localization at the cell membrane. Phosphorylates CREB1. Necessary for vascular remodeling during angiogenesis. Sustained high levels and activity may contribute to conditions such as hypertension and diabetic nephropathy. Isoform 2 exhibited a greater effect on cell plasma membrane expression of SCNN1A/ENAC and Na(+) transport than isoform 1. {ECO:0000269|PubMed:11154281, ECO:0000269|PubMed:11410590, ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886, ECO:0000269|PubMed:12761204, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14623317, ECO:0000269|PubMed:14706641, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175, ECO:0000269|PubMed:15234985, ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15733869, ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389, ECO:0000269|PubMed:15888551, ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16443776, ECO:0000269|PubMed:16982696, ECO:0000269|PubMed:17382906, ECO:0000269|PubMed:18005662, ECO:0000269|PubMed:18304449, ECO:0000269|PubMed:18753299, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:19756449, ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:20730100, ECO:0000269|PubMed:21865597}.	9606	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006814; GO:0006915; GO:0006974; GO:0007616; GO:0008217; GO:0015459; GO:0016607; GO:0017080; GO:0017081; GO:0032411; GO:0035556; GO:0042127; GO:0042981; GO:0048812; GO:0050790; GO:0051090; GO:0060453; GO:0070294; GO:0106310; GO:1901796; GO:1904045	Homo sapiens (Human)
NP_001278924.1	B7Z325	unreviewed	B7Z325_HUMAN	cDNA FLJ55062, highly similar to Serine/threonine-protein kinase Sgk1				9606			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	Homo sapiens (Human)
NP_001278924.1	E9PR89	unreviewed	E9PR89_HUMAN	Serum/glucocorticoid regulated kinase 1	SGK1			9606	cytosol [GO:0005829]; nuclear speck [GO:0016607]		cytosol [GO:0005829]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005829; GO:0016607	Homo sapiens (Human)
NP_001229803.1	Q05513	reviewed	KPCZ_HUMAN	Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta)	PRKCZ PKC2		FUNCTION: Calcium- and diacylglycerol-independent serine/threonine-protein kinase that functions in phosphatidylinositol 3-kinase (PI3K) pathway and mitogen-activated protein (MAP) kinase cascade, and is involved in NF-kappa-B activation, mitogenic signaling, cell proliferation, cell polarity, inflammatory response and maintenance of long-term potentiation (LTP). Upon lipopolysaccharide (LPS) treatment in macrophages, or following mitogenic stimuli, functions downstream of PI3K to activate MAP2K1/MEK1-MAPK1/ERK2 signaling cascade independently of RAF1 activation. Required for insulin-dependent activation of AKT3, but may function as an adapter rather than a direct activator. Upon insulin treatment may act as a downstream effector of PI3K and contribute to the activation of translocation of the glucose transporter SLC2A4/GLUT4 and subsequent glucose transport in adipocytes. In EGF-induced cells, binds and activates MAP2K5/MEK5-MAPK7/ERK5 independently of its kinase activity and can activate JUN promoter through MEF2C. Through binding with SQSTM1/p62, functions in interleukin-1 signaling and activation of NF-kappa-B with the specific adapters RIPK1 and TRAF6. Participates in TNF-dependent transactivation of NF-kappa-B by phosphorylating and activating IKBKB kinase, which in turn leads to the degradation of NF-kappa-B inhibitors. In migrating astrocytes, forms a cytoplasmic complex with PARD6A and is recruited by CDC42 to function in the establishment of cell polarity along with the microtubule motor and dynein. In association with FEZ1, stimulates neuronal differentiation in PC12 cells. In the inflammatory response, is required for the T-helper 2 (Th2) differentiation process, including interleukin production, efficient activation of JAK1 and the subsequent phosphorylation and nuclear translocation of STAT6. May be involved in development of allergic airway inflammation (asthma), a process dependent on Th2 immune response. In the NF-kappa-B-mediated inflammatory response, can relieve SETD6-dependent repression of NF-kappa-B target genes by phosphorylating the RELA subunit at 'Ser-311'. Phosphorylates VAMP2 in vitro (PubMed:17313651). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11035106, ECO:0000269|PubMed:12162751, ECO:0000269|PubMed:15084291, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:17313651, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9447975}.; FUNCTION: [Isoform 2]: Involved in late synaptic long term potention phase in CA1 hippocampal cells and long term memory maintenance. {ECO:0000250|UniProtKB:Q02956}.	9606	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; tight junction [GO:0070160]; vesicle [GO:0031982]	cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; tight junction [GO:0070160]; vesicle [GO:0031982]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term synaptic potentiation [GO:0060291]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000226; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005635; GO:0005737; GO:0005768; GO:0005814; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0006468; GO:0006954; GO:0007165; GO:0008270; GO:0016020; GO:0016324; GO:0016363; GO:0030010; GO:0030054; GO:0031333; GO:0031982; GO:0032733; GO:0032736; GO:0032753; GO:0032754; GO:0032869; GO:0035556; GO:0035748; GO:0036064; GO:0043066; GO:0043203; GO:0043560; GO:0045179; GO:0045197; GO:0045630; GO:0046627; GO:0046628; GO:0051092; GO:0060291; GO:0070062; GO:0070160; GO:0070374; GO:0072659; GO:0097225; GO:0097229; GO:0106310; GO:0120157; GO:1990138; GO:2000463; GO:2000553	Homo sapiens (Human)
NP_001188939.1	A0A0B4JD78	unreviewed	A0A0B4JD78_DROME	protein kinase C (EC 2.7.11.13)	aPKC a-PKC alphaPKC alphaPKCzeta aPkc apkc aPKC zeta aPKC-zeta aPKCzeta CG10261 CG30475 DaPKC daPKC dapkc Dmel\CG42783 i l(2)k06403 PKC pkc-3 PKCl PKCzeta psu CG42783 Dmel_CG42783			7227		establishment or maintenance of cell polarity [GO:0007163]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]; establishment or maintenance of cell polarity [GO:0007163]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0007163; GO:0008270	Drosophila melanogaster (Fruit fly)
NP_001260984.1	A0A0B4KG15	unreviewed	A0A0B4KG15_DROME	protein kinase C (EC 2.7.11.13)	aPKC a-PKC alphaPKC alphaPKCzeta aPkc apkc aPKC zeta aPKC-zeta aPKCzeta CG10261 CG30475 DaPKC daPKC dapkc Dmel\CG42783 i l(2)k06403 PKC pkc-3 PKCl PKCzeta psu CG42783 Dmel_CG42783			7227		establishment or maintenance of cell polarity [GO:0007163]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]; establishment or maintenance of cell polarity [GO:0007163]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0007163; GO:0008270	Drosophila melanogaster (Fruit fly)
NP_001260985.1	A0A0B4KFQ6	unreviewed	A0A0B4KFQ6_DROME	protein kinase C (EC 2.7.11.13)	aPKC a-PKC alphaPKC alphaPKCzeta aPkc apkc aPKC zeta aPKC-zeta aPKCzeta CG10261 CG30475 DaPKC daPKC dapkc Dmel\CG42783 i l(2)k06403 PKC pkc-3 PKCl PKCzeta psu CG42783 Dmel_CG42783			7227		establishment or maintenance of cell polarity [GO:0007163]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]; establishment or maintenance of cell polarity [GO:0007163]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0007163; GO:0008270	Drosophila melanogaster (Fruit fly)
NP_001036542.1	A1Z9X0	reviewed	APKC_DROME	Atypical protein kinase C (EC 2.7.11.13)	aPKC CG30475		FUNCTION: Serine/threonine protein kinase which is required for apico-basal cell polarity in the germ line as well as in epithelial and neural precursor cells, for epithelial planar cell polarity and for cell proliferation. During oocyte development, required for the posterior translocation of oocyte specification factors and for the posterior establishment of the microtubule organizing center within the presumptive oocyte. Phosphorylates l(2)gl which restricts l(2)gl activity to the oocyte posterior and regulates posterior enrichment of par-1, leading to establishment of correct oocyte polarity. Essential for apical localization of l(2)gl and par-6 in neuroblasts and for exclusion of mira from the apical cortex. Phosphorylates baz which is required for targeting of baz to the postsynaptic region where it is involved in actin organization, and for apical exclusion of baz which is necessary for establishment of the apical/lateral border in epithelial cells. Phosphorylates yrt which prevents its premature apical localization and is necessary for correct epithelial cell polarization. Required for the establishment of mitotic spindle orientation during symmetric division of epithelial cells and for apical exclusion of raps/Pins. Involved in symmetric adherens junction positioning during embryogenesis. Required for polarization of the spermatid cyst which is necessary for sperm differentiation. Required for stimulation of the Toll signaling pathway which activates Dif and dl and plays a role in innate immunity. Plays a role in memory enhancement. {ECO:0000269|PubMed:10995441, ECO:0000269|PubMed:11734648, ECO:0000269|PubMed:11914720, ECO:0000269|PubMed:12446795, ECO:0000269|PubMed:14657233, ECO:0000269|PubMed:15302858, ECO:0000269|PubMed:15907474, ECO:0000269|PubMed:17488624, ECO:0000269|PubMed:18094021, ECO:0000269|PubMed:18614576, ECO:0000269|PubMed:19472188, ECO:0000269|PubMed:20434988, ECO:0000269|PubMed:22223679, ECO:0000269|PubMed:24515345, ECO:0000269|PubMed:24830287}.	7227	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]	adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000132; GO:0001738; GO:0002052; GO:0003382; GO:0004674; GO:0004697; GO:0005524; GO:0005938; GO:0007043; GO:0007163; GO:0007283; GO:0007294; GO:0007314; GO:0007416; GO:0007423; GO:0007430; GO:0007613; GO:0008270; GO:0010592; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0017022; GO:0030010; GO:0030011; GO:0030165; GO:0030860; GO:0034332; GO:0035003; GO:0035011; GO:0035331; GO:0035556; GO:0043296; GO:0045167; GO:0045176; GO:0045179; GO:0045186; GO:0045196; GO:0045197; GO:0045198; GO:0045880; GO:0046667; GO:0051491; GO:0051601; GO:0055059; GO:0060446; GO:0072659; GO:0090163; GO:0106310; GO:0120157; GO:0140591; GO:1904580	Drosophila melanogaster (Fruit fly)
NP_001036543.1	A1Z9X0	reviewed	APKC_DROME	Atypical protein kinase C (EC 2.7.11.13)	aPKC CG30475		FUNCTION: Serine/threonine protein kinase which is required for apico-basal cell polarity in the germ line as well as in epithelial and neural precursor cells, for epithelial planar cell polarity and for cell proliferation. During oocyte development, required for the posterior translocation of oocyte specification factors and for the posterior establishment of the microtubule organizing center within the presumptive oocyte. Phosphorylates l(2)gl which restricts l(2)gl activity to the oocyte posterior and regulates posterior enrichment of par-1, leading to establishment of correct oocyte polarity. Essential for apical localization of l(2)gl and par-6 in neuroblasts and for exclusion of mira from the apical cortex. Phosphorylates baz which is required for targeting of baz to the postsynaptic region where it is involved in actin organization, and for apical exclusion of baz which is necessary for establishment of the apical/lateral border in epithelial cells. Phosphorylates yrt which prevents its premature apical localization and is necessary for correct epithelial cell polarization. Required for the establishment of mitotic spindle orientation during symmetric division of epithelial cells and for apical exclusion of raps/Pins. Involved in symmetric adherens junction positioning during embryogenesis. Required for polarization of the spermatid cyst which is necessary for sperm differentiation. Required for stimulation of the Toll signaling pathway which activates Dif and dl and plays a role in innate immunity. Plays a role in memory enhancement. {ECO:0000269|PubMed:10995441, ECO:0000269|PubMed:11734648, ECO:0000269|PubMed:11914720, ECO:0000269|PubMed:12446795, ECO:0000269|PubMed:14657233, ECO:0000269|PubMed:15302858, ECO:0000269|PubMed:15907474, ECO:0000269|PubMed:17488624, ECO:0000269|PubMed:18094021, ECO:0000269|PubMed:18614576, ECO:0000269|PubMed:19472188, ECO:0000269|PubMed:20434988, ECO:0000269|PubMed:22223679, ECO:0000269|PubMed:24515345, ECO:0000269|PubMed:24830287}.	7227	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]	adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000132; GO:0001738; GO:0002052; GO:0003382; GO:0004674; GO:0004697; GO:0005524; GO:0005938; GO:0007043; GO:0007163; GO:0007283; GO:0007294; GO:0007314; GO:0007416; GO:0007423; GO:0007430; GO:0007613; GO:0008270; GO:0010592; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0017022; GO:0030010; GO:0030011; GO:0030165; GO:0030860; GO:0034332; GO:0035003; GO:0035011; GO:0035331; GO:0035556; GO:0043296; GO:0045167; GO:0045176; GO:0045179; GO:0045186; GO:0045196; GO:0045197; GO:0045198; GO:0045880; GO:0046667; GO:0051491; GO:0051601; GO:0055059; GO:0060446; GO:0072659; GO:0090163; GO:0106310; GO:0120157; GO:0140591; GO:1904580	Drosophila melanogaster (Fruit fly)
NP_001260986.1	A0A0B4KEV2	unreviewed	A0A0B4KEV2_DROME	protein kinase C (EC 2.7.11.13)	aPKC a-PKC alphaPKC alphaPKCzeta aPkc apkc aPKC zeta aPKC-zeta aPKCzeta CG10261 CG30475 DaPKC daPKC dapkc Dmel\CG42783 i l(2)k06403 PKC pkc-3 PKCl PKCzeta psu CG42783 Dmel_CG42783			7227		establishment or maintenance of cell polarity [GO:0007163]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]; establishment or maintenance of cell polarity [GO:0007163]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0007163; GO:0008270	Drosophila melanogaster (Fruit fly)
NP_001260987.1	A0A0B4KEQ8	unreviewed	A0A0B4KEQ8_DROME	protein kinase C (EC 2.7.11.13)	aPKC a-PKC alphaPKC alphaPKCzeta aPkc apkc aPKC zeta aPKC-zeta aPKCzeta CG10261 CG30475 DaPKC daPKC dapkc Dmel\CG42783 i l(2)k06403 PKC pkc-3 PKCl PKCzeta psu CG42783 Dmel_CG42783			7227		establishment or maintenance of cell polarity [GO:0007163]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]; establishment or maintenance of cell polarity [GO:0007163]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0007163; GO:0008270	Drosophila melanogaster (Fruit fly)
NP_001036544.1	A1Z9X0	reviewed	APKC_DROME	Atypical protein kinase C (EC 2.7.11.13)	aPKC CG30475		FUNCTION: Serine/threonine protein kinase which is required for apico-basal cell polarity in the germ line as well as in epithelial and neural precursor cells, for epithelial planar cell polarity and for cell proliferation. During oocyte development, required for the posterior translocation of oocyte specification factors and for the posterior establishment of the microtubule organizing center within the presumptive oocyte. Phosphorylates l(2)gl which restricts l(2)gl activity to the oocyte posterior and regulates posterior enrichment of par-1, leading to establishment of correct oocyte polarity. Essential for apical localization of l(2)gl and par-6 in neuroblasts and for exclusion of mira from the apical cortex. Phosphorylates baz which is required for targeting of baz to the postsynaptic region where it is involved in actin organization, and for apical exclusion of baz which is necessary for establishment of the apical/lateral border in epithelial cells. Phosphorylates yrt which prevents its premature apical localization and is necessary for correct epithelial cell polarization. Required for the establishment of mitotic spindle orientation during symmetric division of epithelial cells and for apical exclusion of raps/Pins. Involved in symmetric adherens junction positioning during embryogenesis. Required for polarization of the spermatid cyst which is necessary for sperm differentiation. Required for stimulation of the Toll signaling pathway which activates Dif and dl and plays a role in innate immunity. Plays a role in memory enhancement. {ECO:0000269|PubMed:10995441, ECO:0000269|PubMed:11734648, ECO:0000269|PubMed:11914720, ECO:0000269|PubMed:12446795, ECO:0000269|PubMed:14657233, ECO:0000269|PubMed:15302858, ECO:0000269|PubMed:15907474, ECO:0000269|PubMed:17488624, ECO:0000269|PubMed:18094021, ECO:0000269|PubMed:18614576, ECO:0000269|PubMed:19472188, ECO:0000269|PubMed:20434988, ECO:0000269|PubMed:22223679, ECO:0000269|PubMed:24515345, ECO:0000269|PubMed:24830287}.	7227	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]	adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; PAR polarity complex [GO:0120157]; subapical complex [GO:0035003]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; adherens junction organization [GO:0034332]; apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; asymmetric protein localization involved in cell fate determination [GO:0045167]; branching involved in open tracheal system development [GO:0060446]; cell-cell junction assembly [GO:0007043]; compound eye retinal cell programmed cell death [GO:0046667]; epithelial cell morphogenesis [GO:0003382]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of epithelial cell planar polarity [GO:0090163]; establishment of mitotic spindle orientation [GO:0000132]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of neuroblast polarity [GO:0045196]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; exocyst localization [GO:0051601]; germarium-derived oocyte fate determination [GO:0007294]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; melanotic encapsulation of foreign target [GO:0035011]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of hippo signaling [GO:0035331]; nuclear envelope budding [GO:0140591]; oocyte anterior/posterior axis specification [GO:0007314]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular mRNA localization [GO:1904580]; regulation of polarized epithelial cell differentiation [GO:0030860]; sensory organ development [GO:0007423]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; terminal branching, open tracheal system [GO:0007430]; zonula adherens assembly [GO:0045186]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0000132; GO:0001738; GO:0002052; GO:0003382; GO:0004674; GO:0004697; GO:0005524; GO:0005938; GO:0007043; GO:0007163; GO:0007283; GO:0007294; GO:0007314; GO:0007416; GO:0007423; GO:0007430; GO:0007613; GO:0008270; GO:0010592; GO:0016324; GO:0016327; GO:0016332; GO:0016334; GO:0017022; GO:0030010; GO:0030011; GO:0030165; GO:0030860; GO:0034332; GO:0035003; GO:0035011; GO:0035331; GO:0035556; GO:0043296; GO:0045167; GO:0045176; GO:0045179; GO:0045186; GO:0045196; GO:0045197; GO:0045198; GO:0045880; GO:0046667; GO:0051491; GO:0051601; GO:0055059; GO:0060446; GO:0072659; GO:0090163; GO:0106310; GO:0120157; GO:0140591; GO:1904580	Drosophila melanogaster (Fruit fly)
NP_001188941.1	A0A0B4JD26	unreviewed	A0A0B4JD26_DROME	protein kinase C (EC 2.7.11.13)	aPKC a-PKC alphaPKC alphaPKCzeta aPkc apkc aPKC zeta aPKC-zeta aPKCzeta CG10261 CG30475 DaPKC daPKC dapkc Dmel\CG42783 i l(2)k06403 PKC pkc-3 PKCl PKCzeta psu CG42783 Dmel_CG42783			7227		establishment or maintenance of cell polarity [GO:0007163]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]; establishment or maintenance of cell polarity [GO:0007163]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0007163; GO:0008270	Drosophila melanogaster (Fruit fly)
NP_477213.1	Q03042	reviewed	KGP1_DROME	cGMP-dependent protein kinase, isozyme 1 (cGK) (EC 2.7.11.12)	Pkg21D DG1 CG3324			7227	cytoplasm [GO:0005737]	larval somatic muscle development [GO:0007526]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]; larval somatic muscle development [GO:0007526]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005737; GO:0007165; GO:0007526; GO:0030553; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001097237.1	A8DY76	unreviewed	A8DY76_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_788291.1	A1Z7T1	unreviewed	A1Z7T1_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn Pkn-RC PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154	Drosophila melanogaster (Fruit fly)
NP_788293.2	A1Z7T3	unreviewed	A1Z7T3_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001286241.1	A0A0B4LFX2	unreviewed	A0A0B4LFX2_DROME	protein kinase C (EC 2.7.11.13)	Pkn 3-2 CG2055 CG8 CT6637 CT6660 Dmel\CG2049 DPKN Dpkn dPKN l(2)06736 l(2)45Ca Pk45C Pk?3 PKC-related PKN pkn PRK2 v(2)rG232 CG2049 Dmel_CG2049			7227	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; small GTPase binding [GO:0031267]	GO:0004697; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0030496; GO:0031267; GO:0032154; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001303258.1	P05129	reviewed	KPCG_HUMAN	Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13)	PRKCG PKCG		FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays diverse roles in neuronal cells and eye tissues, such as regulation of the neuronal receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of receptors and neuronal functions related to sensitivity to opiates, pain and alcohol, mediation of synaptic function and cell survival after ischemia, and inhibition of gap junction activity after oxidative stress. Binds and phosphorylates GRIA4/GLUR4 glutamate receptor and regulates its function by increasing plasma membrane-associated GRIA4 expression. In primary cerebellar neurons treated with the agonist 3,5-dihyidroxyphenylglycine, functions downstream of the metabotropic glutamate receptor GRM5/MGLUR5 and phosphorylates GRIN1/NMDAR1 receptor which plays a key role in synaptic plasticity, synaptogenesis, excitotoxicity, memory acquisition and learning. May be involved in the regulation of hippocampal long-term potentiation (LTP), but may be not necessary for the process of synaptic plasticity. May be involved in desensitization of mu-type opioid receptor-mediated G-protein activation in the spinal cord, and may be critical for the development and/or maintenance of morphine-induced reinforcing effects in the limbic forebrain. May modulate the functionality of mu-type-opioid receptors by participating in a signaling pathway which leads to the phosphorylation and degradation of opioid receptors. May also contributes to chronic morphine-induced changes in nociceptive processing. Plays a role in neuropathic pain mechanisms and contributes to the maintenance of the allodynia pain produced by peripheral inflammation. Plays an important role in initial sensitivity and tolerance to ethanol, by mediating the behavioral effects of ethanol as well as the effects of this drug on the GABA(A) receptors. During and after cerebral ischemia modulate neurotransmission and cell survival in synaptic membranes, and is involved in insulin-induced inhibition of necrosis, an important mechanism for minimizing ischemic injury. Required for the elimination of multiple climbing fibers during innervation of Purkinje cells in developing cerebellum. Is activated in lens epithelial cells upon hydrogen peroxide treatment, and phosphorylates connexin-43 (GJA1/CX43), resulting in disassembly of GJA1 gap junction plaques and inhibition of gap junction activity which could provide a protective effect against oxidative stress (By similarity). Phosphorylates p53/TP53 and promotes p53/TP53-dependent apoptosis in response to DNA damage. Involved in the phase resetting of the cerebral cortex circadian clock during temporally restricted feeding. Stabilizes the core clock component BMAL1 by interfering with its ubiquitination, thus suppressing its degradation, resulting in phase resetting of the cerebral cortex clock (By similarity). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000250|UniProtKB:P63318, ECO:0000250|UniProtKB:P63319, ECO:0000269|PubMed:16377624, ECO:0000269|PubMed:36040231}.	9606	calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; synaptic membrane [GO:0097060]	chemical synaptic transmission [GO:0007268]; chemosensory behavior [GO:0007635]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of mismatch repair [GO:0032425]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of circadian rhythm [GO:0042752]; regulation of phagocytosis [GO:0050764]; regulation of response to food [GO:0032095]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to angiotensin [GO:1990776]; response to morphine [GO:0043278]; response to pain [GO:0048265]; response to psychosocial stress [GO:1990911]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]; synaptic signaling via neuropeptide [GO:0099538]	calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; synaptic membrane [GO:0097060]; ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; chemical synaptic transmission [GO:0007268]; chemosensory behavior [GO:0007635]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of mismatch repair [GO:0032425]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of circadian rhythm [GO:0042752]; regulation of phagocytosis [GO:0050764]; regulation of response to food [GO:0032095]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to angiotensin [GO:1990776]; response to morphine [GO:0043278]; response to pain [GO:0048265]; response to psychosocial stress [GO:1990911]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]; synaptic signaling via neuropeptide [GO:0099538]	ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0007200; GO:0007268; GO:0007611; GO:0007635; GO:0008270; GO:0009636; GO:0014069; GO:0030425; GO:0031397; GO:0032095; GO:0032425; GO:0035556; GO:0042177; GO:0042752; GO:0043278; GO:0043524; GO:0044305; GO:0048265; GO:0048471; GO:0048511; GO:0050764; GO:0060291; GO:0060384; GO:0097060; GO:0099171; GO:0099523; GO:0099524; GO:0099538; GO:0106310; GO:1901799; GO:1990776; GO:1990911; GO:2000300	Homo sapiens (Human)
NP_001303258.1	A0A804HIU5	unreviewed	A0A804HIU5_HUMAN	Protein kinase C (EC 2.7.11.13)	PRKCG			9606	dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]	rhythmic process [GO:0048511]	dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; zinc ion binding [GO:0008270]; rhythmic process [GO:0048511]	ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; zinc ion binding [GO:0008270]	GO:0004698; GO:0005524; GO:0005886; GO:0008270; GO:0030425; GO:0048471; GO:0048511; GO:0099524	Homo sapiens (Human)
NP_001303258.1	B2R5T1	unreviewed	B2R5T1_HUMAN	Protein kinase C (EC 2.7.11.13)				9606	dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]	rhythmic process [GO:0048511]	dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]; rhythmic process [GO:0048511]	ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	GO:0004698; GO:0005524; GO:0005886; GO:0008270; GO:0030425; GO:0048471; GO:0048511; GO:0099524; GO:0106310	Homo sapiens (Human)
NP_001303258.1	B7Z3W6	unreviewed	B7Z3W6_HUMAN	Protein kinase C (EC 2.7.11.13)				9606	dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]	rhythmic process [GO:0048511]	dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]; rhythmic process [GO:0048511]	ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	GO:0004698; GO:0005524; GO:0005886; GO:0008270; GO:0030425; GO:0048471; GO:0048511; GO:0099524; GO:0106310	Homo sapiens (Human)
NP_476863.1	P13677	reviewed	KPC2_DROME	Protein kinase C, eye isozyme (EC 2.7.11.13) (Eye-PKC) (Inactivation no after-potential C protein) (Protein INAC) (Photoreceptor-specific PKC) (dPKC53E(EY))	inaC PKC2 CG6518		FUNCTION: This is a calcium-activated, phospholipid-dependent, serine- and threonine-specific enzyme. This isozyme is a negative regulator of the visual transduction cascade and has been shown to be required for photoreceptor cell inactivation and light adaptation. Negative regulation is dependent on interaction with scaffolding protein inaD. Acts in a hh-signaling pathway which regulates the Duox-dependent gut immune response to bacterial uracil; required for the activation of Cad99C and consequently Cad99C-dependent endosome formation, which is essential for the Duox-dependent production of reactive oxygen species (ROS) in response to intestinal bacterial infection (PubMed:25639794). {ECO:0000269|PubMed:25639794}.	7227	inaD signaling complex [GO:0016027]; rhabdomere [GO:0016028]	calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; detection of light stimulus involved in sensory perception [GO:0050962]; female gonad development [GO:0008585]; intracellular signal transduction [GO:0035556]; negative regulation of opsin-mediated signaling pathway [GO:0016059]; phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO:0030845]; phototransduction [GO:0007602]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; response to ethanol [GO:0045471]; response to light stimulus [GO:0009416]; visual perception [GO:0007601]	inaD signaling complex [GO:0016027]; rhabdomere [GO:0016028]; ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; detection of light stimulus involved in sensory perception [GO:0050962]; female gonad development [GO:0008585]; intracellular signal transduction [GO:0035556]; negative regulation of opsin-mediated signaling pathway [GO:0016059]; phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO:0030845]; phototransduction [GO:0007602]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; response to ethanol [GO:0045471]; response to light stimulus [GO:0009416]; visual perception [GO:0007601]	ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0004698; GO:0005524; GO:0007601; GO:0007602; GO:0008270; GO:0008585; GO:0009416; GO:0016027; GO:0016028; GO:0016059; GO:0016477; GO:0019722; GO:0030845; GO:0035556; GO:0045471; GO:0050962; GO:0106310; GO:2000370	Drosophila melanogaster (Fruit fly)
XP_047273315.1	A0A5F9ZHU3	unreviewed	A0A5F9ZHU3_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	positive regulation of cell migration [GO:0030335]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cell migration [GO:0030335]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0030335; GO:0036064	Homo sapiens (Human)
XP_047275142.1	A0A5F9ZHU3	unreviewed	A0A5F9ZHU3_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	positive regulation of cell migration [GO:0030335]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cell migration [GO:0030335]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0030335; GO:0036064	Homo sapiens (Human)
XP_047276597.1	A0A5F9ZHU3	unreviewed	A0A5F9ZHU3_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	positive regulation of cell migration [GO:0030335]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cell migration [GO:0030335]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0030335; GO:0036064	Homo sapiens (Human)
XP_047278347.1	A0A5F9ZHU3	unreviewed	A0A5F9ZHU3_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	positive regulation of cell migration [GO:0030335]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cell migration [GO:0030335]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0030335; GO:0036064	Homo sapiens (Human)
XP_047280288.1	A0A5F9ZHU3	unreviewed	A0A5F9ZHU3_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	positive regulation of cell migration [GO:0030335]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cell migration [GO:0030335]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0030335; GO:0036064	Homo sapiens (Human)
XP_054184600.1	A0A5F9ZHU3	unreviewed	A0A5F9ZHU3_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	positive regulation of cell migration [GO:0030335]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cell migration [GO:0030335]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0030335; GO:0036064	Homo sapiens (Human)
XP_054184601.1	A0A5F9ZHU3	unreviewed	A0A5F9ZHU3_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	positive regulation of cell migration [GO:0030335]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cell migration [GO:0030335]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0030335; GO:0036064	Homo sapiens (Human)
XP_054184602.1	A0A5F9ZHU3	unreviewed	A0A5F9ZHU3_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	positive regulation of cell migration [GO:0030335]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cell migration [GO:0030335]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0030335; GO:0036064	Homo sapiens (Human)
XP_054189661.1	A0A5F9ZHU3	unreviewed	A0A5F9ZHU3_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	positive regulation of cell migration [GO:0030335]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cell migration [GO:0030335]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0030335; GO:0036064	Homo sapiens (Human)
XP_054189662.1	A0A5F9ZHU3	unreviewed	A0A5F9ZHU3_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	positive regulation of cell migration [GO:0030335]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cell migration [GO:0030335]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0030335; GO:0036064	Homo sapiens (Human)
NP_001138191.1	P83099	reviewed	KPC4_DROME	Putative protein kinase C delta type homolog (EC 2.7.11.13)	Pkcdelta CG10524			7227	plasma membrane [GO:0005886]	flight [GO:0060361]; intracellular signal transduction [GO:0035556]	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; myosin light chain kinase activity [GO:0004687]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; flight [GO:0060361]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; myosin light chain kinase activity [GO:0004687]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0004687; GO:0004699; GO:0005524; GO:0005886; GO:0008270; GO:0035556; GO:0060361; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_001138191.1	B7Z147	unreviewed	B7Z147_DROME	Protein kinase C (EC 2.7.11.13)	Pkcdelta CG10524 CG11245 delta PKC Dmel\CG42349 mfd PKCd PKCdelta CG42349 Dmel_CG42349			7227			ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0008270; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_511171.3	P83099	reviewed	KPC4_DROME	Putative protein kinase C delta type homolog (EC 2.7.11.13)	Pkcdelta CG10524			7227	plasma membrane [GO:0005886]	flight [GO:0060361]; intracellular signal transduction [GO:0035556]	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; myosin light chain kinase activity [GO:0004687]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; flight [GO:0060361]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; myosin light chain kinase activity [GO:0004687]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0004674; GO:0004687; GO:0004699; GO:0005524; GO:0005886; GO:0008270; GO:0035556; GO:0060361; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_511171.3	B7Z147	unreviewed	B7Z147_DROME	Protein kinase C (EC 2.7.11.13)	Pkcdelta CG10524 CG11245 delta PKC Dmel\CG42349 mfd PKCd PKCdelta CG42349 Dmel_CG42349			7227			ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0008270; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_572797.3	Q9VYN1	unreviewed	Q9VYN1_DROME	protein kinase C (EC 2.7.11.13)	Pkcdelta CG10524 CG11245 delta PKC Dmel\CG42349 mfd PKCd PKCdelta CG42349 Dmel_CG42349			7227			ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0008270	Drosophila melanogaster (Fruit fly)
NP_001303256.1	Q05655	reviewed	KPCD_HUMAN	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD PKCD		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti-apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression as well as survival of several cancers, is required for oxygen radical production by NADPH oxidase and acts as positive or negative regulator in platelet functional responses (PubMed:21406692, PubMed:21810427). Negatively regulates B cell proliferation and also has an important function in self-antigen induced B cell tolerance induction (By similarity). Upon DNA damage, activates the promoter of the death-promoting transcription factor BCLAF1/Btf to trigger BCLAF1-mediated p53/TP53 gene transcription and apoptosis (PubMed:21406692, PubMed:21810427). In response to oxidative stress, interact with and activate CHUK/IKKA in the nucleus, causing the phosphorylation of p53/TP53 (PubMed:21406692, PubMed:21810427). In the case of ER stress or DNA damage-induced apoptosis, can form a complex with the tyrosine-protein kinase ABL1 which trigger apoptosis independently of p53/TP53 (PubMed:21406692, PubMed:21810427). In cytosol can trigger apoptosis by activating MAPK11 or MAPK14, inhibiting AKT1 and decreasing the level of X-linked inhibitor of apoptosis protein (XIAP), whereas in nucleus induces apoptosis via the activation of MAPK8 or MAPK9. Upon ionizing radiation treatment, is required for the activation of the apoptosis regulators BAX and BAK, which trigger the mitochondrial cell death pathway. Can phosphorylate MCL1 and target it for degradation which is sufficient to trigger for BAX activation and apoptosis. Is required for the control of cell cycle progression both at G1/S and G2/M phases. Mediates phorbol 12-myristate 13-acetate (PMA)-induced inhibition of cell cycle progression at G1/S phase by up-regulating the CDK inhibitor CDKN1A/p21 and inhibiting the cyclin CCNA2 promoter activity. In response to UV irradiation can phosphorylate CDK1, which is important for the G2/M DNA damage checkpoint activation (By similarity). Can protect glioma cells from the apoptosis induced by TNFSF10/TRAIL, probably by inducing increased phosphorylation and subsequent activation of AKT1 (PubMed:15774464). Is highly expressed in a number of cancer cells and promotes cell survival and resistance against chemotherapeutic drugs by inducing cyclin D1 (CCND1) and hyperphosphorylation of RB1, and via several pro-survival pathways, including NF-kappa-B, AKT1 and MAPK1/3 (ERK1/2). Involved in antifungal immunity by mediating phosphorylation and activation of CARD9 downstream of C-type lectin receptors activation, promoting interaction between CARD9 and BCL10, followed by activation of NF-kappa-B and MAP kinase p38 pathways (By similarity). Can also act as tumor suppressor upon mitogenic stimulation with PMA or TPA. In N-formyl-methionyl-leucyl-phenylalanine (fMLP)-treated cells, is required for NCF1 (p47-phox) phosphorylation and activation of NADPH oxidase activity, and regulates TNF-elicited superoxide anion production in neutrophils, by direct phosphorylation and activation of NCF1 or indirectly through MAPK1/3 (ERK1/2) signaling pathways (PubMed:19801500). May also play a role in the regulation of NADPH oxidase activity in eosinophil after stimulation with IL5, leukotriene B4 or PMA (PubMed:11748588). In collagen-induced platelet aggregation, acts a negative regulator of filopodia formation and actin polymerization by interacting with and negatively regulating VASP phosphorylation (PubMed:16940418). Downstream of PAR1, PAR4 and CD36/GP4 receptors, regulates differentially platelet dense granule secretion; acts as a positive regulator in PAR-mediated granule secretion, whereas it negatively regulates CD36/GP4-mediated granule release (PubMed:19587372). Phosphorylates MUC1 in the C-terminal and regulates the interaction between MUC1 and beta-catenin (PubMed:11877440). The catalytic subunit phosphorylates 14-3-3 proteins (YWHAB, YWHAZ and YWHAH) in a sphingosine-dependent fashion (By similarity). Phosphorylates ELAVL1 in response to angiotensin-2 treatment (PubMed:18285462). Phosphorylates mitochondrial phospholipid scramblase 3 (PLSCR3), resulting in increased cardiolipin expression on the mitochondrial outer membrane which facilitates apoptosis (PubMed:12649167). Phosphorylates SMPD1 which induces SMPD1 secretion (PubMed:17303575). {ECO:0000250|UniProtKB:P28867, ECO:0000269|PubMed:11748588, ECO:0000269|PubMed:11877440, ECO:0000269|PubMed:12649167, ECO:0000269|PubMed:15774464, ECO:0000269|PubMed:16940418, ECO:0000269|PubMed:17303575, ECO:0000269|PubMed:18285462, ECO:0000269|PubMed:19587372, ECO:0000269|PubMed:19801500, ECO:0000303|PubMed:21406692, ECO:0000303|PubMed:21810427}.	9606	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of DNA repair [GO:0045739]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of DNA repair [GO:0045739]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006974; GO:0007165; GO:0008047; GO:0008270; GO:0008631; GO:0016064; GO:0016363; GO:0018105; GO:0018107; GO:0019899; GO:0019901; GO:0023021; GO:0030296; GO:0030837; GO:0032930; GO:0032956; GO:0034351; GO:0034644; GO:0035556; GO:0035578; GO:0036019; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043409; GO:0043488; GO:0043560; GO:0045739; GO:0046627; GO:0048471; GO:0050728; GO:0050821; GO:0051490; GO:0060326; GO:0070062; GO:0070301; GO:0070528; GO:0071398; GO:0071447; GO:0090331; GO:0090398; GO:0106310; GO:0141212; GO:1900163; GO:1904385; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001235	Homo sapiens (Human)
NP_001303256.1	B4DFV1	unreviewed	B4DFV1_HUMAN	protein kinase C (EC 2.7.11.13)				9606			ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270]	GO:0004697; GO:0005524; GO:0008270; GO:0106310	Homo sapiens (Human)
NP_001341608.1	Q05655	reviewed	KPCD_HUMAN	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD PKCD		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti-apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression as well as survival of several cancers, is required for oxygen radical production by NADPH oxidase and acts as positive or negative regulator in platelet functional responses (PubMed:21406692, PubMed:21810427). Negatively regulates B cell proliferation and also has an important function in self-antigen induced B cell tolerance induction (By similarity). Upon DNA damage, activates the promoter of the death-promoting transcription factor BCLAF1/Btf to trigger BCLAF1-mediated p53/TP53 gene transcription and apoptosis (PubMed:21406692, PubMed:21810427). In response to oxidative stress, interact with and activate CHUK/IKKA in the nucleus, causing the phosphorylation of p53/TP53 (PubMed:21406692, PubMed:21810427). In the case of ER stress or DNA damage-induced apoptosis, can form a complex with the tyrosine-protein kinase ABL1 which trigger apoptosis independently of p53/TP53 (PubMed:21406692, PubMed:21810427). In cytosol can trigger apoptosis by activating MAPK11 or MAPK14, inhibiting AKT1 and decreasing the level of X-linked inhibitor of apoptosis protein (XIAP), whereas in nucleus induces apoptosis via the activation of MAPK8 or MAPK9. Upon ionizing radiation treatment, is required for the activation of the apoptosis regulators BAX and BAK, which trigger the mitochondrial cell death pathway. Can phosphorylate MCL1 and target it for degradation which is sufficient to trigger for BAX activation and apoptosis. Is required for the control of cell cycle progression both at G1/S and G2/M phases. Mediates phorbol 12-myristate 13-acetate (PMA)-induced inhibition of cell cycle progression at G1/S phase by up-regulating the CDK inhibitor CDKN1A/p21 and inhibiting the cyclin CCNA2 promoter activity. In response to UV irradiation can phosphorylate CDK1, which is important for the G2/M DNA damage checkpoint activation (By similarity). Can protect glioma cells from the apoptosis induced by TNFSF10/TRAIL, probably by inducing increased phosphorylation and subsequent activation of AKT1 (PubMed:15774464). Is highly expressed in a number of cancer cells and promotes cell survival and resistance against chemotherapeutic drugs by inducing cyclin D1 (CCND1) and hyperphosphorylation of RB1, and via several pro-survival pathways, including NF-kappa-B, AKT1 and MAPK1/3 (ERK1/2). Involved in antifungal immunity by mediating phosphorylation and activation of CARD9 downstream of C-type lectin receptors activation, promoting interaction between CARD9 and BCL10, followed by activation of NF-kappa-B and MAP kinase p38 pathways (By similarity). Can also act as tumor suppressor upon mitogenic stimulation with PMA or TPA. In N-formyl-methionyl-leucyl-phenylalanine (fMLP)-treated cells, is required for NCF1 (p47-phox) phosphorylation and activation of NADPH oxidase activity, and regulates TNF-elicited superoxide anion production in neutrophils, by direct phosphorylation and activation of NCF1 or indirectly through MAPK1/3 (ERK1/2) signaling pathways (PubMed:19801500). May also play a role in the regulation of NADPH oxidase activity in eosinophil after stimulation with IL5, leukotriene B4 or PMA (PubMed:11748588). In collagen-induced platelet aggregation, acts a negative regulator of filopodia formation and actin polymerization by interacting with and negatively regulating VASP phosphorylation (PubMed:16940418). Downstream of PAR1, PAR4 and CD36/GP4 receptors, regulates differentially platelet dense granule secretion; acts as a positive regulator in PAR-mediated granule secretion, whereas it negatively regulates CD36/GP4-mediated granule release (PubMed:19587372). Phosphorylates MUC1 in the C-terminal and regulates the interaction between MUC1 and beta-catenin (PubMed:11877440). The catalytic subunit phosphorylates 14-3-3 proteins (YWHAB, YWHAZ and YWHAH) in a sphingosine-dependent fashion (By similarity). Phosphorylates ELAVL1 in response to angiotensin-2 treatment (PubMed:18285462). Phosphorylates mitochondrial phospholipid scramblase 3 (PLSCR3), resulting in increased cardiolipin expression on the mitochondrial outer membrane which facilitates apoptosis (PubMed:12649167). Phosphorylates SMPD1 which induces SMPD1 secretion (PubMed:17303575). {ECO:0000250|UniProtKB:P28867, ECO:0000269|PubMed:11748588, ECO:0000269|PubMed:11877440, ECO:0000269|PubMed:12649167, ECO:0000269|PubMed:15774464, ECO:0000269|PubMed:16940418, ECO:0000269|PubMed:17303575, ECO:0000269|PubMed:18285462, ECO:0000269|PubMed:19587372, ECO:0000269|PubMed:19801500, ECO:0000303|PubMed:21406692, ECO:0000303|PubMed:21810427}.	9606	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of DNA repair [GO:0045739]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of DNA repair [GO:0045739]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006974; GO:0007165; GO:0008047; GO:0008270; GO:0008631; GO:0016064; GO:0016363; GO:0018105; GO:0018107; GO:0019899; GO:0019901; GO:0023021; GO:0030296; GO:0030837; GO:0032930; GO:0032956; GO:0034351; GO:0034644; GO:0035556; GO:0035578; GO:0036019; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043409; GO:0043488; GO:0043560; GO:0045739; GO:0046627; GO:0048471; GO:0050728; GO:0050821; GO:0051490; GO:0060326; GO:0070062; GO:0070301; GO:0070528; GO:0071398; GO:0071447; GO:0090331; GO:0090398; GO:0106310; GO:0141212; GO:1900163; GO:1904385; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001235	Homo sapiens (Human)
NP_001341609.1	Q05655	reviewed	KPCD_HUMAN	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD PKCD		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti-apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression as well as survival of several cancers, is required for oxygen radical production by NADPH oxidase and acts as positive or negative regulator in platelet functional responses (PubMed:21406692, PubMed:21810427). Negatively regulates B cell proliferation and also has an important function in self-antigen induced B cell tolerance induction (By similarity). Upon DNA damage, activates the promoter of the death-promoting transcription factor BCLAF1/Btf to trigger BCLAF1-mediated p53/TP53 gene transcription and apoptosis (PubMed:21406692, PubMed:21810427). In response to oxidative stress, interact with and activate CHUK/IKKA in the nucleus, causing the phosphorylation of p53/TP53 (PubMed:21406692, PubMed:21810427). In the case of ER stress or DNA damage-induced apoptosis, can form a complex with the tyrosine-protein kinase ABL1 which trigger apoptosis independently of p53/TP53 (PubMed:21406692, PubMed:21810427). In cytosol can trigger apoptosis by activating MAPK11 or MAPK14, inhibiting AKT1 and decreasing the level of X-linked inhibitor of apoptosis protein (XIAP), whereas in nucleus induces apoptosis via the activation of MAPK8 or MAPK9. Upon ionizing radiation treatment, is required for the activation of the apoptosis regulators BAX and BAK, which trigger the mitochondrial cell death pathway. Can phosphorylate MCL1 and target it for degradation which is sufficient to trigger for BAX activation and apoptosis. Is required for the control of cell cycle progression both at G1/S and G2/M phases. Mediates phorbol 12-myristate 13-acetate (PMA)-induced inhibition of cell cycle progression at G1/S phase by up-regulating the CDK inhibitor CDKN1A/p21 and inhibiting the cyclin CCNA2 promoter activity. In response to UV irradiation can phosphorylate CDK1, which is important for the G2/M DNA damage checkpoint activation (By similarity). Can protect glioma cells from the apoptosis induced by TNFSF10/TRAIL, probably by inducing increased phosphorylation and subsequent activation of AKT1 (PubMed:15774464). Is highly expressed in a number of cancer cells and promotes cell survival and resistance against chemotherapeutic drugs by inducing cyclin D1 (CCND1) and hyperphosphorylation of RB1, and via several pro-survival pathways, including NF-kappa-B, AKT1 and MAPK1/3 (ERK1/2). Involved in antifungal immunity by mediating phosphorylation and activation of CARD9 downstream of C-type lectin receptors activation, promoting interaction between CARD9 and BCL10, followed by activation of NF-kappa-B and MAP kinase p38 pathways (By similarity). Can also act as tumor suppressor upon mitogenic stimulation with PMA or TPA. In N-formyl-methionyl-leucyl-phenylalanine (fMLP)-treated cells, is required for NCF1 (p47-phox) phosphorylation and activation of NADPH oxidase activity, and regulates TNF-elicited superoxide anion production in neutrophils, by direct phosphorylation and activation of NCF1 or indirectly through MAPK1/3 (ERK1/2) signaling pathways (PubMed:19801500). May also play a role in the regulation of NADPH oxidase activity in eosinophil after stimulation with IL5, leukotriene B4 or PMA (PubMed:11748588). In collagen-induced platelet aggregation, acts a negative regulator of filopodia formation and actin polymerization by interacting with and negatively regulating VASP phosphorylation (PubMed:16940418). Downstream of PAR1, PAR4 and CD36/GP4 receptors, regulates differentially platelet dense granule secretion; acts as a positive regulator in PAR-mediated granule secretion, whereas it negatively regulates CD36/GP4-mediated granule release (PubMed:19587372). Phosphorylates MUC1 in the C-terminal and regulates the interaction between MUC1 and beta-catenin (PubMed:11877440). The catalytic subunit phosphorylates 14-3-3 proteins (YWHAB, YWHAZ and YWHAH) in a sphingosine-dependent fashion (By similarity). Phosphorylates ELAVL1 in response to angiotensin-2 treatment (PubMed:18285462). Phosphorylates mitochondrial phospholipid scramblase 3 (PLSCR3), resulting in increased cardiolipin expression on the mitochondrial outer membrane which facilitates apoptosis (PubMed:12649167). Phosphorylates SMPD1 which induces SMPD1 secretion (PubMed:17303575). {ECO:0000250|UniProtKB:P28867, ECO:0000269|PubMed:11748588, ECO:0000269|PubMed:11877440, ECO:0000269|PubMed:12649167, ECO:0000269|PubMed:15774464, ECO:0000269|PubMed:16940418, ECO:0000269|PubMed:17303575, ECO:0000269|PubMed:18285462, ECO:0000269|PubMed:19587372, ECO:0000269|PubMed:19801500, ECO:0000303|PubMed:21406692, ECO:0000303|PubMed:21810427}.	9606	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of DNA repair [GO:0045739]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of DNA repair [GO:0045739]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006974; GO:0007165; GO:0008047; GO:0008270; GO:0008631; GO:0016064; GO:0016363; GO:0018105; GO:0018107; GO:0019899; GO:0019901; GO:0023021; GO:0030296; GO:0030837; GO:0032930; GO:0032956; GO:0034351; GO:0034644; GO:0035556; GO:0035578; GO:0036019; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043409; GO:0043488; GO:0043560; GO:0045739; GO:0046627; GO:0048471; GO:0050728; GO:0050821; GO:0051490; GO:0060326; GO:0070062; GO:0070301; GO:0070528; GO:0071398; GO:0071447; GO:0090331; GO:0090398; GO:0106310; GO:0141212; GO:1900163; GO:1904385; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001235	Homo sapiens (Human)
NP_006245.2	Q05655	reviewed	KPCD_HUMAN	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD PKCD		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti-apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression as well as survival of several cancers, is required for oxygen radical production by NADPH oxidase and acts as positive or negative regulator in platelet functional responses (PubMed:21406692, PubMed:21810427). Negatively regulates B cell proliferation and also has an important function in self-antigen induced B cell tolerance induction (By similarity). Upon DNA damage, activates the promoter of the death-promoting transcription factor BCLAF1/Btf to trigger BCLAF1-mediated p53/TP53 gene transcription and apoptosis (PubMed:21406692, PubMed:21810427). In response to oxidative stress, interact with and activate CHUK/IKKA in the nucleus, causing the phosphorylation of p53/TP53 (PubMed:21406692, PubMed:21810427). In the case of ER stress or DNA damage-induced apoptosis, can form a complex with the tyrosine-protein kinase ABL1 which trigger apoptosis independently of p53/TP53 (PubMed:21406692, PubMed:21810427). In cytosol can trigger apoptosis by activating MAPK11 or MAPK14, inhibiting AKT1 and decreasing the level of X-linked inhibitor of apoptosis protein (XIAP), whereas in nucleus induces apoptosis via the activation of MAPK8 or MAPK9. Upon ionizing radiation treatment, is required for the activation of the apoptosis regulators BAX and BAK, which trigger the mitochondrial cell death pathway. Can phosphorylate MCL1 and target it for degradation which is sufficient to trigger for BAX activation and apoptosis. Is required for the control of cell cycle progression both at G1/S and G2/M phases. Mediates phorbol 12-myristate 13-acetate (PMA)-induced inhibition of cell cycle progression at G1/S phase by up-regulating the CDK inhibitor CDKN1A/p21 and inhibiting the cyclin CCNA2 promoter activity. In response to UV irradiation can phosphorylate CDK1, which is important for the G2/M DNA damage checkpoint activation (By similarity). Can protect glioma cells from the apoptosis induced by TNFSF10/TRAIL, probably by inducing increased phosphorylation and subsequent activation of AKT1 (PubMed:15774464). Is highly expressed in a number of cancer cells and promotes cell survival and resistance against chemotherapeutic drugs by inducing cyclin D1 (CCND1) and hyperphosphorylation of RB1, and via several pro-survival pathways, including NF-kappa-B, AKT1 and MAPK1/3 (ERK1/2). Involved in antifungal immunity by mediating phosphorylation and activation of CARD9 downstream of C-type lectin receptors activation, promoting interaction between CARD9 and BCL10, followed by activation of NF-kappa-B and MAP kinase p38 pathways (By similarity). Can also act as tumor suppressor upon mitogenic stimulation with PMA or TPA. In N-formyl-methionyl-leucyl-phenylalanine (fMLP)-treated cells, is required for NCF1 (p47-phox) phosphorylation and activation of NADPH oxidase activity, and regulates TNF-elicited superoxide anion production in neutrophils, by direct phosphorylation and activation of NCF1 or indirectly through MAPK1/3 (ERK1/2) signaling pathways (PubMed:19801500). May also play a role in the regulation of NADPH oxidase activity in eosinophil after stimulation with IL5, leukotriene B4 or PMA (PubMed:11748588). In collagen-induced platelet aggregation, acts a negative regulator of filopodia formation and actin polymerization by interacting with and negatively regulating VASP phosphorylation (PubMed:16940418). Downstream of PAR1, PAR4 and CD36/GP4 receptors, regulates differentially platelet dense granule secretion; acts as a positive regulator in PAR-mediated granule secretion, whereas it negatively regulates CD36/GP4-mediated granule release (PubMed:19587372). Phosphorylates MUC1 in the C-terminal and regulates the interaction between MUC1 and beta-catenin (PubMed:11877440). The catalytic subunit phosphorylates 14-3-3 proteins (YWHAB, YWHAZ and YWHAH) in a sphingosine-dependent fashion (By similarity). Phosphorylates ELAVL1 in response to angiotensin-2 treatment (PubMed:18285462). Phosphorylates mitochondrial phospholipid scramblase 3 (PLSCR3), resulting in increased cardiolipin expression on the mitochondrial outer membrane which facilitates apoptosis (PubMed:12649167). Phosphorylates SMPD1 which induces SMPD1 secretion (PubMed:17303575). {ECO:0000250|UniProtKB:P28867, ECO:0000269|PubMed:11748588, ECO:0000269|PubMed:11877440, ECO:0000269|PubMed:12649167, ECO:0000269|PubMed:15774464, ECO:0000269|PubMed:16940418, ECO:0000269|PubMed:17303575, ECO:0000269|PubMed:18285462, ECO:0000269|PubMed:19587372, ECO:0000269|PubMed:19801500, ECO:0000303|PubMed:21406692, ECO:0000303|PubMed:21810427}.	9606	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of DNA repair [GO:0045739]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of DNA repair [GO:0045739]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006974; GO:0007165; GO:0008047; GO:0008270; GO:0008631; GO:0016064; GO:0016363; GO:0018105; GO:0018107; GO:0019899; GO:0019901; GO:0023021; GO:0030296; GO:0030837; GO:0032930; GO:0032956; GO:0034351; GO:0034644; GO:0035556; GO:0035578; GO:0036019; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043409; GO:0043488; GO:0043560; GO:0045739; GO:0046627; GO:0048471; GO:0050728; GO:0050821; GO:0051490; GO:0060326; GO:0070062; GO:0070301; GO:0070528; GO:0071398; GO:0071447; GO:0090331; GO:0090398; GO:0106310; GO:0141212; GO:1900163; GO:1904385; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001235	Homo sapiens (Human)
NP_997704.1	Q05655	reviewed	KPCD_HUMAN	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD PKCD		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti-apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression as well as survival of several cancers, is required for oxygen radical production by NADPH oxidase and acts as positive or negative regulator in platelet functional responses (PubMed:21406692, PubMed:21810427). Negatively regulates B cell proliferation and also has an important function in self-antigen induced B cell tolerance induction (By similarity). Upon DNA damage, activates the promoter of the death-promoting transcription factor BCLAF1/Btf to trigger BCLAF1-mediated p53/TP53 gene transcription and apoptosis (PubMed:21406692, PubMed:21810427). In response to oxidative stress, interact with and activate CHUK/IKKA in the nucleus, causing the phosphorylation of p53/TP53 (PubMed:21406692, PubMed:21810427). In the case of ER stress or DNA damage-induced apoptosis, can form a complex with the tyrosine-protein kinase ABL1 which trigger apoptosis independently of p53/TP53 (PubMed:21406692, PubMed:21810427). In cytosol can trigger apoptosis by activating MAPK11 or MAPK14, inhibiting AKT1 and decreasing the level of X-linked inhibitor of apoptosis protein (XIAP), whereas in nucleus induces apoptosis via the activation of MAPK8 or MAPK9. Upon ionizing radiation treatment, is required for the activation of the apoptosis regulators BAX and BAK, which trigger the mitochondrial cell death pathway. Can phosphorylate MCL1 and target it for degradation which is sufficient to trigger for BAX activation and apoptosis. Is required for the control of cell cycle progression both at G1/S and G2/M phases. Mediates phorbol 12-myristate 13-acetate (PMA)-induced inhibition of cell cycle progression at G1/S phase by up-regulating the CDK inhibitor CDKN1A/p21 and inhibiting the cyclin CCNA2 promoter activity. In response to UV irradiation can phosphorylate CDK1, which is important for the G2/M DNA damage checkpoint activation (By similarity). Can protect glioma cells from the apoptosis induced by TNFSF10/TRAIL, probably by inducing increased phosphorylation and subsequent activation of AKT1 (PubMed:15774464). Is highly expressed in a number of cancer cells and promotes cell survival and resistance against chemotherapeutic drugs by inducing cyclin D1 (CCND1) and hyperphosphorylation of RB1, and via several pro-survival pathways, including NF-kappa-B, AKT1 and MAPK1/3 (ERK1/2). Involved in antifungal immunity by mediating phosphorylation and activation of CARD9 downstream of C-type lectin receptors activation, promoting interaction between CARD9 and BCL10, followed by activation of NF-kappa-B and MAP kinase p38 pathways (By similarity). Can also act as tumor suppressor upon mitogenic stimulation with PMA or TPA. In N-formyl-methionyl-leucyl-phenylalanine (fMLP)-treated cells, is required for NCF1 (p47-phox) phosphorylation and activation of NADPH oxidase activity, and regulates TNF-elicited superoxide anion production in neutrophils, by direct phosphorylation and activation of NCF1 or indirectly through MAPK1/3 (ERK1/2) signaling pathways (PubMed:19801500). May also play a role in the regulation of NADPH oxidase activity in eosinophil after stimulation with IL5, leukotriene B4 or PMA (PubMed:11748588). In collagen-induced platelet aggregation, acts a negative regulator of filopodia formation and actin polymerization by interacting with and negatively regulating VASP phosphorylation (PubMed:16940418). Downstream of PAR1, PAR4 and CD36/GP4 receptors, regulates differentially platelet dense granule secretion; acts as a positive regulator in PAR-mediated granule secretion, whereas it negatively regulates CD36/GP4-mediated granule release (PubMed:19587372). Phosphorylates MUC1 in the C-terminal and regulates the interaction between MUC1 and beta-catenin (PubMed:11877440). The catalytic subunit phosphorylates 14-3-3 proteins (YWHAB, YWHAZ and YWHAH) in a sphingosine-dependent fashion (By similarity). Phosphorylates ELAVL1 in response to angiotensin-2 treatment (PubMed:18285462). Phosphorylates mitochondrial phospholipid scramblase 3 (PLSCR3), resulting in increased cardiolipin expression on the mitochondrial outer membrane which facilitates apoptosis (PubMed:12649167). Phosphorylates SMPD1 which induces SMPD1 secretion (PubMed:17303575). {ECO:0000250|UniProtKB:P28867, ECO:0000269|PubMed:11748588, ECO:0000269|PubMed:11877440, ECO:0000269|PubMed:12649167, ECO:0000269|PubMed:15774464, ECO:0000269|PubMed:16940418, ECO:0000269|PubMed:17303575, ECO:0000269|PubMed:18285462, ECO:0000269|PubMed:19587372, ECO:0000269|PubMed:19801500, ECO:0000303|PubMed:21406692, ECO:0000303|PubMed:21810427}.	9606	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of DNA repair [GO:0045739]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of DNA repair [GO:0045739]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006974; GO:0007165; GO:0008047; GO:0008270; GO:0008631; GO:0016064; GO:0016363; GO:0018105; GO:0018107; GO:0019899; GO:0019901; GO:0023021; GO:0030296; GO:0030837; GO:0032930; GO:0032956; GO:0034351; GO:0034644; GO:0035556; GO:0035578; GO:0036019; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043409; GO:0043488; GO:0043560; GO:0045739; GO:0046627; GO:0048471; GO:0050728; GO:0050821; GO:0051490; GO:0060326; GO:0070062; GO:0070301; GO:0070528; GO:0071398; GO:0071447; GO:0090331; GO:0090398; GO:0106310; GO:0141212; GO:1900163; GO:1904385; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001235	Homo sapiens (Human)
XP_047304520.1	Q05655	reviewed	KPCD_HUMAN	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD PKCD		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti-apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression as well as survival of several cancers, is required for oxygen radical production by NADPH oxidase and acts as positive or negative regulator in platelet functional responses (PubMed:21406692, PubMed:21810427). Negatively regulates B cell proliferation and also has an important function in self-antigen induced B cell tolerance induction (By similarity). Upon DNA damage, activates the promoter of the death-promoting transcription factor BCLAF1/Btf to trigger BCLAF1-mediated p53/TP53 gene transcription and apoptosis (PubMed:21406692, PubMed:21810427). In response to oxidative stress, interact with and activate CHUK/IKKA in the nucleus, causing the phosphorylation of p53/TP53 (PubMed:21406692, PubMed:21810427). In the case of ER stress or DNA damage-induced apoptosis, can form a complex with the tyrosine-protein kinase ABL1 which trigger apoptosis independently of p53/TP53 (PubMed:21406692, PubMed:21810427). In cytosol can trigger apoptosis by activating MAPK11 or MAPK14, inhibiting AKT1 and decreasing the level of X-linked inhibitor of apoptosis protein (XIAP), whereas in nucleus induces apoptosis via the activation of MAPK8 or MAPK9. Upon ionizing radiation treatment, is required for the activation of the apoptosis regulators BAX and BAK, which trigger the mitochondrial cell death pathway. Can phosphorylate MCL1 and target it for degradation which is sufficient to trigger for BAX activation and apoptosis. Is required for the control of cell cycle progression both at G1/S and G2/M phases. Mediates phorbol 12-myristate 13-acetate (PMA)-induced inhibition of cell cycle progression at G1/S phase by up-regulating the CDK inhibitor CDKN1A/p21 and inhibiting the cyclin CCNA2 promoter activity. In response to UV irradiation can phosphorylate CDK1, which is important for the G2/M DNA damage checkpoint activation (By similarity). Can protect glioma cells from the apoptosis induced by TNFSF10/TRAIL, probably by inducing increased phosphorylation and subsequent activation of AKT1 (PubMed:15774464). Is highly expressed in a number of cancer cells and promotes cell survival and resistance against chemotherapeutic drugs by inducing cyclin D1 (CCND1) and hyperphosphorylation of RB1, and via several pro-survival pathways, including NF-kappa-B, AKT1 and MAPK1/3 (ERK1/2). Involved in antifungal immunity by mediating phosphorylation and activation of CARD9 downstream of C-type lectin receptors activation, promoting interaction between CARD9 and BCL10, followed by activation of NF-kappa-B and MAP kinase p38 pathways (By similarity). Can also act as tumor suppressor upon mitogenic stimulation with PMA or TPA. In N-formyl-methionyl-leucyl-phenylalanine (fMLP)-treated cells, is required for NCF1 (p47-phox) phosphorylation and activation of NADPH oxidase activity, and regulates TNF-elicited superoxide anion production in neutrophils, by direct phosphorylation and activation of NCF1 or indirectly through MAPK1/3 (ERK1/2) signaling pathways (PubMed:19801500). May also play a role in the regulation of NADPH oxidase activity in eosinophil after stimulation with IL5, leukotriene B4 or PMA (PubMed:11748588). In collagen-induced platelet aggregation, acts a negative regulator of filopodia formation and actin polymerization by interacting with and negatively regulating VASP phosphorylation (PubMed:16940418). Downstream of PAR1, PAR4 and CD36/GP4 receptors, regulates differentially platelet dense granule secretion; acts as a positive regulator in PAR-mediated granule secretion, whereas it negatively regulates CD36/GP4-mediated granule release (PubMed:19587372). Phosphorylates MUC1 in the C-terminal and regulates the interaction between MUC1 and beta-catenin (PubMed:11877440). The catalytic subunit phosphorylates 14-3-3 proteins (YWHAB, YWHAZ and YWHAH) in a sphingosine-dependent fashion (By similarity). Phosphorylates ELAVL1 in response to angiotensin-2 treatment (PubMed:18285462). Phosphorylates mitochondrial phospholipid scramblase 3 (PLSCR3), resulting in increased cardiolipin expression on the mitochondrial outer membrane which facilitates apoptosis (PubMed:12649167). Phosphorylates SMPD1 which induces SMPD1 secretion (PubMed:17303575). {ECO:0000250|UniProtKB:P28867, ECO:0000269|PubMed:11748588, ECO:0000269|PubMed:11877440, ECO:0000269|PubMed:12649167, ECO:0000269|PubMed:15774464, ECO:0000269|PubMed:16940418, ECO:0000269|PubMed:17303575, ECO:0000269|PubMed:18285462, ECO:0000269|PubMed:19587372, ECO:0000269|PubMed:19801500, ECO:0000303|PubMed:21406692, ECO:0000303|PubMed:21810427}.	9606	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of DNA repair [GO:0045739]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to fatty acid [GO:0071398]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of DNA repair [GO:0045739]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004715; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0006974; GO:0007165; GO:0008047; GO:0008270; GO:0008631; GO:0016064; GO:0016363; GO:0018105; GO:0018107; GO:0019899; GO:0019901; GO:0023021; GO:0030296; GO:0030837; GO:0032930; GO:0032956; GO:0034351; GO:0034644; GO:0035556; GO:0035578; GO:0036019; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043409; GO:0043488; GO:0043560; GO:0045739; GO:0046627; GO:0048471; GO:0050728; GO:0050821; GO:0051490; GO:0060326; GO:0070062; GO:0070301; GO:0070528; GO:0071398; GO:0071447; GO:0090331; GO:0090398; GO:0106310; GO:0141212; GO:1900163; GO:1904385; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001235	Homo sapiens (Human)
NP_001269574.1	Q04759	reviewed	KPCT_HUMAN	Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta)	PRKCQ PRKCT		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that mediates non-redundant functions in T-cell receptor (TCR) signaling, including T-cells activation, proliferation, differentiation and survival, by mediating activation of multiple transcription factors such as NF-kappa-B, JUN, NFATC1 and NFATC2. In TCR-CD3/CD28-co-stimulated T-cells, is required for the activation of NF-kappa-B and JUN, which in turn are essential for IL2 production, and participates in the calcium-dependent NFATC1 and NFATC2 transactivation (PubMed:21964608). Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11 on several serine residues, inducing CARD11 association with lipid rafts and recruitment of the BCL10-MALT1 complex, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. May also play an indirect role in activation of the non-canonical NF-kappa-B (NFKB2) pathway. In the signaling pathway leading to JUN activation, acts by phosphorylating the mediator STK39/SPAK and may not act through MAP kinases signaling. Plays a critical role in TCR/CD28-induced NFATC1 and NFATC2 transactivation by participating in the regulation of reduced inositol 1,4,5-trisphosphate generation and intracellular calcium mobilization. After costimulation of T-cells through CD28 can phosphorylate CBLB and is required for the ubiquitination and subsequent degradation of CBLB, which is a prerequisite for the activation of TCR. During T-cells differentiation, plays an important role in the development of T-helper 2 (Th2) cells following immune and inflammatory responses, and, in the development of inflammatory autoimmune diseases, is necessary for the activation of IL17-producing Th17 cells. May play a minor role in Th1 response. Upon TCR stimulation, mediates T-cell protective survival signal by phosphorylating BAD, thus protecting T-cells from BAD-induced apoptosis, and by up-regulating BCL-X(L)/BCL2L1 levels through NF-kappa-B and JUN pathways. In platelets, regulates signal transduction downstream of the ITGA2B, CD36/GP4, F2R/PAR1 and F2RL3/PAR4 receptors, playing a positive role in 'outside-in' signaling and granule secretion signal transduction. May relay signals from the activated ITGA2B receptor by regulating the uncoupling of WASP and WIPF1, thereby permitting the regulation of actin filament nucleation and branching activity of the Arp2/3 complex. May mediate inhibitory effects of free fatty acids on insulin signaling by phosphorylating IRS1, which in turn blocks IRS1 tyrosine phosphorylation and downstream activation of the PI3K/AKT pathway. Phosphorylates MSN (moesin) in the presence of phosphatidylglycerol or phosphatidylinositol. Phosphorylates PDPK1 at 'Ser-504' and 'Ser-532' and negatively regulates its ability to phosphorylate PKB/AKT1. Phosphorylates CCDC88A/GIV and inhibits its guanine nucleotide exchange factor activity (PubMed:23509302). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11342610, ECO:0000269|PubMed:14988727, ECO:0000269|PubMed:15364919, ECO:0000269|PubMed:16252004, ECO:0000269|PubMed:16356855, ECO:0000269|PubMed:16709830, ECO:0000269|PubMed:19549985, ECO:0000269|PubMed:21964608, ECO:0000269|PubMed:23509302, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:8657160}.	9606	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]	axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of platelet aggregation [GO:0090330]	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of platelet aggregation [GO:0090330]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0001558; GO:0001772; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005829; GO:0005886; GO:0006355; GO:0006509; GO:0006954; GO:0007411; GO:0008270; GO:0016235; GO:0032206; GO:0032740; GO:0032743; GO:0032753; GO:0034451; GO:0035556; GO:0035739; GO:0038095; GO:0046627; GO:0050870; GO:0051092; GO:0060326; GO:0070233; GO:0090330; GO:0106310; GO:2000318; GO:2000563; GO:2000570	Homo sapiens (Human)
NP_001310195.1	Q04759	reviewed	KPCT_HUMAN	Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta)	PRKCQ PRKCT		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that mediates non-redundant functions in T-cell receptor (TCR) signaling, including T-cells activation, proliferation, differentiation and survival, by mediating activation of multiple transcription factors such as NF-kappa-B, JUN, NFATC1 and NFATC2. In TCR-CD3/CD28-co-stimulated T-cells, is required for the activation of NF-kappa-B and JUN, which in turn are essential for IL2 production, and participates in the calcium-dependent NFATC1 and NFATC2 transactivation (PubMed:21964608). Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11 on several serine residues, inducing CARD11 association with lipid rafts and recruitment of the BCL10-MALT1 complex, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. May also play an indirect role in activation of the non-canonical NF-kappa-B (NFKB2) pathway. In the signaling pathway leading to JUN activation, acts by phosphorylating the mediator STK39/SPAK and may not act through MAP kinases signaling. Plays a critical role in TCR/CD28-induced NFATC1 and NFATC2 transactivation by participating in the regulation of reduced inositol 1,4,5-trisphosphate generation and intracellular calcium mobilization. After costimulation of T-cells through CD28 can phosphorylate CBLB and is required for the ubiquitination and subsequent degradation of CBLB, which is a prerequisite for the activation of TCR. During T-cells differentiation, plays an important role in the development of T-helper 2 (Th2) cells following immune and inflammatory responses, and, in the development of inflammatory autoimmune diseases, is necessary for the activation of IL17-producing Th17 cells. May play a minor role in Th1 response. Upon TCR stimulation, mediates T-cell protective survival signal by phosphorylating BAD, thus protecting T-cells from BAD-induced apoptosis, and by up-regulating BCL-X(L)/BCL2L1 levels through NF-kappa-B and JUN pathways. In platelets, regulates signal transduction downstream of the ITGA2B, CD36/GP4, F2R/PAR1 and F2RL3/PAR4 receptors, playing a positive role in 'outside-in' signaling and granule secretion signal transduction. May relay signals from the activated ITGA2B receptor by regulating the uncoupling of WASP and WIPF1, thereby permitting the regulation of actin filament nucleation and branching activity of the Arp2/3 complex. May mediate inhibitory effects of free fatty acids on insulin signaling by phosphorylating IRS1, which in turn blocks IRS1 tyrosine phosphorylation and downstream activation of the PI3K/AKT pathway. Phosphorylates MSN (moesin) in the presence of phosphatidylglycerol or phosphatidylinositol. Phosphorylates PDPK1 at 'Ser-504' and 'Ser-532' and negatively regulates its ability to phosphorylate PKB/AKT1. Phosphorylates CCDC88A/GIV and inhibits its guanine nucleotide exchange factor activity (PubMed:23509302). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11342610, ECO:0000269|PubMed:14988727, ECO:0000269|PubMed:15364919, ECO:0000269|PubMed:16252004, ECO:0000269|PubMed:16356855, ECO:0000269|PubMed:16709830, ECO:0000269|PubMed:19549985, ECO:0000269|PubMed:21964608, ECO:0000269|PubMed:23509302, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:8657160}.	9606	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]	axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of platelet aggregation [GO:0090330]	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of platelet aggregation [GO:0090330]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0001558; GO:0001772; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005829; GO:0005886; GO:0006355; GO:0006509; GO:0006954; GO:0007411; GO:0008270; GO:0016235; GO:0032206; GO:0032740; GO:0032743; GO:0032753; GO:0034451; GO:0035556; GO:0035739; GO:0038095; GO:0046627; GO:0050870; GO:0051092; GO:0060326; GO:0070233; GO:0090330; GO:0106310; GO:2000318; GO:2000563; GO:2000570	Homo sapiens (Human)
NP_001269573.1	Q04759	reviewed	KPCT_HUMAN	Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta)	PRKCQ PRKCT		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that mediates non-redundant functions in T-cell receptor (TCR) signaling, including T-cells activation, proliferation, differentiation and survival, by mediating activation of multiple transcription factors such as NF-kappa-B, JUN, NFATC1 and NFATC2. In TCR-CD3/CD28-co-stimulated T-cells, is required for the activation of NF-kappa-B and JUN, which in turn are essential for IL2 production, and participates in the calcium-dependent NFATC1 and NFATC2 transactivation (PubMed:21964608). Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11 on several serine residues, inducing CARD11 association with lipid rafts and recruitment of the BCL10-MALT1 complex, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. May also play an indirect role in activation of the non-canonical NF-kappa-B (NFKB2) pathway. In the signaling pathway leading to JUN activation, acts by phosphorylating the mediator STK39/SPAK and may not act through MAP kinases signaling. Plays a critical role in TCR/CD28-induced NFATC1 and NFATC2 transactivation by participating in the regulation of reduced inositol 1,4,5-trisphosphate generation and intracellular calcium mobilization. After costimulation of T-cells through CD28 can phosphorylate CBLB and is required for the ubiquitination and subsequent degradation of CBLB, which is a prerequisite for the activation of TCR. During T-cells differentiation, plays an important role in the development of T-helper 2 (Th2) cells following immune and inflammatory responses, and, in the development of inflammatory autoimmune diseases, is necessary for the activation of IL17-producing Th17 cells. May play a minor role in Th1 response. Upon TCR stimulation, mediates T-cell protective survival signal by phosphorylating BAD, thus protecting T-cells from BAD-induced apoptosis, and by up-regulating BCL-X(L)/BCL2L1 levels through NF-kappa-B and JUN pathways. In platelets, regulates signal transduction downstream of the ITGA2B, CD36/GP4, F2R/PAR1 and F2RL3/PAR4 receptors, playing a positive role in 'outside-in' signaling and granule secretion signal transduction. May relay signals from the activated ITGA2B receptor by regulating the uncoupling of WASP and WIPF1, thereby permitting the regulation of actin filament nucleation and branching activity of the Arp2/3 complex. May mediate inhibitory effects of free fatty acids on insulin signaling by phosphorylating IRS1, which in turn blocks IRS1 tyrosine phosphorylation and downstream activation of the PI3K/AKT pathway. Phosphorylates MSN (moesin) in the presence of phosphatidylglycerol or phosphatidylinositol. Phosphorylates PDPK1 at 'Ser-504' and 'Ser-532' and negatively regulates its ability to phosphorylate PKB/AKT1. Phosphorylates CCDC88A/GIV and inhibits its guanine nucleotide exchange factor activity (PubMed:23509302). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11342610, ECO:0000269|PubMed:14988727, ECO:0000269|PubMed:15364919, ECO:0000269|PubMed:16252004, ECO:0000269|PubMed:16356855, ECO:0000269|PubMed:16709830, ECO:0000269|PubMed:19549985, ECO:0000269|PubMed:21964608, ECO:0000269|PubMed:23509302, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:8657160}.	9606	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]	axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of platelet aggregation [GO:0090330]	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of platelet aggregation [GO:0090330]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0001558; GO:0001772; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005829; GO:0005886; GO:0006355; GO:0006509; GO:0006954; GO:0007411; GO:0008270; GO:0016235; GO:0032206; GO:0032740; GO:0032743; GO:0032753; GO:0034451; GO:0035556; GO:0035739; GO:0038095; GO:0046627; GO:0050870; GO:0051092; GO:0060326; GO:0070233; GO:0090330; GO:0106310; GO:2000318; GO:2000563; GO:2000570	Homo sapiens (Human)
NP_001310194.1	Q04759	reviewed	KPCT_HUMAN	Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta)	PRKCQ PRKCT		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that mediates non-redundant functions in T-cell receptor (TCR) signaling, including T-cells activation, proliferation, differentiation and survival, by mediating activation of multiple transcription factors such as NF-kappa-B, JUN, NFATC1 and NFATC2. In TCR-CD3/CD28-co-stimulated T-cells, is required for the activation of NF-kappa-B and JUN, which in turn are essential for IL2 production, and participates in the calcium-dependent NFATC1 and NFATC2 transactivation (PubMed:21964608). Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11 on several serine residues, inducing CARD11 association with lipid rafts and recruitment of the BCL10-MALT1 complex, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. May also play an indirect role in activation of the non-canonical NF-kappa-B (NFKB2) pathway. In the signaling pathway leading to JUN activation, acts by phosphorylating the mediator STK39/SPAK and may not act through MAP kinases signaling. Plays a critical role in TCR/CD28-induced NFATC1 and NFATC2 transactivation by participating in the regulation of reduced inositol 1,4,5-trisphosphate generation and intracellular calcium mobilization. After costimulation of T-cells through CD28 can phosphorylate CBLB and is required for the ubiquitination and subsequent degradation of CBLB, which is a prerequisite for the activation of TCR. During T-cells differentiation, plays an important role in the development of T-helper 2 (Th2) cells following immune and inflammatory responses, and, in the development of inflammatory autoimmune diseases, is necessary for the activation of IL17-producing Th17 cells. May play a minor role in Th1 response. Upon TCR stimulation, mediates T-cell protective survival signal by phosphorylating BAD, thus protecting T-cells from BAD-induced apoptosis, and by up-regulating BCL-X(L)/BCL2L1 levels through NF-kappa-B and JUN pathways. In platelets, regulates signal transduction downstream of the ITGA2B, CD36/GP4, F2R/PAR1 and F2RL3/PAR4 receptors, playing a positive role in 'outside-in' signaling and granule secretion signal transduction. May relay signals from the activated ITGA2B receptor by regulating the uncoupling of WASP and WIPF1, thereby permitting the regulation of actin filament nucleation and branching activity of the Arp2/3 complex. May mediate inhibitory effects of free fatty acids on insulin signaling by phosphorylating IRS1, which in turn blocks IRS1 tyrosine phosphorylation and downstream activation of the PI3K/AKT pathway. Phosphorylates MSN (moesin) in the presence of phosphatidylglycerol or phosphatidylinositol. Phosphorylates PDPK1 at 'Ser-504' and 'Ser-532' and negatively regulates its ability to phosphorylate PKB/AKT1. Phosphorylates CCDC88A/GIV and inhibits its guanine nucleotide exchange factor activity (PubMed:23509302). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11342610, ECO:0000269|PubMed:14988727, ECO:0000269|PubMed:15364919, ECO:0000269|PubMed:16252004, ECO:0000269|PubMed:16356855, ECO:0000269|PubMed:16709830, ECO:0000269|PubMed:19549985, ECO:0000269|PubMed:21964608, ECO:0000269|PubMed:23509302, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:8657160}.	9606	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]	axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of platelet aggregation [GO:0090330]	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of platelet aggregation [GO:0090330]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0001558; GO:0001772; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005829; GO:0005886; GO:0006355; GO:0006509; GO:0006954; GO:0007411; GO:0008270; GO:0016235; GO:0032206; GO:0032740; GO:0032743; GO:0032753; GO:0034451; GO:0035556; GO:0035739; GO:0038095; GO:0046627; GO:0050870; GO:0051092; GO:0060326; GO:0070233; GO:0090330; GO:0106310; GO:2000318; GO:2000563; GO:2000570	Homo sapiens (Human)
NP_006248.1	Q04759	reviewed	KPCT_HUMAN	Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta)	PRKCQ PRKCT		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that mediates non-redundant functions in T-cell receptor (TCR) signaling, including T-cells activation, proliferation, differentiation and survival, by mediating activation of multiple transcription factors such as NF-kappa-B, JUN, NFATC1 and NFATC2. In TCR-CD3/CD28-co-stimulated T-cells, is required for the activation of NF-kappa-B and JUN, which in turn are essential for IL2 production, and participates in the calcium-dependent NFATC1 and NFATC2 transactivation (PubMed:21964608). Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11 on several serine residues, inducing CARD11 association with lipid rafts and recruitment of the BCL10-MALT1 complex, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. May also play an indirect role in activation of the non-canonical NF-kappa-B (NFKB2) pathway. In the signaling pathway leading to JUN activation, acts by phosphorylating the mediator STK39/SPAK and may not act through MAP kinases signaling. Plays a critical role in TCR/CD28-induced NFATC1 and NFATC2 transactivation by participating in the regulation of reduced inositol 1,4,5-trisphosphate generation and intracellular calcium mobilization. After costimulation of T-cells through CD28 can phosphorylate CBLB and is required for the ubiquitination and subsequent degradation of CBLB, which is a prerequisite for the activation of TCR. During T-cells differentiation, plays an important role in the development of T-helper 2 (Th2) cells following immune and inflammatory responses, and, in the development of inflammatory autoimmune diseases, is necessary for the activation of IL17-producing Th17 cells. May play a minor role in Th1 response. Upon TCR stimulation, mediates T-cell protective survival signal by phosphorylating BAD, thus protecting T-cells from BAD-induced apoptosis, and by up-regulating BCL-X(L)/BCL2L1 levels through NF-kappa-B and JUN pathways. In platelets, regulates signal transduction downstream of the ITGA2B, CD36/GP4, F2R/PAR1 and F2RL3/PAR4 receptors, playing a positive role in 'outside-in' signaling and granule secretion signal transduction. May relay signals from the activated ITGA2B receptor by regulating the uncoupling of WASP and WIPF1, thereby permitting the regulation of actin filament nucleation and branching activity of the Arp2/3 complex. May mediate inhibitory effects of free fatty acids on insulin signaling by phosphorylating IRS1, which in turn blocks IRS1 tyrosine phosphorylation and downstream activation of the PI3K/AKT pathway. Phosphorylates MSN (moesin) in the presence of phosphatidylglycerol or phosphatidylinositol. Phosphorylates PDPK1 at 'Ser-504' and 'Ser-532' and negatively regulates its ability to phosphorylate PKB/AKT1. Phosphorylates CCDC88A/GIV and inhibits its guanine nucleotide exchange factor activity (PubMed:23509302). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11342610, ECO:0000269|PubMed:14988727, ECO:0000269|PubMed:15364919, ECO:0000269|PubMed:16252004, ECO:0000269|PubMed:16356855, ECO:0000269|PubMed:16709830, ECO:0000269|PubMed:19549985, ECO:0000269|PubMed:21964608, ECO:0000269|PubMed:23509302, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:8657160}.	9606	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]	axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of platelet aggregation [GO:0090330]	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of platelet aggregation [GO:0090330]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0001558; GO:0001772; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005829; GO:0005886; GO:0006355; GO:0006509; GO:0006954; GO:0007411; GO:0008270; GO:0016235; GO:0032206; GO:0032740; GO:0032743; GO:0032753; GO:0034451; GO:0035556; GO:0035739; GO:0038095; GO:0046627; GO:0050870; GO:0051092; GO:0060326; GO:0070233; GO:0090330; GO:0106310; GO:2000318; GO:2000563; GO:2000570	Homo sapiens (Human)
NP_001158136.1	O15021	reviewed	MAST4_HUMAN	Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1)	MAST4 KIAA0303			9606	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	cytoskeleton organization [GO:0007010]; developmental process [GO:0032502]; intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; developmental process [GO:0032502]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0007010; GO:0015630; GO:0032502; GO:0035556; GO:0106310	Homo sapiens (Human)
NP_055998.1	O15021	reviewed	MAST4_HUMAN	Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1)	MAST4 KIAA0303			9606	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	cytoskeleton organization [GO:0007010]; developmental process [GO:0032502]; intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; developmental process [GO:0032502]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0007010; GO:0015630; GO:0032502; GO:0035556; GO:0106310	Homo sapiens (Human)
NP_001284580.1	O15021	reviewed	MAST4_HUMAN	Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1)	MAST4 KIAA0303			9606	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	cytoskeleton organization [GO:0007010]; developmental process [GO:0032502]; intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; developmental process [GO:0032502]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0007010; GO:0015630; GO:0032502; GO:0035556; GO:0106310	Homo sapiens (Human)
NP_001284580.1	B4DSE5	unreviewed	B4DSE5_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)				9606	cytoplasm [GO:0005737]	developmental process [GO:0032502]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; developmental process [GO:0032502]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0032502	Homo sapiens (Human)
XP_006714669.1	O15021	reviewed	MAST4_HUMAN	Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1)	MAST4 KIAA0303			9606	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	cytoskeleton organization [GO:0007010]; developmental process [GO:0032502]; intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; developmental process [GO:0032502]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0007010; GO:0015630; GO:0032502; GO:0035556; GO:0106310	Homo sapiens (Human)
XP_054189663.1	A0A5F9ZHU3	unreviewed	A0A5F9ZHU3_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	positive regulation of cell migration [GO:0030335]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cell migration [GO:0030335]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0030335; GO:0036064	Homo sapiens (Human)
NP_001193658.1	Q9Y243	reviewed	AKT3_HUMAN	RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2)	AKT3 PKBG		FUNCTION: AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an important role in brain development and is crucial for the viability of malignant glioma cells. AKT3 isoform may also be the key molecule in up-regulation and down-regulation of MMP13 via IL13. Required for the coordination of mitochondrial biogenesis with growth factor-induced increases in cellular energy demands. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. {ECO:0000269|PubMed:18524868, ECO:0000269|PubMed:21191416}.	9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001938; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0007165; GO:0008286; GO:0010821; GO:0032008; GO:0035556; GO:0036064; GO:0043066; GO:0043536; GO:0045766; GO:0045793; GO:0048854; GO:0048873; GO:0090050; GO:0106310; GO:1903898; GO:1905564; GO:1905653; GO:2000773	Homo sapiens (Human)
NP_859029.1	Q9Y243	reviewed	AKT3_HUMAN	RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2)	AKT3 PKBG		FUNCTION: AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an important role in brain development and is crucial for the viability of malignant glioma cells. AKT3 isoform may also be the key molecule in up-regulation and down-regulation of MMP13 via IL13. Required for the coordination of mitochondrial biogenesis with growth factor-induced increases in cellular energy demands. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. {ECO:0000269|PubMed:18524868, ECO:0000269|PubMed:21191416}.	9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0001938; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0007165; GO:0008286; GO:0010821; GO:0032008; GO:0035556; GO:0036064; GO:0043066; GO:0043536; GO:0045766; GO:0045793; GO:0048854; GO:0048873; GO:0090050; GO:0106310; GO:1903898; GO:1905564; GO:1905653; GO:2000773	Homo sapiens (Human)
NP_001229342.1	Q04759	reviewed	KPCT_HUMAN	Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta)	PRKCQ PRKCT		FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that mediates non-redundant functions in T-cell receptor (TCR) signaling, including T-cells activation, proliferation, differentiation and survival, by mediating activation of multiple transcription factors such as NF-kappa-B, JUN, NFATC1 and NFATC2. In TCR-CD3/CD28-co-stimulated T-cells, is required for the activation of NF-kappa-B and JUN, which in turn are essential for IL2 production, and participates in the calcium-dependent NFATC1 and NFATC2 transactivation (PubMed:21964608). Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11 on several serine residues, inducing CARD11 association with lipid rafts and recruitment of the BCL10-MALT1 complex, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. May also play an indirect role in activation of the non-canonical NF-kappa-B (NFKB2) pathway. In the signaling pathway leading to JUN activation, acts by phosphorylating the mediator STK39/SPAK and may not act through MAP kinases signaling. Plays a critical role in TCR/CD28-induced NFATC1 and NFATC2 transactivation by participating in the regulation of reduced inositol 1,4,5-trisphosphate generation and intracellular calcium mobilization. After costimulation of T-cells through CD28 can phosphorylate CBLB and is required for the ubiquitination and subsequent degradation of CBLB, which is a prerequisite for the activation of TCR. During T-cells differentiation, plays an important role in the development of T-helper 2 (Th2) cells following immune and inflammatory responses, and, in the development of inflammatory autoimmune diseases, is necessary for the activation of IL17-producing Th17 cells. May play a minor role in Th1 response. Upon TCR stimulation, mediates T-cell protective survival signal by phosphorylating BAD, thus protecting T-cells from BAD-induced apoptosis, and by up-regulating BCL-X(L)/BCL2L1 levels through NF-kappa-B and JUN pathways. In platelets, regulates signal transduction downstream of the ITGA2B, CD36/GP4, F2R/PAR1 and F2RL3/PAR4 receptors, playing a positive role in 'outside-in' signaling and granule secretion signal transduction. May relay signals from the activated ITGA2B receptor by regulating the uncoupling of WASP and WIPF1, thereby permitting the regulation of actin filament nucleation and branching activity of the Arp2/3 complex. May mediate inhibitory effects of free fatty acids on insulin signaling by phosphorylating IRS1, which in turn blocks IRS1 tyrosine phosphorylation and downstream activation of the PI3K/AKT pathway. Phosphorylates MSN (moesin) in the presence of phosphatidylglycerol or phosphatidylinositol. Phosphorylates PDPK1 at 'Ser-504' and 'Ser-532' and negatively regulates its ability to phosphorylate PKB/AKT1. Phosphorylates CCDC88A/GIV and inhibits its guanine nucleotide exchange factor activity (PubMed:23509302). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000269|PubMed:11342610, ECO:0000269|PubMed:14988727, ECO:0000269|PubMed:15364919, ECO:0000269|PubMed:16252004, ECO:0000269|PubMed:16356855, ECO:0000269|PubMed:16709830, ECO:0000269|PubMed:19549985, ECO:0000269|PubMed:21964608, ECO:0000269|PubMed:23509302, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:8657160}.	9606	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]	axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of platelet aggregation [GO:0090330]	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of platelet aggregation [GO:0090330]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]	GO:0001558; GO:0001772; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005829; GO:0005886; GO:0006355; GO:0006509; GO:0006954; GO:0007411; GO:0008270; GO:0016235; GO:0032206; GO:0032740; GO:0032743; GO:0032753; GO:0034451; GO:0035556; GO:0035739; GO:0038095; GO:0046627; GO:0050870; GO:0051092; GO:0060326; GO:0070233; GO:0090330; GO:0106310; GO:2000318; GO:2000563; GO:2000570	Homo sapiens (Human)
NP_723479.1	P12370	reviewed	KAPC1_DROME	cAMP-dependent protein kinase catalytic subunit 1 (PKA C) (EC 2.7.11.11) (Protein kinase DC0)	Pka-C1 CdkA DC0 CG4379		FUNCTION: Serine/threonine-protein kinase involved in memory formation (PubMed:29473541). Promotes long-term memory by phosphorylating meng and by regulating CrebB protein stability and activity (PubMed:29473541). As part of ethanol response in the glia, mediates ethanol-induced structural remodeling of actin cytoskeleton and perineurial membrane topology when anchored to the membrane (PubMed:29444420). {ECO:0000269|PubMed:29444420, ECO:0000269|PubMed:29473541}.	7227	cAMP-dependent protein kinase complex [GO:0005952]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of Atg1/ULK1 kinase complex assembly [GO:1905866]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]	cAMP-dependent protein kinase complex [GO:0005952]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of Atg1/ULK1 kinase complex assembly [GO:1905866]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005759; GO:0005829; GO:0005886; GO:0005952; GO:0007189; GO:0007314; GO:0007317; GO:0007448; GO:0007476; GO:0007615; GO:0007622; GO:0008103; GO:0008355; GO:0008359; GO:0010628; GO:0019933; GO:0030425; GO:0032436; GO:0032956; GO:0035332; GO:0040040; GO:0042048; GO:0042981; GO:0043005; GO:0043025; GO:0044297; GO:0045187; GO:0045879; GO:0045880; GO:0046823; GO:0048477; GO:0048682; GO:0050804; GO:0071361; GO:0090298; GO:0106310; GO:1905866	Drosophila melanogaster (Fruit fly)
NP_995672.1	P12370	reviewed	KAPC1_DROME	cAMP-dependent protein kinase catalytic subunit 1 (PKA C) (EC 2.7.11.11) (Protein kinase DC0)	Pka-C1 CdkA DC0 CG4379		FUNCTION: Serine/threonine-protein kinase involved in memory formation (PubMed:29473541). Promotes long-term memory by phosphorylating meng and by regulating CrebB protein stability and activity (PubMed:29473541). As part of ethanol response in the glia, mediates ethanol-induced structural remodeling of actin cytoskeleton and perineurial membrane topology when anchored to the membrane (PubMed:29444420). {ECO:0000269|PubMed:29444420, ECO:0000269|PubMed:29473541}.	7227	cAMP-dependent protein kinase complex [GO:0005952]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of Atg1/ULK1 kinase complex assembly [GO:1905866]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]	cAMP-dependent protein kinase complex [GO:0005952]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification, imaginal disc [GO:0007448]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of Atg1/ULK1 kinase complex assembly [GO:1905866]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005759; GO:0005829; GO:0005886; GO:0005952; GO:0007189; GO:0007314; GO:0007317; GO:0007448; GO:0007476; GO:0007615; GO:0007622; GO:0008103; GO:0008355; GO:0008359; GO:0010628; GO:0019933; GO:0030425; GO:0032436; GO:0032956; GO:0035332; GO:0040040; GO:0042048; GO:0042981; GO:0043005; GO:0043025; GO:0044297; GO:0045187; GO:0045879; GO:0045880; GO:0046823; GO:0048477; GO:0048682; GO:0050804; GO:0071361; GO:0090298; GO:0106310; GO:1905866	Drosophila melanogaster (Fruit fly)
NP_002723.2	P22612	reviewed	KAPCG_HUMAN	cAMP-dependent protein kinase catalytic subunit gamma (PKA C-gamma) (EC 2.7.11.11)	PRKACG		FUNCTION: Phosphorylates a large number of substrates in the cytoplasm and the nucleus.	9606	cAMP-dependent protein kinase complex [GO:0005952]; ciliary base [GO:0097546]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; high-density lipoprotein particle assembly [GO:0034380]; male gonad development [GO:0008584]; positive regulation of insulin secretion [GO:0032024]; renal water homeostasis [GO:0003091]; spermatogenesis [GO:0007283]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	cAMP-dependent protein kinase complex [GO:0005952]; ciliary base [GO:0097546]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; potassium channel inhibitor activity [GO:0019870]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; high-density lipoprotein particle assembly [GO:0034380]; male gonad development [GO:0008584]; positive regulation of insulin secretion [GO:0032024]; renal water homeostasis [GO:0003091]; spermatogenesis [GO:0007283]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; potassium channel inhibitor activity [GO:0019870]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0003091; GO:0004674; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005952; GO:0007189; GO:0007283; GO:0008584; GO:0019870; GO:0032024; GO:0034237; GO:0034380; GO:0097546; GO:0097700; GO:0106310	Homo sapiens (Human)
NP_001317440.1	P31751	reviewed	AKT2_HUMAN	RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC protein kinase beta) (RAC-PK-beta)	AKT2		FUNCTION: Serine/threonine kinase closely related to AKT1 and AKT3. All 3 enzymes, AKT1, AKT2 and AKT3, are collectively known as AKT kinase. AKT regulates many processes including metabolism, proliferation, cell survival, growth and angiogenesis, through the phosphorylation of a range of downstream substrates. Over 100 substrates have been reported so far, although for most of them, the precise AKT kinase catalyzing the reaction was not specified. AKT regulates glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1). AKT mediates the antiapoptotic effects of IGF1. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development (PubMed:21432781, PubMed:21620960). In response to lysophosphatidic acid stimulation, inhibits the ciliogenesis cascade. In this context, phosphorylates WDR44, hence stabilizing its interaction with Rab11 and preventing the formation of the ciliogenic Rab11-FIP3-RAB3IP complex. Also phosphorylates RAB3IP/Rabin8, thus may affect RAB3IP guanine nucleotide exchange factor (GEF) activity toward Rab8, which is important for cilia growth (PubMed:31204173). Phosphorylates PKP1, facilitating its interaction with YWHAG and translocation to the nucleus, ultimately resulting in a reduction in keratinocyte intercellular adhesion (By similarity). Phosphorylation of PKP1 increases PKP1 protein stability, translocation to the cytoplasm away from desmosome plaques and PKP1-driven cap-dependent translation (PubMed:23444369). {ECO:0000250|UniProtKB:Q60823, ECO:0000269|PubMed:23444369, ECO:0000269|PubMed:31204173, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.; FUNCTION: Several AKT2-specific substrates have been identified, including ANKRD2, C2CD5, CLK2 and PITX2. May play a role in myoblast differentiation. In this context, may act through PITX2 phosphorylation. Unphosphorylated PITX2 associates with an ELAVL1/HuR-containing complex, which stabilizes CCND1 cyclin mRNA, ensuring cell proliferation. Phosphorylation by AKT2 impairs this association, leading to CCND1 mRNA destabilization and progression towards differentiation (By similarity). Also involved in the negative regulation of myogenesis in response to stress conditions. In this context, acts by phosphorylating ANKRD2 (By similarity). May also be a key regulator of glucose uptake. Regulates insulin-stimulated glucose transport by the increase of glucose transporter GLUT4 translocation from intracellular stores to the plasma membrane. In this context, acts by phosphorylating C2CD5/CDP138 on 'Ser-197' in insulin-stimulated adipocytes (By similarity). Through the phosphorylation of CLK2 on 'Thr-343', involved in insulin-regulated suppression of hepatic gluconeogenesis (By similarity). {ECO:0000250|UniProtKB:Q60823}.	9606	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of D-glucose import [GO:0046326]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to plasma membrane [GO:0072659]; protein modification process [GO:0036211]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of D-glucose import [GO:0046326]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to plasma membrane [GO:0072659]; protein modification process [GO:0036211]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0005978; GO:0006006; GO:0007165; GO:0008286; GO:0010748; GO:0010907; GO:0030334; GO:0030335; GO:0032000; GO:0032287; GO:0032587; GO:0032869; GO:0035556; GO:0036211; GO:0043066; GO:0043536; GO:0045444; GO:0045725; GO:0046326; GO:0046872; GO:0050821; GO:0051726; GO:0060644; GO:0071486; GO:0072659; GO:0090314; GO:0097473; GO:0106310; GO:0140677; GO:1903676; GO:1903898; GO:2000147	Homo sapiens (Human)
NP_001259779.1	Q9VR61	unreviewed	Q9VR61_DROME	non-specific serine/threonine protein kinase (EC 2.7.11.1)	S6kII D-RSK Dmel\CG17596 dRSK dRsk ign RSK Rsk rsk rsk2 S6KII CG17596 Dmel_CG17596			7227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; presynapse [GO:0098793]	associative learning [GO:0008306]; determination of adult lifespan [GO:0008340]; imaginal disc-derived wing vein specification [GO:0007474]; locomotor rhythm [GO:0045475]; negative regulation of compound eye cone cell fate specification [GO:0042683]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pigment cell differentiation [GO:0050941]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0090101]; neuromuscular junction development [GO:0007528]; operant conditioning [GO:0035106]; regulation of neuromuscular junction development [GO:1904396]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; presynapse [GO:0098793]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; mitogen-activated protein kinase binding [GO:0051019]; ribosomal protein S6 kinase activity [GO:0004711]; associative learning [GO:0008306]; determination of adult lifespan [GO:0008340]; imaginal disc-derived wing vein specification [GO:0007474]; locomotor rhythm [GO:0045475]; negative regulation of compound eye cone cell fate specification [GO:0042683]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pigment cell differentiation [GO:0050941]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0090101]; neuromuscular junction development [GO:0007528]; operant conditioning [GO:0035106]; regulation of neuromuscular junction development [GO:1904396]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; mitogen-activated protein kinase binding [GO:0051019]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0004711; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0007474; GO:0007528; GO:0008306; GO:0008340; GO:0031594; GO:0035106; GO:0038202; GO:0042308; GO:0042683; GO:0043204; GO:0045475; GO:0046533; GO:0050941; GO:0051019; GO:0070373; GO:0090101; GO:0098793; GO:1904396	Drosophila melanogaster (Fruit fly)
NP_523437.2	Q9VR61	unreviewed	Q9VR61_DROME	non-specific serine/threonine protein kinase (EC 2.7.11.1)	S6kII D-RSK Dmel\CG17596 dRSK dRsk ign RSK Rsk rsk rsk2 S6KII CG17596 Dmel_CG17596			7227	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; presynapse [GO:0098793]	associative learning [GO:0008306]; determination of adult lifespan [GO:0008340]; imaginal disc-derived wing vein specification [GO:0007474]; locomotor rhythm [GO:0045475]; negative regulation of compound eye cone cell fate specification [GO:0042683]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pigment cell differentiation [GO:0050941]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0090101]; neuromuscular junction development [GO:0007528]; operant conditioning [GO:0035106]; regulation of neuromuscular junction development [GO:1904396]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; presynapse [GO:0098793]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; mitogen-activated protein kinase binding [GO:0051019]; ribosomal protein S6 kinase activity [GO:0004711]; associative learning [GO:0008306]; determination of adult lifespan [GO:0008340]; imaginal disc-derived wing vein specification [GO:0007474]; locomotor rhythm [GO:0045475]; negative regulation of compound eye cone cell fate specification [GO:0042683]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pigment cell differentiation [GO:0050941]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0090101]; neuromuscular junction development [GO:0007528]; operant conditioning [GO:0035106]; regulation of neuromuscular junction development [GO:1904396]; TORC1 signaling [GO:0038202]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; mitogen-activated protein kinase binding [GO:0051019]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0004711; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0007474; GO:0007528; GO:0008306; GO:0008340; GO:0031594; GO:0035106; GO:0038202; GO:0042308; GO:0042683; GO:0043204; GO:0045475; GO:0046533; GO:0050941; GO:0051019; GO:0070373; GO:0090101; GO:0098793; GO:1904396	Drosophila melanogaster (Fruit fly)
NP_001261884.1	Q9VUQ9	unreviewed	Q9VUQ9_DROME	non-specific serine/threonine protein kinase (EC 2.7.11.1)	dop Dmel\CG6498 MAST 205 MAST205 CG6498 Dmel_CG6498			7227	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet transport along microtubule [GO:0031887]; positive regulation of cell size [GO:0045793]; protein localization to plasma membrane [GO:0072659]; wing disc development [GO:0035220]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet transport along microtubule [GO:0031887]; positive regulation of cell size [GO:0045793]; protein localization to plasma membrane [GO:0072659]; wing disc development [GO:0035220]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0007030; GO:0007032; GO:0007298; GO:0007349; GO:0009047; GO:0015630; GO:0031887; GO:0035220; GO:0035556; GO:0045793; GO:0072659	Drosophila melanogaster (Fruit fly)
NP_648778.1	Q9VUQ9	unreviewed	Q9VUQ9_DROME	non-specific serine/threonine protein kinase (EC 2.7.11.1)	dop Dmel\CG6498 MAST 205 MAST205 CG6498 Dmel_CG6498			7227	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet transport along microtubule [GO:0031887]; positive regulation of cell size [GO:0045793]; protein localization to plasma membrane [GO:0072659]; wing disc development [GO:0035220]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lipid droplet transport along microtubule [GO:0031887]; positive regulation of cell size [GO:0045793]; protein localization to plasma membrane [GO:0072659]; wing disc development [GO:0035220]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0007030; GO:0007032; GO:0007298; GO:0007349; GO:0009047; GO:0015630; GO:0031887; GO:0035220; GO:0035556; GO:0045793; GO:0072659	Drosophila melanogaster (Fruit fly)
XP_006710540.1	A0A669KBJ4	unreviewed	A0A669KBJ4_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	MAST2			9606	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737	Homo sapiens (Human)
NP_476867.1	P32866	reviewed	GPRK2_DROME	G protein-coupled receptor kinase 2 (EC 2.7.11.16)	Gprk2 Gprk-2 CG17998		FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors (By similarity). Required during oogenesis and embryogenesis; component of a signaling pathway that functions during egg chamber maturation. {ECO:0000250, ECO:0000269|PubMed:9217001}.	7227	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane [GO:0005886]	apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0003384; GO:0004672; GO:0004674; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006963; GO:0007165; GO:0007476; GO:0009898; GO:0009966; GO:0045752; GO:0045879; GO:0045880; GO:0048260; GO:0048601; GO:0050830; GO:0070273	Drosophila melanogaster (Fruit fly)
NP_476867.1	A0A0B4KI69	unreviewed	A0A0B4KI69_DROME	G protein-coupled receptor kinase (EC 2.7.11.-)	Gprk2 154978_at Dmel\CG17998 Gprk 2 Gprk-2 GPRK2 gprk2 nosh CG17998 Dmel_CG17998			7227		signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]	GO:0004703; GO:0005524; GO:0007165	Drosophila melanogaster (Fruit fly)
NP_001269414.1	Q13237	reviewed	KGP2_HUMAN	cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII)	PRKG2 PRKGR2		FUNCTION: Crucial regulator of intestinal secretion and bone growth. Phosphorylates and activates CFTR on the plasma membrane. Plays a key role in intestinal secretion by regulating cGMP-dependent translocation of CFTR in jejunum (PubMed:33106379). Acts downstream of NMDAR to activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By similarity). Acts as a regulator of gene expression and activator of the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2 in mechanically stimulated osteoblasts. Under fluid shear stress, mediates ERK activation and subsequent induction of FOS, FOSL1/FRA1, FOSL2/FRA2 and FOSB that play a key role in the osteoblast anabolic response to mechanical stimulation (By similarity). {ECO:0000250|UniProtKB:Q61410, ECO:0000250|UniProtKB:Q64595, ECO:0000269|PubMed:33106379}.	9606	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; intracellular signal transduction [GO:0035556]; negative regulation of chloride transport [GO:2001226]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of protein localization [GO:1903829]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]	GO:0004692; GO:0005524; GO:0005829; GO:0007165; GO:0016324; GO:0030553; GO:0031965; GO:0032332; GO:0035556; GO:0042802; GO:0046146; GO:0051019; GO:0072659; GO:0106310; GO:1903829; GO:2001226	Homo sapiens (Human)
NP_001277155.1	O15021	reviewed	MAST4_HUMAN	Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1)	MAST4 KIAA0303			9606	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	cytoskeleton organization [GO:0007010]; developmental process [GO:0032502]; intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; developmental process [GO:0032502]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0007010; GO:0015630; GO:0032502; GO:0035556; GO:0106310	Homo sapiens (Human)
NP_001277155.1	B4DS23	unreviewed	B4DS23_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)				9606	cytoplasm [GO:0005737]	developmental process [GO:0032502]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; developmental process [GO:0032502]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0032502	Homo sapiens (Human)
NP_001277156.1	B4DKT8	unreviewed	B4DKT8_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)				9606	cytoplasm [GO:0005737]	developmental process [GO:0032502]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; developmental process [GO:0032502]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0032502	Homo sapiens (Human)
NP_001287353.1	Q8INB9	reviewed	AKT1_DROME	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Protein kinase B) (PKB)	Akt Akt1 CG4006		FUNCTION: Serine/threonine kinase involved in various developmental processes (PubMed:10587646, PubMed:10962553, PubMed:11740943, PubMed:11872800, PubMed:12172554, PubMed:12893776, PubMed:14525946, PubMed:15466161, PubMed:15712201, PubMed:9601646). During early embryogenesis, acts as a survival protein (PubMed:10962553, PubMed:9601646). During mid-embryogenesis, phosphorylates and activates trh, a transcription factor required for tracheal cell fate determination (PubMed:11740943). Also regulates tracheal cell migration (PubMed:11740943, PubMed:14525946). Later in development, acts downstream of PI3K and Pk61C/PDK1 in the insulin receptor transduction pathway which regulates cell growth and organ size, by phosphorylating and antagonizing FOXO transcription factor (PubMed:10587646, PubMed:10962553, PubMed:11752451, PubMed:12893776, PubMed:24603715, PubMed:25329475, PubMed:29025897). Controls follicle cell size during oogenesis (PubMed:15712201). May also stimulate cell growth by phosphorylating Gig/Tsc2 and inactivating the Tsc complex (PubMed:12172554, PubMed:15466161). Dephosphorylation of 'Ser-586' by Phlpp triggers apoptosis and suppression of tumor growth (PubMed:10962553). {ECO:0000269|PubMed:10587646, ECO:0000269|PubMed:10962553, ECO:0000269|PubMed:11740943, ECO:0000269|PubMed:11752451, ECO:0000269|PubMed:11872800, ECO:0000269|PubMed:12172554, ECO:0000269|PubMed:12893776, ECO:0000269|PubMed:14525946, ECO:0000269|PubMed:15466161, ECO:0000269|PubMed:15712201, ECO:0000269|PubMed:24603715, ECO:0000269|PubMed:25329475, ECO:0000269|PubMed:29025897, ECO:0000269|PubMed:9601646}.	7227	cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing, spreading of cells [GO:0044319]	cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing, spreading of cells [GO:0044319]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005938; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007623; GO:0008284; GO:0008286; GO:0010884; GO:0010897; GO:0030307; GO:0031104; GO:0032869; GO:0035206; GO:0035264; GO:0035331; GO:0035556; GO:0040014; GO:0040018; GO:0042632; GO:0043025; GO:0043066; GO:0043491; GO:0043524; GO:0043536; GO:0044319; GO:0045793; GO:0045886; GO:0046622; GO:0048010; GO:0048477; GO:0048680; GO:0050773; GO:0055088; GO:0060292; GO:0090278; GO:0106310; GO:1903688; GO:1904263	Drosophila melanogaster (Fruit fly)
NP_001287353.1	A0A0B4LIA3	unreviewed	A0A0B4LIA3_DROME	non-specific serine/threonine protein kinase (EC 2.7.11.1)	Akt AKT akt AKT-1 Akt-1 AKT/PKB Akt/PKB AKT1 Akt1 akt1 D-Akt DAKT DAkt Dakt dAKT dAkt dakt dAKT/dPKB dAkt/PKB DAKT1 DAkt1 Dakt1 dAKT1 dAkt1 dakt1 DAKT1/PKB Dkat1 Dmel\CG4006 DPKB Dpkb dPKB DRAC-PK DRAC-PK66 DRAC-PK85 l(3)04226 l(3)89Bq P-AKT P-Akt p-Akt pAkt PBB PKB PKB/AKT PKB/Akt PKB/dAKT RAC RacPK CG4006 Dmel_CG4006			7227		insulin receptor signaling pathway [GO:0008286]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; insulin receptor signaling pathway [GO:0008286]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0008286; GO:0008582	Drosophila melanogaster (Fruit fly)
NP_001287354.1	Q8INB9	reviewed	AKT1_DROME	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Protein kinase B) (PKB)	Akt Akt1 CG4006		FUNCTION: Serine/threonine kinase involved in various developmental processes (PubMed:10587646, PubMed:10962553, PubMed:11740943, PubMed:11872800, PubMed:12172554, PubMed:12893776, PubMed:14525946, PubMed:15466161, PubMed:15712201, PubMed:9601646). During early embryogenesis, acts as a survival protein (PubMed:10962553, PubMed:9601646). During mid-embryogenesis, phosphorylates and activates trh, a transcription factor required for tracheal cell fate determination (PubMed:11740943). Also regulates tracheal cell migration (PubMed:11740943, PubMed:14525946). Later in development, acts downstream of PI3K and Pk61C/PDK1 in the insulin receptor transduction pathway which regulates cell growth and organ size, by phosphorylating and antagonizing FOXO transcription factor (PubMed:10587646, PubMed:10962553, PubMed:11752451, PubMed:12893776, PubMed:24603715, PubMed:25329475, PubMed:29025897). Controls follicle cell size during oogenesis (PubMed:15712201). May also stimulate cell growth by phosphorylating Gig/Tsc2 and inactivating the Tsc complex (PubMed:12172554, PubMed:15466161). Dephosphorylation of 'Ser-586' by Phlpp triggers apoptosis and suppression of tumor growth (PubMed:10962553). {ECO:0000269|PubMed:10587646, ECO:0000269|PubMed:10962553, ECO:0000269|PubMed:11740943, ECO:0000269|PubMed:11752451, ECO:0000269|PubMed:11872800, ECO:0000269|PubMed:12172554, ECO:0000269|PubMed:12893776, ECO:0000269|PubMed:14525946, ECO:0000269|PubMed:15466161, ECO:0000269|PubMed:15712201, ECO:0000269|PubMed:24603715, ECO:0000269|PubMed:25329475, ECO:0000269|PubMed:29025897, ECO:0000269|PubMed:9601646}.	7227	cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing, spreading of cells [GO:0044319]	cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing, spreading of cells [GO:0044319]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005938; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007623; GO:0008284; GO:0008286; GO:0010884; GO:0010897; GO:0030307; GO:0031104; GO:0032869; GO:0035206; GO:0035264; GO:0035331; GO:0035556; GO:0040014; GO:0040018; GO:0042632; GO:0043025; GO:0043066; GO:0043491; GO:0043524; GO:0043536; GO:0044319; GO:0045793; GO:0045886; GO:0046622; GO:0048010; GO:0048477; GO:0048680; GO:0050773; GO:0055088; GO:0060292; GO:0090278; GO:0106310; GO:1903688; GO:1904263	Drosophila melanogaster (Fruit fly)
NP_001287354.1	A0A0B4LIA3	unreviewed	A0A0B4LIA3_DROME	non-specific serine/threonine protein kinase (EC 2.7.11.1)	Akt AKT akt AKT-1 Akt-1 AKT/PKB Akt/PKB AKT1 Akt1 akt1 D-Akt DAKT DAkt Dakt dAKT dAkt dakt dAKT/dPKB dAkt/PKB DAKT1 DAkt1 Dakt1 dAKT1 dAkt1 dakt1 DAKT1/PKB Dkat1 Dmel\CG4006 DPKB Dpkb dPKB DRAC-PK DRAC-PK66 DRAC-PK85 l(3)04226 l(3)89Bq P-AKT P-Akt p-Akt pAkt PBB PKB PKB/AKT PKB/Akt PKB/dAKT RAC RacPK CG4006 Dmel_CG4006			7227		insulin receptor signaling pathway [GO:0008286]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; insulin receptor signaling pathway [GO:0008286]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0008286; GO:0008582	Drosophila melanogaster (Fruit fly)
NP_732113.3	Q8INB9	reviewed	AKT1_DROME	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Protein kinase B) (PKB)	Akt Akt1 CG4006		FUNCTION: Serine/threonine kinase involved in various developmental processes (PubMed:10587646, PubMed:10962553, PubMed:11740943, PubMed:11872800, PubMed:12172554, PubMed:12893776, PubMed:14525946, PubMed:15466161, PubMed:15712201, PubMed:9601646). During early embryogenesis, acts as a survival protein (PubMed:10962553, PubMed:9601646). During mid-embryogenesis, phosphorylates and activates trh, a transcription factor required for tracheal cell fate determination (PubMed:11740943). Also regulates tracheal cell migration (PubMed:11740943, PubMed:14525946). Later in development, acts downstream of PI3K and Pk61C/PDK1 in the insulin receptor transduction pathway which regulates cell growth and organ size, by phosphorylating and antagonizing FOXO transcription factor (PubMed:10587646, PubMed:10962553, PubMed:11752451, PubMed:12893776, PubMed:24603715, PubMed:25329475, PubMed:29025897). Controls follicle cell size during oogenesis (PubMed:15712201). May also stimulate cell growth by phosphorylating Gig/Tsc2 and inactivating the Tsc complex (PubMed:12172554, PubMed:15466161). Dephosphorylation of 'Ser-586' by Phlpp triggers apoptosis and suppression of tumor growth (PubMed:10962553). {ECO:0000269|PubMed:10587646, ECO:0000269|PubMed:10962553, ECO:0000269|PubMed:11740943, ECO:0000269|PubMed:11752451, ECO:0000269|PubMed:11872800, ECO:0000269|PubMed:12172554, ECO:0000269|PubMed:12893776, ECO:0000269|PubMed:14525946, ECO:0000269|PubMed:15466161, ECO:0000269|PubMed:15712201, ECO:0000269|PubMed:24603715, ECO:0000269|PubMed:25329475, ECO:0000269|PubMed:29025897, ECO:0000269|PubMed:9601646}.	7227	cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing, spreading of cells [GO:0044319]	cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing, spreading of cells [GO:0044319]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005938; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007623; GO:0008284; GO:0008286; GO:0010884; GO:0010897; GO:0030307; GO:0031104; GO:0032869; GO:0035206; GO:0035264; GO:0035331; GO:0035556; GO:0040014; GO:0040018; GO:0042632; GO:0043025; GO:0043066; GO:0043491; GO:0043524; GO:0043536; GO:0044319; GO:0045793; GO:0045886; GO:0046622; GO:0048010; GO:0048477; GO:0048680; GO:0050773; GO:0055088; GO:0060292; GO:0090278; GO:0106310; GO:1903688; GO:1904263	Drosophila melanogaster (Fruit fly)
NP_732114.1	Q8INB9	reviewed	AKT1_DROME	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Protein kinase B) (PKB)	Akt Akt1 CG4006		FUNCTION: Serine/threonine kinase involved in various developmental processes (PubMed:10587646, PubMed:10962553, PubMed:11740943, PubMed:11872800, PubMed:12172554, PubMed:12893776, PubMed:14525946, PubMed:15466161, PubMed:15712201, PubMed:9601646). During early embryogenesis, acts as a survival protein (PubMed:10962553, PubMed:9601646). During mid-embryogenesis, phosphorylates and activates trh, a transcription factor required for tracheal cell fate determination (PubMed:11740943). Also regulates tracheal cell migration (PubMed:11740943, PubMed:14525946). Later in development, acts downstream of PI3K and Pk61C/PDK1 in the insulin receptor transduction pathway which regulates cell growth and organ size, by phosphorylating and antagonizing FOXO transcription factor (PubMed:10587646, PubMed:10962553, PubMed:11752451, PubMed:12893776, PubMed:24603715, PubMed:25329475, PubMed:29025897). Controls follicle cell size during oogenesis (PubMed:15712201). May also stimulate cell growth by phosphorylating Gig/Tsc2 and inactivating the Tsc complex (PubMed:12172554, PubMed:15466161). Dephosphorylation of 'Ser-586' by Phlpp triggers apoptosis and suppression of tumor growth (PubMed:10962553). {ECO:0000269|PubMed:10587646, ECO:0000269|PubMed:10962553, ECO:0000269|PubMed:11740943, ECO:0000269|PubMed:11752451, ECO:0000269|PubMed:11872800, ECO:0000269|PubMed:12172554, ECO:0000269|PubMed:12893776, ECO:0000269|PubMed:14525946, ECO:0000269|PubMed:15466161, ECO:0000269|PubMed:15712201, ECO:0000269|PubMed:24603715, ECO:0000269|PubMed:25329475, ECO:0000269|PubMed:29025897, ECO:0000269|PubMed:9601646}.	7227	cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing, spreading of cells [GO:0044319]	cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing, spreading of cells [GO:0044319]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005938; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007623; GO:0008284; GO:0008286; GO:0010884; GO:0010897; GO:0030307; GO:0031104; GO:0032869; GO:0035206; GO:0035264; GO:0035331; GO:0035556; GO:0040014; GO:0040018; GO:0042632; GO:0043025; GO:0043066; GO:0043491; GO:0043524; GO:0043536; GO:0044319; GO:0045793; GO:0045886; GO:0046622; GO:0048010; GO:0048477; GO:0048680; GO:0050773; GO:0055088; GO:0060292; GO:0090278; GO:0106310; GO:1903688; GO:1904263	Drosophila melanogaster (Fruit fly)
NP_732114.1	A0A0B4LIA3	unreviewed	A0A0B4LIA3_DROME	non-specific serine/threonine protein kinase (EC 2.7.11.1)	Akt AKT akt AKT-1 Akt-1 AKT/PKB Akt/PKB AKT1 Akt1 akt1 D-Akt DAKT DAkt Dakt dAKT dAkt dakt dAKT/dPKB dAkt/PKB DAKT1 DAkt1 Dakt1 dAKT1 dAkt1 dakt1 DAKT1/PKB Dkat1 Dmel\CG4006 DPKB Dpkb dPKB DRAC-PK DRAC-PK66 DRAC-PK85 l(3)04226 l(3)89Bq P-AKT P-Akt p-Akt pAkt PBB PKB PKB/AKT PKB/Akt PKB/dAKT RAC RacPK CG4006 Dmel_CG4006			7227		insulin receptor signaling pathway [GO:0008286]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; insulin receptor signaling pathway [GO:0008286]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0008286; GO:0008582	Drosophila melanogaster (Fruit fly)
NP_732115.1	Q8INB9	reviewed	AKT1_DROME	RAC serine/threonine-protein kinase (DAkt) (DRAC-PK) (Dakt1) (EC 2.7.11.1) (Protein kinase B) (PKB)	Akt Akt1 CG4006		FUNCTION: Serine/threonine kinase involved in various developmental processes (PubMed:10587646, PubMed:10962553, PubMed:11740943, PubMed:11872800, PubMed:12172554, PubMed:12893776, PubMed:14525946, PubMed:15466161, PubMed:15712201, PubMed:9601646). During early embryogenesis, acts as a survival protein (PubMed:10962553, PubMed:9601646). During mid-embryogenesis, phosphorylates and activates trh, a transcription factor required for tracheal cell fate determination (PubMed:11740943). Also regulates tracheal cell migration (PubMed:11740943, PubMed:14525946). Later in development, acts downstream of PI3K and Pk61C/PDK1 in the insulin receptor transduction pathway which regulates cell growth and organ size, by phosphorylating and antagonizing FOXO transcription factor (PubMed:10587646, PubMed:10962553, PubMed:11752451, PubMed:12893776, PubMed:24603715, PubMed:25329475, PubMed:29025897). Controls follicle cell size during oogenesis (PubMed:15712201). May also stimulate cell growth by phosphorylating Gig/Tsc2 and inactivating the Tsc complex (PubMed:12172554, PubMed:15466161). Dephosphorylation of 'Ser-586' by Phlpp triggers apoptosis and suppression of tumor growth (PubMed:10962553). {ECO:0000269|PubMed:10587646, ECO:0000269|PubMed:10962553, ECO:0000269|PubMed:11740943, ECO:0000269|PubMed:11752451, ECO:0000269|PubMed:11872800, ECO:0000269|PubMed:12172554, ECO:0000269|PubMed:12893776, ECO:0000269|PubMed:14525946, ECO:0000269|PubMed:15466161, ECO:0000269|PubMed:15712201, ECO:0000269|PubMed:24603715, ECO:0000269|PubMed:25329475, ECO:0000269|PubMed:29025897, ECO:0000269|PubMed:9601646}.	7227	cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing, spreading of cells [GO:0044319]	cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration, open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid homeostasis [GO:0055088]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing, spreading of cells [GO:0044319]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005938; GO:0006915; GO:0006979; GO:0007424; GO:0007427; GO:0007623; GO:0008284; GO:0008286; GO:0010884; GO:0010897; GO:0030307; GO:0031104; GO:0032869; GO:0035206; GO:0035264; GO:0035331; GO:0035556; GO:0040014; GO:0040018; GO:0042632; GO:0043025; GO:0043066; GO:0043491; GO:0043524; GO:0043536; GO:0044319; GO:0045793; GO:0045886; GO:0046622; GO:0048010; GO:0048477; GO:0048680; GO:0050773; GO:0055088; GO:0060292; GO:0090278; GO:0106310; GO:1903688; GO:1904263	Drosophila melanogaster (Fruit fly)
NP_732115.1	A0A0B4LIA3	unreviewed	A0A0B4LIA3_DROME	non-specific serine/threonine protein kinase (EC 2.7.11.1)	Akt AKT akt AKT-1 Akt-1 AKT/PKB Akt/PKB AKT1 Akt1 akt1 D-Akt DAKT DAkt Dakt dAKT dAkt dakt dAKT/dPKB dAkt/PKB DAKT1 DAkt1 Dakt1 dAKT1 dAkt1 dakt1 DAKT1/PKB Dkat1 Dmel\CG4006 DPKB Dpkb dPKB DRAC-PK DRAC-PK66 DRAC-PK85 l(3)04226 l(3)89Bq P-AKT P-Akt p-Akt pAkt PBB PKB PKB/AKT PKB/Akt PKB/dAKT RAC RacPK CG4006 Dmel_CG4006			7227		insulin receptor signaling pathway [GO:0008286]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; insulin receptor signaling pathway [GO:0008286]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0008286; GO:0008582	Drosophila melanogaster (Fruit fly)
NP_037487.2	Q6P5Z2	reviewed	PKN3_HUMAN	Serine/threonine-protein kinase N3 (EC 2.7.11.13) (Protein kinase PKN-beta) (Protein-kinase C-related kinase 3)	PKN3 PKNBETA		FUNCTION: Contributes to invasiveness in malignant prostate cancer. {ECO:0000269|PubMed:15282551}.	9606	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]	GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005794; GO:0005829; GO:0006468; GO:0007165; GO:0010631; GO:0031267; GO:0035556; GO:0048471; GO:0106310	Homo sapiens (Human)
NP_001306174.1	Q6P0Q8	reviewed	MAST2_HUMAN	Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1)	MAST2 KIAA0807 MAST205		FUNCTION: Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation (By similarity). {ECO:0000250}.	9606	microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]	microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310	Homo sapiens (Human)
NP_055927.2	Q6P0Q8	reviewed	MAST2_HUMAN	Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1)	MAST2 KIAA0807 MAST205		FUNCTION: Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation (By similarity). {ECO:0000250}.	9606	microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]	microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310	Homo sapiens (Human)
NP_004681.1	O95835	reviewed	LATS1_HUMAN	Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts)	LATS1 WARTS		FUNCTION: Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:10518011, PubMed:10831611, PubMed:18158288, PubMed:26437443, PubMed:28068668). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:18158288, PubMed:26437443, PubMed:28068668). Phosphorylation of YAP1 by LATS1 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:18158288, PubMed:26437443, PubMed:28068668). Acts as a tumor suppressor which plays a critical role in maintenance of ploidy through its actions in both mitotic progression and the G1 tetraploidy checkpoint (PubMed:15122335, PubMed:19927127). Negatively regulates G2/M transition by down-regulating CDK1 kinase activity (PubMed:9988268). Involved in the control of p53 expression (PubMed:15122335). Affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1 (PubMed:15220930). May also play a role in endocrine function. Plays a role in mammary gland epithelial cell differentiation, both through the Hippo signaling pathway and the intracellular estrogen receptor signaling pathway by promoting the degradation of ESR1 (PubMed:28068668). Acts as an activator of the NLRP3 inflammasome by mediating phosphorylation of 'Ser-265' of NLRP3 following NLRP3 palmitoylation, promoting NLRP3 activation by NEK7 (PubMed:39173637). {ECO:0000269|PubMed:10518011, ECO:0000269|PubMed:10831611, ECO:0000269|PubMed:15122335, ECO:0000269|PubMed:15220930, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:19927127, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:28068668, ECO:0000269|PubMed:39173637, ECO:0000269|PubMed:9988268}.	9606	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynapse [GO:0098794]; spindle pole [GO:0000922]	cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of postsynaptic density assembly [GO:0099151]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynapse [GO:0098794]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of postsynaptic density assembly [GO:0099151]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0008104; GO:0009755; GO:0017015; GO:0019901; GO:0030216; GO:0030331; GO:0030496; GO:0030833; GO:0033146; GO:0035329; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051301; GO:0060644; GO:0090090; GO:0098794; GO:0098978; GO:0099151; GO:0106310; GO:1900181; GO:1900227; GO:2000058	Homo sapiens (Human)
XP_047275474.1	O95835	reviewed	LATS1_HUMAN	Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts)	LATS1 WARTS		FUNCTION: Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:10518011, PubMed:10831611, PubMed:18158288, PubMed:26437443, PubMed:28068668). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:18158288, PubMed:26437443, PubMed:28068668). Phosphorylation of YAP1 by LATS1 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:18158288, PubMed:26437443, PubMed:28068668). Acts as a tumor suppressor which plays a critical role in maintenance of ploidy through its actions in both mitotic progression and the G1 tetraploidy checkpoint (PubMed:15122335, PubMed:19927127). Negatively regulates G2/M transition by down-regulating CDK1 kinase activity (PubMed:9988268). Involved in the control of p53 expression (PubMed:15122335). Affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1 (PubMed:15220930). May also play a role in endocrine function. Plays a role in mammary gland epithelial cell differentiation, both through the Hippo signaling pathway and the intracellular estrogen receptor signaling pathway by promoting the degradation of ESR1 (PubMed:28068668). Acts as an activator of the NLRP3 inflammasome by mediating phosphorylation of 'Ser-265' of NLRP3 following NLRP3 palmitoylation, promoting NLRP3 activation by NEK7 (PubMed:39173637). {ECO:0000269|PubMed:10518011, ECO:0000269|PubMed:10831611, ECO:0000269|PubMed:15122335, ECO:0000269|PubMed:15220930, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:19927127, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:28068668, ECO:0000269|PubMed:39173637, ECO:0000269|PubMed:9988268}.	9606	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynapse [GO:0098794]; spindle pole [GO:0000922]	cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of postsynaptic density assembly [GO:0099151]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynapse [GO:0098794]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of postsynaptic density assembly [GO:0099151]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0008104; GO:0009755; GO:0017015; GO:0019901; GO:0030216; GO:0030331; GO:0030496; GO:0030833; GO:0033146; GO:0035329; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051301; GO:0060644; GO:0090090; GO:0098794; GO:0098978; GO:0099151; GO:0106310; GO:1900181; GO:1900227; GO:2000058	Homo sapiens (Human)
XP_054212722.1	O95835	reviewed	LATS1_HUMAN	Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts)	LATS1 WARTS		FUNCTION: Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:10518011, PubMed:10831611, PubMed:18158288, PubMed:26437443, PubMed:28068668). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:18158288, PubMed:26437443, PubMed:28068668). Phosphorylation of YAP1 by LATS1 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:18158288, PubMed:26437443, PubMed:28068668). Acts as a tumor suppressor which plays a critical role in maintenance of ploidy through its actions in both mitotic progression and the G1 tetraploidy checkpoint (PubMed:15122335, PubMed:19927127). Negatively regulates G2/M transition by down-regulating CDK1 kinase activity (PubMed:9988268). Involved in the control of p53 expression (PubMed:15122335). Affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1 (PubMed:15220930). May also play a role in endocrine function. Plays a role in mammary gland epithelial cell differentiation, both through the Hippo signaling pathway and the intracellular estrogen receptor signaling pathway by promoting the degradation of ESR1 (PubMed:28068668). Acts as an activator of the NLRP3 inflammasome by mediating phosphorylation of 'Ser-265' of NLRP3 following NLRP3 palmitoylation, promoting NLRP3 activation by NEK7 (PubMed:39173637). {ECO:0000269|PubMed:10518011, ECO:0000269|PubMed:10831611, ECO:0000269|PubMed:15122335, ECO:0000269|PubMed:15220930, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:19927127, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:28068668, ECO:0000269|PubMed:39173637, ECO:0000269|PubMed:9988268}.	9606	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynapse [GO:0098794]; spindle pole [GO:0000922]	cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of postsynaptic density assembly [GO:0099151]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynapse [GO:0098794]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of postsynaptic density assembly [GO:0099151]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0008104; GO:0009755; GO:0017015; GO:0019901; GO:0030216; GO:0030331; GO:0030496; GO:0030833; GO:0033146; GO:0035329; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051301; GO:0060644; GO:0090090; GO:0098794; GO:0098978; GO:0099151; GO:0106310; GO:1900181; GO:1900227; GO:2000058	Homo sapiens (Human)
NP_055387.2	Q9NRM7	reviewed	LATS2_HUMAN	Serine/threonine-protein kinase LATS2 (EC 2.7.11.1) (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase)	LATS2 KPM		FUNCTION: Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:18158288, PubMed:26437443, PubMed:26598551, PubMed:34404733). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:26437443, PubMed:26598551, PubMed:34404733). Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:26598551, PubMed:34404733). Also phosphorylates YAP1 in response to cell contact inhibition-driven WWP1 ubiquitination of AMOTL2, which results in LATS2 activation (PubMed:34404733). Acts as a tumor suppressor which plays a critical role in centrosome duplication, maintenance of mitotic fidelity and genomic stability (PubMed:10871863). Negatively regulates G1/S transition by down-regulating cyclin E/CDK2 kinase activity (PubMed:12853976). Negative regulator of the androgen receptor (PubMed:15131260). Phosphorylates SNAI1 in the nucleus leading to its nuclear retention and stabilization, which enhances its epithelial-mesenchymal transition and tumor cell invasion/migration activities (PubMed:21952048). This tumor-promoting activity is independent of its effects upon YAP1 or WWTR1/TAZ (PubMed:21952048). Acts as an activator of the NLRP3 inflammasome by mediating phosphorylation of 'Ser-265' of NLRP3 following NLRP3 palmitoylation, promoting NLRP3 activation by NEK7 (PubMed:39173637). {ECO:0000269|PubMed:10871863, ECO:0000269|PubMed:12853976, ECO:0000269|PubMed:15131260, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:21952048, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:26598551, ECO:0000269|PubMed:34404733, ECO:0000269|PubMed:39173637}.	9606	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]	canonical Wnt signaling pathway [GO:0060070]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in contact inhibition [GO:0060243]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; canonical Wnt signaling pathway [GO:0060070]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in contact inhibition [GO:0060243]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0008104; GO:0009755; GO:0017015; GO:0030216; GO:0034451; GO:0035329; GO:0035556; GO:0043065; GO:0045736; GO:0046620; GO:0046872; GO:0051301; GO:0060070; GO:0060243; GO:0090090; GO:0106310; GO:1900181; GO:1900227	Homo sapiens (Human)
XP_005266399.1	Q9NRM7	reviewed	LATS2_HUMAN	Serine/threonine-protein kinase LATS2 (EC 2.7.11.1) (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase)	LATS2 KPM		FUNCTION: Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:18158288, PubMed:26437443, PubMed:26598551, PubMed:34404733). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:26437443, PubMed:26598551, PubMed:34404733). Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:26598551, PubMed:34404733). Also phosphorylates YAP1 in response to cell contact inhibition-driven WWP1 ubiquitination of AMOTL2, which results in LATS2 activation (PubMed:34404733). Acts as a tumor suppressor which plays a critical role in centrosome duplication, maintenance of mitotic fidelity and genomic stability (PubMed:10871863). Negatively regulates G1/S transition by down-regulating cyclin E/CDK2 kinase activity (PubMed:12853976). Negative regulator of the androgen receptor (PubMed:15131260). Phosphorylates SNAI1 in the nucleus leading to its nuclear retention and stabilization, which enhances its epithelial-mesenchymal transition and tumor cell invasion/migration activities (PubMed:21952048). This tumor-promoting activity is independent of its effects upon YAP1 or WWTR1/TAZ (PubMed:21952048). Acts as an activator of the NLRP3 inflammasome by mediating phosphorylation of 'Ser-265' of NLRP3 following NLRP3 palmitoylation, promoting NLRP3 activation by NEK7 (PubMed:39173637). {ECO:0000269|PubMed:10871863, ECO:0000269|PubMed:12853976, ECO:0000269|PubMed:15131260, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:21952048, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:26598551, ECO:0000269|PubMed:34404733, ECO:0000269|PubMed:39173637}.	9606	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]	canonical Wnt signaling pathway [GO:0060070]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in contact inhibition [GO:0060243]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; canonical Wnt signaling pathway [GO:0060070]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in contact inhibition [GO:0060243]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0008104; GO:0009755; GO:0017015; GO:0030216; GO:0034451; GO:0035329; GO:0035556; GO:0043065; GO:0045736; GO:0046620; GO:0046872; GO:0051301; GO:0060070; GO:0060243; GO:0090090; GO:0106310; GO:1900181; GO:1900227	Homo sapiens (Human)
XP_047286222.1	Q9NRM7	reviewed	LATS2_HUMAN	Serine/threonine-protein kinase LATS2 (EC 2.7.11.1) (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase)	LATS2 KPM		FUNCTION: Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:18158288, PubMed:26437443, PubMed:26598551, PubMed:34404733). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:26437443, PubMed:26598551, PubMed:34404733). Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:26598551, PubMed:34404733). Also phosphorylates YAP1 in response to cell contact inhibition-driven WWP1 ubiquitination of AMOTL2, which results in LATS2 activation (PubMed:34404733). Acts as a tumor suppressor which plays a critical role in centrosome duplication, maintenance of mitotic fidelity and genomic stability (PubMed:10871863). Negatively regulates G1/S transition by down-regulating cyclin E/CDK2 kinase activity (PubMed:12853976). Negative regulator of the androgen receptor (PubMed:15131260). Phosphorylates SNAI1 in the nucleus leading to its nuclear retention and stabilization, which enhances its epithelial-mesenchymal transition and tumor cell invasion/migration activities (PubMed:21952048). This tumor-promoting activity is independent of its effects upon YAP1 or WWTR1/TAZ (PubMed:21952048). Acts as an activator of the NLRP3 inflammasome by mediating phosphorylation of 'Ser-265' of NLRP3 following NLRP3 palmitoylation, promoting NLRP3 activation by NEK7 (PubMed:39173637). {ECO:0000269|PubMed:10871863, ECO:0000269|PubMed:12853976, ECO:0000269|PubMed:15131260, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:21952048, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:26598551, ECO:0000269|PubMed:34404733, ECO:0000269|PubMed:39173637}.	9606	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]	canonical Wnt signaling pathway [GO:0060070]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in contact inhibition [GO:0060243]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; canonical Wnt signaling pathway [GO:0060070]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in contact inhibition [GO:0060243]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0008104; GO:0009755; GO:0017015; GO:0030216; GO:0034451; GO:0035329; GO:0035556; GO:0043065; GO:0045736; GO:0046620; GO:0046872; GO:0051301; GO:0060070; GO:0060243; GO:0090090; GO:0106310; GO:1900181; GO:1900227	Homo sapiens (Human)
NP_733403.1	Q9VA38	reviewed	WARTS_DROME	Serine/threonine-protein kinase Warts (EC 2.7.11.1)	wts CG12072		FUNCTION: Negative regulator of Yorkie (Yki) in the Hippo/SWH (Sav/Wts/Hpo) signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein Hippo (Hpo), in complex with its regulatory protein Salvador (Sav), phosphorylates and activates Warts (Wts) in complex with its regulatory protein Mats, which in turn phosphorylates and inactivates the Yorkie (Yki) oncoprotein. The Hippo/SWH signaling pathway inhibits the activity of the transcriptional complex formed by Scalloped (sd) and Yki and the target genes of this pathway include cyclin-E (cycE), diap1 and bantam. Inhibits nuclear localization of Yki. Regulates salivary gland degradation in a PI3K-dependent manner and Yki- and Sd-independent, mechanism. {ECO:0000269|PubMed:16096061, ECO:0000269|PubMed:18256197, ECO:0000269|PubMed:18818081}.	7227	apicomedial cortex [GO:0106037]; centrosome [GO:0005813]; cytosol [GO:0005829]	border follicle cell migration [GO:0007298]; cell fate specification [GO:0001708]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; imaginal disc growth [GO:0007446]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of protein import into nucleus [GO:0042308]; open tracheal system development [GO:0007424]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lipophagy [GO:1904504]; R8 cell development [GO:0045463]; R8 cell fate specification [GO:0045464]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; regulation of organ growth [GO:0046620]; response to ionizing radiation [GO:0010212]; stem cell proliferation [GO:0072089]	apicomedial cortex [GO:0106037]; centrosome [GO:0005813]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; border follicle cell migration [GO:0007298]; cell fate specification [GO:0001708]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; imaginal disc growth [GO:0007446]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of protein import into nucleus [GO:0042308]; open tracheal system development [GO:0007424]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lipophagy [GO:1904504]; R8 cell development [GO:0045463]; R8 cell fate specification [GO:0045464]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; regulation of organ growth [GO:0046620]; response to ionizing radiation [GO:0010212]; stem cell proliferation [GO:0072089]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000082; GO:0001708; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0007298; GO:0007406; GO:0007424; GO:0007446; GO:0008285; GO:0008360; GO:0010212; GO:0035329; GO:0042308; GO:0042771; GO:0043065; GO:0045463; GO:0045464; GO:0045571; GO:0046620; GO:0046872; GO:0048814; GO:0060253; GO:0072089; GO:0090090; GO:0106037; GO:0106310; GO:1904504	Drosophila melanogaster (Fruit fly)
NP_001380433.1	A0A8I5KST9	unreviewed	A0A8I5KST9_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	MAST3			9606	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737	Homo sapiens (Human)
NP_001380436.1	A0A8V8TLL8	unreviewed	A0A8V8TLL8_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	MAST3			9606	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737	Homo sapiens (Human)
NP_001380446.1	A0A8V8TMW0	unreviewed	A0A8V8TMW0_HUMAN	non-specific serine/threonine protein kinase (EC 2.7.11.1)	MAST3			9606	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737	Homo sapiens (Human)
NP_055831.1	O60307	reviewed	MAST3_HUMAN	Microtubule-associated serine/threonine-protein kinase 3 (EC 2.7.11.1)	MAST3 KIAA0561			9606	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0007010; GO:0015630; GO:0035556; GO:0106310	Homo sapiens (Human)
NP_002920.1	Q15835	reviewed	GRK1_HUMAN	Rhodopsin kinase GRK1 (RK) (EC 2.7.11.14) (G protein-coupled receptor kinase 1)	GRK1 RHOK		FUNCTION: Retina-specific kinase involved in the signal turnoff via phosphorylation of rhodopsin (RHO), the G protein- coupled receptor that initiates the phototransduction cascade (PubMed:15946941). This rapid desensitization is essential for scotopic vision and permits rapid adaptation to changes in illumination (By similarity). May play a role in the maintenance of the outer nuclear layer in the retina (By similarity). {ECO:0000250|UniProtKB:Q9WVL4, ECO:0000269|PubMed:15946941}.	9606	cytoplasm [GO:0005737]; photoreceptor disc membrane [GO:0097381]	G protein-coupled opsin signaling pathway [GO:0016056]; protein autophosphorylation [GO:0046777]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of opsin-mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; photoreceptor disc membrane [GO:0097381]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; G protein-coupled opsin signaling pathway [GO:0016056]; protein autophosphorylation [GO:0046777]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of opsin-mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; visual perception [GO:0007601]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]	GO:0004672; GO:0005524; GO:0005737; GO:0007601; GO:0008277; GO:0009966; GO:0016056; GO:0022400; GO:0046777; GO:0050254; GO:0097381	Homo sapiens (Human)
NP_730083.2	P16912	reviewed	KAPC3_DROME	cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2)	Pka-C3 DC2 CG6117		FUNCTION: Does not have an essential role in development. {ECO:0000269|PubMed:8601490}.	7227	cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; imaginal disc-derived wing morphogenesis [GO:0007476]	cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; imaginal disc-derived wing morphogenesis [GO:0007476]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]	GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0007155; GO:0007189; GO:0007476; GO:0106310	Drosophila melanogaster (Fruit fly)
NP_055790.1	Q9Y2H9	reviewed	MAST1_HUMAN	Microtubule-associated serine/threonine-protein kinase 1 (EC 2.7.11.1) (Syntrophin-associated serine/threonine-protein kinase)	MAST1 KIAA0973 SAST		FUNCTION: Microtubule-associated protein essential for correct brain development (PubMed:30449657). Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins (By similarity). {ECO:0000250|UniProtKB:Q9R1L5, ECO:0000269|PubMed:30449657}.	9606	axon [GO:0030424]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	axon [GO:0030424]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0007010; GO:0007420; GO:0008017; GO:0015630; GO:0030424; GO:0030425; GO:0035556; GO:0043005; GO:0043025; GO:0106310	Homo sapiens (Human)
NP_609349.1	Q9VL34	unreviewed	Q9VL34_DROME	cGMP-dependent protein kinase (EC 2.7.11.12)	Dmel\CG4839 CG4839 Dmel_CG4839			7227	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	signal transduction [GO:0007165]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]	GO:0004692; GO:0005524; GO:0005737; GO:0005886; GO:0007165; GO:0030553	Drosophila melanogaster (Fruit fly)
NP_723525.1	Q9VL34	unreviewed	Q9VL34_DROME	cGMP-dependent protein kinase (EC 2.7.11.12)	Dmel\CG4839 CG4839 Dmel_CG4839			7227	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	signal transduction [GO:0007165]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]	GO:0004692; GO:0005524; GO:0005737; GO:0005886; GO:0007165; GO:0030553	Drosophila melanogaster (Fruit fly)
XP_024302660.1	A0A7P0TB32	unreviewed	A0A7P0TB32_HUMAN	AKT serine/threonine kinase 3	AKT3			9606	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737	Homo sapiens (Human)
XP_054184603.1	A0A7P0TB32	unreviewed	A0A7P0TB32_HUMAN	AKT serine/threonine kinase 3	AKT3			9606	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737	Homo sapiens (Human)
XP_054189664.1	A0A7P0TB32	unreviewed	A0A7P0TB32_HUMAN	AKT serine/threonine kinase 3	AKT3			9606	cytoplasm [GO:0005737]		cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005737	Homo sapiens (Human)
XP_024303706.1	A0A7P0TBJ6	unreviewed	A0A7P0TBJ6_HUMAN	AKT serine/threonine kinase 3	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0036064	Homo sapiens (Human)
XP_054184605.1	A0A7P0TBJ6	unreviewed	A0A7P0TBJ6_HUMAN	AKT serine/threonine kinase 3	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0036064	Homo sapiens (Human)
XP_054189666.1	A0A7P0TBJ6	unreviewed	A0A7P0TBJ6_HUMAN	AKT serine/threonine kinase 3	AKT3			9606	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0036064	Homo sapiens (Human)
